Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1( L ) ASCORBATO DI CALCIO1件: Calcium---2件: 96, 97 💬
2(+) erythromefloquine----1件: 46 💬
3(+) isomer of racemic mefloquine1件: Mefloquine1件: Mefloquine 💬--1件: 46 💬
4(+) isomer or racemic mefloquine1件: Mefloquine1件: Mefloquine 💬--1件: 46 💬
5(+)- Epicatechin1件: Epicatechin---1件: 113 💬
6(+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid1件: Propanoic acid---1件: 271 💬
7(-)-3-(4-Aminophenyl)-2-methoxypropionic acid----1件: 97 💬
8(1-13C) Sodium Acetate2件: Acetate,
Sodium acetate		1件: Sodium acetate 💬--1件: 251 💬
9(1-3)-beta-D-Glucan (BDG) assay (Fungitell)----1件: 107 💬
10(1-3)-ß-D-Glucan (BDG) assay (Fungitell)----1件: 107 💬
11(18)F-FDG----1件: 85 💬
12(18F)FPGLU----1件: 86 💬
13(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide----1件: 11 💬
14(2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)----1件: 6 💬
15(2R)-2-Propyloctanoic acid----1件: 2 💬
16(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----1件: 309 💬
17(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----1件: 309 💬
18(3beta, 5beta, 25R)-spirostan-3-ol----1件: 6 💬
19(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-----1件: 46 💬
20(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-piperidinepropanenitrile,----1件: 46 💬
21(3R,4R)-4-metil-3-(metil-1H-pirrolo [2,3-d]pirimidin-4-ilamino)-beta-oxo-1-----1件: 46 💬
22(3R,4R)-4-metil-3-(metil-1H-pirrolo [2,3-d]pirimidin-4-ilamino)-ß-oxo-1-----1件: 46 💬
23(3ß, 5ß, 25R)-spirostan-3-ol----1件: 6 💬
24(6R)-4, 5, 6, 7 - tetrahydro-N6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate----1件: 2 💬
25(6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol----1件: 6 💬
26(7R,8R,9R)-2.3-Dimethyl-8-hydroxy-7(2-methoxyethoxy)- 9-phenyl-7.8.9.10-tetrahydro-imidazo-[1.2-h].[1.7].- naphthyridine----1件: 301 💬
27(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime----1件: 161 💬
28(IM) AVONEX®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
29(minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate----1件: 6 💬
30(Pyr1)apelin-13----1件: 86 💬
31(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide----1件: 13 💬
32(R)-(-)-2-Propyloctaroic acid----1件: 2 💬
33(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-1件: Pyrazole---1件: 75 💬
34(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75 💬
35(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75 💬
36(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4YL)SULFONYL)4,4A,5,6,7,8HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN4AYL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75 💬
37(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid2件: Butyric Acid,
Chloride ion		---1件: 97 💬
38(R)-[N-metil-11C1-PK11195(PK)----1件: 127 💬
39(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE1件: Pyrazole---1件: 58 💬
40(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1H-PYRAZOLE-4-CARBOXAMIDE1件: Pyrazole---1件: 58 💬
41(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1HPYRAZOLE-4-CARBOXAMIDE----1件: 58 💬
42(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate1件: Piperazine1件: Piperazine 💬--1件: 272 💬
43(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate1件: Piperazine1件: Piperazine 💬--1件: 272 💬
44(RS)-baclofen, naltrexone hydrochloride and D-sorbitol3件: Baclofen,
Naltrexone,
Sorbitol		3件: Sorbitol solution ,
Baclofen ,
Naltrexone 💬		5件: GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬		9件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
45(S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol----1件: 6 💬
46(S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate----1件: 6 💬
47(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid----1件: 97 💬
48(S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid----1件: 86 💬
49(S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one----1件: 240 💬
50(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2- YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----1件: 86 💬
51(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2-YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----1件: 86 💬
52(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride----1件: 97 💬
53(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben----1件: 97 💬
54(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride----1件: 97 💬
55* D.3.4 Solution for infusion in pre-filled syringe----1件: 97 💬
56* D.3.4 Solution for injection in pre-filled syringe----1件: 97 💬
57* D.3.4 Solution for injection/infusion in pre-filled syringe----1件: 97 💬
58* D.3.6.2.1 - valore : Every 4 weeks dosing of 200 mg----1件: 41 💬
59* D.3.6.2.1 - valore :Every 4 weeks dosing of 400 mg----1件: 41 💬
60**Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter.1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
61-aminosalicylic acid1件: Aminosalicylic acid1件: Aminosalicylic acid 💬--2件: 96, 97 💬
62.Nusinersen1件: Nusinersen1件: Nusinersen 💬1件: SMN2 💬-1件: 3 💬
630,5 mg Fingolimod1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
640,5 mg Prevenar i.m.----1件: 51 💬
650,5 mg seasonal influenza vaccine i.m.----1件: 51 💬
660.005% Lacripep----1件: 53 💬
670.01% Lacripep----1件: 53 💬
680.02% Fm, SH----1件: 53 💬
690.02% Fm, SH, 0.05% CsA----1件: 53 💬
700.02% Fm, SH, AS----1件: 53 💬
710.04 mg Lu AE04621----1件: 6 💬
720.08 mg Lu AE04621----1件: 6 💬
730.12% saline----1件: 299 💬
740.2 mg Lu AE04621----1件: 6 💬
750.4 mg Lu AE04621----1件: 6 💬
760.5 mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
770.5% marcaine----1件: 70 💬
780.6 mg Lu AE04621----1件: 6 💬
790.8 mg Lu AE04621----1件: 6 💬
800.9% Isotonic Saline (IS)----1件: 299 💬
810.9% Isotonic Saline (IS), 4mL----1件: 299 💬
820.9% normal saline (control)----1件: 299 💬
830.9% physiological saline----1件: 266 💬
840.9% saline----2件: 6, 70 💬
850.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--4件: 6, 14, 51, 53 💬
860.9% sodium chloride (normal saline)2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 6 💬
870.9% Sodium Chloride Injection2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 168 💬
880.9% w/v isotonic sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 50 💬
890.9% w/v sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
90009-A0----1件: 6 💬
91009-A1----1件: 6 💬
92009-A2----1件: 6 💬
93009-A3----1件: 6 💬
941 - Andrographis paniculata p/st extract----1件: 13 💬
951 mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
961 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
971 ml 0.9 % NaCl----1件: 46 💬
981% lignocaine1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 84 💬
991% Steroid Cream----1件: 13 💬
1001) Inosine 5'-monophosphate1件: Inosine1件: Inosine 💬--1件: 17 💬
1011,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyridin-6(5H)-yl]c----1件: 46 💬
1021- Deoxygalactonojirimycin----1件: 19 💬
1031-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----1件: 17 💬
1041-(6-BENZOTHIAZOLYLSULFONYL)-5-CHLORO-1H-INDOLE-2-BUTANOIC ACID2件: Butyric Acid,
Indole		---1件: 51 💬
1051-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299 💬
1061. Tesofensine (NS 2330)1件: Tesofensine---1件: 6 💬
1071.0 mg Lu AE04621----1件: 6 💬
1081.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2 💬
1091.2 mg Lu AE04621----1件: 6 💬
1101.2 mg ZGN-440 for injectable suspension----1件: 193 💬
1111.8 mg ZGN-440 for injectable suspension----1件: 193 💬
11210 mg Natura-alpha capsule----1件: 97 💬
11310 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
11410% intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---1件: 14 💬
11510% liquid formulation of human immunoglobulin----1件: 14 💬
11610% Metronidazole Ointment1件: Metronidazole1件: Metronidazole 💬--1件: 96 💬
11710% nifedipine cream1件: Nifedipine1件: Nifedipine 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 50 💬
11810% Nitroglycerine in Propylene Glycol, USP2件: Nitroglycerin,
Propylene glycol		2件: Propylene glycol ,
Nitroglycerin 💬		--1件: 51 💬
11910-mg dose of E5501-P21% powder----1件: 63 💬
12010-nitro-9(E)-octadec-9-enoic acid----1件: 86 💬
121100 mg AP1189----2件: 46, 222 💬
122100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC----1件: 299 💬
123100 mg ELX /50 mg TEZ /75 mg IVA FDC----1件: 299 💬
124100 mg ELX/50 mg TEZ /75 mg IVA FDC----1件: 299 💬
125100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination----1件: 299 💬
126100 mg TEZ/150 mg IVA FDC----1件: 299 💬
127100 mg VX-445 /50 mg TEZ/75 mg IVA FDC----1件: 299 💬
128100 mg VX-445/50 mg TEZ /75 mg IVA FDC----1件: 299 💬
129100 µg Brimonidine Tartrate Implant1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
130100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC----1件: 299 💬
131100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC----1件: 299 💬
132100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC----1件: 299 💬
133100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC----1件: 299 💬
134100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC----1件: 299 💬
135100-mg VX-445/50-mg TEZ/75-mg IVA FDC----1件: 299 💬
1361000 IU D3----1件: 96 💬
137100g ELX / 50mg TEZ / 75mg IVA----1件: 299 💬
138100mg ELX/50mg TEZ /75mg IVA----1件: 299 💬
139100mg VX-445/50mg TEZ /75mg IVA FDC----1件: 299 💬
14011-ß-hydroxysteroid dehydrogenase type 1----1件: 75 💬
14111C-ACETATE2件: Acetate,
Acetic acid C-11		---4件: 6, 13, 86, 88 💬
14211C-flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206 💬
14311C]flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
144120 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
145124I-AT03----1件: 28 💬
146124I-labeled monoclonal antibody Mu 11-1F4----1件: 28 💬
147124I-p5+14 Injection----1件: 28 💬
14812S-IT----1件: 19 💬
14913N-Ammonia1件: Ammonia1件: Ammonia solution, strong 💬--1件: 6 💬
15013N-Amonia----1件: 6 💬
15114C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----3件: 13, 96, 97 💬
15215 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
15315 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
15415 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
155150 mg Induction/Chronic----1件: 97 💬
156150-mg IVACAFTOR1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
157150mg IVACAFTOR1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
15815N ammonium chloride (15NH4Cl)2件: Ammonium chloride,
Chloride ion		1件: Ammonium chloride 💬--1件: 251 💬
15916,5% Cutaquig----1件: 65 💬
16018 FDG----1件: 145 💬
16118-F]DPA-714----1件: 127 💬
16218-FDTBZ----1件: 6 💬
16318F florbetaben----1件: 6 💬
16418F- DTBZ----1件: 6 💬
16518F-AV-1331件: Florbenazine F-18---1件: 6 💬
16618F-AV-1451----3件: 5, 7, 127 💬
16718F-AV-45----2件: 6, 127 💬
16818F-DPA-714 and 18F-FDG1件: Fludeoxyglucose (18F)---1件: 13 💬
16918F-DTBZ AV-133----1件: 6 💬
17018F-FDG1件: Fludeoxyglucose (18F)---8件: 5, 6, 7, 13, 84, 85, 127, 300 💬
17118f-florbetaben----1件: 6 💬
17218F-Fluoro-L-dopa1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
17318F-fluorodeoxyglucose----1件: 84 💬
17418F-FSPG1件: Florilglutamic acid F-18---1件: 84 💬
17518F-FTC-146----1件: 206 💬
17618F] LBT-999----1件: 6 💬
17718F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane----1件: 6 💬
17818F]FE-PE2I----1件: 6 💬
17918F]Fluoride----1件: 271 💬
18018F]PEG-Folate1件: Folic acid1件: Folic acid 💬--2件: 41, 46 💬
18119 nor vitamin d1件: Vitamin D---1件: 13 💬
1821[(6- Allyl- 8beta- erg----1件: 6 💬
1831[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
1841[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
1851[(6- Allyl- 8ß- erg----1件: 6 💬
1861[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
1871[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
1881mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1891mg/kg/hr TXA intravenous infusion till the last suture----1件: 70 💬
1902 - Excipients----1件: 13 💬
1912 x 10 mg Natura-alpha capsules----1件: 97 💬
1922% Chlorhexidine solution wipes1件: Chlorhexidine1件: Chlorhexidine 💬--1件: 299 💬
1932% lignocaine1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 84 💬
1942% sodium chondroitin sulfate2件: Chondroitin sulfate,
Sulfate ion		---1件: 226 💬
1952',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid1件: Diflunisal1件: Diflunisal 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 28 💬
1962'-Fucosyllactose----2件: 96, 97 💬
1972'-O-(2-METHOXYETHYL)-D-RIBOSE ANTISENSE OLIGONUCLEOTIDE TARGETING1件: Ribose---1件: 131 💬
1982'-O-(2-METHOXYETHYL)-D-RIBOSE ANTISENSE OLIGONUCLEOTIDE TARGETING GLIAL FIBRILLARY ACIDIC PROTEIN MESSENGER RIBONUCLEIC ACID1件: Ribose---1件: 131 💬
1992(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACID----2件: 19, 65 💬
2002,3-dihydroxybutanedioic acid----1件: 299 💬
2012,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide----1件: 6 💬
2022-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)benzoic acid1件: Benzoic acid1件: Benzoic acid 💬--1件: 51 💬
2032-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester1件: Famciclovir1件: Famciclovir 💬--1件: 13 💬
2042-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----1件: 86 💬
2052-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE----2件: 6, 162 💬
2062-amino-4-(methyl[11C]sulfanyl)butanoic acid1件: Butyric Acid---1件: 34 💬
2072-aminoethanethiol1件: Cysteamine1件: Cysteamine 💬--2件: 19, 299 💬
2082-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2092-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2102-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2112-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2122-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2132-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2142-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2152-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2162-chloro-2'-deoxyadenosine, 2CdA1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2172-chloro-2?-deoxy-beta-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2182-chloro-2?-deoxy-ß-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2192-chloro-2’-deoxy-beta-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2202-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2212-chloro-2’-deoxy-ß-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2222-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2232-deoxy-2 [F-18] fluoro-2-d-glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬--1件: 49 💬
2242-Hydroxybenzoic acid1件: Salicylic acid1件: Salicylic acid 💬--1件: 97 💬
2252-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide1件: Acetamide---1件: 86 💬
2262-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[e]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1H-benz[e]-indolium hydroxide,inner salt1件: Hydroxide ion---1件: 46 💬
2272.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2 💬
22820 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
229200 µg Brimonidine Tartrate Implant1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
2302011-2012 seasonal flu vaccine Intramuscular----2件: 3, 113 💬
2312011-2012 seasonal flu vaccine Subcutaneous----2件: 3, 113 💬
23220mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer		---1件: 13 💬
233240mg Amantadine HCl ER tablets1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
23425% MTD sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
23526 common Fabry mutation types in Taiwan----1件: 19 💬
23629180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----1件: 113 💬
2372L polyethylene glycol/ascorbic acid2件: Ascorbic acid,
Polyethylene glycol		2件: Ascorbic acid ,
Polyethylene glycol 3350 💬		--1件: 97 💬
2382mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2392S,4R-(-)-ketoconazole, levoketoconazole2件: Ketoconazole,
Levoketoconazole		2件: Ketoconazole ,
Levoketoconazole 💬		3件: CYP11A1,
CYP11B1,
CYP17A1 💬		7件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75 💬
2403 mg [14C]-A4250 capsule----3件: 93, 297, 338 💬
2413 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
2423 MPDN pulse + PDN----1件: 50 💬
2433 MPDN pulse + PDN + CSA----1件: 50 💬
2443 MPDN pulse + PDN + MTX----1件: 50 💬
2453- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----1件: 6 💬
2463-(3,4-Dihydroxyphenyl)-L-alanine1件: Alanine1件: Alanine 💬--1件: 6 💬
2473-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID1件: Pyrazole---1件: 28 💬
2483-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid----1件: 93 💬
2493-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt----2件: 51, 85 💬
2503-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)1件: Tromethamine1件: Tromethamine 💬--2件: 96, 97 💬
2513-methyl-1-phenyl-4, 5-dihydro-1H-pyrazol-5-one.1件: Pyrazole---1件: 2 💬
252320mg Amantadine HCl ER tablets1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
2533a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid----1件: 93 💬
2543a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid----1件: 93 💬
2553K3A-APC Protein----1件: 2 💬
2564 cholesten-3-one, oxime----1件: 2 💬
2574% chlorhexidine gluconate liquid skin cleanser1件: Chlorhexidine1件: Chlorhexidine 💬--1件: 299 💬
2584'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-biphenyl-4-sulphonamide----1件: 46 💬
2594'-iodo-4'-deoxydoxorubicin1件: Iodine1件: Iodine 💬--1件: 28 💬
2604-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base1件: Methane---1件: 2 💬
2614-[5-(4-methylphenyl)-3-(trifluoromethyl)- 1H-pyrazol-1-yl] benzenesulfonamide1件: Pyrazole---1件: 46 💬
2624-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide1件: Pyrazole---1件: 46 💬
2634-Aminopyridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 13 💬
2644-Aminosalicylic acid1件: Aminosalicylic acid1件: Aminosalicylic acid 💬--1件: 96 💬
2654-Aminosalicylic acid extended release granules1件: Aminosalicylic acid1件: Aminosalicylic acid 💬--1件: 96 💬
2664-AP1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2674-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 5 💬
2684-Benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione----1件: 113 💬
2694-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 113 💬
2704-cholesten-3-one, oxime----2件: 2, 3 💬
2714-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46 💬
2724.2% NaCl/Inhalation solution----1件: 299 💬
2734.5 mg Naltrexone1件: Naltrexone1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
27440 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13 💬
27540 mg Glatiramer acetato1件: Glatiramer---1件: 13 💬
27640 mg QD Alogabat----1件: 201 💬
27740 MG- SOLUZIONE INIETTABILE IN SIRINGHE PRE-RIEMPITE- USO SOTTOCUTANEO- SIRINGA PRERIEMPITA (0,4ML)- 2 SIRINGHE PRE-RIEMPITE + 2 TAMPONI IMBEVUTI DI ALCOOL----1件: 107 💬
278400 µg Brimonidine Tartrate Implant1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
27945 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
280450 mg Induction/Chronic----1件: 97 💬
2814cc of lidocaïne®----1件: 149 💬
2824D-125 IVT Injection----1件: 90 💬
2835 ASA, enemas, suppositories, corticosteroids----1件: 97 💬
2845% glucose water solution2件: Dextrose, unspecified form,
Water		1件: Water 💬--1件: 2 💬
2855% lidocaine/5 mg/ml 0.02% estradiol compound cream2件: Estradiol,
Lidocaine		3件: Estradiol ,
Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		7件: ESR1,
ESR2,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		13件: Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬1件: 226 💬
2865% sildenafil cream1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 50 💬
2875-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole----1件: 113 💬
2885-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride1件: 2,4-thiazolidinedione---1件: 20 💬
2895-ALA1件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 180 💬
2905-amino salicylic acid1件: Salicylic acid1件: Salicylic acid 💬--1件: 97 💬
2915-amino salicylic acid (5-ASA)2件: Mesalazine,
Salicylic acid		2件: Salicylic acid ,
Mesalamine 💬		--1件: 97 💬
2925-amino-2-hydroxybenzoic acid1件: Salicylic acid1件: Salicylic acid 💬--1件: 97 💬
2935-aminolevulinic acid1件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 96 💬
2945-Aminosalicyclic acid----1件: 97 💬
2955-Aminosalicyl acid----1件: 96 💬
2965-aminosalicylate (Pentasa, Ferring)----2件: 96, 97 💬
2975-Aminosalicylic acid2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--2件: 96, 97 💬
2985-Aminosalicylic acid (5-ASA)2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--1件: 97 💬
2995-ASA1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3005-ASA (5-Aminosalicylate)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3015-ASA MMx1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3025-Chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin1件: Chlorine---2件: 46, 271 💬
3035-Chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide sodium----1件: 8 💬
3045-Hydroxytryptophan / Vitamin B61件: Pyridoxine1件: Pyridoxine 💬--1件: 206 💬
3055-methyltetrahydrofolate and vitamin B121件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 299 💬
30650 mg AP1189----1件: 46 💬
30750 mg ELX/25 mg TEZ/37.5 mg IVA----1件: 299 💬
30850 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination----1件: 299 💬
30950 mg Induction/Chronic----1件: 97 💬
3105000 IU D3----1件: 96 💬
3115000 IU of cholecalciferol1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299 💬
312549-0261/F02-01----2件: 96, 97 💬
3136 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----1件: 93 💬
3146% Hypertonic Saline (HS), 4mL----1件: 299 💬
3156-(nitrooxy)hexyl(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate----1件: 46 💬
3166-[(methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine----1件: 96 💬
3176-[18F]Fluorodopa----1件: 6 💬
3186-[18F]Fluorodopamine----1件: 6 💬
3196-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid----1件: 97 💬
3206-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3216-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one----1件: 2 💬
3226-Mercaptopurine (Puri-Nethol)1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
32360 mg QD Alogabat----1件: 201 💬
32468Ga-FAPI----2件: 46, 300 💬
32568Ga-NEB----3件: 46, 89, 280 💬
32668GaNOTA-Anti-MMR-VHH2----1件: 84 💬
3276?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3286a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3296a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3306a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3316a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3326a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3336a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3346a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3356a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3366a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3376a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3386a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3396abeta - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3406aß - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3417 mg QD Alogabat----1件: 201 💬
3427 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
3437% Hypertonic Saline (HS)----1件: 299 💬
3447% NaCl----1件: 299 💬
3457% saline----1件: 299 💬
34675-mg IVACAFTOR1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
347750 mg metformin and 7.5 g L-citrulline daily p.o.2件: Citrulline,
Metformin		1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
348800 mg ibuprofen/26.6 mg famotidine2件: Famotidine,
Ibuprofen		2件: Ibuprofen ,
Famotidine 💬		3件: HRH2,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 107 💬
34980mg ELX / 40mg TEZ / 60mg IVA----1件: 299 💬
35081mg aspirin1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
35189 Zirconium Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) (radiolabeled)----1件: 19 💬
3529-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxaline----1件: 46 💬
3539-CIS, 12-CIS-11,11-D2-LINOLEIC ACID ETHYL ESTER1件: Linoleic acid---2件: 2, 5 💬
35490 mg hydrocortisone acetate suppository with Sephure suppository applicator3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
35590 mg idrocortisone acetato in supposta con appli----1件: 97 💬
35690 mg idrocortisone acetato in supposta con applicatore per supposte Sephure----1件: 97 💬
35790 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
35895% Pure ECGC capsules 200mg----1件: 13 💬
35998% dehydrated alcohol1件: Ethanol1件: Ethanol 💬--1件: 298 💬
36099m technetium infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 84 💬
36199mTc-Infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 84 💬
362: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-N-----1件: 86 💬
363: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14 💬
364?-3 polyunsaturated fatty acid----1件: 96 💬
365[123I] 5-IA----1件: 6 💬
366[123I] IBVM and SPECT imaging----1件: 6 💬
367[123I] mZINT injection and serial dynamic SPECT imaging----1件: 6 💬
368[123I]-IBVM----1件: 6 💬
369[123I]B-CIT SPECT imaging----1件: 6 💬
370[123I]beta CIT and SPECT imaging----1件: 6 💬
371[123I]beta-CIT and SPECT imaging----1件: 6 💬
372[123I]ß CIT----1件: 6 💬
373[123I]ß CIT and SPECT imaging----1件: 6 💬
374[123I]ß-CIT----1件: 6 💬
375[123I]ß-CIT and SPECT imaging----1件: 6 💬
376[124I]IB PF 06687234----2件: 96, 97 💬
377[14C] AT1001----1件: 19 💬
378[18F] CFPyPB----1件: 6 💬
379[18F] FES----1件: 86 💬
380[18F] GE-180----1件: 2 💬
381[18F] LBT-999 PET----1件: 6 💬
382[18F] PBR06----2件: 6, 13 💬
383[18F] PI-2620----1件: 6 💬
384[18F]-FBA-A20FMDV2----1件: 85 💬
385[18F]-FEPPA----2件: 6, 13 💬
386[18F]-FLT-PET/CT scans----1件: 34 💬
387[18F]FDOPA----2件: 6, 17 💬
388[18F]FDOPA PET/CT----1件: 6 💬
389[18F]Florbetaben----1件: 28 💬
390[18F]Florbetapir----1件: 5 💬
391[18F]Florbetapir PET imaging----1件: 13 💬
392[18F]flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206 💬
393[18F]Fluoro-2-deoxy-2-D-glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬--2件: 86, 88 💬
394[18F]FP-R01-MG-F2----2件: 85, 94 💬
395[18F]FPEB----3件: 6, 8, 206 💬
396[18F]FPEB PET imaging----1件: 206 💬
397[18F]FSPG----2件: 96, 97 💬
398[21CFR640.30] Plasma from 18 - 25 year old volunteer donors----1件: 6 💬
399[F-18]PBR06----1件: 13 💬
400[F-18]SDM-8----1件: 13 💬
401[F18]-FDDNP----1件: 5 💬
402A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin ,
Clofazimine ,
Rifabutin 💬		--1件: 96 💬
403A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)----1件: 60 💬
404A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs----1件: 46 💬
405A novel synthetic, orally-administered, non-peptide small molecule, which acts as----1件: 254 💬
406A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R)----1件: 51 💬
407A single blood sample for HLA typing----3件: 35, 38, 162 💬
408A-623 or AMG 623----1件: 66 💬
409A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)----1件: 299 💬
410A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA)1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
411A4I Antagonist----1件: 13 💬
412A: 1 dosis----1件: 97 💬
413A: PTH (1-84)----1件: 235 💬
414AAV1-gamma-sarcoglycan vector injection----1件: 113 💬
415AB (antibiotics)----1件: 97 💬
416ABA, open-label (OL)----1件: 46 💬
417Abacavir sulfate, Lamivudine and Zidovudine4件: Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		3件: Lamivudine ,
Zidovudine ,
Abacavir 💬		--1件: 265 💬
418Abatacept (ABA)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 97 💬
419Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)2件: Abatacept,
Methotrexate		2件: Methotrexate ,
Abatacept 💬		4件: CD80,
CD86,
DHFR,
DHFR2 💬		18件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
420Abatacept (CTLA4-Ig)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 44 💬
421Abatacept (IV)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
422Abatacept + csDMARD1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
423Abatacept + Methotrexate2件: Abatacept,
Methotrexate		2件: Methotrexate ,
Abatacept 💬		4件: CD80,
CD86,
DHFR,
DHFR2 💬		18件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
424Abatacept + Vaccines1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
425Abatacept Active Treatment1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 50 💬
426Abatacept also known as Orencia also known as CTLA4-Ig1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 49 💬
427Abatacept Injection1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬2件: 11, 46 💬
428Abatacept, rituximab or tocilizumab3件: Abatacept,
Rituximab,
Tocilizumab		3件: Tocilizumab ,
Rituximab ,
Abatacept 💬		4件: CD80,
CD86,
IL6R,
MS4A1 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
429ABBV-105, A-1519938.0----1件: 46 💬
430ABBV-323 Dose A----1件: 97 💬
431ABC/DTG/3TC STR - Tablet----1件: 256 💬
432Abiraterone Acetate2件: Abiraterone,
Acetate		---2件: 75, 81 💬
433Abiraterone acetato1件: Abiraterone---1件: 75 💬
434Abobotulinumtoxin A----1件: 13 💬
435ABP 710 - Biosimilar to infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
436ABP 798 - Biosimilar to rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
437ABP 959 - biosimilar to eculizumab1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
438ABP 959 - proposed biosimilar to eculizumab1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
439ABT-874/Human monoclonal antibody against IL-12----1件: 13 💬
440AC-203 1% Topical Ointment----1件: 162 💬
441Accelerated 1 hour-infusion----2件: 96, 97 💬
442Accelerated 30 minutes-infusion----2件: 96, 97 💬
443Access program - sildenafil citrate, Viagra, Revatio1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
444Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
445Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
446Accordion Pill? Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
447Accordion Pill? Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
448Accordion Pill¿ Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
449Accordion Pill™ Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
450Accordion Pill™ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
451Accordion Pill™ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
452ACE I, ATA II and Statins----1件: 218 💬
453ACE inhibitor----1件: 66 💬
454ACE inhibitor + statin----1件: 66 💬
455ACE Inhibitor or Angiotensin receptor antagonist1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
456ACE-011 / MK - 7962----1件: 86 💬
457ACE-011 / MK-7962----1件: 86 💬
458ACE-011/ MK-7962----1件: 86 💬
459ACE-031 (Extension of cohort 1 from core study, A031-03)----1件: 113 💬
460ACE-031 (Extension of cohort 2 from core study, A031-03)----1件: 113 💬
461ACE-031 (Extension of cohort 3 from core study, A031-03)----1件: 113 💬
462ACE-inhibitor----1件: 218 💬
463ACE/ARB----1件: 66 💬
464ACEI/ARB and corticosteroids----1件: 66 💬
465ACENEURAMIC ACID1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
466Aceneuramic Acid Extended-Release1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
467Aceneuramic acid extended-release (Ace-ER)1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
468Aceneuramic Acid Extended-Release Tablets1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
469ACER-002 (celiprolol) 200 mg BID1件: Celiprolol1件: Celiprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 168 💬
470ACETATO DI AMMONIO----1件: 97 💬
471Acetic acid1件: Acetic acid1件: Acetic acid, glacial 💬--1件: 97 💬
472Acetohydroxamic Acid1件: Acetohydroxamic acid1件: Acetohydroxamic acid 💬--1件: 251 💬
473Acetohydroxamic Acid Oral Tablet [Lithostat]1件: Acetohydroxamic acid1件: Acetohydroxamic acid 💬--1件: 251 💬
474ACETYL- L- CARNITINE1件: Levocarnitine1件: Levocarnitine 💬--1件: 265 💬
475Acetyl-L-carnitine 1000mg 2X per day for 3 months2件: Acetylcarnitine,
Levocarnitine		1件: Levocarnitine 💬--1件: 298 💬
476ACETYLSALICYLIC ACID1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 51, 210 💬
477Acetylsalicylic acid at 1st visit,1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
478ACHIM as solute (10^9 intestinal microbes/ml)----1件: 51 💬
479Acide folique1件: Folic acid1件: Folic acid 💬--1件: 46 💬
480ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299 💬
481ACIDO ASCORBICO----1件: 10 💬
482ACIDO ASCORBICO DC.IT----1件: 10 💬
483Acido fusidico1件: Fusidic acid1件: Fusidic acid 💬--1件: 272 💬
484ACIDO FUSIDICO/IDROCORTISONE ACETATO1件: Fusidic acid1件: Fusidic acid 💬--1件: 272 💬
485Acido Sialico - Sialic acid (INN: aceneuramic acid)1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
486Acidum ascorbicum1件: Ascorbic acid1件: Ascorbic acid 💬--1件: 206 💬
487ACIDUM ASCORBICUM D61件: Ascorbic acid1件: Ascorbic acid 💬--1件: 206 💬
488Aclasta 5 mg Infusionslösung1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
489Aclasta 5mg solution for infusion----1件: 13 💬
490ACOMPLIA 20 mg film-coated tablets1件: Rimonabant1件: Rimonabant 💬1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193 💬
491ACR16 hydrochloride, ASP2314 hydrochloride, FR310826----1件: 8 💬
492ACT - 064992----1件: 86 💬
493ACT-064992 / JNJ-67896062----1件: 86 💬
494ACT-064992/ JNJ-67896062----1件: 86 💬
495ACT-293987 (NS-304)----1件: 86 💬
496ACT-293987 / JNJ-67896049----1件: 84 💬
497ACT-385781A (Actelion Epoprostenol)1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
498ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 61, 62 💬
499Actemra, MRA1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107 💬
500ACTH (Acthar) Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66 💬
501Acthar 80 unit injection1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66 💬
502ACTHAR Gel (ACTH)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
503ACTHAR Gel (adrenocorticotropic hormone)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
504Acthar Injectable Product1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 46 💬
505ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 62, 66 💬
506Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily.----1件: 276 💬
507Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.----1件: 6 💬
508Active drug: pimavanserin 17mg (2 strength tablets)1件: Pimavanserin---1件: 6 💬
509Active Investigational Treatment ENT-01----1件: 6 💬
510Active topical NS2 1% dermatologic cream----1件: 160 💬
511Active Treatment Group 7% Hypertonic Saline----1件: 299 💬
512Actonel 5mg Film Coated Tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
513Actonel Once a Week 35 mg film-coated tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
514Actonel Once a week 5mg film coated tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 113 💬
515Actonel/Optinate 5mg film-coated tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
516Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299 💬
517ActRIIA-IgG1Fc----1件: 86 💬
518Acylated and unacylated ghrelin dosages1件: Lenomorelin---3件: 193, 201, 202 💬
519ACZ885 (investigational)----1件: 46 💬
520ACZ885, 150mg/1.0ml----2件: 266, 267 💬
521Adalimuab, Etanercept, Tocilizumab, or Abatacept3件: Abatacept,
Etanercept,
Tocilizumab		3件: Etanercept ,
Tocilizumab ,
Abatacept 💬		5件: CD80,
CD86,
IL6R,
LTA,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
522Adalimumab (ADA)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
523Adalimumab - GP20171件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
524Adalimumab - US licensed Humira1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
525Adalimumab 40 mg subcutaneous (SC) every other week (EOW)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
526Adalimumab Ab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
527Adalimumab and Infliximab2件: Adalimumab,
Infliximab		2件: Adalimumab ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
528Adalimumab and its biosimilars1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
529Adalimumab Injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 40, 46, 96 💬
530Adalimumab PFS and Pen1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
531Adalimumab, current formulation1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
532Adalimumab, Etanercept, Golimumab or infliximab4件: Adalimumab,
Etanercept,
Golimumab,
Infliximab		4件: Etanercept ,
Adalimumab ,
Infliximab ,
Golimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
533Adalimumab, new formulation1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
534Adalimumab, plus prednisone2件: Adalimumab,
Prednisone		2件: Prednisone ,
Adalimumab 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
535Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
536ADCIRCA 20 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
537Adempas (Riociguat, BAY63-2521)1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
538ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
539ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
540ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
541ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
542ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
543Adempas 0.5 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
544Adempas 1 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
545Adempas 1.5 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
546Adempas 2 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
547Adempas 2.5 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
548Adempas® 0.5 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
549Adempas® 1.0 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
550Adempas® 1.5 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
551Adempas® 2.0 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
552Adempas® 2.5 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
553Adempas¿ 0.5 mg compressa rivestita con film1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
554Adempas¿ 1.01件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
555Adempas¿ 1.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
556Adempas¿ 2.0 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
557Adempas¿ 2.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
558ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE1件: Levothyroxine1件: Levothyroxine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 19 💬
559Adeno-associated viral vector serotype 3B encoding shortened human ATP7B----1件: 171 💬
560Adeno-associated viral vector serotype 8 containing the human MD1 gene----1件: 113 💬
561Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene----1件: 113 💬
562Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene----1件: 19 💬
563Adeno-associated viral vector serotype 9 encoding human ATP7B----1件: 171 💬
564ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE RH10 CONTAINING THE HUMAN CHOLESTEROL 24-HYDROXYLASE GENE1件: Cholesterol1件: Cholesterol 💬--1件: 8 💬
565Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal)----1件: 19 💬
566Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal)----1件: 19 💬
567Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
568Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
569Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector----1件: 19 💬
570Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector----1件: 19 💬
571Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector----1件: 19 💬
572ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE----1件: 8 💬
573Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a----1件: 113 💬
574Adeno-associated virus serotype hu68 containing the human GALC gene----1件: 19 💬
575Adeno-associated virus serotype rh.10 expressing beta-galactosidase1件: Tilactase1件: Lactase 💬--1件: 19 💬
576ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE----1件: 113 💬
577Adeno-associated virus type 2 vector encoding Rab escort protein 1----1件: 90 💬
578Adeno-associated virus-CFTR vector----1件: 299 💬
579Adipose derived allogenic mesenchymal stem cells (adAMSC)----1件: 96 💬
580Adipose derived stromal cells intravenously injected----1件: 39 💬
581Adipose derived, autologous mesenchymal stem cells----1件: 97 💬
582Adipose-cord mesenchymal stromal cells (A-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 97 💬
583Adipose-derived stromal vascular fraction cells----1件: 6 💬
584Adjunctive analgesics----1件: 70 💬
585Adjunctive anti-depressants----1件: 70 💬
586Adjuvant without active component----2件: 6, 17 💬
587Administration of a high dose of desipramine1件: Desipramine1件: Desipramine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156 💬
588Administration of a low dose of desipramine1件: Desipramine1件: Desipramine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156 💬
589Administration of an ACE-inhibitor or not----1件: 210 💬
590Administration of drug (Interferon-gamma 1-b) subcutaneously----1件: 65 💬
591Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil4件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: Methylprednisolone ,
Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
592Administration of methylprednisolone, paracetamol and dexchlorpheniramine3件: Acetaminophen,
Dexchlorpheniramine,
Methylprednisolone		3件: Acetaminophen ,
Methylprednisolone ,
Dexchlorpheniramine 💬		4件: HRH1,
NR3C1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
593Administration of rituximab and methylprednisolone2件: Methylprednisolone,
Rituximab		2件: Methylprednisolone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51 💬
594Administration of stable isotope-labelled leucine-1件: Leucine1件: Leucine 💬--1件: 6 💬
595Adrenergic receptor binder (ARB)----1件: 224 💬
596Adrenocorticotrophic hormone ACTH1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222 💬
597Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
598ADS-5102 (extended release amantadine HCl)1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
599ADS-5102, 137 mg----1件: 13 💬
600ADS-5102, 274 mg----1件: 13 💬
601ADSVF application in the right hand----1件: 51 💬
602ADVATE (rAHF - PFM)1件: Antihemophilic factor, human recombinant---1件: 288 💬
603ADVATE 1000 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288 💬
604ADVATE 1000IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288 💬
605ADVATE 500 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288 💬
606Adverse Reactions of Gammagard subcutaneously at Week 12----1件: 65 💬
607Adverse Reactions of Gammagard subcutaneously at Week 24----1件: 65 💬
608Adverse Reactions of Gammagard subcutaneously at Week 36----1件: 65 💬
609Adverse Reactions of Gammagard subdermally at Week 12----1件: 65 💬
610Adverse Reactions of Gammagard subdermally at Week 24----1件: 65 💬
611Adverse Reactions of Gammagard subdermally at Week 36----1件: 65 💬
612ADX-102 1% Topical Dermal Cream (reproxalap)1件: Reproxalap1件: Reproxalap 💬--1件: 160 💬
613AER-901 Solution for Nebulization----1件: 86 💬
614Aerolised Liposomal Ciclosporin A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
615Aerolised Liposomal Ciclosporin A 10mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
616Aerolised Liposomal Ciclosporin A 5mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
617Aerosol interferon-gamma----1件: 85 💬
618Aerosolized human Alpha-1 Antitrypsin----1件: 231 💬
619Aerosolized iloprost1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
620Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299 💬
621AERT, (R)-Baclofen1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
622Aesculus Hippocastanum / Horse Chestnut1件: Horse chestnut1件: Horse chestnut 💬--1件: 210 💬
623AEZS-130 (formerly ARD-07)----1件: 78 💬
624AF37702 Injection----1件: 283 💬
625AF37702, Hematide1件: Peginesatide1件: Peginesatide 💬1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
626Afamelanotide (16 mg implant)1件: Afamelanotide1件: Afamelanotide 💬1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 159 💬
627Afamelanotide Implant1件: Afamelanotide1件: Afamelanotide 💬1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 254 💬
628AFFITOPE® PD01A----1件: 6 💬
629AFFITOPE® PD01A + Adjuvant----2件: 6, 17 💬
630AFFITOPE® PD03A + Adjuvant----1件: 17 💬
631Afucosylated IgG1 kappa monoclonal antibody----1件: 300 💬
632AG011 - Capsules----1件: 97 💬
633AG011 - Enema----1件: 97 💬
634AGALSIDASE ALFA1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
635Agalsidase Alpha1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
636Agalsidase beta (recombinant form)1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
637Agalsidase beta from Biosidus 1 mg/kg1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
638AGALSIDASI ALFA----1件: 19 💬
639Agri-King Synbiotic (AKSB)----1件: 96 💬
640Agrippal S1 (Influenza vaccination)----1件: 46 💬
641AGT-181 (HIRMAb-IDUA)----1件: 19 💬
642AGUA PARA PREPARACIONES INYECTABLES----1件: 78 💬
643AIDSVAX® B/E----1件: 49 💬
644AIN457, 150 mg----1件: 271 💬
645AIN457, 150mg----1件: 37 💬
646AIN457, 75 mg----1件: 271 💬
647AIR001 (sodium nitrite inhalation solution)1件: Nitrite---1件: 86 💬
648AIR001 Inhalation Solution----1件: 86 💬
649AIR001 Inhalation Solution (Expansion arm)----1件: 86 💬
650Ajulemic acid1件: Ajulemic acid1件: Lenabasum 💬1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299 💬
651AKCEA-ANGPTL3-LRX----2件: 79, 265 💬
652AKR-501, YM-477----1件: 63 💬
653ALAC, inulin, FOS, and sodium butyrate2件: Butyric Acid,
Inulin		1件: Inulin 💬--1件: 156 💬
654Albumin (Human) 20%, United States Pharmacopeia (USP)----1件: 231 💬
655Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14 💬
656Albunorm® 5%,----1件: 20 💬
657Albuterol inhaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 89 💬
658Albuterol nebulizer1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 89 💬
659ALD518 monoclonal antibody (anti IL-6 mAb)----1件: 46 💬
660Aldurazyme (Recombinant Human Alpha-L-Iduronidase)1件: Laronidase1件: Laronidase 💬1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
661ALDURAZYME*INFUS 1FL 5ML 500U1件: Laronidase1件: Laronidase 💬1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
662Alemtuzumab (already received by alemtuzumab cohort between 1991 and 19941件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 46 💬
663Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994)1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 46 💬
664Alemtuzumab and Rituximab2件: Alemtuzumab,
Rituximab		2件: Alemtuzumab ,
Rituximab 💬		2件: CD52,
MS4A1 💬		1件: Hematopoietic cell lineage 💬1件: 60 💬
665Alemtuzumab immunotherapy1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
666Alemtuzumab Injection1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
667Alemtuzumab Injection [Lemtrada]1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
668Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: Alemtuzumab ,
Rituximab 💬		2件: CD52,
MS4A1 💬		1件: Hematopoietic cell lineage 💬1件: 63 💬
669Alendronate versus alfacalcidol (1-alpha OH vitamin D)3件: Alendronic acid,
Alfacalcidol,
Vitamin D		2件: Alfacalcidol ,
Alendronic acid 💬		2件: FDPS,
VDR 💬		9件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬3件: 41, 46, 50 💬
670ALENDRONIC ACID1件: Alendronic acid1件: Alendronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 46, 274 💬
671Alginic acid1件: Alginic acid1件: Alginic acid 💬--1件: 51 💬
672ALGLUCOSIDASE ALFA1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
673Alglucosidase Alfa (Genetical Recombination)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
674Alglucosidase alfa (GZ419829)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
675ALGLUCOSIDASE ALFA (MYOZYME)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
676Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA])1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
677Alglucosidase alfa GZ4198291件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
678Alglucosidase alpha----1件: 256 💬
679ALGLUCOSIDASI ALFA UMANA RICOMBINANTE----1件: 256 💬
680Alicalm (polymeric liquid formula)----1件: 96 💬
681ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE----1件: 19 💬
682ALK-001 (No generic name)----1件: 301 💬
683ALKS 8700 Delayed Release (DR) Capsule1件: Manganese citrate---1件: 13 💬
684All patients in the study will be treated with ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
685All subjects will receive maraviroc 300mg orally twice a day for 6 weeks1件: Maraviroc1件: Maraviroc 💬1件: CCR5 💬11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 84 💬
686All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine----1件: 2 💬
687All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-----1件: 2 💬
688All-trans retinoic acid1件: Tretinoin1件: Tretinoin 💬3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 94 💬
689All-Trans Retinoid Acid(ATRA)1件: Tretinoin1件: Tretinoin 💬3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 63 💬
690Allergy immunotherapy (allergy shots)----1件: 98 💬
691Allo-APZ2-EB----1件: 36 💬
692Allo-APZ2-OTS----1件: 36 💬
693ALLO-ASC----1件: 96 💬
694ALLO-ASC-CD----1件: 96 💬
695ALLO-ASC-DFU----1件: 36 💬
696ALLO-ASC-SHEET----1件: 36 💬
697Allogeneic adipose tissue-derived mesenchymal stem cells----1件: 97 💬
698ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED----5件: 36, 38, 53, 96, 162 💬
699Allogeneic adipose tissue-derived MSC----1件: 36 💬
700Allogeneic adipose tissue-derived stromal/stem cells----1件: 53 💬
701Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)1件: Remestemcel-L1件: Remestemcel-L 💬--1件: 85 💬
702Allogeneic Mesenchymal Stem Cells (AlloMSC)----2件: 51, 53 💬
703ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 49 💬
704Allogeneic MSC (AlloMSC)----1件: 49 💬
705ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED----1件: 90 💬
706Allogeneic skin-derived ABCB5-positive mesenchymal stem cells----1件: 36 💬
707Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation----1件: 17 💬
708Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation----1件: 17 💬
709Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601----1件: 96 💬
710Allogenic eASCs 5 million cells/ml suspension for injection CX601----1件: 96 💬
711Allogenic eASCs 5 million cells/ml suspension for injection. CX601----1件: 96 💬
712Allogenic eASCs 5 million/ml suspension for injection.----1件: 96 💬
713Allogenic mesenchymal stem cell isolated from adipose tissue----3件: 38, 96, 162 💬
714Allopurinol Sandoz 100 mg, tabletten1件: Allopurinol1件: Allopurinol 💬1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬1件: 96 💬
715ALN-AAT----1件: 231 💬
716ALN-AAT02----1件: 231 💬
717ALN-AS1----1件: 254 💬
718Alpha 1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
719Alpha 1-proteinase inhibitor (human)1件: Alpha-1-proteinase inhibitor---1件: 231 💬
720Alpha interferon----1件: 56 💬
721Alpha Lipoic Acid1件: Lipoic acid---1件: 13 💬
722Alpha-1 Antitrypsin (AAT)----1件: 231 💬
723Alpha-1 Antitrypsin (human)----1件: 231 💬
724Alpha-1 proteinase inhibitor (human)----1件: 231 💬
725ALPHA-1-ANTITRYPSIN1件: Alpha-1-proteinase inhibitor---1件: 231 💬
726Alpha-2C AR antagonist----1件: 51 💬
727Alpha-galactosidase A1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
728ALPHA-LIPOIC ACID1件: Lipoic acid---2件: 2, 13 💬
729Alpha-lipoic acid and L-acetyl carnitine2件: Levocarnitine,
Lipoic acid		1件: Levocarnitine 💬--1件: 5 💬
730Alpha-proteinase inhibitor----1件: 98 💬
731Alpha1-antitrypsin----1件: 13 💬
732Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---2件: 231, 299 💬
733Alpha1-Proteinase Inhibitor (Human)1件: Alpha-1-proteinase inhibitor---2件: 231, 299 💬
734Alphanate 1000 I.U.3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
735Alphanate 1500 I.U.3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
736ALPHANATE*INF 1F 1000UI+F 10ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
737ALPHANATE*INF 1F 1500UI+F 10ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
738ALPHANATE*INF 1F 250UI+F 5ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
739ALPHANATE*INF 1F 500UI+F 5ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
740Also referred to as 'MEDI2070'----2件: 96, 97 💬
741Also referred to as MED2070----1件: 96 💬
742Also referred to as MEDI2070----2件: 96, 97 💬
743ALTRI FARMACI DEL SISTEMA NERVOSO----1件: 13 💬
744Altropane (123I) Injection1件: Altropane---1件: 6 💬
745Alvelestat oral tablet - dose 11件: Alvelestat---1件: 231 💬
746Alvelestat oral tablet - dose 21件: Alvelestat---1件: 231 💬
747ALX-0061 Nanobody----1件: 46 💬
748ALXN2040 (ACH-0144471)----1件: 62 💬
749Ambrisentan - high dose1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
750Ambrisentan - low dose1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
751Ambrisentan 5 mg film-coated tablets1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
752Ambrisentan 5mg film-coated tablets [marketed product]1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
753AMBROXOL HYDROCHLORIDE PH. EUR.1件: Ambroxol1件: Ambroxol 💬--1件: 19 💬
754AMGEVITA (Adalimumab biosimilar )1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
755Amgevita 40 mg Injektionslösung im Fertigpen1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
756Amgevita 40 mg Injektionslösung in einer Fertigspritze1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
757Amgevita 40Mg Solution for Injection----2件: 96, 97 💬
758Amifampridina fosfato----2件: 3, 11 💬
759Amikacin nebulization1件: Amikacin1件: Amikacin 💬--1件: 299 💬
760Amikacina liposomal (Arikace?)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
761Amikacine nebulization1件: Amikacin1件: Amikacin 💬--1件: 299 💬
762Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin1件: Amikacin 💬--1件: 299 💬
763Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin1件: Amikacin 💬--1件: 299 💬
764AMILORIDE HYDROCHLORIDE, 2 H2O1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13 💬
765Amiloride Solution for Inhalation1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299 💬
766Amino acids1件: Amino acids---3件: 70, 240, 298 💬
767Aminocaproic acid1件: Aminocaproic acid1件: Aminocaproic acid 💬1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 70 💬
768Aminohippurate Sodium Inj 20%1件: Aminohippuric acid1件: Aminohippuric acid 💬--1件: 67 💬
769Aminolevulinic acid1件: Aminolevulinic acid1件: Aminolevulinic acid 💬--4件: 34, 96, 180, 286 💬
770AMINOSALICYLIC ACID1件: Aminosalicylic acid1件: Aminosalicylic acid 💬--2件: 96, 97 💬
771Amitriptyline, fluoxetine and tramadol alone (control group)3件: Amitriptyline,
Fluoxetine,
Tramadol		3件: Fluoxetine ,
Amitriptyline ,
Tramadol 💬		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78 💬
772Ammonium (15N) chloride1件: Chloride ion---1件: 251 💬
773Amniotic Fluid Allograft----1件: 70 💬
774Amniotic membrane extract eye drops (AMEED)----1件: 53 💬
775Amoxapine & dipyridamole2件: Amoxapine,
Dipyridamole		2件: Amoxapine ,
Dipyridamole 💬		4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬		8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
776Amoxicillin and Clavulanic acid2件: Amoxicillin,
Clavulanic acid		3件: Amoxicillin ,
Amoxicillin ,
Clavulanic acid 💬		--1件: 299 💬
777Amoxicillin and doxycyclin2件: Amoxicillin,
Doxycycline		4件: Amoxicillin ,
Doxycycline ,
Amoxicillin ,
Doxycycline 💬		--1件: 97 💬
778Amoxicillin, metronidazole and doxycycline3件: Amoxicillin,
Doxycycline,
Metronidazole		5件: Amoxicillin ,
Doxycycline ,
Metronidazole ,
Amoxicillin ,
Doxycycline 💬		--1件: 97 💬
779AMPHOTERICINE B, LIPOSOME----1件: 60 💬
780Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----1件: 265 💬
781Ampyra first,1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 6 💬
782Amyl Nitrite2件: Amyl Nitrite,
Nitrite		1件: Amyl nitrite 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
783Amyl nitrite inhalation2件: Amyl Nitrite,
Nitrite		1件: Amyl nitrite 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
784AN100226, BG00002----1件: 13 💬
785ANA001XHCl (Syntagon) or VEXA-04 (Patheon)----1件: 156 💬
786Anaerobically Cultivated Human Intestinal Microbiota----1件: 51 💬
787Anakinra / kineret1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 107 💬
788Anakinra and PEG sTNF-R12件: Anakinra,
Pegsunercept		2件: Anakinra ,
Pegsunercept 💬		3件: IL1R1,
IL1R2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
789Analysis of selected single nucleotide polymorphisms (SNPs)----1件: 46 💬
790Anatomical Landmark-guided Suprascapular Nerve Block----1件: 149 💬
791AND (Andrographolide)1件: Andrographolide---1件: 97 💬
792AndroGel 1 % Topical Gel----1件: 13 💬
793Anesthetic Topical Adhesive Synera----1件: 13 💬
794Angiotensin II1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
795Angiotensin-converting enzyme (ACE) inhibitor1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224 💬
796Angiotensin-converting enzyme inhibitor(ACEI)1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224 💬
797Anhydrous Amiloride Hydrochloride1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 225 💬
798Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46 💬
799Anti BAFF (B cell activating factor)----1件: 49 💬
800Anti CD3 monoclonal antibody----1件: 97 💬
801Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL----1件: 46 💬
802Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody----1件: 46 💬
803Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46 💬
804Anti IL 6 mAb----1件: 46 💬
805Anti IL-1beta antibody----1件: 46 💬
806Anti IL-1beta antibody, subclass IgG4----1件: 46 💬
807Anti IL-1ß antibody----1件: 46 💬
808Anti IL-1ß antibody, subclass IgG4----1件: 46 💬
809Anti LP40 antibody, subclass IgG4----1件: 49 💬
810Anti LP40 antibody, subclass IgG4 LA294----2件: 13, 46 💬
811Anti LP40 anticuerpo, subclase IgG4----1件: 49 💬
812Anti Lymphotoxin Alpha----1件: 46 💬
813Anti TNF + Meth----1件: 46 💬
814Anti TNF Alfa.----1件: 96 💬
815Anti TNF alpha agent----1件: 271 💬
816Anti TNF alpha therapy----1件: 271 💬
817Anti TNF humanized antibody Fab fragment-PEG conjugate----1件: 96 💬
818Anti TNF therapy including infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
819Anti-(complement C5a) IgG4 chimeric monoclonal antibody----1件: 269 💬
820Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain)----1件: 271 💬
821Anti-(misfolded human superoxide dismutase 1) human IgG1m3 monoclonal antibody----1件: 2 💬
822Anti-arrhythmic Drugs (AADs)----1件: 84 💬
823Anti-BAFFR antibody----1件: 95 💬
824Anti-Beta Interferon (PF-06823859)----1件: 50 💬
825Anti-blood dendritic cell antigen 2----1件: 49 💬
826Anti-C5 antibody----4件: 11, 14, 62, 109 💬
827Anti-CD20 antibody----1件: 64 💬
828Anti-CD20 small modular immunopharmaceutical, WYE-400087----1件: 46 💬
829Anti-CD25 Humanized Monoclonal Antibody----1件: 13 💬
830Anti-CD3 Monoclonal antibody1件: Muromonab---2件: 96, 97 💬
831Anti-CD52 monoclonal antibody----1件: 13 💬
832Anti-CT51 antigen mAb----1件: 51 💬
833Anti-GM-CSF receptor alpha----1件: 46 💬
834Anti-human immunoglobulin, equine----1件: 60 💬
835Anti-Human Interleukin-23 Monoclonal Antibody----1件: 271 💬
836Anti-human T-lymphocyte immunoglobulin from horse----1件: 60 💬
837ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS----1件: 51 💬
838Anti-IL-12----2件: 13, 96 💬
839Anti-IL-201件: Fletikumab1件: Fletikumab 💬1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
840Anti-IL-20 (109-0012)1件: Fletikumab1件: Fletikumab 💬1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
841Anti-IL-23 monoclonal antibody----1件: 96 💬
842Anti-IL-36R monoclonal antibody----1件: 37 💬
843Anti-IL-6 mAb----2件: 46, 96 💬
844Anti-IL6----1件: 46 💬
845Anti-inflammatory drugs----1件: 46 💬
846Anti-integrin alphaV mAb----1件: 51 💬
847Anti-Interferon-gamma monoclonal antibody----1件: 96 💬
848Anti-interleukin 5 (IL-5) humanized monoclonal----2件: 44, 45 💬
849Anti-interleukin-1B monoclonal antibody----1件: 106 💬
850Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----2件: 96, 97 💬
851Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----2件: 96, 97 💬
852Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----2件: 96, 97 💬
853Anti-Interleukin-6 Monoclonal----1件: 46 💬
854Anti-Interleukin-6 Monoclonal Antibody----2件: 46, 96 💬
855Anti-IP-10 Antibody----1件: 97 💬
856Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody----1件: 49 💬
857Anti-MAdCAM antibody----2件: 96, 97 💬
858Anti-Mullerian hormone (AMH) level----1件: 13 💬
859Anti-Myostatin Adnectin----1件: 113 💬
860Anti-pandemic H1N1 influenza vaccine----6件: 46, 49, 50, 51, 53, 107 💬
861Anti-pseudomonas IgY gargle----1件: 299 💬
862ANTI-SCLEROSTIN MONOCLONAL ANTIBODY----1件: 274 💬
863Anti-thymocyte globulin (ATG)----1件: 164 💬
864Anti-Thymocyte Globulin, Rabbit1件: Rabbit---1件: 51 💬
865Anti-TNF agents----1件: 271 💬
866Anti-TNF discontinuation: Physiological saline solution----2件: 96, 97 💬
867Anti-TNF humanized antibody Fab fragment - PEG conjugate----1件: 46 💬
868Anti-TNF humanized antibody Fab' fragment - PEG conjugate----1件: 46 💬
869Anti-TNF therapy (etanercept or adalimumab)2件: Adalimumab,
Etanercept		2件: Etanercept ,
Adalimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
870Anti-TNF-alpha----1件: 46 💬
871Anti-TNF: Infliximab (Infusion)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
872Anti-TNF:Adalimumab (Subcutaneus)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
873Anti-Tumor Necrosing Factor (TNF) Therapy----1件: 46 💬
874Anti-Tumor Necrosis Factor----1件: 271 💬
875Anti-Tumor Necrosis Factor Alpha Drug (Product)----1件: 46 💬
876Anti-tumor necrosis factor alpha monoclonal antibody----1件: 107 💬
877Anti-von Willebrand Factor Nanobody1件: Von Willebrand factor human---1件: 64 💬
878Anti-von Willebrand Factor Nanobody, Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
879Anti-von Willebrand Factor Nanobody, INN = Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
880Anticorpo monoclonale anti GM-CSF umano----1件: 46 💬
881Anticorpo monoclonale anti IL-23----1件: 96 💬
882Anticorpo monoclonale anti-IL-23----1件: 96 💬
883Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2)----1件: 96 💬
884Anticuerpo monoclonal anti-humano recombinante humanizado, receptor de IL-6R.----1件: 46 💬
885Anticuerpo monoclonal anti-LINGO-1 humano----1件: 13 💬
886Antigen-specific T cells CART/CTL and DCvac----1件: 34 💬
887Antihemophilic Factor (Recombinant)----1件: 288 💬
888Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal----1件: 46 💬
889Antimicrobial therapy: Co-trimoxazole or Doxycycline1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--1件: 85 💬
890Antiparkinsonian Agent(s)----1件: 6 💬
891Antiretroviral/Anti HIV----1件: 265 💬
892Antistaminici H1 - H2----1件: 299 💬
893Antithymocyte Globulin (ATG)----1件: 60 💬
894ANTITHYMOCYTE IMMUNOGLOBULIN1件: Antithymocyte immunoglobulin (rabbit)---2件: 13, 96 💬
895Antithymocyte immunoglobulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96 💬
896Antituberculous therapy along with steroids----1件: 84 💬
897Antivirale ad uso diretto----1件: 107 💬
898ANTOX (vers) 1.2----1件: 298 💬
899Anxiety/depression and work and activities----1件: 13 💬
900Any other approved Antiepileptic Drug----1件: 144 💬
901AODG (Apigenin-7-O-glucuronide)1件: Apigenin---1件: 97 💬
902AP1189, 100 mg----1件: 46 💬
903AP1189, 60 mg----1件: 46 💬
904AP1189, 80 mg----1件: 46 💬
905AP1903 A594----3件: 60, 285, 326 💬
906Apadamtase alfa1件: Apadamtase alfa---1件: 64 💬
907Apademtase alfa----1件: 64 💬
908APCC, aPCC + TXA----1件: 288 💬
909APD334 L-arginine2件: Arginine,
L-arginine		1件: Arginine 💬--1件: 97 💬
910API-AAT----1件: 231 💬
911API-AAT, AD00370, ARC-AAT, API drug Substance----1件: 231 💬
912Apitox - pure honeybee toxin----1件: 13 💬
913Apomorphine 0.25% (2.5mg/ml)1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
914Apomorphine HCl injection1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
915Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
916Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
917Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
918Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
919Apomorphine infusion1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
920Apomorphine Injectable Solution1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
921Apomorphine Nasal Powder1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
922Application of Adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
923Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side1件: Sinecatechins1件: Sinecatechins 💬--1件: 160 💬
924Apraclonidine Hcl 0.5% Oph Soln1件: Apraclonidine1件: Apraclonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11 💬
925APT-1011 - 3 mg----1件: 98 💬
926AR401959 L-arginine2件: Arginine,
L-arginine		1件: Arginine 💬--3件: 96, 97, 98 💬
927Arava 20 mg filmdrasjerte tabletter----1件: 46 💬
928Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)1件: Leflunomide1件: Leflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46 💬
929ARC-AAT----1件: 231 💬
930ARC-AAT Injection----1件: 231 💬
931ARC1779 Injection----2件: 64, 288 💬
932ARGX-117 IV----1件: 14 💬
933Aricept 10 mg filmdragerade tabletter1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
934Aricept 5 mg filmdragerade tabletter1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
935Aricept 5 mg-Filmtabletten----1件: 6 💬
936Aricept 5mg-Filmtabletten----1件: 6 💬
937Arikayce™ 140 mg1件: Amikacin1件: Amikacin 💬--1件: 299 💬
938Arikayce™ 560 mg1件: Amikacin1件: Amikacin 💬--1件: 299 💬
939Arikayce™ 70 mg1件: Amikacin1件: Amikacin 💬--1件: 299 💬
940Arimidex (Anastrozole)1件: Anastrozole1件: Anastrozole 💬1件: CYP19A1 💬3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬1件: 78 💬
941Arm 1 - GEH120714 (18F) Injection----1件: 13 💬
942Arm B: Rituxan®/Mabthera®1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
943ARO-AAT----1件: 231 💬
944ARO-AAT Injection----1件: 231 💬
945ARO-ANG 3 Injection----1件: 79 💬
946ARO-MMP7 Inhalation Solution----1件: 85 💬
947ARRY-371797, p38 inhibitor----2件: 46, 271 💬
948ARRY-438162, MEK inhibitor----1件: 46 💬
949ART-I02----1件: 46 💬
950Arthroscopy & saline irrigation alone----1件: 46 💬
951Arundic Acid1件: Arundic acid1件: Arundic acid 💬--1件: 2 💬
952Arylsulfatase A----1件: 19 💬
953ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
954ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
955Asacol (mesalamine) Delayed-release Tablets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
956Asacol® 400 mg----1件: 97 💬
957Ascal(r) / carbasalate calcium2件: Calcium,
Carbaspirin calcium		1件: Carbaspirin calcium 💬--1件: 46 💬
958Ascorbic acid1件: Ascorbic acid1件: Ascorbic acid 💬--4件: 10, 97, 206, 298 💬
959Ascorbic acid (Vitamin C)1件: Ascorbic acid1件: Ascorbic acid 💬--1件: 10 💬
960Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)3件: Ascorbic acid,
Tocopherol,
Vitamin E		3件: Ascorbic acid ,
Vitamin E ,
Tocopherol 💬		--1件: 206 💬
961Ascorbic acid vit C1件: Ascorbic acid1件: Ascorbic acid 💬--1件: 10 💬
962ASCs: Adipose derived Stem Cells----1件: 96 💬
963Asfotas Alfa----1件: 172 💬
964ASFOTASE ALFA1件: Asfotase alfa1件: Asfotase alfa 💬1件: ALPL 💬4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬1件: 172 💬
965Asfotase Alfa (ALXN1215)1件: Asfotase alfa1件: Asfotase alfa 💬1件: ALPL 💬4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬1件: 172 💬
966ASK Nr. 21972----1件: 5 💬
967ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46 💬
968Aspirin and meloxicam2件: Acetylsalicylic acid,
Meloxicam		2件: Aspirin ,
Meloxicam 💬		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
969Assigned Interventions CD19/BCMA CAR T-cells----3件: 49, 51, 53 💬
970AT1-inhibitor----1件: 218 💬
971AT2221 65 mg Formulated Capsules----1件: 256 💬
972Atacicept: with loading dose1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
973Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		2件: Ritonavir ,
Atazanavir 💬		--1件: 265 💬
974ATG-F----1件: 66 💬
975ATG-Fresenius----1件: 60 💬
976ATM FOG in PD----1件: 6 💬
977Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet2件: Acetylcysteine,
Atorvastatin		2件: Acetylcysteine ,
Atorvastatin 💬		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63 💬
978Atypical Antipsychotics----1件: 6 💬
979AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
980AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
981Aubagio 14 mg film-coated tablets1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
982Aurexis® (tefibazumab)1件: Tefibazumab1件: Tefibazumab 💬--1件: 299 💬
983Auto Injector----1件: 46 💬
984Autofluorescent detection + Injection of indocyanine green1件: Indocyanine green1件: Indocyanine green 💬--1件: 235 💬
985Autologous (self) mononuclear cells derived from umbilical cord blood----1件: 211 💬
986Autologous adipose derived mesenchymal cells----1件: 13 💬
987Autologous Adipose Derived MSCs (ADMSCs)----1件: 85 💬
988Autologous adipose derived stem cells----1件: 46 💬
989Autologous ADIpose derived stromal vascular fraction----1件: 96 💬
990Autologous Adipose Mesenchymal Stem Cell Implantation----1件: 17 💬
991Autologous Adipose-derived Mesenchymal Stromal Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 2 💬
992Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded----1件: 2 💬
993Autologous adult bone marrow mononuclear cells unexpanded----1件: 2 💬
994Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----1件: 13 💬
995Autologous apoptotic cells injection----1件: 46 💬
996Autologous ASC----1件: 51 💬
997Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene----1件: 65 💬
998AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65 💬
999AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE----1件: 19 💬
1000Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA----1件: 19 💬
1001AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA----1件: 20 💬
1002Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65 💬
1003Autologous CD34+ cells transduced with WASP lentiviral vector----1件: 65 💬
1004Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65 💬
1005Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII----1件: 19 💬
1006Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65 💬
1007AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65 💬
1008Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13 💬
1009Autologous EBV specific CTL infusion----1件: 49 💬
1010Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
1011Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA----1件: 20 💬
1012Autologous mesenchymal stem cells derived from bone marrow----1件: 85 💬
1013Autologous MSC-NTF cells----1件: 2 💬
1014Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells----1件: 51 💬
1015Autologous Stromal Vascular Fraction (SVF)----1件: 85 💬
1016Autologous stromal vascular fraction cells----1件: 46 💬
1017Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)1件: Myelin basic protein---1件: 13 💬
1018Avalglucosidase Alfa1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1019Avalglucosidase alfa (GZ402666)1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1020Avalglucosidase Alfa (NeoGAA)1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1021Avalglucosidase alfa GZ4026661件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1022Avalglucosidase alfa-NGPT (GZ402666)1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1023Avalglucosidase alfa-NGPT (GZ402666) IV1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1024Avalglucosidasi alfa----1件: 256 💬
1025AVALOX - 400----1件: 6 💬
1026Avandia administration for 6-12 weeks----1件: 265 💬
1027AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung1件: Bevacizumab1件: Bevacizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227 💬
1028AVCN583601 (3% Cannabidiol cream)1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 36 💬
1029Avdoralimab (IPH5401)1件: Avdoralimab---1件: 162 💬
1030Avelox- Moxifloxacin1件: Moxifloxacin1件: Moxifloxacin 💬--1件: 46 💬
1031AVI-4658 for Injection----1件: 113 💬
1032Avian polyclonal IgY antibody against PA----1件: 299 💬
1033Aviptadil, 66 microgram/mL1件: Aviptadil1件: Aviptadil 💬--1件: 85 💬
1034Avonex (Interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1035Avonex (interferon beta-1a), Biogen Idec Ltd2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1036AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1037Avonex 30 microgram/0.5 ml Solution for Injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1038AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1039Avonex 30 microgramos/0.5 ml Solución para inyección1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1040AVONEX 30 µg/0,5 ml solution for injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1041Avonex and Topamax1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1042AVONEX IM 4SIR 30MCG/0,5ML 4AG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1043AVONEX*IM 4SIR 30MCG/0,5ML+4AG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1044Avonex® monotherapy (6.0 MIU administered i.m. each week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1045AVTX-803 (L-Fucose)1件: Fucose---1件: 65 💬
1046AVXS-101 (previously known as scAAV9.CB.SMN)----1件: 3 💬
1047AXO-AAV-GM2 High Dose----1件: 19 💬
1048AXO-AAV-GM2 Low Dose----1件: 19 💬
1049AXO-AAV-GM2 Middle Dose----1件: 19 💬
1050AXO-AAV-GM2 Starting Dose----1件: 19 💬
1051AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL----1件: 97 💬
1052Azathioprin-ratiopharm 25mg Filmtabletten----1件: 96 💬
1053Azathioprin-ratiopharm 50 mg Filmtabletten----1件: 96 💬
1054Azathioprin-ratiopharm® 25 mg Filmtabletten----1件: 44 💬
1055Azathioprine (AZA)1件: Azathioprine1件: Azathioprine 💬--3件: 13, 19, 97 💬
1056Azathioprine (AZA) caps1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1057Azathioprine (AZA) or 6-mercaptopurine (6-MP)2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97 💬
1058Azathioprine (Imuran) 50 mg Overencapsulated Tablet1件: Azathioprine1件: Azathioprine 💬--1件: 97 💬
1059Azathioprine + infliximab2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1060Azathioprine - ratiopharm 50 mg1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1061Azathioprine / 6 Mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
1062Azathioprine and Allopurinol2件: Allopurinol,
Azathioprine		2件: Allopurinol ,
Azathioprine 💬		1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬1件: 97 💬
1063Azathioprine in case of endoscopic recurrence1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1064Azathioprine individualised dose1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1065Azathioprine or adalimumab and infliximab3件: Adalimumab,
Azathioprine,
Infliximab		3件: Azathioprine ,
Adalimumab ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1066Azathioprine+enteral nutrition1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1067AZATIOPRINA ASPEN - 50 COMPRESSE1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1068AZATIOPRINA HEX. 50CPR 50MG BL1件: Azathioprine1件: Azathioprine 💬--1件: 13 💬
1069AZD3241 Alternative titration scheme with formulation 1 or 2----1件: 6 💬
1070AZD3241 ER formulation 1----1件: 6 💬
1071AZD4017 and prednisolone1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75 💬
1072AZD5634 for infusion----1件: 299 💬
1073AZD5634 for inhalation----1件: 299 💬
1074AZILECT® 1 mg Tabletten1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 2 💬
1075Azithromycin + Metronidazole2件: Azithromycin,
Metronidazole		3件: Metronidazole ,
Azithromycin ,
Azithromycin 💬		--1件: 96 💬
1076Azithromycin + N-acetylcystein + inhaled corticosteroid1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 228 💬
1077Azithromycin 500 mg film-coated tablet1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
1078AZLI 75 mg three times a day (TID)----1件: 299 💬
1079AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299 💬
1080AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299 💬
1081Aztreonam for Inhalation (AI)1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1082Aztreonam for Inhalation Solution1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1083Aztreonam for Inhalation Solution (AZLI)1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1084Aztreonam Lysine for Inhalation2件: Aztreonam,
Lysine		2件: Aztreonam ,
Lysine 💬		--1件: 299 💬
1085Aztreonam Lysine for Inhalation (AZLI)2件: Aztreonam,
Lysine		2件: Aztreonam ,
Lysine 💬		--1件: 228 💬
1086Aztreonam solución para inhalación1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1087Aún no establecido----1件: 53 💬
1088B / Phuket / 3073/2013-like virus)----1件: 53 💬
1089B. lactis B94----1件: 193 💬
1090B. theta----1件: 96 💬
1091B001 injection----1件: 13 💬
1092B2-ASmedic----1件: 97 💬
1093B6, B12, L-methylfolate1件: Levomefolic acid1件: Levomefolic acid 💬--1件: 6 💬
1094B: 2 dosis----1件: 97 💬
1095Baclofen (baclofen Tab. 10mg) treatment1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 70 💬
1096Baclofen ER Capsules (GRS) 10 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1097Baclofen ER Capsules (GRS) 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1098Baclofen ER Capsules (GRS) 30mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1099Baclofen ER Capsules (GRS) 40mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1100Baclofen ER Capsules (GRS) 50 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1101Baclofen IR1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1102Baminercept alfa1件: Baminercept1件: Baminercept 💬1件: LTB 💬3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
1103Baminercept alfa (BG9924)1件: Baminercept1件: Baminercept 💬1件: LTB 💬3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
1104BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 86 💬
1105Baricitinib, olumiant®1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
1106BAT1806 injection----1件: 46 💬
1107Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-1件: 14 💬
1108BAX930 - RECOMBINANT HUMAN ADAMTS13----1件: 64 💬
1109BAY 63-2521 IR coated tablet 1.0 mg----1件: 88 💬
1110BAY 63-2521 IR coated tablet 1.5 mg----1件: 88 💬
1111BAY 63-2521 IR coated tablet 2.0 mg----1件: 88 💬
1112BAY 63-2521 IR coated tablet 2.5 mg----1件: 88 💬
1113BAY 63-2521 IR tablet 0.5 mg----1件: 88 💬
1114BAY 63-2521 IR tablet 1.0 mg----1件: 88 💬
1115BAY 63-2521 IR tablet 1.5 mg----1件: 88 💬
1116BAY 63-2521 IR tablet 2.0 mg----1件: 88 💬
1117BAY 63-2521 IR tablet 2.5 mg----1件: 88 💬
1118BAY 63-2521 IR tablets 0.5 mg----1件: 86 💬
1119BAY 63-2521 IR tablets 1 mg----1件: 86 💬
1120BAY 63-2521 IR tablets 1.0 mg----1件: 86 💬
1121BAY 63-2521 IR tablets 1.5 mg----1件: 86 💬
1122BAY 63-2521 IR tablets 2.0 mg----1件: 86 💬
1123BAY 63-2521 IR tablets 2.5 mg----1件: 86 💬
1124Bazedoxifene Acetate2件: Acetate,
Bazedoxifene		---1件: 13 💬
1125BBT-401-1S, Multiple doses----1件: 97 💬
1126BBT-401-1S, Single dose----1件: 97 💬
1127BBT-877, Multiple doses----1件: 85 💬
1128BBT-877, Single dose----1件: 85 💬
1129BCD-033 (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1130BCD-089, 162 mg, s/c, q2w----1件: 46 💬
1131BCD-089, 162 mg, s/c, qw----1件: 46 💬
1132BCD-132, 125 mg----1件: 13 💬
1133BCD-132, 500 mg----1件: 13 💬
1134BDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept)5件: Abatacept,
Adalimumab,
Etanercept,
Golimumab,
Infliximab		5件: Etanercept ,
Adalimumab ,
Infliximab ,
Abatacept ,
Golimumab 💬		4件: CD80,
CD86,
LTA,
TNF 💬		74件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1135BEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongée----1件: 94 💬
1136Belantamab mafodotin 1.9mg/kg or 2.5mg/kg every 4 weeks, 6 weeks or 8 weeks as determined by Part 1 recommended dosages1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1137Belimumab for IV1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1138Belimumab for SC1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1139Belimumab in SLE patients / Rituximab in RA patients2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬		2件: MS4A1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
1140Belimumab Injection1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1141Belimumab Injection [Benlysta]1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1142Benazepril hydrochloride 10 milligram (mg) Tab1件: Benazepril1件: Benazepril 💬1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 218 💬
1143Benazepril, Valsartan and Fluvastatin3件: Benazepril,
Fluvastatin,
Valsartan		3件: Valsartan ,
Benazepril ,
Fluvastatin 💬		3件: ACE,
AGTR1,
HMGCR 💬		22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 218 💬
1144Bendamustine, Rituximab2件: Bendamustine,
Rituximab		2件: Rituximab ,
Bendamustine 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61 💬
1145BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 53 💬
1146Benlysta 400 mg powder for concentrate for solution for infusion1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 43, 49 💬
1147Benlysta 400 mg powder for concentrate for solution for infusions1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1148Benlysta 400mg polvere per concentrato per soluzione per infusione1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 43 💬
1149BENLYSTA? (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1150BENLYSTA® (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 11, 66, 222 💬
1151BENLYSTA™ (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1152Benzbromaron AL----1件: 86 💬
1153Benzimidazole,5-methoxy-2-[[(4-methoxy- 3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole1件: Benzimidazole---1件: 46 💬
1154Benzoic acid1件: Benzoic acid1件: Benzoic acid 💬--1件: 51 💬
1155Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)1件: Alanine1件: Alanine 💬--1件: 298 💬
1156Best Available Therapy (BAT)----1件: 13 💬
1157Beta carotene from Dunaliella algae1件: Beta carotene1件: beta Carotene 💬--1件: 96 💬
1158Beta-1b interferoni----1件: 13 💬
1159Beta-Adrenergic cocktail----1件: 299 💬
1160Beta-Alanine2件: Alanine,
beta-Alanine		2件: Alanine ,
beta-Alanine 💬		--1件: 13 💬
1161Beta-alanine supplementation2件: Alanine,
beta-Alanine		2件: Alanine ,
beta-Alanine 💬		--1件: 13 💬
1162Beta-Interferon----1件: 13 💬
1163Beta-lactam antibiotic----1件: 299 💬
1164Beta-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1165BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1166Betaferon 250 microgram/ml, powder and solvent for solution for injection1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1167Betaferon 250 microgram/mL, powder and solvent for solution for injection.1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1168BETAFERON® (interferon beta-1b)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1169Betaloc ZOK 100, 95 mg----1件: 113 💬
1170Betaloc ZOK 25, 23,75 mg----1件: 113 💬
1171BETAMETHASONE ACIBUTATE1件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
1172Betamethasone Oral Solution Period 1 and Period 21件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
1173Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days3件: Acetate,
Betamethasone,
Phosphate ion		1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 2 💬
1174Betamethasone solution as intramuscular injection Period 1 and Period 21件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
1175Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1176Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1177Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)2件: Bevacizumab,
Imatinib		2件: Bevacizumab ,
Imatinib 💬		4件: ABL1,
KIT,
PDGFRA,
VEGFA 💬		45件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway, Viral myocarditis 💬1件: 87 💬
1178BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA P4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---1件: 62 💬
1179BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---1件: 66 💬
1180BEXSERO – Sospensione iniettabile – Siringa preriempita4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---2件: 61, 62 💬
1181Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬		2件: NR1H4,
PPARA 💬		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 94 💬
1182Bezafibrate (INN 3968)1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 324 💬
1183Bezafibrate IR1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1184Bezafibrate, Beza, BZF, Bezalip1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1185Bezafibrate, Beza, BZF, Bezalip mono1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1186Bezafilbrate IR----1件: 93 💬
1187BG00002 (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1188BG00002-E (natalizumab high titer)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1189BG00012 (DMF) (Tecfidera®.)----1件: 13 💬
1190BG0002 (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1191BG9418 (interferon beta 1-a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1192BG9418 (interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97 💬
1193BGJ398 (also known as BBP-831)----1件: 276 💬
1194BHV3241, verdiperstat1件: Verdiperstat1件: Verdiperstat 💬1件: MPO 💬5件: Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬1件: 17 💬
1195BI 1015550 18 mg Film Coated Tablet----1件: 85 💬
1196BI 1015550 9 mg Film Coated Tablet----1件: 85 💬
1197BI 695501 Autoinjector----1件: 46 💬
1198BIA 9-1067 non-micronized1件: BIA---1件: 6 💬
1199Biaxin ( clarithromycin)1件: Clarithromycin1件: Clarithromycin 💬--1件: 299 💬
1200BIBR 796 BS, 20 mg----1件: 96 💬
1201BIBR 796 BS, 5 mg----1件: 96 💬
1202Bifidobacterium infantis1件: Bifidobacterium longum infantis---2件: 96, 97 💬
1203Bifidobacterium infantis 356241件: Bifidobacterium longum infantis---2件: 96, 97 💬
1204BIIB033 (ANTI-LINGO)----1件: 13 💬
1205BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957----1件: 13 💬
1206BIIB041 (fampridine)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1207BIIB041 (Fampridine-SR)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1208BIIB041 (PR Fampridine)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1209BIIB050 / KNS-760704----1件: 2 💬
1210BIIB067 (ISIS666853)----1件: 2 💬
1211BIIL 283 BS (Amelubent)----1件: 299 💬
1212BIIL 284 BS, high dose----1件: 299 💬
1213BIIL 284 BS, high dose, adult patients----1件: 299 💬
1214BIIL 284 BS, high dose, pediatric patients----1件: 299 💬
1215BIIL 284 BS, low dose----1件: 299 💬
1216BIIL 284 BS, low dose, adult patients----1件: 299 💬
1217BIIL 284 BS, low dose, pediatric patients----1件: 299 💬
1218BIIL 284 BS, medium dose, adult patients----1件: 299 💬
1219BIIL 284 BS, medium dose, pediatric patients----1件: 299 💬
1220Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
1221Bilateral transforaminal epidural steroid injections----1件: 70 💬
1222Biobanking with genetic analysis----3件: 13, 51, 56 💬
1223Biologic Agents----1件: 46 💬
1224Biologic: IC14 (monoclonal antibody against human CD14)----1件: 2 💬
1225Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14 💬
1226Biological agents----1件: 46 💬
1227Biological disease-modifying antirheumatic drugs (bDMARDs)----1件: 46 💬
1228Biological/Vaccine: Allogeneic HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---1件: 6 💬
1229Biological: Benralizumab, Biological: Placebo to Mepolizumab2件: Benralizumab,
Mepolizumab		2件: Mepolizumab ,
Benralizumab 💬		2件: IL5,
IL5RA 💬		13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
1230Biological: Mepolizumab, Biological: Placebo to Benralizumab2件: Benralizumab,
Mepolizumab		2件: Mepolizumab ,
Benralizumab 💬		2件: IL5,
IL5RA 💬		13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
1231Biologically active human fecal microbiota----1件: 97 💬
1232Biomarker identification in Parkinson disease----1件: 6 💬
1233Biosimilar adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
1234Biosimilar Infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
1235Biosimilar product to adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1236BIRB 796 BS, high dose----1件: 46 💬
1237BIRB 796 BS, low dose----1件: 46 💬
1238BIS-CHOLINE TETRATHIOMOLYBDATE, bis[(2-Hydroxyethyl)trimethylammonium] tetrathiomolybdate2件: Choline,
Tetrathiomolybdate		1件: Choline 💬--1件: 171 💬
1239Bisoprolol Fumarate1件: Bisoprolol1件: Bisoprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 113 💬
1240BITTER CANDYTUFT FRESH PLANT EXTRACT----1件: 97 💬
1241Bladder instillation with heparin/ lidocaine2件: Heparin,
Lidocaine		3件: Lidocaine ,
Adomiparin ,
Lidocaine hydrochloride monohydrate 💬		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226 💬
1242Bladder instillation WITH triamcinolone acetonide1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 226 💬
1243Bladder instillation WITHOUT triamcinolone acetonide1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 226 💬
1244Bladder Instillations----1件: 226 💬
1245Bladder tissue of Interstitial Cystitis and normal bladder tissue----1件: 226 💬
1246Bleomycin + Fibrovein1件: Bleomycin1件: Bleomycin 💬--1件: 279 💬
1247Blinded (Avatrombopoag tablets)----1件: 63 💬
1248Blisibimod Injection1件: Blisibimod1件: Blisibimod 💬--1件: 66 💬
1249Blood and stools samples----1件: 96 💬
1250Blood and urine sampling----1件: 195 💬
1251Blood and/or skin biopsy----2件: 90, 301 💬
1252Blood assays----1件: 113 💬
1253Blood coagulation Factor VIII and vWF, human1件: Beroctocog alfa---1件: 288 💬
1254Blood coagulation factor XIII1件: Factor XIII (human)---1件: 51 💬
1255Blood draw for the laboratory assessment----1件: 303 💬
1256Blood sample and environmental survey----1件: 2 💬
1257Blood Sampling and DNA collection----1件: 6 💬
1258Blood sampling for biological and genetic analysis----1件: 19 💬
1259BMN 044 IV 6 mg/kg----1件: 113 💬
1260BMN 044 IV 9 mg/kg----1件: 113 💬
1261BMN 110 - Every Other Week----1件: 19 💬
1262BMN 110 - Weekly----1件: 19 💬
1263BMS 188667 (Abatacept)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 13 💬
1264BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)5件: Digoxin,
Flurbiprofen,
Midazolam,
Montelukast,
Omeprazole		5件: Digoxin ,
Flurbiprofen ,
Omeprazole ,
Midazolam ,
Montelukast 💬		25件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
ATP4A,
ATP4B,
CYSLTR1,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
PTGS1,
PTGS2 💬		49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
1265BMS-582949 and Methotrexate2件: BMS-582949,
Methotrexate		1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
1266BMS-936557 (Anti-IP-10 Antibody)----1件: 96 💬
1267BMS-986004 1500 mg IV----1件: 63 💬
1268BMS-986004 225 mg IV----1件: 63 💬
1269BMS-986004 675 mg IV----1件: 63 💬
1270BMS-986004 75 mg IV----1件: 63 💬
1271BMS-986089-01 (RO7239361) , anti-myostatin----1件: 113 💬
1272BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
1273BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
1274BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
1275BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
1276BMS-986089-01 (RO7239361), anti-myostatin----1件: 113 💬
1277BMS-986089-01 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
1278BMS-986089-01 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
1279BMS-986089-01 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
1280BMS-986089-01 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
1281BMS-986089-01, Anti-myostatin----1件: 113 💬
1282BMS-986256-06, TLR7/8 Antagonist1件: Afimetoran1件: Afimetoran 💬--1件: 49 💬
1283BNT162b2, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
1284Bof-, Mazelen-, Rubellavaccin, poeder voor injectievloeistof----1件: 107 💬
1285Bone marrow autologous mesenchymal stem cells transplantation----1件: 13 💬
1286BoNT-A----1件: 6 💬
1287BORAGE OIL 20% GLA1件: Borage oil---1件: 13 💬
1288Bortezomib Accord2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1289Bortezomib Injection1件: Bortezomib1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 64 💬
1290Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone2件: Bortezomib,
Dexamethasone		2件: Dexamethasone ,
Bortezomib 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1291Bosentan administration1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
1292Bosentan and Sildenafil2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
1293Bosentan, Ambrisentan2件: Ambrisentan,
Bosentan		3件: Bosentan ,
Ambrisentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
1294Bosutinib (anhydrous)1件: Bosutinib1件: Bosutinib 💬2件: ABL1,
SRC 💬		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 67 💬
1295Boswellic acids (BOSWELAN)----1件: 13 💬
1296BOTOX 100 UNITES ALLERGAN (PR1)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 2 💬
1297Botox 100 UNT Injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1298BOTOX 100U in normal saline1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 226 💬
1299BOTOX 200U in normal saline1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 226 💬
1300Botox injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 2, 47 💬
1301BOTOX® solution1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 51 💬
1302Botulinum A toxin----1件: 118 💬
1303Botulinum Neurotoxin----1件: 226 💬
1304Botulinum toxin A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 13, 51, 149, 226 💬
1305BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1306BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
1307Botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 70 💬
1308Botulinum Toxin Type A 200U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1309Botulinum Toxin Type A 300U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1310Botulinum toxin type B (2500 units / vial)1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 51 💬
1311Botulinum Toxin: Xeomin1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
1312Bovine intesastinal alkaline phosphatase (bIAP)1件: Alkaline Phosphatase---1件: 46 💬
1313Bovine intestinal alkaline phosphatase (BIAP)1件: Alkaline Phosphatase---1件: 97 💬
1314Bovine type I collagen1件: Bovine type I collagen---1件: 51 💬
1315Bovine-Calf Alkaline Phosphatase (BIAP)1件: Alkaline Phosphatase---1件: 97 💬
1316Bovine-Calf Alkaline Phosphatase BIAP1件: Alkaline Phosphatase---1件: 97 💬
1317BPN14770/ zatolmilast1件: Zatolmilast1件: Zatolmilast 💬1件: PDE4D 💬5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 206 💬
1318BPR277 ointment (controlled application)----1件: 160 💬
1319BPS804, UX143----1件: 274 💬
1320BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML----1件: 299 💬
1321BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML----1件: 299 💬
1322Bramitob 300mg/4ml Nebuliser Solution----1件: 299 💬
1323BRAMITOB*NEBUL 28F 300MG/4ML----1件: 299 💬
1324BRAMITOB*NEBUL 56F 300MG/4ML----1件: 299 💬
1325Bramitob® administered by PARI eFlow® rapid electronic nebulizer----1件: 299 💬
1326Bramitob® administered by PARI LC® PLUS nebulizer----1件: 299 💬
1327Brazikumab Induction Dose1件: Brazikumab1件: Brazikumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
1328Brazikumab IV Infusion1件: Brazikumab1件: Brazikumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
1329Brazikumab SC Injection1件: Brazikumab1件: Brazikumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
1330Break in L-carnitine treatment1件: Levocarnitine1件: Levocarnitine 💬--1件: 316 💬
1331Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
1332Bromocriptine and other dopamine agonists2件: Bromocriptine,
Dopamine		2件: Bromocriptine ,
Dopamine 💬		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬		15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1333Bromure d'Ipratropium1件: Ipratropium---1件: 86 💬
1334Bronchoalveolar lavage fluid collection----1件: 229 💬
1335BT-11 Active----2件: 96, 97 💬
1336BT061 (CD4 monoclonal antibody)----1件: 46 💬
1337BTK Inhibitor----3件: 46, 53, 160 💬
1338BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product----1件: 94 💬
1339BTX-A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
1340Bucelipase alfa1件: Bucelipase alfa---1件: 299 💬
1341Budenofalk 2mg rectal foam----1件: 97 💬
1342Budenofalk rectal foam----1件: 97 💬
1343Budenofalk® suppositories----1件: 97 💬
1344Budenofalk® suppositories (BUS)----1件: 97 💬
1345Budesonide ( Zentacort Capsules 3mg )1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
1346Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1347Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1348Budesonide 9 mg capsules, hard (BUX-PV)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1349Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1350Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1351Budesonide [0.4mg/ml] viscous suspension1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1352Budesonide MMX® 6 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1353Budesonide MMX® 9 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1354Budesonide-formoterol single inhaler2件: Budesonide,
Formoterol		2件: Budesonide ,
Formoterol 💬		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
1355Budesonide-MMX® 6 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1356Budesonide-MMX® 9 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1357Budesonide/formoterol2件: Budesonide,
Formoterol		2件: Budesonide ,
Formoterol 💬		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1358Bumetanide white, oblong, scored tablet1件: Bumetanide1件: Bumetanide 💬1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
1359Bupivacaine hydrochloride 0.5% (Marcaine, Pfizer)1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 46 💬
1360Bupivacaine Injection 0.5%1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 168 💬
1361Bupivacaine, triamcinolone, and heparin (BTH)3件: Bupivacaine,
Heparin,
Triamcinolone		3件: Triamcinolone ,
Adomiparin ,
Bupivacaine 💬		7件: NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		5件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬1件: 226 💬
1362Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine3件: Bupivacaine,
Clonidine,
Epinephrine		3件: Epinephrine ,
Clonidine ,
Bupivacaine 💬		14件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 70 💬
1363Bupivacaïne HCl 0,125% / Sufentanil 50 µg flacon à 50 ml1件: Sufentanil1件: Sufentanil 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
1364Bupivicaine alone----1件: 298 💬
1365Bupropion & Citalopram2件: Bupropion,
Citalopram		2件: Bupropion ,
Citalopram 💬		3件: SLC6A2,
SLC6A3,
SLC6A4 💬		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 18 💬
1366BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI1件: Busulfan1件: Busulfan 💬--2件: 19, 65 💬
1367Busulfan, Cyclophosphamide, Antithymocyte Globulin2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 19, 20 💬
1368Busulfan, Cyclophosphamide, ATG2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 19 💬
1369Busulfan, Cyclophosphamide, ATG, GCSF2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 65, 284 💬
1370Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)4件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Cyclophosphamide,
Fludarabine		4件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 326 💬
1371Busulfan, Fludarabine and ATG2件: Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
1372Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.4件: Busulfan,
Cyclophosphamide,
Cyclosporine,
Fludarabine		5件: Cyclosporine ,
Busulfan ,
Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		6件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬		39件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 285 💬
1373Busulfan, Fludarabine, ATG, TLI2件: Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
1374Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF6件: Busulfan,
Filgrastim,
Fludarabine,
Methotrexate,
Phosphate ion,
Tacrolimus		6件: Tacrolimus ,
Methotrexate ,
Busulfan ,
Filgrastim ,
Fludarabine ,
Tacrolimus 💬		9件: CSF3R,
DHFR,
DHFR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬		48件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1375Butanoic acid1件: Butyric Acid---3件: 34, 51, 97 💬
1376Butyrate enemas + routine management1件: Butyric Acid---1件: 291 💬
1377Butyric Acid1件: Butyric Acid---1件: 222 💬
1378Bydureon 2 mg powder and solvent for prolonged-release suspension2件: Exenatide,
Manganese citrate		1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1379Béfizal----1件: 302 💬
1380C-82 Topical Gel, 1%----1件: 51 💬
1381C-kit+ cells----1件: 211 💬
1382C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker1件: Polyethylene glycol1件: Polyethylene glycol 3350 💬--1件: 276 💬
1383C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER1件: Polyethylene glycol1件: Polyethylene glycol 3350 💬--1件: 276 💬
1384C. albicans----1件: 46 💬
1385C01CA04 - Dopamina1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299 💬
1386C1 ESTERASE INHIBITOR (HUMAN)----1件: 65 💬
1387C1 Esterase Inhibitor Human----1件: 65 💬
1388C1 inhibitor1件: Human C1-esterase inhibitor---1件: 65 💬
1389C1 inhibitor concentrate1件: Human C1-esterase inhibitor---1件: 65 💬
1390C1-esterase inhibitor (Cinryze)1件: Human C1-esterase inhibitor---1件: 13 💬
1391C1-esterase inhibitor [recombinant] (C1-INH-R)1件: Human C1-esterase inhibitor---1件: 65 💬
1392C1-INH1件: Human C1-esterase inhibitor---1件: 65 💬
1393C326, IL-6 Inhibitory Avimer protein----1件: 96 💬
1394C5 inh MAb, SKY59, RO/CH7092230----2件: 62, 109 💬
1395C5 Inhibitor----1件: 62 💬
1396Cabaletta for IV infusion once weekly during 24 weeks1件: Trehalose---1件: 18 💬
1397Cabaseril, 1,0 mg Tablette----1件: 6 💬
1398Cabaseril, 2,0 mg Tablette----1件: 6 💬
1399Cabotegravir (CAB) tablet1件: Cabotegravir1件: Cabotegravir 💬--1件: 256 💬
1400Cabotegravir - Injectable Suspension (CAB LA)1件: Cabotegravir1件: Cabotegravir 💬--1件: 256 💬
1401Caffeic acid tablets----1件: 63 💬
1402Caffeine alkaloid1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1403Calcichew D3 Forte----1件: 113 💬
1404Calcineurin Inhibitors----1件: 50 💬
1405Calcineurin inhibitors maintenance----1件: 67 💬
1406CALCIO FOLINATO DC.IT1件: Calcium---1件: 13 💬
1407Calcitonin nasal spray (salmon)1件: Salmon, unspecified---2件: 96, 97 💬
1408Calcitriol & Calcium2件: Calcitriol,
Calcium		1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 235 💬
1409Calcium and cholecalciferol2件: Calcium,
Cholecalciferol		1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 46 💬
1410Calcium and Vit D1件: Calcium---1件: 49 💬
1411Calcium and Vitamin D combination2件: Calcium,
Vitamin D		---1件: 13 💬
1412Calcium carbonate and alphacalcidol3件: Calcium,
Calcium carbonate,
Carbonate ion		2件: Calcium carbonate ,
Calcium carbonate 💬		--1件: 235 💬
1413CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬		--1件: 274 💬
1414Calcium, Dietary1件: Calcium---1件: 298 💬
1415CALD HR-D (High-Risk, Regimen C)----5件: 19, 20, 125, 234, 326 💬
1416CALD HR-D (High-Risk, Regimen D)----5件: 19, 20, 125, 234, 326 💬
1417CALD SR-A (Standard-Risk, Regimen A)----5件: 19, 20, 125, 234, 326 💬
1418CALD SR-B (Standard-Risk, Regimen B)----5件: 19, 20, 125, 234, 326 💬
1419Calvan® 100 mg----1件: 8 💬
1420Camoteskimab (CERC-007, AVTX-007, AEVI-007)----1件: 107 💬
1421Campath, Busulfan, Clofarabine2件: Busulfan,
Clofarabine		2件: Busulfan ,
Clofarabine 💬		3件: POLA1,
POLA2,
RRM1 💬		7件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 326 💬
1422Campath, Chemo and/or TBI Allo SCT1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-3件: 60, 62, 283 💬
1423Campath, Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
1424CAMPATH-1H (Alemtuzumab)1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 60 💬
1425Canakinumab (ACZ885)1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
1426Canakinumab (company code: ACZ885D)1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
1427Canakinumab (investigational)1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 46 💬
1428Canakinumab (WHO approval pending)1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
1429Canakinumab Injection1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 46 💬
1430Canakinumab Injection [Ilaris]1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 113 💬
1431Candesartan and Cilnidipine2件: Candesartan,
Cilnidipine		2件: Candesartan ,
Cilnidipine 💬		6件: AGTR1,
CACNA1B,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		49件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 67 💬
1432Candesartan plus non-CCB agents1件: Candesartan1件: Candesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 67 💬
1433Cannabidiol , synthetic form1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 96 💬
1434Cannabidiol / Dronabinol capsule 5 mg+2,5 mg2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1435Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US.1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
1436Cannabis sativa L., folium cum flore1件: Medical Cannabis---1件: 19 💬
1437Cannabis, Medical1件: Medical Cannabis---5件: 2, 6, 13, 96, 97 💬
1438Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients.1件: Colchicine1件: Colchicine 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 266 💬
1439Caplacizumab (ALX-0081)1件: Caplacizumab1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
1440Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
1441Caplacizumab (an anti-von Willebrand Factor Nanobody)2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
1442Capsule fecal microbiota material (cap-FMT)----1件: 96 💬
1443Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1444Capsules with 160 mg Teavigo (at least 94% EGCG)1件: Epigallocatechin gallate---1件: 13 💬
1445CARBIDOPA (FU)1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1446Carbidopa and Levodopa 25mg/100mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1447Carbidopa and Levodopa Controlled Release Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1448Carbidopa and Levodopa Tablets, USP2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1449CARBIDOPA ANIDRA1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1450CARBIDOPA FU1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1451CARBIDOPA INN1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1452Carbidopa, levodopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1453Carbidopa- Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1454Carbidopa/levodopa, as prescribed by treating physician2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1455Carbidopa/Levodopa, immediate release2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1456Carbohydrates intake----1件: 257 💬
1457Cardiac progenitor cell infusion----2件: 210, 211 💬
1458Care as usual----1件: 15 💬
1459Carglumic Acid1件: Carglumic acid1件: Carglumic acid 💬1件: CPS1 💬6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬3件: 245, 246, 251 💬
1460Carglumic Acid (Carbaglu®)1件: Carglumic acid1件: Carglumic acid 💬1件: CPS1 💬6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬2件: 245, 246 💬
1461Carmustine, etoposide, cytarabine, and melphalan (BEAM)4件: Carmustine,
Cytarabine,
Etoposide,
Melphalan		4件: Etoposide ,
Cytarabine ,
Carmustine ,
Melphalan 💬		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
1462Carnosine, capsulle, 2 g/day, 8 weeks1件: Carnosine---1件: 13 💬
1463CARVI EXTRACTUM FLUIDUM----1件: 97 💬
1464CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----1件: 254 💬
1465CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one----1件: 58 💬
1466CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one----1件: 58 💬
1467CAS No.: 7758-16-9----1件: 166 💬
1468CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----1件: 254 💬
1469CASPOFUNGIN ACETATE2件: Acetate,
Caspofungin		1件: Caspofungin 💬--1件: 60 💬
1470Catapres ampoules1件: Clonidine1件: Clonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
1471Catapresan 75, Tabletten----1件: 65 💬
1472Cathepsin S Inhibitor----1件: 53 💬
1473Caudal epidural injection----1件: 70 💬
1474Caudal Epidural Injection with Celestone----1件: 70 💬
1475Caudal Epidural Injection with DepoMedrol----1件: 70 💬
1476Caudal Epidural Injection with generic Celestone----1件: 70 💬
1477Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1478CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1479CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA.1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 140, 144 💬
1480CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution,1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
1481CBD - Oral Solution, is known as Epidyolex, and is the approved name1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1482CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1483CBD Oral solution, is known as Epidyolex and is the approved name in the EU1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1484CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1485CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA.1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
1486CCD 1042, MD 9150000, Mepalon 1042, SPT316----2件: 152, 206 💬
1487CCD 1042, MD 9150000, Mepalon 1042, SPT3162----1件: 152 💬
1488CCR1 Antagonist----1件: 46 💬
1489CD-4 guided therapy interruption----1件: 265 💬
1490CD-C-Food----1件: 96 💬
1491CD-LD IR----1件: 6 💬
1492CD19-directed humanised afucosylated monoclonal antibody----1件: 11 💬
1493CD3/CD19 neg allogeneic BMT----1件: 65 💬
1494CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65 💬
1495CD3/CD19 negative hematopoietic stem cells----1件: 85 💬
1496CD34 selected autologous hematopoietic cells----1件: 51 💬
1497CD34+ CELLS----1件: 285 💬
1498CD34+ cells transduced with ADA retrovir----1件: 65 💬
1499CD34+ enriched, T Cell Depleted donor stem cell product----1件: 326 💬
1500CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT----1件: 65 💬
1501CD34+ selected cells----1件: 285 💬
1502CD62L- Tem----1件: 60 💬
1503CDP870 Fab'-PEG----1件: 46 💬
1504CEBION 500MG 20CPR MAST.ARAN----1件: 10 💬
1505Ceftazidim Fresenius Kabi1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
1506Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
1507Ceftazidime and tobramycin2件: Ceftazidime,
Tobramycin		3件: Tobramycin ,
Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
1508Ceftazidime/avibactam2件: Avibactam,
Ceftazidime		2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
1509Celebrex 200 mg capsule, hard1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1510Celecoxib, Celebrex®1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
1511Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients----1件: 2 💬
1512CellCept 500 mg film-coated tablets1件: Mycophenolate mofetil1件: Mycophenolate mofetil 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 11 💬
1513Cellcept® in autoimmune bullous dermatoses----2件: 35, 162 💬
1514Cellular therapy with EBV specific autologous CTL infusion----1件: 13 💬
1515Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi----1件: 19 💬
1516Celulas hepatocitos troncales adultas alogenicas de higado expandidas----1件: 251 💬
1517Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida----1件: 274 💬
1518Ceramic on Polyethylene articulation----1件: 46 💬
1519CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])----1件: 6 💬
1520CERE-120: AAV2-NTN----1件: 6 💬
1521CERE-120: Adeno-Associated Virus Delivery of Neurturin----1件: 6 💬
1522Cerebral Dopamine Neurotrophic Factor1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1523Cerebro-spinal fluid----1件: 13 💬
1524CERETEC (TM) Estabilizado2件: Cobalt chloride,
Technetium Tc-99m exametazime		---1件: 6 💬
1525Cerezyme (imiglucerase for injection)1件: Imiglucerase1件: Imiglucerase 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
1526Cerezyme 400 Units Powder for concentrate for solution for infusion1件: Imiglucerase1件: Imiglucerase 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
1527Cerezyme® / Imiglucerase1件: Imiglucerase1件: Imiglucerase 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
1528Cerliponase Alfa1件: Cerliponase alfa1件: Cerliponase alfa 💬1件: TPP1 💬1件: Lysosome 💬1件: 19 💬
1529Certolizumab pegol (CDP870, CZP)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1530Certolizumab pegol (CDP870, tradename Cimzia)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1531Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1532Certolizumab Pegol (CZP) 200 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1533Certolizumab Pegol (CZP) 400 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1534Certolizumab Pegol + Methotrexate (MTX)2件: Certolizumab pegol,
Methotrexate		2件: Methotrexate ,
Certolizumab pegol 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1535Certolizumab pegol / CIMZIA1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
1536CertolizumabPegol injection----1件: 46 💬
1537Cervarix suspensie voor injectie4件: Human papillomavirus type 16 L1 capsid protein antigen,
Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen,
Human papillomavirus type 18 L1 capsid protein antigen,
Human papillomavirus type 18 L1 capsid protein residues 2-472 antigen		---3件: 49, 50, 107 💬
1538Cesamet™ (nabilone)1件: Nabilone1件: Nabilone 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1539CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 300 💬
1540CF patients with a G551D mutation and treated with Ivacaftor1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
1541CFZ533 (iscalimab)1件: Iscalimab1件: Iscalimab 💬1件: CD40 💬17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬1件: 53 💬
1542CFZ533 active - Cohort 1----1件: 53 💬
1543CFZ533 active - Cohort 2----1件: 53 💬
1544CFZ533 active - Cohort 3----1件: 53 💬
1545CFZ533 active -Cohort 3----1件: 53 💬
1546Ch11-1F4 (NSC-711516)----1件: 28 💬
1547ChAdOx1 nCoV-191件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299 💬
1548Change in daily dosage of Growth Hormone1件: Somatotropin---1件: 78 💬
1549Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001)1件: Somatotropin---1件: 78 💬
1550Chenodeoxycholic acid1件: Chenodeoxycholic acid1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬4件: 20, 96, 234, 263 💬
1551CHF10067 intermediate dose----1件: 85 💬
1552CHF6333 (Part 1 - SAD)----1件: 299 💬
1553CHF6333 (Part 2 - MAD)----1件: 299 💬
1554Chicken type II collagen1件: Chicken---1件: 46 💬
1555CHIMERIC FIBRIL-REACTIVE IGG1K MONOCLONAL ANTIBODY 11-1F4----1件: 28 💬
1556Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4----1件: 28 💬
1557Chimeric Human-Murine IgG1 ----1件: 46 💬
1558Chimeric human/mouse anti-CD-20 monoclonal antibody----1件: 46 💬
1559Chimeric IgG1 monoclonal antibody----1件: 96 💬
1560Chimeric monoclonal antibody, IgG4 subtype----2件: 43, 44 💬
1561Chimeric murine human anti-IL-6 monoclonal antibody----1件: 331 💬
1562Chinese herbal concoction twice a day for 6 months----1件: 60 💬
1563Chlorogenic Acid1件: Chlorogenic Acid---1件: 97 💬
1564Cholecalciferol 10,000 IU1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
1565Cholecalciferol 400 IU1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
1566Cholecalciferol and C. Xanthorrhiza1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
1567CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM)2件: Cholecalciferol,
Water		2件: Water ,
Cholecalciferol 💬		1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
1568Cholecalciferol, Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
1569Cholic Acid1件: Cholic Acid1件: Cholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬4件: 20, 234, 265, 310 💬
1570Cholic Acids----2件: 20, 234 💬
1571CHR-1103 / GBR500----1件: 13 💬
1572Chromosomal microarray analysis (CMA) and whole exome sequencing (WES)----1件: 179 💬
1573Chronocort® 10 mg----1件: 81 💬
1574Chronocort® 20 mg----1件: 81 💬
1575Chronocort® 5 mg----1件: 81 💬
1576CHX A-DTPA anti-CD66 antibody1件: Pentetic acid1件: Pentetic acid 💬--1件: 28 💬
1577CHX-A-DTPA-Anti-CD661件: Pentetic acid1件: Pentetic acid 💬--1件: 28 💬
1578CI-984, 17AA70, PD 132301-2----1件: 81 💬
1579CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 75 💬
1580Cialis 10 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
1581Cialis 2.5 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
1582Cialis 20 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
1583Cialis 5 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
1584CIANOCOBALAMINA FU DC.IT1件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 13 💬
1585CICLOSPORIN A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1586Ciclosporina / Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1587Ciclosporina A Liposomica Aerolised Liposomal Ciclosporin A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1588Ciclosporina/ Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1589Ciclosporine A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1590Ciclosporine, Ciclosporina1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1591Ciliary neurotrophic factor1件: Ciliary neurotrophic factor---1件: 90 💬
1592Ciliary Neurotrophic Factor Implant NT-5011件: Ciliary neurotrophic factor---1件: 90 💬
1593CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1594CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI ALCOOL1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1595Cimzia 200 mg injeksjonsvæske, oppløsning1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1596Cimzia 200 mg solution for injection1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 271 💬
1597CIMZIA certolizumab pegol 200 mg/ml solution for injection1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
1598CINRYZE® (C1 esterase inhibitor [human])1件: Human C1-esterase inhibitor---1件: 61 💬
1599Cipaglucosidase Alfa1件: Cipaglucosidase alfa1件: Cipaglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1600Cipaglucosidasi alfa----1件: 256 💬
1601Cipro (Ciprofloxacin, BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1602Cipro Inhale1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1603Ciprofloxacin (BAYQ3939) dry powder for inhalation1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1604Ciprofloxacin (Cipro Inhale, BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1605Ciprofloxacin (Cipro, BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1606Ciprofloxacin dispersion for inhalation1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1607Ciprofloxacin for Inhalation1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1608Ciprofloxacin Inhale1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
1609CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE----1件: 299 💬
1610Circadin ( INN= Melatonin)1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
1611CIRCADIN 2 mg comprimidos de liberación prolongada1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 90 💬
1612CITICOLIN*1G/4ML IM IV 5 F----1件: 6 💬
1613CITOCHINE ED IMMUNOMODULATORI----1件: 13 💬
1614Citric acid1件: Citric acid1件: Citric acid monohydrate 💬--2件: 53, 291 💬
1615Citric Acid based Mouthwash1件: Citric acid1件: Citric acid monohydrate 💬--1件: 53 💬
1616CJNJ-68150420-ZZZ-G001 (ACT- 064992D)----1件: 86 💬
1617CJNJ-68150420-ZZZ-G001 (ACT-064992D)----1件: 86 💬
1618CJNJ-68150420-ZZZ-G001(ACT-064992D)----1件: 86 💬
1619CK-2017357 (Part A)----1件: 2 💬
1620CK-3773274 (10 - 30 mg)----1件: 58 💬
1621CK-3773274 (5 - 15 mg)----1件: 58 💬
1622CK-3773274 (5 - 20 mg)----1件: 58 💬
1623CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)----1件: 58 💬
1624CK-3773274 - Granules in Capsule----1件: 58 💬
1625CK-3773274 - Tablets----1件: 58 💬
1626CL20-i4-EF1a-h?c-OPT----1件: 65 💬
1627CLA (Chlorogenic acid)1件: Chlorogenic Acid---1件: 97 💬
1628Clarithromycin (Not used as of 4/2020)1件: Clarithromycin1件: Clarithromycin 💬--1件: 6 💬
1629Claritromycin 500mg film coated tablets----1件: 299 💬
1630Clartihromycin, amoxicillin, and omeprazole2件: Amoxicillin,
Omeprazole		3件: Amoxicillin ,
Omeprazole ,
Amoxicillin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 6 💬
1631CLAVULANIC ACID1件: Clavulanic acid1件: Clavulanic acid 💬--1件: 299 💬
1632CLEMASTINE FUMARATE1件: Clemastine1件: Clemastine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
1633Clemastine Milstein 1 mg, tabletten1件: Clemastine1件: Clemastine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
1634Clobetasol 0.05% ointment1件: Clobetasol1件: Clobetasol 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 39 💬
1635Clobetasol 0.05% Topical Ointment1件: Clobetasol1件: Clobetasol 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
1636Clobetasol propionate + Methotrexate3件: Clobetasol,
Clobetasol propionate,
Methotrexate		3件: Methotrexate ,
Clobetasol propionate ,
Clobetasol 💬		3件: DHFR,
DHFR2,
NR3C1 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 162 💬
1637Clobetasol propionate alone2件: Clobetasol,
Clobetasol propionate		2件: Clobetasol propionate ,
Clobetasol 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
1638Clonidine HCl CF 0,150 mg, tabletten1件: Clonidine1件: Clonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 78 💬
1639CLOSTRIDIUM BOTULINUM TOXIN TYPE A2件: Botulinum toxin type A,
Clostridium botulinum		1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1640CNM-Au8----2件: 2, 13 💬
1641CNS10-NPC implantation----1件: 90 💬
1642CNS10-NPC-GDNF----1件: 2 💬
1643CNTO 136 IgG----1件: 46 💬
1644CNTO 1959 + MTX (Group 4)----1件: 46 💬
1645CNTO 1959 + MTX (Group 5)----1件: 46 💬
1646CNTO 1959 IgG----1件: 46 💬
1647Co-medication: Synthetic DMARDs----1件: 46 💬
1648Coagulación factor VIII1件: Beroctocog alfa---1件: 288 💬
1649Coagulation factor VIII1件: Beroctocog alfa---1件: 288 💬
1650Coagulation factor X1件: Coagulation factor X human---1件: 288 💬
1651Coagulation factor XIII1件: Factor XIII (human)---1件: 288 💬
1652Coconut oil and epigallocatechin gallate4件: Coconut,
Coconut oil,
Epigallocatechin,
Epigallocatechin gallate		1件: Coconut oil 💬--1件: 13 💬
1653Coenzym Q10 Nanodispersion----1件: 5 💬
1654Coenzym Q10, Ubiquinon, Ubichinon----1件: 5 💬
1655Coenzyme A1件: Coenzyme A---1件: 246 💬
1656Coenzyme Q-10 in Normal Control subjects1件: Ubidecarenone1件: Ubidecarenone 💬--1件: 86 💬
1657Coenzyme Q-10 in Pulmonary Hypertension subjects1件: Ubidecarenone1件: Ubidecarenone 💬--1件: 86 💬
1658Coenzyme Q10 and Lisinopril2件: Lisinopril,
Ubidecarenone		3件: Lisinopril ,
Ubidecarenone ,
Lisinopril 💬		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113 💬
1659Coenzyme Q10 Nanodispersion (Nanoquinone)1件: Ubidecarenone1件: Ubidecarenone 💬--1件: 6 💬
1660Cofactor supplementation (thiamine, riboflavin, L-carnitine)3件: Levocarnitine,
Riboflavin,
Thiamine		3件: Riboflavin ,
Levocarnitine ,
Thiamine 💬		--1件: 265 💬
1661Cogane™ (PYM50028)----1件: 6 💬
1662Cohort 1: 1.0 x 10^8 PolyTregs----1件: 35 💬
1663Cohort 1: hATG, CsA, EPAG Day 14 to Month 61件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
1664Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
1665Cohort 2: 2.5x10^8 PolyTregs----1件: 35 💬
1666Cohort 2: hATG, CsA, EPAG Day 14 to Month 31件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
1667Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
1668Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 61件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
1669COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin----1件: 36 💬
1670COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE1件: Colchicine1件: Colchicine 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
1671COLECALCIFEROL CONCENTRATE (OILY FORM)1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
1672Colfinair 2 MIU Powder for Nebuliser Solution----1件: 299 💬
1673COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML----1件: 299 💬
1674COLIMYCINE inhalation----1件: 299 💬
1675COLIMYCINE injectable----1件: 299 💬
1676Colistimethat-Natrium----1件: 299 💬
1677Colistimethate 75 mg inhaled two times daily1件: Colistimethate---1件: 299 💬
1678COLISTIMETHATE SODIUM (A COMPONENT)1件: Colistimethate---1件: 299 💬
1679Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate2件: Colistimethate,
Colistin		1件: Colistin 💬--1件: 299 💬
1680Colistin Forest - Trockenstechampullen mit Lösungsmittel1件: Colistin1件: Colistin 💬--1件: 299 💬
1681Collect of 10 ml of peripheric blood for DNA extraction----1件: 46 💬
1682Collection of biological sample (blood and/or CSF)----2件: 2, 6 💬
1683Collection of blood and urine----1件: 25 💬
1684Collection of samples of blood and urine----1件: 167 💬
1685Colonoscopic fecal microbiota material (colo-FMT)----1件: 96 💬
1686Combination antiviral therapy----1件: 93 💬
1687Combination fish oil and borage seed oil1件: Fish oil---1件: 46 💬
1688Combination injection of EPO and G-CSF1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 6 💬
1689Combination of a single dose anti-CD20 antibody and bortezomib1件: Bortezomib1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 61 💬
1690Combination of fish oil and colesevelam2件: Colesevelam,
Fish oil		1件: Colesevelam 💬--1件: 260 💬
1691Combination of Minocycline and MTX or MTX alone1件: Minocycline1件: Minocycline 💬--1件: 46 💬
1692Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine3件: Azathioprine,
Dexamethasone,
Rituximab		3件: Azathioprine ,
Dexamethasone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35 💬
1693Combination of thrombopoietin mimetic and cyclosporin A2件: Cyclosporine,
Thrombopoietin		1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1694Combination Oral Budesonide and Rectal Hydrocortisone2件: Budesonide,
Hydrocortisone		2件: Hydrocortisone ,
Budesonide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1695Combination Product: Active treatment with dual therapy----1件: 2 💬
1696Combination Product: Beclomethasone dipropionate in addition to MC-EVOO1件: Beclomethasone dipropionate1件: Beclomethasone dipropionate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1697Combination Product: Beclomethasone dipropionate in addition to refined oil1件: Beclomethasone dipropionate1件: Beclomethasone dipropionate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1698Combination Product: Belimumab1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1699Combination Product: EGCG 300 mg + Nintedanib2件: Epigallocatechin gallate,
Nintedanib		1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
1700Combination Product: EGCG 300 mg + Pirfenidone2件: Epigallocatechin gallate,
Pirfenidone		1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
1701Combination Product: EGCG 600 mg + Nintedanib2件: Epigallocatechin gallate,
Nintedanib		1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
1702Combination Product: EGCG 600 mg + Pirfenidone2件: Epigallocatechin gallate,
Pirfenidone		1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
1703Combination Product: Exercise, and methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
1704Combination Product: Goldic serum----1件: 70 💬
1705Combination Product: high MCT formula----1件: 296 💬
1706Combination Product: Humira (adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
1707Combination Product: Implantable System for Remodulin (treprostinil)1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1708Combination Product: L-dopa 140 mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1709Combination Product: L-dopa 35 mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1710Combination Product: L-dopa 70mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1711Combination Product: L-dopa 70mg/carbidopa 7mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1712Combination Product: Laser, exercise, and methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
1713Combination Product: lipid injectable emulsion with Fish oil1件: Fish oil---1件: 294 💬
1714Combination Product: mavrilimumab1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 41 💬
1715Combination Product: Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
1716Combination Product: ND0612 Solution for SC infusion----1件: 6 💬
1717Combination Product: ofatumumab with AI1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1718Combination Product: ofatumumab with PRF1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1719Combination Product: PRP combined Magnovision----1件: 90 💬
1720Combination Product: Ravulizumab OBDS1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
1721Combination Product: Sanacoach Parkinson (SCP)----1件: 6 💬
1722Combination Product: TransCon PTH----1件: 235 💬
1723Combination Product: Treprostinil via implanted pump1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1724Combination therapy with vigabatrin and prednisolone2件: Prednisolone,
Vigabatrin		2件: Prednisolone ,
Vigabatrin 💬		2件: ABAT,
NR3C1 💬		8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
1725Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 85 💬
1726Combivir (zidovudine [AZT] / lamivudine [3TC])2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬		--1件: 265 💬
1727Comirnaty concentrate for dispersion for injection1件: Tozinameran1件: Tozinameran 💬--2件: 53, 299 💬
1728Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion1件: Tozinameran1件: Tozinameran 💬--1件: 13 💬
1729Commercial Formulation Etanercept1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1730Commercial Ventavis® (iloprost)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1731Common Name: Sialic Acid----1件: 30 💬
1732Comparator: carbidopa1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1733Comparator: diclofenac1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1734Comparator: Diclofenac sodium1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1735Comparator: ezetimibe1件: Ezetimibe1件: Ezetimibe 💬1件: NPC1L1 💬1件: Fat digestion and absorption 💬2件: 79, 260 💬
1736Comparator: levodopa1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1737Comparator: naproxen tablet 500 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1738COMPLEMENT C1 ESTERASE INHIBITOR1件: Conestat alfa1件: Conestat alfa 💬3件: C1R,
C1S,
KLKB1 💬		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 61 💬
1739Compound thrombosis capsule sig: 1.5g/tid----1件: 90 💬
1740COMTAN 200* 60 CPR 200 MG1件: Entacapone1件: Entacapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
1741Concentration unit: mg milligram(s)----1件: 254 💬
1742Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d1件: Conjugated estrogens1件: Estrogens, conjugated 💬--1件: 49 💬
1743Continuation of azathioprine1件: Azathioprine1件: Azathioprine 💬--1件: 49 💬
1744Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----1件: 265 💬
1745Continue IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1746Continue IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1747Continue IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1748Continuous Apomorphine infusion1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1749Continuous infusion Cefepime1件: Cefepime1件: Cefepime 💬--1件: 299 💬
1750Continuous infusion Ceftazidime1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
1751Continuous infusion Meropenem1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
1752Continuous infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
1753Continuous infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: Clavulanic acid ,
Ticarcillin 💬		--1件: 299 💬
1754Continuous intrajejunal infusion of levodopa-carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1755Continuous Release Dopamine Agonists1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1756Continuous Subcutaneous Lisuride Infusion1件: Lisuride1件: Lisuride 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1757Control Group 0.9% Isotonic Saline----1件: 299 💬
1758Control intervention (no dexamethasone)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
1759Controlled-release levodopa / carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1760Convection enhanced delivery/AAV2-GDNF----1件: 6 💬
1761Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)7件: Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		6件: Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone ,
Cortisone acetate ,
Cortisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1762Conventional synthetic antirheumatic drugs----1件: 46 💬
1763Conventional therapy users for the last 5 years----1件: 271 💬
1764Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)1件: Mesalazine1件: Mesalamine 💬--2件: 96, 97 💬
1765COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE1件: Glatiramer---1件: 13 💬
1766COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE1件: Glatiramer---1件: 13 💬
1767COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN1件: Glatiramer---1件: 13 💬
1768COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO1件: Glatiramer---1件: 13 💬
1769COPAXONE 20 mg/ml solución inyectable en jeringa precargada1件: Glatiramer---1件: 13 💬
1770Copaxone 20 mg/ml solución para inyección en jeringa precargada1件: Glatiramer---1件: 13 💬
1771Copaxone 20 mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
1772Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes1件: Glatiramer---1件: 13 💬
1773Copaxone 20mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
1774Copaxone 40 mg/ml solution for injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
1775Copaxone subcutaneous injection syringe1件: Glatiramer---1件: 13 💬
1776COPPER (64CU) CHLORIDE2件: Chloride ion,
Copper		---1件: 171 💬
1777Cortancyl ® 1 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1778Cortancyl ® 20 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1779Cortancyl ® 5 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
1780Corticoids+ tocilizumab 8mg/Kg/4 weeks1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
1781Corticosteroid and azathioprine1件: Azathioprine1件: Azathioprine 💬--4件: 42, 43, 44, 45 💬
1782Corticosteroid and non-biological agents.----1件: 46 💬
1783Corticosteroid or NSAID----1件: 46 💬
1784Corticosteroids & tanCART19/20----1件: 13 💬
1785Corticosteroids (Aprednislon)----1件: 63 💬
1786Corticosteroids +immune suppressive +amino salicylic acid1件: Salicylic acid1件: Salicylic acid 💬--1件: 97 💬
1787Corticosteroids for Systemic Use----1件: 41 💬
1788Cortisone acetate4件: Acetate,
Cortisone,
Cortisone acetate,
Hydrocortisone		3件: Hydrocortisone ,
Cortisone acetate ,
Cortisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
1789COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 107 💬
1790COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 107 💬
1791Cosentyx 300 mg solution for injection in pre-filled syringe1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
1792Cosentyx 300mg solution for injection in pre-filled syringe1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
1793Cosintropina acetato----1件: 113 💬
1794CosmoFer 50mg/ml solution for infusion or injection----2件: 96, 97 💬
1795Cosyntropin acetate2件: Acetate,
Tetracosactide		1件: Cosyntropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113 💬
1796Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin2件: Tetracosactide,
Vigabatrin		2件: Cosyntropin ,
Vigabatrin 💬		2件: ABAT,
MC2R 💬		12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬1件: 145 💬
1797Cosyntropin Injectable Suspension, 1 mg/mL1件: Tetracosactide1件: Cosyntropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 145 💬
1798COVID-19 mRNA Vaccine (nucleoside modified)----3件: 13, 46, 51 💬
1799COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299 💬
1800COVID-19 vaccine (Ad26.COV2-S [recombinant])----1件: 299 💬
1801COVID-19 Vaccine AstraZeneca1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 53 💬
1802COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299 💬
1803COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant])1件: AstraZeneca COVID-19 Vaccine---1件: 53 💬
1804COVID-19 Vaccine Janssen suspension for injection1件: Janssen COVID-19 Vaccine1件: COVID-19 vaccine 💬--1件: 299 💬
1805COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant])1件: Janssen COVID-19 Vaccine1件: COVID-19 vaccine 💬--2件: 53, 299 💬
1806COVID-19 Vaccine Moderna dispersion for injection1件: Moderna COVID-19 Vaccine1件: Elasomeran 💬--1件: 299 💬
1807COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula1件: Losartan1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
1808CP- 690 550----1件: 97 💬
1809CP-690, 550 - 10----1件: 46 💬
1810CP-690, 550-10----2件: 97, 107 💬
1811CP-690,550 + methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
1812CP-690,550 – 10----1件: 46 💬
1813CPL500036 - high dose----1件: 6 💬
1814CPL500036 - low dose----1件: 6 💬
1815CR002 Liquid API1件: CR002---1件: 299 💬
1816CRC (A3384)----3件: 93, 297, 338 💬
1817CRC3357, ZK-355322, Leukoton----1件: 299 💬
1818Crema de rapamicina al 1% y excipientes----1件: 157 💬
1819Creon 10.000, hårde enterokapsler----1件: 299 💬
1820Creon 25.000, hårde enterokapsler----1件: 299 💬
1821Creon 40.000, hårde enterokapsler----1件: 299 💬
1822CREON IR----1件: 299 💬
1823Creon N----1件: 299 💬
1824CREON N 25000----1件: 299 💬
1825Creon® (DR/GR)----1件: 299 💬
1826Creon® 25,000----1件: 299 💬
1827Crestor Film-Coated Tablet1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 79 💬
1828Crestor Tablets (calcium rosuvastatin) Film-Coated tablets2件: Calcium,
Rosuvastatin		1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 79 💬
1829Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
1830Crocin and Apigenin2件: Apigenin,
Crocin		---1件: 6 💬
1831Crohns Disease Exclusion Diet + PEN----1件: 96 💬
1832Cromolyn sodio (cromoglicato disodico, DSCG)1件: Cromoglicic acid1件: Cromoglicic acid 💬--1件: 85 💬
1833CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE----1件: 19 💬
1834Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
1835Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells----1件: 65 💬
1836Crysvita (burosumab-twza) Treatment1件: Burosumab1件: Burosumab 💬1件: FGF23 💬11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
1837CS (corticosteroids) Only----1件: 97 💬
1838CS1 Administration----1件: 86 💬
1839CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)----1件: 49 💬
1840CSM allogéniques issues de cordons ombilicaux ( MTI-PP)----1件: 49 💬
1841CT- P10----1件: 46 💬
1842CT-P13 SC (Infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
1843CT-P17 SC AI (adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1844CT-P47 AI (tocilizumab)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
1845CTLA4-IgG4m (RG2077)----1件: 49 💬
1846CTNS-RD-04 or CTNS-RD-04-LB (where the suffix -LB stands for LentiBOOST)----1件: 19 💬
1847Cu(II)ATSM----2件: 2, 6 💬
1848Cultured allogeneic fibroblasts----1件: 36 💬
1849Cultured Thymus Tissue for Implantation (CTTI)----1件: 65 💬
1850Cultured Thymus Tissue Implantation (CTTI)----1件: 65 💬
1851Cuprior 150 mg film-coated tablets1件: Triethylenetetramine---1件: 171 💬
1852Cuprior 150mg film-coated tablets1件: Triethylenetetramine---1件: 171 💬
1853Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg1件: Turmeric---1件: 299 💬
1854Current marketed FLOLAN (epoprostenol sodium)1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1855Current treatment of AL-CM----1件: 28 💬
1856Currently available therapy in the community----1件: 51 💬
1857Cutaneous iontophoresis of treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
1858Cuvitru 200 mg/ml solution for subcutaneous injection1件: Human immunoglobulin G---1件: 65 💬
1859CVT-301, LIP----1件: 6 💬
1860CX-4945 oral formulation----1件: 331 💬
1861CX516 (Ampalex®)1件: CX516---1件: 206 💬
1862Cy-ATG----1件: 60 💬
1863Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate----1件: 75 💬
1864Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate----1件: 75 💬
1865Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate----1件: 75 💬
1866CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL]----1件: 299 💬
1867Cyclophosphamide (CY) (Plan 1)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 60, 285 💬
1868Cyclophosphamide (CY) (Plan 2)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 60, 285 💬
1869Cyclophosphamide + pred1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 283 💬
1870Cyclophosphamide and ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
1871Cyclophosphamide and fludarabine2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 11, 13 💬
1872Cyclophosphamide and steroids1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 222 💬
1873Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids3件: Azathioprine,
Cyclophosphamide,
Methotrexate		4件: Methotrexate ,
Azathioprine ,
Cyclophosphamide ,
Cyclophosphamide 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
1874Cyclophosphamide Injection 1g1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--3件: 50, 51, 52 💬
1875Cyclophosphamide, Azathioprine,prednisone,methylprednisolone4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		5件: Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
1876Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1877Cyclophosphamide, Bortezomib, dexamethasone3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1878Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab4件: Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		5件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬		3件: CD38,
NR3C1,
PSMB5 💬		16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬
1879Cyclophosphamide, fludarabine , thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
1880Cyclophosphamide, Fludarabine, Rabbit ATG4件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine,
Rabbit		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
1881Cyclophosphamide, Fludarabine, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
1882Cyclophosphamide,Campath IH and TBI1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 60 💬
1883Cyclophosphamide,cyclosporine A2件: Cyclophosphamide,
Cyclosporine		3件: Cyclosporine ,
Cyclophosphamide ,
Cyclophosphamide 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1884Cyclophosphamide-prednisone-azathioprine3件: Azathioprine,
Cyclophosphamide,
Prednisone		4件: Azathioprine ,
Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
1885Cyclophosphamide/ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
1886Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer		2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
1887Cyclosporin A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬
1888Cyclosporin A+Glucocorticoids1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 62 💬
1889Cyclosporin, low dose steroid1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
1890Cyclosporin, Methotrexate (GVHD prophylaxis)2件: Cyclosporine,
Methotrexate		2件: Methotrexate ,
Cyclosporine 💬		7件: DHFR,
DHFR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 326 💬
1891Cyclosporine 0.09% Ophthalmic Solution1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 53 💬
1892Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 19, 20, 36, 49, 50, 53, 58, 60, 107, 234, 283 💬
1893Cyclosporine A (CsA)1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 19, 60 💬
1894Cyclosporine A dry powder inhalation (Drug)1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1895Cyclosporine Inhalation Solution1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1896Cyclosporine Inhalation Solution (CIS)1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
1897CYCLOSPORINE VS INFLIXIMAB2件: Cyclosporine,
Infliximab		2件: Cyclosporine ,
Infliximab 💬		6件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
TNF 💬		86件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 97 💬
1898Cyclosporine-A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 95 💬
1899Cystadane anhydrous1件: Betaine1件: Betaine 💬--1件: 19 💬
1900CYSTADROPS 0.55% eye drops, solution1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1901Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine1件: Cysteamine 💬--1件: 299 💬
1902Cystagon® (Cysteamine Bitartrate)1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1903Cysteamine (mercaptamine) viscous solution1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1904Cysteamine bitartrate (INN: mercaptamine bitartrate1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1905Cysteamine bitartrate (INN: mercaptamine bitartrate )1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1906Cysteamine bitartrate (INN: mercaptamine bitartrate)1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1907Cystic Fibrosis Ready to Use Supplemental Food----1件: 299 💬
1908Cystic fibrosis transmembrane conductance regulator----1件: 299 💬
1909Cystoscopic injection of Botox into the urinary bladder1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
1910Cytochrome P450 (CYP) Substrates----2件: 96, 97 💬
1911Cytogenetic analysis----1件: 285 💬
1912Cytolytic CD4+ T cells----1件: 13 💬
1913Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant----1件: 62 💬
1914Células madre mesenquimales de tejido adiposo autólogo----1件: 2 💬
1915Células madre mesenquimales haploidénticas derivadas de médula ósea----1件: 36 💬
1916Células Mesenquimales de tejido adiposo----1件: 2 💬
1917Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas----1件: 274 💬
1918Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088)----1件: 274 💬
1919Células mesenquimales troncales adultas autólogas de medula ósea expandidas----1件: 117 💬
1920Células mesenquimales troncales adultas autólogas de médula ósea expandidas----1件: 117 💬
1921Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea----1件: 2 💬
1922D-a-tocopheryl PEG 1000 succinate----1件: 299 💬
1923D-aspartate----1件: 13 💬
1924D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)1件: Sorbitol1件: Sorbitol solution 💬--1件: 28 💬
1925D-glucitol, 1-deoxy-1-(methylamino)-,2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)1件: Sorbitol1件: Sorbitol solution 💬--1件: 28 💬
1926D-IVA----1件: 299 💬
1927D.3.2 Product code where applicable13:----1件: 193 💬
1928D.3.6.2 - dose massima specificare: giornaliera----1件: 86 💬
1929D.3.6.2.1 - valore: 45 / 0.45 mg/ml----1件: 97 💬
1930D.3.6.2.1 - valore: 5 o 10 mg/kg----1件: 97 💬
1931D9421-C, 15mg----1件: 96 💬
1932D9421-C, 9mg----1件: 96 💬
1933Dacepton 5 mg/ml infuusioneste, liuos----1件: 6 💬
1934Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1935Dacortín 2,5mg----1件: 222 💬
1936Dacortín 30mg----1件: 222 💬
1937Dacortín 5mg----1件: 222 💬
1938Daily ingestion of Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
1939Dalfampridine ER, 10 Mg Oral Tablet, Extended Release1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1940Danicopan (ALXN2040)1件: Danicopan1件: Danicopan 💬1件: CFD 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 62 💬
1941Danzhu Fuyuan Granule----1件: 222 💬
1942Dapagliflozin 10 MG [Farxiga]1件: Dapagliflozin1件: Dapagliflozin 💬1件: SLC5A2 💬-2件: 86, 88 💬
1943Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)3件: Daratumumab,
Hyaluronidase,
Hyaluronidase (human recombinant)		4件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase ,
Daratumumab 💬		1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 28 💬
1944Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 28 💬
1945Daratumumab Injection1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 49, 63 💬
1946Dark chocolate (85% cocoa)1件: Cocoa---1件: 6 💬
1947Dasatinib + Quercetin2件: Dasatinib,
Quercetin		2件: Dasatinib ,
Dasatinib 💬		8件: ABL1,
EPHA2,
FYN,
KIT,
LCK,
PDGFRB,
SRC,
YES1 💬		77件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 85 💬
1948DaTSCAN 74 MBq/ml solution for injection1件: Ioflupane I-123---1件: 6 💬
1949Davunetide (AL-108, NAP)1件: Davunetide1件: Davunetide 💬--3件: 5, 7, 127 💬
1950DB adalimumab 40 mg eow1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1951DB adalimumab 40 mg ew1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1952Decadron Phosphate, Injectable1件: Phosphate ion---1件: 70 💬
1953DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
1954Decrease Tocilizumab, Abatacept2件: Abatacept,
Tocilizumab		2件: Tocilizumab ,
Abatacept 💬		3件: CD80,
CD86,
IL6R 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
1955Defanyl 50 and 100 mg----1件: 46 💬
1956Deferiprone (Ferriprox)1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
1957Deferiprone 80 mg/mL oral solution (Ferriprox)1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
1958Dehydrated Alcohol (Absolute Alcohol) BP for Injection1件: Ethanol1件: Ethanol 💬--1件: 279 💬
1959Dehydrated human amnion/chorion membrane----1件: 269 💬
1960Dehydroepiandrosterone 100 and 400 mg1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
1961Dekristol 20.000 ie----1件: 96 💬
1962Dekristol 20000 IE----1件: 13 💬
1963Dekristol® 400-Tabletten----1件: 13 💬
1964Dekristol®-Tablette 1 (400 IE)----1件: 13 💬
1965Delayed and extended release mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1966Delayed Release 6MP or Calcitriol vs. Purinethol1件: Calcitriol1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
1967Delmitide acetate1件: Acetate---1件: 97 💬
1968Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 8 💬
1969DELTACORTENE FORTE*10CPR 25MG----2件: 46, 97 💬
1970Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
1971Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
1972Denufosol tetrasodium (INS37217)1件: Denufosol---1件: 299 💬
1973Denufosol Tetrasodium (INS37217) Inhalation Solution1件: Denufosol---1件: 299 💬
1974Denufosol tetrasodium Inhalation Solution1件: Denufosol---1件: 299 💬
1975DEPAKINE CHRONO® 500 mg----1件: 233 💬
1976Depletion in CD45RA graft donor----1件: 65 💬
1977Depletion of CD3/CD19 in an autologous stem cell transplant----2件: 49, 51 💬
1978Depo-Medrol 40Mg/Ml Suspension for Injection----1件: 70 💬
1979Depot leuprolide acetate 3.75 mg2件: Acetate,
Leuprolide		---1件: 51 💬
1980Desert Harvest Aloe Vera Capsules1件: Aloe vera leaf---1件: 226 💬
1981Desflurane anesthetics1件: Desflurane1件: Desflurane 💬--1件: 296 💬
1982Desmopressin Acetat1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 6 💬
1983Desmopressin acetate2件: Acetate,
Desmopressin		1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 64, 288 💬
1984DESMOPRESSIN ACETATE TRIHYDRATE2件: Acetate,
Desmopressin		1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 225 💬
1985Desmopressin intranasal1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
1986Desmopressine nasal spray 10 mg/ml, flacon 60 doses1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 225 💬
1987Desmotabs® 0,2 mg Tabletten----1件: 6 💬
1988Desmotabs® 0,2mg Tabletten----1件: 6 💬
1989Determination of drug effects through amantadine cessation1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
1990Detoxifying agents for antineoplastic treatment----2件: 299, 337 💬
1991Deuterated Ivacaftor1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
1992Deutetrabenazine Oral Tablet [Austedo]1件: Deutetrabenazine1件: Deutetrabenazine 💬1件: SLC18A2 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
1993Dexametasone Fosfato Sodico----1件: 65 💬
1994Dexamethasone (50mg 1dd6, 3 consecutive days/month)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
1995Dexamethasone 0.5mg/5ml solution in Mucolox™1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
1996Dexamethasone Abcur1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
1997Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab		2件: Dexamethasone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
1998Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235 💬
1999Dexamethasone Oral, 10 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2000Dexamethasone Oral, 20 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2001Dexamethasone Parotid Irrigation1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 53 💬
2002Dexamethasone sodium phosphate 250 mg/ 10 ml2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
2003DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
2004Dexamethasone, 40 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2005Dexamethasone, procarbazine2件: Dexamethasone,
Procarbazine		2件: Dexamethasone ,
Procarbazine 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
2006Dexmedetomidine Hcl 100 Mcg/mL Inj1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
2007Dexmedetomidine Hydrochloride Infusion1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
2008Dexrazoxane (DRZ) plus Mitoxantrone (MX)2件: Dexrazoxane,
Mitoxantrone		2件: Dexrazoxane ,
Mitoxantrone 💬		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
2009DEXTRAN 1 FOR INJECTION1件: Dextran1件: Dextran 1 💬--1件: 97 💬
2010Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS)2件: Dextran,
Sulfate ion		1件: Dextran 1 💬--1件: 2 💬
2011Dextromethorphan and Caffeine2件: Caffeine,
Dextromethorphan		3件: Caffeine ,
Caffeine hydrate ,
Dextromethorphan 💬		17件: ADORA1,
ADORA2A,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A,
SIGMAR1 💬		37件: Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 78 💬
2012Dextromethorphan HBr and quinidine sulfate3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
2013Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
2014Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
2015Dextrose, 5% in Water2件: Dextrose, unspecified form,
Water		1件: Water 💬--1件: 65 💬
2016Diacerein 1% Ointment1件: Diacerein1件: Diacerein 💬--1件: 36 💬
2017Diagnosis of Fabry disease----1件: 19 💬
2018Diazepam, melatonin2件: Diazepam,
Melatonin		2件: Diazepam ,
Melatonin 💬		18件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
MTNR1A,
MTNR1B 💬		8件: Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 46 💬
2019DIBASE*IM OS 2F 1ML 300000UI/M----1件: 46 💬
2020Diclofenac + Omeprazole2件: Diclofenac,
Omeprazole		2件: Omeprazole ,
Diclofenac 💬		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2021Diet A group----1件: 85 💬
2022Dietary Fiber Supplementation----1件: 46 💬
2023Dietary Supplement for PKU patients----1件: 240 💬
2024Dietary supplement omega3 fatty acids aand vitamins----1件: 46 💬
2025Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride2件: Ammonium chloride,
Chloride ion		1件: Ammonium chloride 💬--1件: 107 💬
2026Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon2件: Ammonium chloride,
Chloride ion		1件: Ammonium chloride 💬--1件: 96 💬
2027Dimebon + Dextromethorphan2件: Dextromethorphan,
Latrepirdine		2件: Dextromethorphan ,
Latrepirdine 💬		7件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2028Dimebon + Ketoconazole2件: Ketoconazole,
Latrepirdine		2件: Ketoconazole ,
Latrepirdine 💬		7件: ACHE,
CYP17A1,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		28件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2029Dimebon + Omeprazole2件: Latrepirdine,
Omeprazole		2件: Omeprazole ,
Latrepirdine 💬		8件: ACHE,
ATP4A,
ATP4B,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2030Dimebon alone1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2031Dimebon IR1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2032Dimebon IR Tablet1件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2033DIMETHYL FUMARATE1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬4件: 13, 51, 86, 296 💬
2034Dimethyl Fumarate (DMF)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬3件: 13, 51, 86 💬
2035Dimethyl fumarate 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
2036Dimethyl fumarate [DMF]1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
2037DIMETIL-FUMARATO----1件: 13 💬
2038Dimeythl Fumarate----1件: 46 💬
2039Diosmin and Hesperidin Combination2件: Diosmin,
Hesperidin		2件: Hesperidin ,
Diosmin 💬		--1件: 46 💬
2040Diosminex, 500 mg, tabletki powlekane----1件: 265 💬
2041Diphenhydramine IV1件: Diphenhydramine1件: Diphenhydramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
2042Dipyridamole and Amoxapine2件: Amoxapine,
Dipyridamole		2件: Amoxapine ,
Dipyridamole 💬		4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬		8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
2043Diroximel Fumarate1件: Diroximel fumarate1件: Diroximel fumarate 💬--1件: 13 💬
2044Diroximel Fumarate (DRF)1件: Diroximel fumarate1件: Diroximel fumarate 💬--1件: 13 💬
2045Dirucotide acetate2件: Acetate,
Dirucotide		1件: Dirucotide 💬--1件: 13 💬
2046Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
2047Disease modified antirheumatic drugs or biological agents----1件: 46 💬
2048Disease-modifying anti-rheumatic drugs----1件: 46 💬
2049Disease-modifying antirheumatic drug----1件: 46 💬
2050Disease-modifying antirheumatic drugs (DMARDs)----1件: 46 💬
2051Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias)1件: Amiodarone1件: Amiodarone 💬16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 28 💬
2052Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG2件: Amiodarone,
Epigallocatechin gallate		1件: Amiodarone 💬16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 28 💬
2053Dl-3-n-butylphthalide (NBP)1件: Butylphthalide---1件: 22 💬
2054DMARDs (disease-modifying antirheumatic drugs)----1件: 46 💬
2055DNA analysis----1件: 60 💬
2056DNL151, DN0001575, DN1575----1件: 6 💬
2057Docosahexaenoic acid1件: Doconexent---7件: 6, 49, 90, 94, 240, 299, 301 💬
2058Docosahexaenoic Acid (DHA)1件: Doconexent---3件: 6, 94, 299 💬
2059Docosahexaenoic Acid (DHA) Dietary Supplement1件: Doconexent---1件: 301 💬
2060Docosahexaenoic acid administration: 50 mg/kg/day during 12 months1件: Doconexent---1件: 299 💬
2061Docosahexanoic Acid1件: Doconexent---1件: 299 💬
2062Docosahexanoic Acid Supplement1件: Doconexent---1件: 299 💬
2063Dolutegravir / Lamivudine Oral Tablet2件: Dolutegravir,
Lamivudine		2件: Lamivudine ,
Dolutegravir 💬		--1件: 265 💬
2064Dolutegravir, Abacavir and Lamivudine3件: Abacavir,
Dolutegravir,
Lamivudine		3件: Lamivudine ,
Abacavir ,
Dolutegravir 💬		--1件: 2 💬
2065Donor Lymphocyte Infusion (DLI)----1件: 60 💬
2066Donor mesenchymal stem cell infusions----1件: 36 💬
2067Dopamine Agent1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2068Dopamine agonist treatment1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
2069Dopamine Agonists1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 74 💬
2070Dopamine Agonists (pramipexole, ropirinole)2件: Dopamine,
Pramipexole		2件: Pramipexole ,
Dopamine 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2071Dopaminergic Agonist + Apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2072Dopaminergic Agonists----1件: 6 💬
2073Doptelet 20 mg film-coated tablets1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
2074Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]4件: Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil		3件: Lamivudine ,
Tenofovir ,
Doravirine 💬		--1件: 265 💬
2075Dornase alfa1件: Dornase alfa1件: Dornase alfa 💬--2件: 53, 299 💬
2076Dornase alfa (Pulmozyme)1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
2077Dornase alfa [Pulmozyme®]1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
2078Dornase alpha1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
2079Dose of 60 mg/kg alpha1-proteinase inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
2080Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
2081Dose-Establishing Study 1 Niacin 250mg1件: Niacin1件: Niacin 💬--1件: 78 💬
2082Dose-Establishing Study 1 Niacin 500mg1件: Niacin1件: Niacin 💬--1件: 78 💬
2083Dose-Establishing Study 2 Niacin 500mg1件: Niacin1件: Niacin 💬--1件: 78 💬
2084Dosing Interruption of Natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
2085Double-blind Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
2086Double-blind adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107 💬
2087Doxepin and Zopiclone2件: Doxepin,
Zopiclone		2件: Zopiclone ,
Doxepin 💬		19件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HRH1,
SLC6A2,
SLC6A4 💬		10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬1件: 6 💬
2088Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase4件: Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin,
Methotrexate		4件: Methotrexate ,
Cyclophosphamide ,
Doxorubicin ,
Cyclophosphamide 💬		4件: DHFR,
DHFR2,
TOP2A,
TOP2B 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬1件: 65 💬
2089Doxycycline 100-200mg capsules daily for 6 months1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--1件: 167 💬
2090Doxycycline Injection [Doxy]1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--1件: 34 💬
2091DoxyHEXAL® tabs 100 mg Tabletten----1件: 28 💬
2092Dr. Reddy’s Rituximab (DRL_RI) 100mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
2093Dr. Reddy’s Rituximab (DRL_RI) 500mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
2094Dried blood spot (DBS) sampling----1件: 19 💬
2095Dronabinol 25 mg/ml, oral drops1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
2096Dronabinol capsule 2.5. mg1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 46, 271 💬
2097Droxidopa 100 MG [Northera]1件: Droxidopa1件: Droxidopa 💬9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
2098Drug - SHR1459----1件: 13 💬
2099Drug free, IS monotherapy and GC combined with IS----1件: 300 💬
2100Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom----2件: 46, 49 💬
2101DTR Melatonin (NIH CC PDS)1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
2102Dulaglutide 0.75Mg/0.5Ml Inj Pen1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299 💬
2103Duo-Therapy with Sildenafil + Bosentan2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2104Duodopa gel intestinale2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2105Duodopa intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2106Duodopa intestinalgel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2107Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2108Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2109DUODOPA®Intestinal Gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2110Dupilumab 300Mg Solution for Injection1件: Dupilumab1件: Dupilumab 💬1件: IL4R 💬8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 51 💬
2111Dupilumab Injection1件: Dupilumab1件: Dupilumab 💬1件: IL4R 💬8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 160 💬
2112Duramycin, 2622U901件: Lancovutide---1件: 299 💬
2113Dynacirc CR (Isradipine)1件: Isradipine1件: Isradipine 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
2114DYSPORT*SC IM 2FL 500U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
2115Dysport® (Botulinumtoxin A (Btx A))1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 36 💬
2116E. coli Nissle----1件: 97 💬
2117E. coli Nissle 1917 (Mutaflor®)----1件: 97 💬
2118E5501 40 mg 2 x 20-mg tablets, orally, fasted----1件: 63 💬
2119E5501 40 mg 2 x 20-mg tablets, orally, with food----1件: 63 💬
2120E5501 40mg 2 x 20-mg tablets, orally, fasted----1件: 63 💬
2121Early immunosuppressants (azathioprine, methotrexate)2件: Azathioprine,
Methotrexate		2件: Methotrexate ,
Azathioprine 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96 💬
2122Early retreatment with ATG----1件: 60 💬
2123EB-101 Surgical application of RDEB wounds----1件: 36 💬
2124EB8018 (First-in-class FimH blocker)----1件: 96 💬
2125Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml----1件: 96 💬
2126Echo and myocardial contrast echocardiography perfusion imaging----1件: 58 💬
2127Edratide Acetate2件: Acetate,
Edratide		1件: Edratide 💬--1件: 49 💬
2128EDS-EP dose range of ~14-22 mg DSP/infusion----1件: 65 💬
2129EDS-EP dose range of ~5-10 mg DSP/infusion----1件: 65 💬
2130EEN (Nestle Modulen®)----1件: 96 💬
2131EEN intervention group----1件: 96 💬
2132EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells----1件: 65 💬
2133EF1aS-ADA lentiviral vector transduced patient CD34+ cells----1件: 65 💬
2134Efanesoctocog alfa1件: Efanesoctocog alfa1件: Efanesoctocog alfa 💬--1件: 288 💬
2135EFAVALEUKIN ALFA1件: Efavaleukin alfa1件: Efavaleukin alfa 💬--2件: 49, 97 💬
2136Efficacy of Gammagard subcutaneously at Week 12----1件: 65 💬
2137Efficacy of Gammagard subcutaneously at Week 24----1件: 65 💬
2138Efficacy of Gammagard subcutaneously at Week 36----1件: 65 💬
2139Efficacy of Gammagard subdermally at Week 12----1件: 65 💬
2140Efficacy of Gammagard subdermally at Week 24----1件: 65 💬
2141Efficacy of Gammagard subdermally at Week 36----1件: 65 💬
2142EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: Efgartigimod alfa 💬1件: FCGRT 💬-6件: 11, 14, 35, 53, 63, 162 💬
2143Efgartigimod alpha----1件: 63 💬
2144Efgartigimod concentrate for solution for infusion 20 mg/mL----1件: 11 💬
2145Efgartigimod IV----1件: 11 💬
2146Efgartigimod PH20 SC in stage B----1件: 14 💬
2147EFI/ACT-385781A----1件: 86 💬
2148Eflornithine plus Nifurtimox combination therapy2件: Eflornithine,
Nifurtimox		2件: Nifurtimox ,
Eflornithine 💬		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65 💬
2149Efmarodocokin alfa1件: Efmarodocokin alfa1件: Efmarodocokin alfa 💬1件: IL22 💬4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬2件: 96, 97 💬
2150EGB 761 (r) 120 mg----1件: 18 💬
2151EGb 761® (Tanakan®)1件: Ginkgo biloba---1件: 13 💬
2152EGCG + Tocotrienol2件: Epigallocatechin gallate,
Tocotrienol		---1件: 299 💬
2153EGCG as putative neuroprotective agent1件: Epigallocatechin gallate---1件: 17 💬
2154EGCG FontUp1件: Epigallocatechin gallate---1件: 206 💬
2155Egg Albumen Powder2件: Egg,
Egg white		---1件: 96 💬
2156Egg substitute, without cholesterol2件: Cholesterol,
Egg		1件: Cholesterol 💬--1件: 310 💬
2157EH301 (Nicotinamide Riboside/Pterostilbene)2件: Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬--1件: 2 💬
2158Eicosapentaenoic acid1件: Icosapent1件: Icosapent 💬--6件: 49, 96, 97, 296, 297, 338 💬
2159Elamipretide (intermediate dose)1件: Elamipretide1件: Elamipretide 💬--1件: 21 💬
2160Elaprase for intravenous (IV) infusion1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2161Elexacaftor / Ivacaftor / Tezacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2162Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2163Elexacaftor-tezacaftor-ivacaftor exposure3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2164Elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2165Eliglustat Tartrate – Powder for Oral Suspension1件: Eliglustat1件: Eliglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2166Elivaldogene autotemcel1件: Elivaldogene autotemcel1件: Elivaldogene autotemcel 💬1件: ABCD1 💬2件: ABC transporters, Peroxisome 💬1件: 20 💬
2167Elosulfase alfa1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2168Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM]1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2169Else nutrition formula----1件: 98 💬
2170Eltrombopag olamine, Revolade, Promacta1件: Eltrombopag---1件: 63 💬
2171ELX (VX-445)/TEZ (VX-661)/IVA (VX-770)----1件: 299 💬
2172ELX/TEZ/IVA----1件: 299 💬
2173Emapalumab-Izsg1件: Emapalumab1件: Emapalumab 💬1件: IFNG 💬32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 65 💬
2174EMFLAZA® (DEFLAZACORT)1件: Deflazacort1件: Deflazacort 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
2175Emicizumab (ACE910, RO5534262)1件: Emicizumab1件: Emicizumab 💬2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288 💬
2176Emicizumab Injection1件: Emicizumab1件: Emicizumab 💬2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288 💬
2177EMIXUSTAT HYDROCHLORIDE (ACU-4429)1件: Emixustat1件: Emixustat 💬--1件: 301 💬
2178Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)3件: Emtricitabine,
Tenofovir,
Tenofovir disoproxil		2件: Emtricitabine ,
Tenofovir 💬		--1件: 93 💬
2179EnaHexal®, 10mg----1件: 113 💬
2180Enalapril and other angiotensin converting enzyme inhibitors2件: Angiotensin II,
Enalapril		3件: Angiotensin II ,
Angiotensin II ,
Enalapril 💬		3件: ACE,
AGTR1,
AGTR2 💬		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
2181EnalHexal®, 5 mg----1件: 113 💬
2182ENBREL - 50 MG POLV SOLUZ INIET SOTTOC. POLV. FLAC VETRO SOLV. SIRI. VET. SOLV 1 ML (50 MG/ML) 12 FLAC+12 SIRI. PRE+12 AGHI+12 ADAT PER FLAC+24 TAMP. PRE INIEZ1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2183ENBREL - 50 MG SOLUZIONE INIETTABILE IN SIRINGA (VETRO DA 1 ML) PRERIEMPITA - USO SOTTOCUTANEO 12 SIRINGHE PRERIEMPITE + 24 TAMPONI IMBEVUTI DI ALCOL1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2184ENBREL 25 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte.1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2185Enbrel 25 mg powder and solvent for solution for injection1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2186ENBREL 25 mg/ml polvo y disolvente para solución inyectable para uso pediátrico1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2187ENBREL 25MG PFS INJ.1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2188Enbrel 50 mg powder and solvent for solution for injection1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2189ENBREL 50 mg solución inyectable en jeringas precargadas1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2190Enbrel 50 mg solution for injection in pre-filled syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2191Enbrel 50mg pre-filled pen1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2192Enbrel 50mg pre-filled syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2193Enbrel Auto Injector1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2194Enbrel pre-filled pen1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2195Enbrel Pre-filled syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2196Enbrel, Benepali, Erelzi1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2197Enbrel® 50 mg Solution for Injection in Pre-filled Syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2198Encapsulated faecal microbiota----1件: 97 💬
2199Encapsulated faecal microbiota filtrate----1件: 97 💬
2200Encorton, 5 mg, tablets----1件: 46 💬
2201End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care----2件: 113, 299 💬
2202Endobronchial infusion of adult mesenchymal stem cells----1件: 85 💬
2203ENDOPROST - 0.05 MG/0.5 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA----1件: 51 💬
2204ENDOPROST 50*INFUS 1F 0,050MG/----1件: 51 💬
2205Endothelin receptor antagonist therapy----1件: 86 💬
2206Endothelin Receptor Antagonists----1件: 86 💬
2207Endoxan - ciclofosfamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
2208Endoxan® 500 mg----1件: 44 💬
2209Engineerd Protein Inhibitor of human Neutrophil Elastase----1件: 299 💬
2210Engineered humanized monoclonal anti-human CD19 antibody.----1件: 46 💬
2211Engineered humanized monoclonal anti-human CD19 antibody. Lot Numbers: 1-FIN-1588 (9.6mg/ml)----1件: 46 💬
2212Engineered Protein Inhibitor of human Neutrophil Elastase----1件: 299 💬
2213Engineered recombinant human FGF19----1件: 94 💬
2214ENOS transfected EPCs will be delivered via a PA line----1件: 86 💬
2215Enriched Hematopoetic Stem Cell Infusion----2件: 19, 284 💬
2216Entacapone and carbidopa2件: Carbidopa,
Entacapone		2件: Carbidopa ,
Entacapone 💬		2件: COMT,
DDC 💬		10件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
2217ENTACAPONE INN1件: Entacapone1件: Entacapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
2218Enteral nutrition----1件: 96 💬
2219Enteral nutrition.----1件: 96 💬
2220Entocort EC® 3 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2221Entocort® CR1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2222Entocort® Kapseln1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
2223ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
2224ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
2225ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
2226Enzyme Replacement Agent----1件: 256 💬
2227Enzyme replacement therapy (Agalsidase alpha (Replagal®))1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2228Eosinophilic Esophagitis (E0E) food introduction-2nd----1件: 98 💬
2229Eosinophilic Esophagitis (EoE) food introduction-1st----1件: 98 💬
2230Eosinophilic Esophagitis (EoE) Food introduction-3rd dose----1件: 98 💬
2231EP2006 (Filgrastim)1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
2232EPA and DHA----1件: 113 💬
2233EPA and DHA supplementation----2件: 48, 49 💬
2234Epanova™ (Omega-3 Free Fatty Acids)1件: Omega-3 fatty acids---1件: 96 💬
2235Epaxal Berna (virosomal hepatitis A vaccine)1件: Hepatitis A Vaccine---2件: 96, 97 💬
2236Epidermal growth factor----1件: 97 💬
2237Epidermal growth factor enema----1件: 97 💬
2238Epidural injection----1件: 70 💬
2239Epidural Steroid Injection----1件: 70 💬
2240Epidyolex and is the approved name in the EU1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
2241Epithelial sheet generated from transduced autologous keratinocytes using pCCL-INVO-SP----1件: 160 💬
2242Epoetin alfa1件: Erythropoietin---3件: 13, 18, 46 💬
2243Epoprostenol for injection1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2244Epoprostenol-Actelion1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2245Epoprostenolo per iniezione----1件: 86 💬
2246Epratuzumab iv1件: Epratuzumab1件: Epratuzumab 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
2247EPREX IV SC 1FL 1ML 40000 UI----1件: 2 💬
2248Epsilon-Aminocaproic Acid (EACA)1件: Aminocaproic acid1件: Aminocaproic acid 💬1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 70 💬
2249ER tablet 100 mg AZD3241----1件: 6 💬
2250ER tablet 25 mg AZD3241----1件: 6 💬
2251ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)4件: Bosentan,
Macitentan,
Sildenafil,
Tadalafil		5件: Bosentan ,
Tadalafil ,
Bosentan ,
Sildenafil ,
Macitentan 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2252ERA as specific PAH treatment----1件: 86 💬
2253Eradication therapy for H.pylori infection----1件: 6 💬
2254Eradication therapy for Helicobacter pylori----1件: 6 💬
2255ERCP with Bupivacaine infusion1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 298 💬
2256Erypo/Erypo FS----1件: 13 💬
2257ESBRIET - 267 MG - CAPSULA RIGIDA - USO ORALE - FLACONE (HDPE) 270 CAPSULE1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2258Esbriet® (Pirfenidon)1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2259Escitalopram oxalate antidepressant1件: Escitalopram1件: Escitalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
2260Essential amino acid intake + Leucine vs total AA supplement1件: Leucine1件: Leucine 💬--1件: 299 💬
2261Essential fatty acids----1件: 13 💬
2262Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab4件: Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		4件: Tocilizumab ,
Rituximab ,
Abatacept ,
Sarilumab 💬		4件: CD80,
CD86,
IL6R,
MS4A1 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
2263Etanercept (50mg per week, for 2 weeks)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2264Etanercept (50mg per week, for 4 weeks)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2265Etanercept (Full-Dose)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2266Etanercept + Methotrexate2件: Etanercept,
Methotrexate		2件: Methotrexate ,
Etanercept 💬		4件: DHFR,
DHFR2,
LTA,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2267Etanercept , Methotrexate2件: Etanercept,
Methotrexate		2件: Methotrexate ,
Etanercept 💬		4件: DHFR,
DHFR2,
LTA,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2268Etanercept / Autoinjector A1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2269Etanercept 50 mg sc day 0 and day 31件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 38, 39 💬
2270Etanercept and its biosimilars1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2271Etanercept Auto-Injector1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2272Etanercept or adalimumab2件: Adalimumab,
Etanercept		2件: Etanercept ,
Adalimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2273Etanercept Pre-filled syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2274Etanercept pre-filled syringe subcutaneous injection1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2275Etanercept via Autoinjector A1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2276Etanercept via Autoinjector B1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2277Etanercept, methotrexate and depomedrone2件: Etanercept,
Methotrexate		2件: Methotrexate ,
Etanercept 💬		4件: DHFR,
DHFR2,
LTA,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2278Etanercept, Methotrexate, Prednisolone3件: Etanercept,
Methotrexate,
Prednisolone		3件: Methotrexate ,
Prednisolone ,
Etanercept 💬		5件: DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 56 💬
2279Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2280Eteplirsen Injection1件: Eteplirsen1件: Eteplirsen 💬1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
2281Ethanol 96% Gel1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2282Ethanol 98% Solution1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2283Ethanol-amine Oleate Sclerotherapy Injection1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2284Ethyl Icosapent2件: Icosapent,
Icosapent ethyl		2件: Icosapent ethyl ,
Icosapent 💬		--1件: 8 💬
2285Ethyl-Icosapent2件: Icosapent,
Icosapent ethyl		2件: Icosapent ethyl ,
Icosapent 💬		--1件: 8 💬
2286Ethylhydrogenfumarat, Calciumsalz----1件: 49 💬
2287Ethylhydrogenfumarat, Magnesiumsalz----1件: 49 💬
2288Ethylhydrogenfumarat, Zinksalz----1件: 49 💬
2289Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below)----1件: 6 💬
2290ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)1件: Myelin basic protein---1件: 13 💬
2291ETN Alone----1件: 46 💬
2292Etoposide, cytarabine, mercaptopurine3件: Cytarabine,
Etoposide,
Mercaptopurine		4件: Etoposide ,
Mercaptopurine ,
Cytarabine ,
Mercaptopurine 💬		3件: HPRT1,
TOP2A,
TOP2B 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Platinum drug resistance, Purine metabolism 💬1件: 65 💬
2293Etrasimod L-arginine3件: Arginine,
Etrasimod,
L-arginine		2件: Arginine ,
Etrasimod 💬		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 96, 97, 98 💬
2294EU Orphan Designation Number EU/3/02/120----1件: 299 💬
2295EU-approved RoActemra1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
2296EU/1/06/362/003: 5µg (1 pen)----1件: 193 💬
2297EU/1/08/454/001-002, EU/1/08/454/005-007----1件: 13 💬
2298EUR-1008 (APT-1008)----1件: 299 💬
2299EUR-1008 (APT-1008) High Dose----1件: 298 💬
2300EUR-1008 (APT-1008) Low Dose----1件: 298 💬
2301EUR-1066-A----1件: 298 💬
2302EUS procedure with drug injection----1件: 298 💬
2303EV substance code: SUB188638----1件: 113 💬
2304Everolimus (RAD001) , Afinitor®1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
2305Evolocumab (AMG 145)1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
2306Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector----1件: 65 💬
2307Ex vivo immunotherapy----1件: 60 💬
2308Ex-vivo approach concerning 25 patients----2件: 102, 299 💬
2309Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA.----1件: 36 💬
2310EXCL-100, 600 MG Oral Tablet----1件: 85 💬
2311Exclusive Enteral Nutrition----1件: 96 💬
2312Exclusive Enteral Nutrition Therapy----1件: 96 💬
2313Exenatide Pen Injector [Bydureon]1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 17 💬
2314EXG001-307 injection----1件: 3 💬
2315Expanded allogenic adipose-derived adult stem cells----1件: 96 💬
2316Expanded autologous adipose-derived adult stem cells (eASCs)----1件: 96 💬
2317Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eASCs)----1件: 96 💬
2318Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eASCs)----1件: 96 💬
2319Expanded human allogenic mesenchymal adult stem cells extracted from adipose----1件: 96 💬
2320Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue----1件: 96 💬
2321Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs----1件: 96 💬
2322Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs)----1件: 96 💬
2323Expanded human first trimester fetal liver-derived mesenchymal stem cells----1件: 274 💬
2324Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
2325Experimental Glatiramer Acetate2件: Acetate,
Glatiramer		---1件: 13 💬
2326Experimental: Arm A: DRL_RI----1件: 46 💬
2327Experimental: CRH administration----2件: 72, 78 💬
2328Experimental: GLP1-RA (exenatide) administration1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 72, 78 💬
2329Experimental: Seladelpar / MBX-8025 200 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
2330Experimental: Seladelpar / MBX-8025 50 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
2331Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS----1件: 13 💬
2332Extavia (interferon beta-1b), Novartis Pharma AG2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2333Extended release dipyridamole 200mg/aspirin 25mg2件: Acetylsalicylic acid,
Dipyridamole		2件: Aspirin ,
Dipyridamole 💬		4件: PDE4A,
PDE5A,
PTGS1,
PTGS2 💬		28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 49 💬
2334Extended release fampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2335Extended-release quetiapine fumarate1件: Quetiapine1件: Quetiapine 💬2件: DRD2,
HTR2A 💬		11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 13 💬
2336Ezetimibe + other lipid-lowering medication(s)1件: Ezetimibe1件: Ezetimibe 💬1件: NPC1L1 💬1件: Fat digestion and absorption 💬1件: 260 💬
2337F-18 AV 1451----2件: 5, 127 💬
2338F-18 FDG----1件: 127 💬
2339F-18 FEDAA1106 (BAY85-8101)----1件: 13 💬
2340F-18 FPCIT----1件: 6 💬
2341F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299 💬
2342Fabrazyme (agalsidase beta)1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2343Fabrazyme (agalsidase beta) 1 mg/kg1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2344FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2345FACS analyses----1件: 65 💬
2346FACTANE 200 IU/ml----1件: 288 💬
2347Factor XIIa antagonist monoclonal antibody----1件: 85 💬
2348Factor XIII Concentrate (Human), Pasteurized1件: Factor XIII (human)---1件: 288 💬
2349Fampridine-SR b.i.d. (Twice Daily)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2350FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2351Fang yi qing feng shi granule----1件: 46 💬
2352Fanhdi 100 UI FVIII-120 UI FVW----1件: 288 💬
2353Fanhdi 25 UI FVIII-30 UI FVW----1件: 288 💬
2354FANHDI 250UI*1F 250UI+F 10ML----1件: 288 💬
2355Fanhdi 50 UI FVIII-60 UI FVW----1件: 288 💬
2356FANHDI*INF FL 250UI+SIR SOLV+S----1件: 288 💬
2357FANHDI*INF FL 500UI+SIR SOLV+S----1件: 288 💬
2358FANHDI*INF FL1000UI+SIR SOLV+S----1件: 288 💬
2359FANHDI*INF FL250UI+SIR SOLV+S----1件: 288 💬
2360Fansidar (pyrimethamine and sulfadoxine)2件: Pyrimethamine,
Sulfadoxine		2件: Pyrimethamine ,
Sulfadoxine 💬		--1件: 65 💬
2361Faxe Kondi Free----1件: 257 💬
2362Fazisiran Injection----1件: 231 💬
2363Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
2364FDL176 & FDL169 coadministration1件: FDL169---1件: 299 💬
2365Fecal microbial transplant (FMT)----1件: 13 💬
2366Fecal Microbiota Transplant (FMT)----2件: 96, 97 💬
2367Fecal Microbiota Transplantation (FMT)----2件: 96, 97 💬
2368Fecal Microbiota Transplantation (FMT), OpenBiome----1件: 97 💬
2369Fecal Microbiota Transplantation by Intra-rectal enemas----1件: 97 💬
2370Fendrix suspension for injection1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
2371Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
2372Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine1件: Fenfluramine1件: Fenfluramine 💬5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 144 💬
2373Fengshigutong Capsule plus Imrecoxib1件: Imrecoxib---1件: 271 💬
2374Fenofibrate Combined With Ursodeoxycholic Acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: Fenofibrate ,
Ursodiol 💬		2件: NR1H4,
PPARA 💬		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
2375Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: Fenofibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
2376Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		2件: Fentanyl ,
Dexmedetomidine 💬		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
2377Ferrograd Folic Tablets----1件: 46 💬
2378Ferulic acid1件: Ferulic acid---1件: 127 💬
2379Fetal porcine cells, Neurocell-PD----1件: 6 💬
2380FG-3019 10mg/mL in 10 mL vials----1件: 85 💬
2381Fibrinogen (coagulation factorI)1件: Fibrinogen human---1件: 65 💬
2382Fibrinogen Concentrate from Human Plasma1件: Fibrinogen human---1件: 65 💬
2383Fibrogammin® 1250----1件: 51 💬
2384Fibrogammin® P----1件: 288 💬
2385Fibrogammin®P, coagulation factor XIII concentrate (Human)1件: Factor XIII (human)---1件: 51 💬
2386Filamentous haemagglutinin adsorbed1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46 💬
2387Filgrastim, Alemtuzumab2件: Alemtuzumab,
Filgrastim		2件: Alemtuzumab ,
Filgrastim 💬		2件: CD52,
CSF3R 💬		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
2388Finely ground flaxseed powder1件: Flax seed---1件: 299 💬
2389Fingolimob (FTY)----1件: 13 💬
2390Fingolimod (FTY720)1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 156 💬
2391Firategrast (USAN approved name)1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
2392Firategrast immediate release tablet1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
2393FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE1件: Amifampridine1件: Amifampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11 💬
2394Fish oil, gamma-linolenic acid3件: Fish oil,
Gamolenic acid,
alpha-Linolenic acid		1件: Gamolenic acid 💬--1件: 46 💬
2395FISH OIL, RICH IN OMEGA-3-ACIDS2件: Fish oil,
Omega-3 fatty acids		---1件: 13 💬
2396FISH OIL,RICH IN OMEGA 3 ACIDS1件: Fish oil---1件: 13 💬
2397FITC-Adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
2398FK506 level 2-3 ng/ml----1件: 86 💬
2399FK506 level 3-5 ng/ml----1件: 86 💬
2400FK506 level < 2 ng/ml----1件: 86 💬
2401FKB327 AI----1件: 46 💬
2402Flaxseed lignan-enriched complex (FLC)1件: Flax seed---1件: 97 💬
2403Flebogamma 5% DIF----1件: 65 💬
2404FLECAINIDE ACETATE2件: Acetate,
Flecainide		1件: Flecainide 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
2405FLOLAN injection with currently marketed diluent1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2406FLOLAN injection with reformulated diluent1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2407FLOLAN TM and Glycine Diluent2件: Epoprostenol,
Glycine		2件: Glycine ,
Epoprostenol 💬		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2408FLOLAN™ and Glycine Diluent2件: Epoprostenol,
Glycine		2件: Glycine ,
Epoprostenol 💬		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2409Florbetapir 18F Injection----1件: 127 💬
2410Florbetapir F 18----1件: 6 💬
2411Flortaucipir F181件: Flortaucipir1件: Flortaucipir F 18 💬1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127 💬
2412Flu-ATG----1件: 60 💬
2413Flucinolone acetonide----1件: 56 💬
2414Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin1件: Floxacillin 💬--1件: 299 💬
2415Fludarabina Accord1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
2416FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
2417FLUDARABINA FOSFATO1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
2418FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
2419Fludarabine (FLU)1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 60, 285 💬
2420Fludarabine, Busulfan, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
2421Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
2422Fludarabine, Melphalan, Thiotepa3件: Fludarabine,
Melphalan,
Thiotepa		3件: Melphalan ,
Thiotepa ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
2423Fludarabine/ melphalan2件: Fludarabine,
Melphalan		2件: Melphalan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
2424Fluimucil (acetylcysteine)1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 193 💬
2425Fluimucil® 600 mg effervescent tablets----1件: 85 💬
2426Fluocinolone Acetonide2件: Fluocinolone,
Fluocinolone acetonide		1件: Fluocinolone acetonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 90 💬
2427Fluorescence in situ hybridization----1件: 285 💬
2428FLUORINE (18F) FLUDEOXYGLUCOSE1件: Fludeoxyglucose1件: Fludeoxyglucose F 18 💬--2件: 84, 85 💬
2429Fluticasone Propionate, USP2件: Fluticasone,
Fluticasone propionate		2件: Fluticasone propionate ,
Fluticasone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2430FMT infusions----1件: 97 💬
2431Focetria (Monovalent MF59-Adjuvanted vaccine)----3件: 46, 49, 271 💬
2432Folic (or folinic) acid----1件: 46 💬
2433Folic acid1件: Folic acid1件: Folic acid 💬--5件: 6, 46, 49, 84, 296 💬
2434Folic acid (non-investigational product)1件: Folic acid1件: Folic acid 💬--1件: 46 💬
2435Folic acid or folate1件: Folic acid1件: Folic acid 💬--1件: 46 💬
2436Folic Acid, Vitamin B6, Vitamin B123件: Cyanocobalamin,
Folic acid,
Pyridoxine		6件: Folic acid ,
Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 ,
Pyridoxine 💬		--1件: 6 💬
2437Folic/folinic acid1件: Leucovorin2件: Folinic acid ,
Folinic acid calcium salt pentahydrate 💬		--2件: 46, 107 💬
2438Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6 💬
2439Folinic acid1件: Leucovorin2件: Folinic acid ,
Folinic acid calcium salt pentahydrate 💬		--3件: 46, 107, 320 💬
2440FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299 💬
2441FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----1件: 13 💬
2442Formoterol fumarate dihydrate1件: Formoterol1件: Formoterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
2443Formulation A----1件: 13 💬
2444Fortecortin Inject 40 mg Amp.----1件: 65 💬
2445Foscarbidopa and Foslevodopa2件: Foscarbidopa,
Foslevodopa		2件: Foslevodopa ,
Foscarbidopa 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2446Fospropofol (Lusedra®) 101件: Fospropofol---1件: 226 💬
2447Fospropofol (Lusedra®) 121件: Fospropofol---1件: 226 💬
2448Fospropofol (Lusedra®) 6.51件: Fospropofol---1件: 226 💬
2449Fostamatinib 50 mg blue film-coated tablet1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
2450Frameshift Array blood sample test----1件: 34 💬
2451Free amino acids intake1件: Amino acids---1件: 240 💬
2452Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45 💬
2453Fresh Frozen Plasma----1件: 5 💬
2454From August 2020 'no additional treatment'----1件: 51 💬
2455Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----1件: 19 💬
2456FSME-IMMUN----1件: 46 💬
2457FTI, AZLI----1件: 299 💬
2458Fully human anti-interferon gamma monoclonal antibody1件: Interferon Gamma---1件: 107 💬
2459Fully human IgG1 monoclonal antibody specific for TL1A----2件: 96, 97 💬
2460Fully human IgG2 lambda monoclonal antibody----1件: 172 💬
2461Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
2462Fully humanised, recombinant monoclonal antibody (IgG1)----1件: 96 💬
2463Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13 💬
2464Fumaderm® initial----1件: 49 💬
2465Fumaric acid1件: Fumaric acid1件: Fumaric acid 💬--1件: 13 💬
2466FURESTEM-RA Inj----1件: 46 💬
2467FURESTEM-RA Inj.----1件: 46 💬
2468Furosemide Injection1件: Furosemide1件: Furosemide 💬1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
2469FUSIDIC ACID1件: Fusidic acid1件: Fusidic acid 💬--1件: 299 💬
2470FXIIa inhibitor monoclonal antibody----1件: 85 💬
2471FXIII Concentrate (Human) (FXIII)----1件: 288 💬
2472G-CSF for Conditioning before HSCT.1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
2473G04BE03- Sildenafil - sildenafil (citrato)1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
2474G1XCGD transduced CD34+ cells----1件: 65 💬
2475G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)----1件: 13 💬
2476Ga-68-DOTA-NOC----1件: 84 💬
2477GA-GCB (velaglucerase alfa)1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
2478Gabapentin (neurontin® capsule 300mg) treatment1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
2479Gaboxadol monohydrate 0.5 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
2480Gaboxadol monohydrate 2 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
2481Gaboxadol monohydrate 5 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
2482Gadolinium For abdomen1件: Gadolinium---1件: 65 💬
2483Gadolinium For lower back1件: Gadolinium---1件: 65 💬
2484Gadoteric acid1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
2485GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado----1件: 13 💬
2486Gadovist 1.0 mmol/ml Injektionslösung1件: Gadobutrol1件: Gadobutrol 💬--1件: 13 💬
2487GALEN® tablet----2件: 43, 44 💬
2488Gallium nitrate2件: Gallium nitrate,
Nitrate		2件: Gallium nitrate ,
Nitric acid 💬		--1件: 299 💬
2489Gallium-68-DOTA-N-Octreotide1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
2490Gallium68-Dota-Noc----1件: 85 💬
2491Gamma interferon----1件: 18 💬
2492Gamma-Linolenic acid2件: Gamolenic acid,
alpha-Linolenic acid		1件: Gamolenic acid 💬--1件: 46 💬
2493Gamma-secretase/Notch signalling pathway inhibitor RO4929097----1件: 74 💬
2494Gammaplex (Intravenous immunoglobulin)----1件: 65 💬
2495Gammaplex, intravenous immunoglobulin----1件: 63 💬
2496Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)1件: Ganaxolone1件: Ganaxolone 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 152 💬
2497Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)1件: Ganaxolone1件: Ganaxolone 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 152 💬
2498GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO1件: Obinutuzumab1件: Obinutuzumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
2499GB-0998 (Intravenous immunoglobulin)----1件: 11 💬
2500GB0139 (previously known as TD139)----1件: 85 💬
2501GDNF & Synchro Med Infusion System----1件: 5 💬
2502Gene Activated a-Galactosidase A----1件: 19 💬
2503Gene Activated Human Glucocerebrosidase----1件: 19 💬
2504Gene activated human glucocerebrosidase, velaglucerase alfa1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
2505Gene analysis----1件: 79 💬
2506Gene Therapy Method for CGD----1件: 65 💬
2507Gene Therapy product:vMCO-I----1件: 90 💬
2508Gene transduced PBL and/or gene transduced HSC----1件: 65 💬
2509Gene-Activated Human Glucocerebrosidase----1件: 19 💬
2510Gene-Activated Human Glucocerebrosidase 200U/vial----1件: 19 💬
2511Gene-Activated Human Glucocerebrosidase 400U/vial----1件: 19 💬
2512Gene-modified autologous fibroblasts----1件: 36 💬
2513Gene-modified autologous stem cells----1件: 285 💬
2514Gene-Transduced Autologous CD34+ Stem Cells----1件: 65 💬
2515General anesthesia----1件: 6 💬
2516Genetic analyses----1件: 19 💬
2517Genetic analysis----6件: 34, 85, 90, 93, 94, 96 💬
2518Genetic analysis by SANGER and WHOLE EXOME NEXT GENERATION SEQUENCING----1件: 84 💬
2519Genetically corrected cultured epidermal autograft (ATMP)----1件: 36 💬
2520Genetically modified autologous blood stem cells----1件: 65 💬
2521Genicular nerve block----1件: 107 💬
2522Genistein (Unconjugated Isoflavones 100)1件: Genistein1件: Genistein 💬--1件: 299 💬
2523Genistein aglycone1件: Genistein1件: Genistein 💬--1件: 19 💬
2524Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg----1件: 299 💬
2525Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin)1件: Somatotropin---1件: 78 💬
2526Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin)1件: Somatotropin---1件: 78 💬
2527Genotropin (PN-180,307) Somatropin1件: Somatotropin---1件: 78 💬
2528GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made.1件: Somatotropin---1件: 193 💬
2529GENOTROPIN 12 mg powder and solvent for solution for injection.1件: Somatotropin---1件: 78 💬
2530Genotropin 5.3 mg in injection system Genotropin pen1件: Somatotropin---1件: 78 💬
2531Genotropin miniquick 0.5 mg, injection----1件: 78 💬
2532Genotropin, Genotropin MiniQuick1件: Somatotropin---1件: 78 💬
2533Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms----1件: 11 💬
2534Gentamicin infusions twice a week for six months1件: Gentamicin1件: Gentamicin 💬--1件: 113 💬
2535Gentamicin sulfate 0.1% ointment2件: Gentamicin,
Sulfate ion		1件: Gentamicin 💬--1件: 36 💬
2536Gentamicin Sulfate, Injectable2件: Gentamicin,
Sulfate ion		1件: Gentamicin 💬--1件: 36 💬
2537Genz-682452-AA1件: Venglustat1件: Venglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2538Genz-682452-AU1件: Venglustat1件: Venglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 6, 19, 67 💬
2539GFI 38518168-AEK-B-007----1件: 46 💬
2540GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2541GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2542GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2543GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2544Gilenya / Imusera1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2545Ginkgo biloba pills sig: 300mg/tid1件: Ginkgo biloba---1件: 90 💬
2546Givinostat (idrocloruro monoidrato)1件: Givinostat---1件: 113 💬
2547Givosiran (ALN-AS1)1件: Givosiran1件: Givosiran 💬1件: ALAS1 💬4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254 💬
2548Glargine insulin----1件: 299 💬
2549GLATIRAMER ACETATE2件: Acetate,
Glatiramer		---3件: 13, 96, 156 💬
2550Glatiramer Acetate (Copaxone®)2件: Acetate,
Glatiramer		---2件: 13, 156 💬
2551Glatiramer Acetate (DB)2件: Acetate,
Glatiramer		---1件: 13 💬
2552Glatiramer Acetate (GA)2件: Acetate,
Glatiramer		---1件: 13 💬
2553Glatiramer Acetate (GA) 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
2554Glatiramer Acetate (GTR)2件: Acetate,
Glatiramer		---1件: 13 💬
2555Glatiramer Acetate (OL)2件: Acetate,
Glatiramer		---1件: 13 💬
2556Glatiramer acetate 150mg enteric coated tablets2件: Acetate,
Glatiramer		---1件: 13 💬
2557Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets2件: Acetate,
Glatiramer		---1件: 13 💬
2558Glatiramer acetate 20 mg2件: Acetate,
Glatiramer		---1件: 13 💬
2559Glatiramer acetate 20 mg, with mitoxantrone3件: Acetate,
Glatiramer,
Mitoxantrone		1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
2560Glatiramer Acetate 20 mg/0.5 mL2件: Acetate,
Glatiramer		---1件: 13 💬
2561Glatiramer acetate 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
2562Glatiramer Acetate [GA]2件: Acetate,
Glatiramer		---1件: 13 💬
2563Glatiramer acetate injection with oral cetirizine hydrochloride3件: Acetate,
Cetirizine,
Glatiramer		1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
2564Glatiramer acetate with minocycline3件: Acetate,
Glatiramer,
Minocycline		1件: Minocycline 💬--1件: 13 💬
2565Glatiramer acetate, (Copaxone®)2件: Acetate,
Glatiramer		---1件: 13 💬
2566Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b2件: Acetate,
Glatiramer		---1件: 13 💬
2567Glatiramer Acetate, N-Acetylcysteine3件: Acetate,
Acetylcysteine,
Glatiramer		1件: Acetylcysteine 💬--1件: 13 💬
2568GLATIRAMER ACETATO1件: Glatiramer---1件: 13 💬
2569GLATIRAMERO ACETATO----1件: 13 💬
2570Glentek 50 mg compresse rivestite con film----1件: 18 💬
2571Glentek 50 mg film-coated tablets----1件: 18 💬
2572Glial cell line-derived neurotrophic factor----1件: 6 💬
2573Glial Cell Line-Derived Neurotrophic Factor (GDNF)----1件: 6 💬
2574Glivec 100 mg Filmtabletten1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 51, 86 💬
2575Glivec® 100 mg Filmtabletten1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
2576Global DNA methylation will be quantified in the DNA samples by colorimetry----1件: 63 💬
2577GLPG2451 dose regimen A----1件: 299 💬
2578GLPG3970 film-coated tablet----1件: 49 💬
2579GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO----1件: 19 💬
2580Glucocorticoid + cytoxan----1件: 222 💬
2581Glucocorticoid + tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
2582Glucocorticoid Agent----1件: 46 💬
2583Glucocorticoid combined with cyclophosphamide induction + maintenance1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 222 💬
2584Glucocorticoids (permitted,not necessary)----1件: 46 💬
2585Glucocorticoids - Reduced Dose----2件: 43, 44 💬
2586Glucocorticoids - Standard Dose----2件: 43, 44 💬
2587Glucose intake1件: Dextrose, unspecified form---1件: 257 💬
2588Glucosidase alfa----1件: 256 💬
2589Glutamate and aspartate----1件: 13 💬
2590Gluten-free diet----1件: 94 💬
2591Glycolic acid1件: Glycolic acid---1件: 65 💬
2592GlycosBio Nutritional Supplement----1件: 299 💬
2593Glycyrrhetinic Acid----1件: 63 💬
2594GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.)----1件: 299 💬
2595GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)1件: Sargramostim1件: Sargramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
2596GM-CSF inhalation therapy----1件: 229 💬
2597GM-CSF, fosfomycin and metronidazole2件: Fosfomycin,
Metronidazole		2件: Metronidazole ,
Fosfomycin 💬		--1件: 97 💬
2598GMA301 Injection----1件: 86 💬
2599GNbAC1 Monoclonal Antibody----1件: 13 💬
2600GnRH agonist1件: Gonadorelin1件: Gonadorelin 💬1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
2601Gold Nanocrystals1件: Gold---3件: 2, 6, 13 💬
2602Golimumab 100 mg injections1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2603Golimumab 2 mg/kg IV1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2604Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
2605Golimumab 50 mg injections1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2606Golimumab Final Vialed Product (FVP)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2607Golimumab Injection1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2608Golimumab Intravenous1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2609Golimumab Intravenous (IV)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2610Golimumab liquid in prefilled pen1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2611Golimumab liquid in prefilled pen or Prefilled Syringe1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2612Golimumab Liquid in prefilled syringe1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 84, 97, 107 💬
2613Golimumab Liquid in Vial1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 97, 271 💬
2614Golimumab Pre-Filled Syringe1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
2615Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]1件: Golodirsen1件: Golodirsen 💬1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
2616GP2013 - A Proposed biosimilar rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
2617GP2017 (adalimumab biosimilar)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2618GR181413A/AT1001 capsule----1件: 19 💬
2619GR181413A/AT1001 solution----1件: 19 💬
2620Graft intracerebral of foetal neurons----1件: 8 💬
2621Graft-versus-tumor induction therapy----2件: 60, 285 💬
2622GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)1件: Lenograstim1件: Lenograstim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 57 💬
2623Granulocyte - colony stimulating factor (G-CSF)1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 2 💬
2624Granulocyte Colony Stimulating Factor1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬6件: 2, 28, 36, 57, 65, 85 💬
2625Granulocyte colony stimulating factor (G-CSF)1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
2626Granulocyte Colony Stimulating Factor (GCSF)1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬2件: 36, 57 💬
2627Granulocyte Colony-Stimulating Factor----1件: 296 💬
2628Granulocyte colony-stimulating factor (Filgrastim)1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 113 💬
2629Granulocyte-colony stimulating factor (G-CSF) and prednisone2件: Filgrastim,
Prednisone		2件: Prednisone ,
Filgrastim 💬		2件: CSF3R,
NR3C1 💬		6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 13 💬
2630Granulocyte-macrophage colony stimulating factor (GM-CSF)----1件: 229 💬
2631Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)----1件: 11 💬
2632Group 1- Control Diet----1件: 97 💬
2633Group 2- UCD Diet----1件: 97 💬
2634Group 3: ustekinumab approximately 6 mg/kg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
2635Group AD Anti-PD + Antidepressant----1件: 6 💬
2636Group R+AD Rasagiline + Antidepressant1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
2637Growth hormone (Genotonorm® or Omnitrope®)1件: Somatotropin---2件: 78, 193 💬
2638Growth hormone (Nutropin)1件: Somatotropin---1件: 78 💬
2639Growth hormone - LB030021件: Somatotropin---1件: 78 💬
2640Growth hormone administration for 6 months1件: Somatotropin---1件: 78 💬
2641Growth hormone releasing hormone (GHRH) 1-442件: Somatorelin,
Somatotropin		1件: Somatorelin 💬1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 78 💬
2642Growth hormone releasing hormone (GHRH) and arginine3件: Arginine,
Somatorelin,
Somatotropin		2件: Arginine ,
Somatorelin 💬		1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 78 💬
2643Growth hormone replacement therapy in growth hormone deficient patients only.1件: Somatotropin---1件: 78 💬
2644Growth Hormone, GH1件: Somatotropin---1件: 78 💬
2645GS-5745 IV1件: GS-5745---1件: 97 💬
2646GSK1265744B (sodium salt) containing 14C-GSK1265744B----1件: 265 💬
2647GSK1550188 IV----1件: 49 💬
2648GSK1605786 ChemoCentryx: formulation A----1件: 96 💬
2649GSK1605786 GSK direct-fill: formulation C----1件: 96 💬
2650GSK1605786 GSK modified-process: formulation D----1件: 96 💬
2651GSK1605786 GSK tablet: formulation E----1件: 96 💬
2652GSK1605786 GSK: formulation B----1件: 96 💬
2653GSK2018682 CD3 non-micronised Tablet----1件: 13 💬
2654GSK2018682 CD3 non-micronised Tablet in fed state----1件: 13 💬
2655GSK2330811 Solution for Injection, 100mg/ml----1件: 51 💬
2656GSK2586184 800mg single and repeat dose----1件: 49 💬
2657GSK2586184 new formulation----1件: 49 💬
2658GSK2586184 standard formulation----1件: 49 💬
2659GSK2831781 - Double Blind Phase----1件: 97 💬
2660GSK2831781 - Open Label phase----1件: 97 💬
2661GSK2982772A, where A denotes the free base----2件: 46, 97 💬
2662GSK3008348 Nebuliser solution----1件: 85 💬
2663GSK315234 Injection 100mg/mL----1件: 46 💬
2664GTA: Glyceryltriacetate----1件: 307 💬
2665GTR.ace----1件: 13 💬
2666GTX-102 high dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
2667GTX-102 low dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
2668GTX-102 medium dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
2669GTX-102 medium dose slow Period 1 and Period 21件: GTX-102---1件: 65 💬
2670GUANABENZ ACETATO1件: Guanabenz1件: Guanabenz 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 2 💬
2671Gum Arabic1件: Acacia1件: Acacia 💬--1件: 46 💬
2672Guna-Anti Interleukin 1----1件: 46 💬
2673Guna-Antiinterleukin 1 alfa----1件: 46 💬
2674Guna-Antiinterleukin 1 beta----1件: 46 💬
2675Guna-Interleukin 10----1件: 46 💬
2676Guna-Interleukin 4----1件: 46 💬
2677Gusperimus + glucocorticoids1件: Gusperimus1件: Gusperimus 💬--1件: 44 💬
2678GYPP-06 (GKT137831 free base), C10071301-D----1件: 93 💬
2679GZ402671 / SAR402671----1件: 19 💬
2680H-ATG (ATGAM )1件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2681H.P. Acthar Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 46, 49, 50, 84, 222 💬
2682H.P. Acthar Gel (repository corticotropin injection)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
2683H.P. Acthar® Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14 💬
2684H02 - Corticosteroidi Sistemici----1件: 299 💬
2685HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----2件: 6, 49 💬
2686HA20 (IMMU-106)----1件: 46 💬
2687Haemate P® (Human Coagulation Factor VIII)2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
2688Haemate-P, Wilate1件: Von Willebrand factor human---1件: 288 💬
2689Haemate® P 250----1件: 288 💬
2690Haemocomplettan(R) P----1件: 65 💬
2691Haemocomplettan(R) P 1g/2g----1件: 65 💬
2692HAEMOPHILUS INFLUENZAE----3件: 61, 62, 66 💬
2693Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 60 💬
2694HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---5件: 2, 6, 13, 14, 46 💬
2695HBM9161 Dose A----1件: 63 💬
2696HBM9161 Injection----1件: 13 💬
2697HBM9161 Injection (340 mg)----1件: 11 💬
2698HBM9161 Injection (680mg and 340 mg)----1件: 11 💬
2699HBM9161 Injection (680mg)----1件: 11 💬
2700HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA)1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
2701HBVAXPRO® 40 micrograms1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
2702HCQ/CQ and CAB combined treatment----1件: 74 💬
2703Helium / oxygen mixed gas inhalation therapy2件: Helium,
Oxygen		2件: Oxygen ,
Helium 💬		--1件: 330 💬
2704Hematide, peginesatide1件: Peginesatide1件: Peginesatide 💬1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
2705Hematopoietic stem cell infusion----2件: 19, 20 💬
2706Heme arginate1件: Heme arginate---1件: 254 💬
2707Hemin for injection1件: Hemin1件: Hemin 💬2件: ALAS1,
ALAS2 💬		4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254 💬
2708Heparin & Alkalinized Lidocaine Bladder Instillation2件: Heparin,
Lidocaine		3件: Lidocaine ,
Adomiparin ,
Lidocaine hydrochloride monohydrate 💬		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226 💬
2709Heparin 25mg inhalation powder, hard capsule1件: Heparin1件: Adomiparin 💬1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 299 💬
2710Heparán N sulfatasa humana recombinante----1件: 19 💬
2711Heparán N sulfatasa humana recombinante (rhHNS)----1件: 19 💬
2712HepaStem Infusion----1件: 251 💬
2713Hepatitis A Vaccine1件: Hepatitis A Vaccine---3件: 46, 96, 97 💬
2714Hepatitis A vaccine ( HAVRIX or EPAXAL)1件: Hepatitis A Vaccine---1件: 46 💬
2715Hepatitis A vaccine and tetanus vaccine1件: Hepatitis A Vaccine---1件: 46 💬
2716HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN)----1件: 46 💬
2717Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)1件: Reynoutria multiflora root---1件: 6 💬
2718Herpes Zoster Subunit (HZ/su) Vaccine----1件: 49 💬
2719Heterologous Human Adult Liver-derived Progenitor Cells----1件: 251 💬
2720Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC)----1件: 251 💬
2721HGH-hyFc, recombinant human growth hormone1件: Somatotropin---1件: 78 💬
2722HGH-ViaDerm™ System (hGH or somatropin)1件: Somatotropin---1件: 78 💬
2723HGS1006, LymphoStat-B----1件: 53 💬
2724HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 49, 53 💬
2725HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen---3件: 61, 62, 66 💬
2726Hidrocloruro de fingolimod1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
2727High cheese intake.----1件: 238 💬
2728High dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
2729High dose ANAVEX2-73----1件: 6 💬
2730High Dose Aspirin (1300 mg/day)1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
2731High Fiber supplement----1件: 6 💬
2732High milk intake.----1件: 238 💬
2733High protein high fiber diet----2件: 93, 95 💬
2734High Protein. T-Diet plus Range----1件: 6 💬
2735High water intake1件: Water1件: Water 💬--1件: 67 💬
2736High-caloric fatty diet----1件: 2 💬
2737High-dose intravenous immunoglobulin (IVIG)----1件: 18 💬
2738High-dose intravenous immunoglobulin (Venoglobulin-IH)----1件: 51 💬
2739High-dose vitamin D (2000 IU per day)1件: Vitamin D---1件: 274 💬
2740Hiomega-3 supplement of Naturalis® company -----1件: 49 💬
2741Histone Deacetylase Inhibitor----1件: 127 💬
2742Histrelin Subcutaneous Implant1件: Histrelin1件: Histrelin 💬1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
2743HIV Anti-retroviral Background Therapy----1件: 265 💬
2744HLA-identical allogeneic mesoangioblasts----1件: 113 💬
2745HLL2 (trivial name or chemical description)----1件: 49 💬
2746HLL2,IMMU-103----1件: 49 💬
2747HM71224 food effect----1件: 46 💬
2748HM71224 Multiple ascending dose----1件: 46 💬
2749HM71224 single ascending dose----1件: 46 💬
2750HMED-IdeS1件: Imlifidase1件: Imlifidase 💬--2件: 64, 221 💬
2751HMG-Coenzyme inhibitor (statin)----1件: 218 💬
2752Homeostasis Model Assessment of insulin resistance (HOMA)----1件: 17 💬
2753HORA-PDE6B (AAV2/5.hPDE6B)----1件: 90 💬
2754Horse anti-thymocyte globulin1件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2755Horse anti-thymocyte globulin (ATG)1件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2756Horse anti-thymocyte globulin (hATG)1件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2757Horse-Anti-thymocyte-Globulin----1件: 60 💬
2758Hourly dosing of the nychtemeral secretion of melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
2759HPC cell infusion----1件: 45 💬
2760HrIL-2 active----3件: 46, 49, 53 💬
2761Hu Leptin (A-100)1件: Leptin---1件: 265 💬
2762HUC-MSC + DMARDs----1件: 46 💬
2763HuCNS-SC transplant in the lead-in phase----1件: 139 💬
2764Humalog Mix50 100 U/ml sospensione iniettabile----1件: 78 💬
2765Human acylated ghrelin1件: Lenomorelin---1件: 78 💬
2766Human albumin1件: Albumin human1件: Albumin human 💬--2件: 2, 96 💬
2767HUMAN ALBUMIN AS MACROAGGREGATES1件: Albumin human1件: Albumin human 💬--1件: 96 💬
2768HUMAN ALBUMIN SOLUTION1件: Albumin human1件: Albumin human 💬--1件: 2 💬
2769Human allogeneic adipose tissue-derived mesenchymal stem cells expanded----1件: 36 💬
2770Human Allogeneic WJ-MSCs1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36 💬
2771Human anti TNF-alpha monoclonal----1件: 46 💬
2772Human anti TNF-alpha monoclonal antibody----2件: 46, 84 💬
2773Human anti-IL 12/23 monoclonal antibody----1件: 84 💬
2774Human Anti-IL-12 Antibody----1件: 96 💬
2775Human anti-IL-12 IgG1 Mab----1件: 13 💬
2776Human anti-IL-12 Mab----1件: 13 💬
2777Human anti-IL6 monoclonal antibody----1件: 46 💬
2778Human anti-IP10 monoclonal antibody----2件: 96, 97 💬
2779Human anti-LINGO-1 monoclonal antibody----1件: 13 💬
2780HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY----1件: 3 💬
2781Human Anti-TNF IgG1 Monoclonal Antibody----3件: 46, 97, 271 💬
2782Human anti-TNF-alpha monoclonal antibody----3件: 46, 97, 107 💬
2783Human anti-TNFa monoclonal antibody----1件: 271 💬
2784Human Anti-TNFalfa----3件: 46, 97, 271 💬
2785Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody----1件: 51 💬
2786Human autologous mesenchymal stem cells----2件: 2, 13 💬
2787HUMAN COAGULATION FACTOR VIII2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
2788Human coagulation Factor VIII / von Willebrand Factor3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
2789Human coagulation factor VIII associated with Von Willebrand factor (VWF)3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
2790Human Coagulation Factor VIII, Von Willebrand Factor3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
2791HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
2792HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
2793Human Coagulation FACTOR X1件: Coagulation factor X human---1件: 288 💬
2794Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh----1件: 36 💬
2795Human factor X1件: Coagulation factor X human---1件: 288 💬
2796Human fetal-derived Neural Stem Cells (hNSCs)----1件: 13 💬
2797HUMAN FIBRINOGEN1件: Fibrinogen human---1件: 65 💬
2798Human Fibrinogen Concentrate1件: Fibrinogen human---1件: 65 💬
2799Human fibroblast-derived dermal substitute, Dermagraft----1件: 36 💬
2800Human glucocerebrosidase gene into autologous peripheral blood stem cells----1件: 19 💬
2801Human heterologous liver cells (for infusion)----1件: 251 💬
2802Human IgG1 monoclonal antibody against alpha-synuclein----1件: 17 💬
2803HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY----1件: 60 💬
2804Human IgG4 monoclonal antibody against CD40----1件: 46 💬
2805Human Immunglobulin G (IgG)----1件: 65 💬
2806Human Immunoglobulin----2件: 63, 65 💬
2807HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65 💬
2808Human insulin1件: Insulin human1件: Insulin human 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬2件: 96, 156 💬
2809Human interferon beta1件: Human interferon beta---2件: 13, 26 💬
2810Human interferon beta 1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2811Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2812Human interleukin-21件: Human interleukin-2---1件: 35 💬
2813HUMAN LEUCOCYTE INTERFERON-ALPHA----1件: 13 💬
2814Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40----1件: 96 💬
2815Human monoclonal antibody (CNTO 1275) to interleukin-12p40----1件: 13 💬
2816Human monoclonal antibody directed against CD20 on B-cells----1件: 46 💬
2817Human monoclonal antibody directed against complement 5 protein----1件: 62 💬
2818Human neural stem cell----1件: 6 💬
2819Human Neural Stem Cells----2件: 2, 13 💬
2820Human normal 10% immunoglobulin for intravenous administration----1件: 14 💬
2821Human normal 10% immunoglobulin for intravenous administrationn----1件: 14 💬
2822Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
2823HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65 💬
2824Human normal immunoglobulin (IVIg)1件: Human immunoglobulin G---3件: 14, 50, 65 💬
2825Human normal immunoglobulin (SCIg)1件: Human immunoglobulin G---1件: 14 💬
2826Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)1件: Human immunoglobulin G---1件: 65 💬
2827Human normal immunoglobulin (subcutaneous)1件: Human immunoglobulin G---1件: 65 💬
2828HUMAN NORMAL IMMUNOGLOBULIN FOR1件: Human immunoglobulin G---1件: 65 💬
2829Human normal immunoglobulin for intravenous (IV) administration1件: Human immunoglobulin G---1件: 51 💬
2830Human normal immunoglobulin for intravenous administration1件: Human immunoglobulin G---3件: 14, 51, 65 💬
2831HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE1件: Human immunoglobulin G---2件: 63, 65 💬
2832Human normal immunoglobulin for intravenous use (IVIG)1件: Human immunoglobulin G---1件: 65 💬
2833HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE1件: Human immunoglobulin G---1件: 63 💬
2834Human normal immunoglobulin for subcutaneous administration1件: Human immunoglobulin G---2件: 51, 65 💬
2835Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)1件: Human immunoglobulin G---1件: 65 💬
2836Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65 💬
2837Human normal immunoglobulin G (IgG)1件: Human immunoglobulin G---1件: 11 💬
2838Human normal immunoglogulin (IVIg)1件: Human immunoglobulin G---1件: 50 💬
2839Human Placenta-Derived Cells PDA001 Intravenous Infusion----1件: 96 💬
2840HUMAN PLASMA FOR FRACTIONATION----1件: 96 💬
2841Human primary Retinal Pigment Epithelial (HuRPE) cells----1件: 90 💬
2842Human Recombinant IgG1, lambda----1件: 46 💬
2843Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein1件: Alkaline Phosphatase---1件: 172 💬
2844Human serum albumin1件: Albumin human1件: Albumin human 💬--1件: 78 💬
2845HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)2件: Albumin human,
Somatotropin		1件: Albumin human 💬--1件: 78 💬
2846Human Serum Albumin (HSA) fused to somatropin2件: Albumin human,
Somatotropin		1件: Albumin human 💬--1件: 78 💬
2847Human soluble recombinant Fc-gamma receptor IIB----1件: 66 💬
2848Human T Lymphoid Progenitor (HTLP) injection----1件: 65 💬
2849Human TH-SC01 cell injection----1件: 96 💬
2850Human Transthyretin Antisense Oligonucleotide----1件: 28 💬
2851Human umbilical cord derived MSC transplantation for SLE----1件: 49 💬
2852Human umbilical cord mesenchymal stem cell injection----1件: 85 💬
2853HUMAN VON WILLEBRAND FACTOR1件: Von Willebrand factor human---1件: 288 💬
2854Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII)2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
2855Human VWF/FVIII concentrate----1件: 288 💬
2856Humanised anti-CD 20 antibody----1件: 46 💬
2857Humanised anti-CD4 IgG1 monoclonal----1件: 46 💬
2858Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2----1件: 49 💬
2859Humanised IgG1 monoclonal antibody against human eotaxin-2----1件: 94 💬
2860Humanised IgG1K monoclonal antibody against interferon beta1件: Human interferon beta---1件: 50 💬
2861Humanized anti-alpha v beta 6 mAb----1件: 85 💬
2862Humanized IgG1 kappa antiamyloid----1件: 28 💬
2863Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody----1件: 28 💬
2864Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody----1件: 46 💬
2865Humanized recombinant IgG4 monoclonal antibody against CD-127----1件: 97 💬
2866Humanized TNFa monoclonal antibody----1件: 46 💬
2867Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten1件: Somatotropin---1件: 193 💬
2868Humatrope® 6 mg, powder and solvent for solution for injection1件: Somatotropin---1件: 78 💬
2869HuMax-CD38, 3003-005----1件: 28 💬
2870Humira (adalimumab original)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
2871HUMIRA (ADALIMUMAB)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
2872Humira (adalimumab) 40 mg in 0.4 ml s.c. injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2873Humira (adalimumab) 40 mg s.c. injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2874Humira (adalimumab) 40mg in 0.4 ml s.c. injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2875Humira (adalimumab) 40mg in 0.4ml s.c.injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2876HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 56, 97 💬
2877HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2878HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
2879Humira 20 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2880Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
2881Humira 40 mg injekcní roztok v predplnené injekcní stríkacce1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2882Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte----1件: 46 💬
2883HUMIRA 40 mg solución inyectable en jeringa precargada1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
2884Humira 40 mg solution for injection in pre-filled pen1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2885Humira 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
2886Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
2887Humira 40 mg solution for injection in pre-filled syringes----1件: 97 💬
2888Humira 40 mg/0.8 ml solution for injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
2889Humira 40 mg/0.8 ml solution for injection for paediatric use1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
2890Humira 40mg Injektionslösung----1件: 46 💬
2891HUMIRA 40Mg Solution for Injection----2件: 96, 97 💬
2892Humira 40mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2893Humira 40mg solution for injection in pre-filled syringe (adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2894Humira 40mg/0.4ml pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2895Humira 40mg/0.8 ml solution for injection for paediatric use1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2896Humira 40mg/0.8ml solution for injection for paediatric use1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2897Humira 40mg/0.8ml solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2898Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
2899Humira pre-filled PEN1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2900Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2901HUMIRA*SC 2SIR+F 40MG 0,8ML+2T1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
2902Humira, 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2903Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2904Humira® (adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2905Humira® 40 mg Injektionslösung in Fertigspritze1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2906Humira® 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2907Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2908Hyaluronic acid1件: Hyaluronic acid1件: Hyaluronic acid 💬--5件: 46, 53, 70, 226, 231 💬
2909Hyaluronic Acid and Chondroitin Sulfate3件: Chondroitin sulfate,
Hyaluronic acid,
Sulfate ion		1件: Hyaluronic acid 💬--1件: 226 💬
2910Hyaluronic Acid Inhalation Solution1件: Hyaluronic acid1件: Hyaluronic acid 💬--1件: 231 💬
2911Hyaluronic acid/chondroitin sulfate3件: Chondroitin sulfate,
Hyaluronic acid,
Sulfate ion		1件: Hyaluronic acid 💬--1件: 226 💬
2912Hyaluronidase injected intradermally1件: Hyaluronidase3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--1件: 51 💬
2913Hydrochlorothiazide/amiloride2件: Amiloride,
Hydrochlorothiazide		2件: Hydrochlorothiazide ,
Amiloride 💬		4件: SCNN1A,
SCNN1B,
SCNN1G,
SLC12A3 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 225 💬
2914Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----1件: 83 💬
2915HYDROCORTISONE ACETATE3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2916Hydrocortisone cream 10mg/g FNA Fagron1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
2917Hydrocortisone sodium acetate3件: Acetate,
Hydrocortisone,
Sodium acetate		2件: Hydrocortisone ,
Sodium acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2918Hydrocortisone TAKEDA, tabletter1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
2919HYDROCORTISONE- hydrocortisone tablet1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2920Hydrokortison APL kapsel 2,5 mg----1件: 83 💬
2921Hydroxychloroquine + low-dose prednisone2件: Hydroxychloroquine,
Prednisone		2件: Prednisone ,
Hydroxychloroquine 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
2922Hydroxychloroquine + Prednisone2件: Hydroxychloroquine,
Prednisone		2件: Prednisone ,
Hydroxychloroquine 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
2923Hydroxychloroquine Sulfate 100 milligram (mg) Tab2件: Hydroxychloroquine,
Sulfate ion		1件: Hydroxychloroquine 💬--1件: 218 💬
2924Hydroxypropyl-ß-cyclodextrin----1件: 19 💬
2925HYNR-CS inj----1件: 2 💬
2926HYNR-CS-Allo----1件: 2 💬
2927HYNRCS-Allo inj----1件: 2 💬
2928Hyperglycemic Clamp with concurrent GIP infusion----1件: 299 💬
2929Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299 💬
2930Hyperimmune caprine serum against HIV lysate----1件: 13 💬
2931Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment1件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 85 💬
2932Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment1件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 85 💬
2933Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299 💬
2934Hypertonic saline 6% -----1件: 299 💬
2935HyQvia 100 mg/ml solution for infusion for subcutaneous use2件: Human immunoglobulin G,
Hyaluronidase (human recombinant)		---1件: 65 💬
2936I-123-5-IA853801件: Iodide I-123---1件: 6 💬
2937I-123] ADAM1件: Iodide I-123---1件: 2 💬
2938I-FACTOR----1件: 70 💬
2939I.v. immunoglobulins----1件: 151 💬
2940I.v. selexipag1件: Selexipag1件: Selexipag 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2941I124-AT01 only----1件: 28 💬
2942I2S-IT----1件: 19 💬
2943Ibandronate+alfacalcidol+calcium3件: Alfacalcidol,
Calcium,
Ibandronate		1件: Alfacalcidol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
2944Ibandronic acid1件: Ibandronate---1件: 274 💬
2945Iberogast N----1件: 97 💬
2946Ibuprofen Sandoz 400 mg Filmtabletten1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
2947ICG-guided bowel perfusion assessment----1件: 96 💬
2948ICI 182,780 (Faslodex)1件: Fulvestrant1件: Fulvestrant 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
2949Idebenone 150 mg film-coated tablets1件: Idebenone1件: Idebenone 💬--1件: 113 💬
2950IDEC-C2B8, Ro 45-2294----1件: 64 💬
2951Identification of COMT HH, COMT HL or COMT LL genes----1件: 6 💬
2952IDPM: Inhaled Dry Powder Mannitol1件: Mannitol1件: Mannitol 💬--1件: 299 💬
2953IDROCORTISONE ACETATO----1件: 97 💬
2954IDROCORTISONE ACETATO DYNACREN - 1 % CREMA 1 TUBO DA 30 G----1件: 272 💬
2955IDROCORTISONE ACETATO DYNACREN 1% CREMA----1件: 272 💬
2956IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR----1件: 19 💬
2957Idursulfase (I2S)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2958Idursulfase (I2S)-IT1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2959Idursulfase IT (1 mg)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2960Idursulfase IT (10 mg)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2961Idursulfase IT (30 mg)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2962Idursulfase(12S)-IT1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2963Idursulfase(I2S)-IT1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2964Idursulfase-IT1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2965IFA Incomplete Freund's Adjuvant----1件: 13 💬
2966IFN ß-1a----1件: 13 💬
2967IFN-a 2b Kinoid Drug Substance----1件: 49 💬
2968IFN-a2b Kinoid----1件: 49 💬
2969IFN-beta-1a, (Avonex®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2970IFN-ß-1a (Rebif®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2971IFN-ß-1a, (Avonex®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2972Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set----2件: 63, 65 💬
2973IgG IL2/RO7049665----1件: 95 💬
2974IgG Next Generation----2件: 63, 65 💬
2975IgG Next Generation (BT595)----1件: 65 💬
2976IGG2 ANTIBODIES----1件: 96 💬
2977IGIV, 10%----2件: 14, 65 💬
2978IGSC 20% 150 mg/kg----1件: 65 💬
2979IGSC 20% daily push versus 2 times per week pump----1件: 65 💬
2980IGSC 20% daily push versus every 2 weeks pump----1件: 65 💬
2981IGSC 20% daily push versus once a week pump----1件: 65 💬
2982IGSC 20% infusion----1件: 65 💬
2983IGSC, 16%----1件: 65 💬
2984IGSC, 20%----1件: 65 💬
2985IGVENA*FL 200ML 10G+SET----2件: 14, 50 💬
2986IL-6 receptor inhibitor, humanized monoclonal antibody----1件: 46 💬
2987IL-6 receptor inhibitor, recombinant humanized monoclonal antibody----2件: 46, 107 💬
2988IL-6R Monoclonal Antibody Injection 4mg/kg----1件: 46 💬
2989IL-6R Monoclonal Antibody Injection 6mg/kg----1件: 46 💬
2990IL-6R Monoclonal Antibody Injection 8mg/kg----1件: 46 💬
2991IL-6R nanobody----1件: 49 💬
2992ILB: 100mg/ml solution for injection and infusion----1件: 2 💬
2993Ilomedin 20 [20 µg / ml]----1件: 86 💬
2994Iloprost (Ventavis inhaled, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2995Iloprost (Ventavis, BAYQ 6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2996Iloprost (Ventavis, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2997Iloprost Inhalation Solution (Ventavis)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬2件: 85, 86 💬
2998Iloprost Injection, for intravenous use1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
2999Iloprost therapy up to 2 ng/kg x min1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
3000Iloprost,(Ventavis, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3001Imiglucérase (drug) pharmacokinetics----1件: 19 💬
3002Imipenem / cilastatine2件: Cilastatin,
Imipenem		3件: Imipenem ,
Imipenem ,
Cilastatin 💬		1件: DPEP1 💬-1件: 60 💬
3003Imiquimod 5% Cream1件: Imiquimod1件: Imiquimod 💬1件: TLR7 💬5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬2件: 34, 51 💬
3004Immune Ablation and Hematopoietic Stem Cell Support----1件: 96 💬
3005Immune ablation and hematopoietic stem cell support.----1件: 49 💬
3006Immune ablation and hematopoietic stem cell transplant----1件: 46 💬
3007Immune Globulin (Human), 10% Caprylate/Chromatography Purified----1件: 11 💬
3008Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C)----1件: 11 💬
3009Immune Globulin 10% Intravenous Solution----1件: 14 💬
3010Immune Globulin Infusion (Human), 10%----1件: 65 💬
3011Immune Globulin Intravenous----1件: 65 💬
3012Immune Globulin Intravenous (Human)----1件: 65 💬
3013Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™----1件: 65 💬
3014Immune Globulin Intravenous (human), 10%----2件: 14, 65 💬
3015Immune Globulin Intravenous (Human), 10% Solution----1件: 65 💬
3016Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution----1件: 63 💬
3017Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution----1件: 65 💬
3018Immune Globulin Intravenous (IGIV)----1件: 65 💬
3019Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified----1件: 65 💬
3020Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----1件: 14 💬
3021Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified----1件: 13 💬
3022Immune Globulin Subcutaneos, 20%----1件: 65 💬
3023Immune Globulin Subcutaneous (Human) (SCIG)----1件: 65 💬
3024Immune Globulin Subcutaneous (Human), 20%----1件: 65 💬
3025Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%)----1件: 65 💬
3026Immune Globulin Subcutaneous (Human), 20% Solution----1件: 65 💬
3027Immune Globulin Subcutaneous (Human), 20%, Caprylate/Chromatography Purified----1件: 65 💬
3028Immune Globulin Subcutaneous, 20%----1件: 65 💬
3029Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)----1件: 65 💬
3030Immunoglobulin G (Ig NextGen 16%)----1件: 65 💬
3031Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy----1件: 2 💬
3032Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer----1件: 2 💬
3033Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer----1件: 49 💬
3034Immunoglobulin intravenous (human)----1件: 65 💬
3035Immunoglobulina normale umana----1件: 51 💬
3036Immunoglobulina Normale Umana per somministrazione endovenosa----1件: 51 💬
3037Immunoglobulina Normale Umana per somministrazione sottocutanea----1件: 51 💬
3038IMMUNOGLOBULINA UMANA NORMALE----2件: 51, 65 💬
3039IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa----1件: 14 💬
3040Immunoglobulins Intravenous (Human)----1件: 65 💬
3041Immunoglobulins, normal human----1件: 65 💬
3042Immunoglobulins, normal human, for extravascular adm.----1件: 14 💬
3043Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15 💬
3044Immunosuppression Only Conditioning -Closed with amendment L----1件: 65 💬
3045IMMUNOSUPPRESSIVE AGENTS----2件: 13, 50 💬
3046Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate)4件: Azathioprine,
Methotrexate,
Mycophenolate mofetil,
Mycophenolic acid		4件: Methotrexate ,
Azathioprine ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		4件: DHFR,
DHFR2,
IMPDH1,
IMPDH2 💬		8件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬1件: 49 💬
3047Immunosuppressive treatment (eg, rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 64 💬
3048IMod.Fc, H-Fcv3-N4----1件: 84 💬
3049IMP will be labeled as ''PF-04236921 106mg/vial, Clonal SC lyophilized form''.----1件: 96 💬
3050IMP will be labeled as PF-04236921 106mg/vial, Clonal SC lyophilized form----1件: 96 💬
3051Impact-Nutridrink----1件: 299 💬
3052IMUKIN - 6 FLACONI 0.5 ML 100 MCG----2件: 18, 58 💬
3053Imurek 25mg Filmtabletten----1件: 97 💬
3054Imurek 50mg Filmtabletten----1件: 97 💬
3055In double-blind phase: treatment with tofacitinib1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 107 💬
3056In open-label phase: treatment with tofacitinib1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 107 💬
3057In-vitro approach concerning 25 patients----2件: 102, 299 💬
3058Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus----1件: 53 💬
3059Inactivated hepatitis A virus----1件: 46 💬
3060Inactivated Trivalent Influenza vaccine----1件: 63 💬
3061INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI----1件: 294 💬
3062INBRX-101/rhAAT-Fc----1件: 231 💬
3063INCB000928 fumarate dihydrate----1件: 272 💬
3064Inclisiran Sodium for injection1件: Inclisiran1件: Inclisiran 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
3065Incobotulinum Toxin A----3件: 2, 6, 13 💬
3066INCRELEX 10 mg/ml, solución inyectable1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 78 💬
3067Increlex 10mg/ml solution for injection1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 96 💬
3068Indium 111-radiolabelled anti-CD661件: Indium---1件: 28 💬
3069Indium­ 111 ­labelled Anti­-CD661件: Indium---1件: 28 💬
3070Indocyanine green(ICG)1件: Indocyanine green1件: Indocyanine green 💬--1件: 46 💬
3071INDUSIL*OS GTT FL 30MG+FL 15ML----1件: 299 💬
3072Inflectra (Infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 95 💬
3073INFLECTRA - 100 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 1 FLACONCINO1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 56 💬
3074Inflectra 100 mg powder for concentrate for solution for infusion1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3075Infliximab (IFX alone)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3076Infliximab (IFX)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3077Infliximab (INF) + MTX, DB1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3078Infliximab (Remicade): 100 mg of lyophilized infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3079Infliximab + methotrexate (MTX)2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3080Infliximab 5 mg/kg body weight infused over 2 hours1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3081Infliximab [infliximab biosimilar 3]1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 37, 46, 96, 97 💬
3082Infliximab and adalimumab2件: Adalimumab,
Infliximab		2件: Adalimumab ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3083Infliximab and azathioprine combination at week 02件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3084Infliximab and azathioprine combination at week 142件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3085Infliximab and immunosuppressives1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3086Infliximab and MTX1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
3087Infliximab Increased Dose1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3088Infliximab Increased Frequency1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3089Infliximab induction1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3090Infliximab infusion1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3091Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab5件: Adalimumab,
Golimumab,
Infliximab,
Ustekinumab,
Vedolizumab		5件: Adalimumab ,
Infliximab ,
Golimumab ,
Vedolizumab ,
Ustekinumab 💬		6件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3092Infliximab with azathioprine (IIFX + AZA)2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3093Infliximab+azathioprine2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3094Infliximab, adalimumab, certolizumab pegol3件: Adalimumab,
Certolizumab pegol,
Infliximab		3件: Adalimumab ,
Infliximab ,
Certolizumab pegol 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3095Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab5件: Adalimumab,
Golimumab,
Infliximab,
Ustekinumab,
Vedolizumab		5件: Adalimumab ,
Infliximab ,
Golimumab ,
Vedolizumab ,
Ustekinumab 💬		6件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3096Infliximab, azathioprine2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3097Infliximab, etanercept2件: Etanercept,
Infliximab		2件: Etanercept ,
Infliximab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3098Infliximab, etanercept, adalimumab3件: Adalimumab,
Etanercept,
Infliximab		3件: Etanercept ,
Adalimumab ,
Infliximab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3099Infliximab, methylprednisolone, methotrexate3件: Infliximab,
Methotrexate,
Methylprednisolone		3件: Methotrexate ,
Methylprednisolone ,
Infliximab 💬		4件: DHFR,
DHFR2,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3100Infliximab-Innovator1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3101Infliximab: Adalimumab2件: Adalimumab,
Infliximab		2件: Adalimumab ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
3102Influenz virus surface antigens----1件: 49 💬
3103INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)----1件: 49 💬
3104Influenza vaccine, Immune function----1件: 107 💬
3105Infudopa i.v.----1件: 6 💬
3106Infusion of ADR-001 (Mesenchymal stem cell)----1件: 66 💬
3107Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)----1件: 65 💬
3108Infusion of autologous EFS-ADA LV CD34+ cells----1件: 65 💬
3109Infusion of autologous mononuclear bone marrow cells----1件: 57 💬
3110Infusion of lentiviral TYF-CGD-modified autologous stem cells----1件: 65 💬
3111Infusion without ALD518'----1件: 46 💬
3112Inhaled 7% hypertonic saline (HS)----1件: 299 💬
3113Inhaled AR-501----1件: 299 💬
3114Inhaled Iloprost (5 µg)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3115Inhaled iloprost (Ventavis, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3116Inhaled Nitric Oxide1件: Nitric Oxide1件: Nitric oxide 💬--2件: 85, 86 💬
3117Inhaled nitric oxide & INOpulse delivery1件: Nitric Oxide1件: Nitric oxide 💬--1件: 86 💬
3118Inhaled Nitric Oxide (iNO) use1件: Nitric Oxide1件: Nitric oxide 💬--1件: 294 💬
3119Inhaled Nitric Oxide - 30 mcg/kg IBW/hr1件: Nitric Oxide1件: Nitric oxide 💬--1件: 85 💬
3120Inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hr1件: Nitric Oxide1件: Nitric oxide 💬--1件: 85 💬
3121Inhaled nitric oxide 75 mcg/kg IBW/hr1件: Nitric Oxide1件: Nitric oxide 💬--2件: 85, 86 💬
3122Inhaled NO with pulsed delivery----1件: 86 💬
3123INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS----1件: 51 💬
3124Injection of apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3125Injection of autologous bone marrow derived mesenchymal stem cells----1件: 13 💬
3126Injection of autologous stromal vascular fraction----1件: 51 💬
3127Injection of cell free media----1件: 13 💬
3128Injection of iron----1件: 96 💬
3129Injection of normal saline----1件: 6 💬
3130Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa----1件: 90 💬
3131Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa----1件: 90 💬
3132INM-755 (cannabinol) cream1件: Cannabinol---1件: 36 💬
3133INN - FILGOTINIB1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
3134INN Not available----2件: 19, 46 💬
3135INN not available yet----1件: 222 💬
3136INN Not yet proposed----1件: 193 💬
3137INN Parathyroid Hormone (1-84) human1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
3138INN: aceneuramic acid1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
3139Innovator infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
3140INOmax 400ppm mol/mol inhalation gas1件: Nitric Oxide1件: Nitric oxide 💬--2件: 85, 299 💬
3141INOmax 800ppm mol/mol inhalatiegas1件: Nitric Oxide1件: Nitric oxide 💬--1件: 294 💬
3142Insulin Asparte----1件: 299 💬
3143Insulin detemir [rDNA origin] injection1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
3144Insulin like growth factor, type 1----1件: 2 💬
3145INT-747, OCA----2件: 93, 94 💬
3146INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE1件: Etravirine1件: Etravirine 💬--1件: 18 💬
3147Interferon alfa1件: Interferon alfa1件: Interferon alfa 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬5件: 25, 26, 28, 56, 96 💬
3148Interferon Alfa-2A2件: Interferon alfa,
Interferon alfa-2a		2件: Interferon alfa-2a ,
Interferon alfa 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
3149Interferon alfa-2b2件: Interferon alfa,
Interferon alfa-2b		2件: Interferon alfa-2b ,
Interferon alfa 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 25 💬
3150Interferon alpha oral lozenge----1件: 85 💬
3151Interferon alpha-2a1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
3152Interferon alpha-2B1件: Interferon alfa-2b1件: Interferon alfa-2b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 34 💬
3153INTERFERON BETA - 1A1件: Human interferon beta---1件: 13 💬
3154Interferon beta - 1a (IFN)1件: Human interferon beta---1件: 13 💬
3155Interferon Beta 1-A2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3156Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)1件: Human interferon beta---1件: 13 💬
3157Interferon beta 1a 30 ug IM once weekly2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3158Interferon beta 1a, oral doxycycline3件: Doxycycline,
Human interferon beta,
Interferon beta-1a		3件: Doxycycline ,
Interferon beta-1a ,
Doxycycline 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3159Interferon beta 1b (Betaseron, BAY86-5046)1件: Human interferon beta---1件: 13 💬
3160Interferon beta treatment to add-on atorvastatin treatment2件: Atorvastatin,
Human interferon beta		1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
3161Interferon beta-1 a1件: Human interferon beta---1件: 13 💬
3162Interferon beta-1a (Avonex)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3163INTERFERON BETA-1A (Avonex®)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3164Interferon beta-1a (current approved manufacturing process invloving FBS)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3165Interferon beta-1a (new process, manufactured without FBS)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3166Interferon beta-1a (Rebif®) alone2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3167Interferon beta-1a FBS-free/HSA free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3168Interferon beta-1a FBS-free/HSA-free2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3169Interferon beta-1a FBS-free/HSA-free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3170Interferon beta-1a HSA+ biosimilar2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3171Interferon beta-1a HSA-free biosimilar2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3172Interferon beta-1a, 30 µg/0.5 ml2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3173Interferon beta-1b (Betaferon, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3174Interferon beta-1b (Betaferon, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3175Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3176Interferon beta-1b (Betaferon®, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3177Interferon beta-1b (Betaseron, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3178Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3179Interferon beta-1b (PF530, Betaferon)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3180Interferon beta-1b and Tacrolimus3件: Human interferon beta,
Interferon beta-1b,
Tacrolimus		3件: Tacrolimus ,
Interferon beta-1b ,
Tacrolimus 💬		7件: IFNAR1,
IFNAR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		48件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
3181Interferon beta-1b, (Betaseron BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3182Interferon beta-1b, FRP about 6 weeks after randomization2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3183Interferon beta-1b, FRP within 15 days after randomization2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3184Interferon beta-1b/Atorvastatin group3件: Atorvastatin,
Human interferon beta,
Interferon beta-1b		2件: Interferon beta-1b ,
Atorvastatin 💬		3件: HMGCR,
IFNAR1,
IFNAR2 💬		22件: AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway 💬1件: 13 💬
3185Interferon gamma-1b (Actimmune)2件: Interferon Gamma,
Interferon gamma-1b		1件: Interferon gamma-1b 💬2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬1件: 85 💬
3186Interferon ß-1a----1件: 13 💬
3187Interferon ß-1a 30 µg----1件: 13 💬
3188Interferon ß-1b----1件: 13 💬
3189Interferon-1beta (Betaseron, BAY86-5046)1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3190Interferon-alpha----1件: 331 💬
3191Interferon-alpha lozenges----1件: 85 💬
3192Interferon-alpha2a----1件: 56 💬
3193Interferon-beta (IFN-beta)1件: Human interferon beta---1件: 13 💬
3194Interferon-beta 1a FBS-free/HSA free, RNF1件: Human interferon beta---1件: 13 💬
3195Interferon-beta 1a FBS-free/HSA-free, RNF1件: Human interferon beta---1件: 13 💬
3196Interferon-beta [IFN-beta]1件: Human interferon beta---1件: 13 💬
3197Interferon-beta and human leukocyte Interferon-a1件: Human interferon beta---1件: 13 💬
3198Interferon-beta-1a (Avonex) plus methylprednisolone3件: Human interferon beta,
Interferon beta-1a,
Methylprednisolone		2件: Methylprednisolone ,
Interferon beta-1a 💬		3件: IFNAR1,
IFNAR2,
NR3C1 💬		19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3199Interferon-beta-1a FBS-free/HSA free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3200Interferon-beta-1a FBS-free/HSA-free2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3201Interferon-beta-1a, 44 microgram2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 97 💬
3202Interferon-beta-1a, 66 microgram2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 97 💬
3203Interferon-beta-1b (BETASERON, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3204Interferon-ß----1件: 13 💬
3205Interferon-ß [IFN-ß]----1件: 13 💬
3206Interferon-ß-1----1件: 13 💬
3207Interferon-ß-1a----1件: 13 💬
3208Interferon-ß-1b----1件: 13 💬
3209Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬
3210Interferón beta 1a----1件: 13 💬
3211Interferón beta 1a pegilado----1件: 13 💬
3212Interferón Beta-1a pegilado----1件: 13 💬
3213Interleukin-2 (aldesleukin).2件: Aldesleukin,
Human interleukin-2		1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬2件: 96, 97 💬
3214Intermittent, short infusion Cefepime1件: Cefepime1件: Cefepime 💬--1件: 299 💬
3215Intermittent, short infusion Ceftazidime1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
3216Intermittent, short infusion Meropenem1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
3217Intermittent, short infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
3218Intermittent, short infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: Clavulanic acid ,
Ticarcillin 💬		--1件: 299 💬
3219Intervention for incipient patients at low risk of disease progression----1件: 66 💬
3220Intervention for patients at high risk of disease progression----1件: 66 💬
3221Intestinal flora capsule----1件: 97 💬
3222Intestinal microbiota transplant (IMT)----1件: 86 💬
3223Intra venous injection of stem cell----1件: 2 💬
3224Intra-articular Compound Betamethasone1件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
3225Intra-articular corticosteroid injection----1件: 46 💬
3226Intra-articular steroid injection----1件: 107 💬
3227Intra-articular Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
3228Intraarticular injection----1件: 46 💬
3229Intracerebral administration of AAVrh.10cuARSA----1件: 19 💬
3230Intradetrusor injection of Botulinum Toxin-A----1件: 13 💬
3231Intranasal Foralumab Solution1件: Foralumab---1件: 13 💬
3232Intranasal glutathione - (in)GSH1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬		--1件: 6 💬
3233Intranasal Insulin----2件: 6, 17 💬
3234Intranasal Oxytocin (IN-OXT)1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
3235Intraparenchymal rAAV1 - (mi)RNA HTT----1件: 8 💬
3236Intrathecal administration of autologous MSC-NP----1件: 13 💬
3237Intrathecal autologous stem cell----1件: 2 💬
3238Intrathecal injection----1件: 2 💬
3239Intrathecal MSC-NP injection----1件: 13 💬
3240Intrathecal recombinant human alpha iduronidase----1件: 19 💬
3241Intravenous (i.v.) methylprednisolone 1000 mg, total 91件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
3242Intravenous (IV) Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
3243Intravenous (IV) infusions----2件: 13, 97 💬
3244Intravenous administration of 1 million of MSC----1件: 2 💬
3245Intravenous administration of 2 million of MSC----1件: 2 💬
3246Intravenous administration of 4 million of MSC----1件: 2 💬
3247Intravenous administration of ferric carboxymaltose1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬--1件: 86 💬
3248Intravenous bone marrow mesenchymal stem cells infusion----1件: 60 💬
3249Intravenous immune globulin----1件: 256 💬
3250Intravenous immune globulin G----1件: 14 💬
3251Intravenous ImmuneGlobulin----1件: 11 💬
3252Intravenous Immunoglobulin----7件: 13, 14, 35, 38, 39, 51, 309 💬
3253Intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---4件: 14, 17, 164, 296 💬
3254Intravenous immunoglobulin (IVIG), 10% solution for infusion----1件: 63 💬
3255Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)----1件: 11 💬
3256Intravenous immunoglobulin infusion----1件: 65 💬
3257Intravenous immunoglobulins (human immunoglobulins G)----1件: 43 💬
3258Intravenous Infusion----2件: 6, 51 💬
3259Intravenous Infusion of Diclofenac Sodium1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 78 💬
3260Intravenous infusion of MSCs----1件: 271 💬
3261Intravenous infusion of transduced cells----1件: 65 💬
3262Intravenous injection----1件: 222 💬
3263Intravenous injection autologous mesenchymal stem cells----1件: 67 💬
3264Intravenous injection of mesenchymal stem cells----1件: 13 💬
3265Intraventricular injection----1件: 2 💬
3266Intravesical injection of Botulinum A toxin----2件: 6, 17 💬
3267Intravesical onabotulinumtoxinA injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 226 💬
3268Intravitreal autologous CD34+ cells----1件: 90 💬
3269Intravitreal Infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 56 💬
3270Intravitreal injection of Autologous bone marrow Stem Cell----1件: 90 💬
3271Intravitreal injection of autologous bone marrow stem cells----1件: 90 💬
3272Intravitreal injection ranibizumab1件: Ranibizumab1件: Ranibizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 166 💬
3273Intubated with Propofol (IP)1件: Propofol1件: Propofol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 98 💬
3274Intubated with Sevoflurane (IS)1件: Sevoflurane1件: Sevoflurane 💬--1件: 98 💬
3275Investigators Choice of Approved AED----1件: 144 💬
3276Investigators choice of approved AEDs----1件: 144 💬
3277IODIO IOFLUPANO-123I----1件: 6 💬
3278Ioflupane [123 I]----1件: 6 💬
3279Ioflupane I 1232件: Iodide I-123,
Ioflupane I-123		---1件: 6 💬
3280Iohexol Inj 300 milligrams per milliliter (MG/ML)1件: Iohexol1件: Iohexol 💬--1件: 67 💬
3281IPD® (Japanese tradename)----1件: 226 💬
3282IPD® (suplatast tosilate)----1件: 226 💬
3283IPP - 201101----1件: 49 💬
3284IPP-201101, P140----1件: 49 💬
3285Ips-nsc cells----1件: 6 💬
3286IR CD-LD (carbidopa-levodopa) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3287IR LD / CD----1件: 6 💬
3288Irbesartan 150-300mg capsules daily for 6 months1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
3289Irbesartan tablets (ANDA 203071)1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
3290Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-031件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
3291Irbesartan tablets (NDA 020 757)1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
3292Irbesartan tablets (NDC# 31722-729-30 approved in the United states)1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
3293Irbesartan tablets (NDC# 43547-0374-03 and NDC 43547-374-09, approved in the USA) Generic tablets distributed by Solco Healthcare US, LLC1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
3294IRON CHELATING AGENTS1件: Iron---1件: 284 💬
3295Iron chelating intervention1件: Iron---1件: 18 💬
3296Iron(III)- hydroxide dextran complex3件: Dextran,
Hydroxide ion,
Iron		1件: Dextran 1 💬--2件: 96, 97 💬
3297ISIS 396443, BIIB058----1件: 3 💬
3298Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung----1件: 50 💬
3299Isotopic Intravenous [13C]-Urea1件: Urea2件: Urea ,
Urea C13 💬		--1件: 251 💬
3300IST (ATG + CsA)----1件: 60 💬
3301Istradefylline ( KW-6002)1件: Istradefylline1件: Istradefylline 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
3302ITACITINIB ADIPATE2件: Iron (III) oxide adipate,
Itacitinib		1件: Itacitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 97, 228 💬
3303Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally.2件: Itraconazole,
Terbinafine		2件: Itraconazole ,
Terbinafine 💬		--1件: 96 💬
3304Itraconazole? SHR0302 tablets1件: Itraconazole1件: Itraconazole 💬--1件: 46 💬
3305IUPAC name: 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----1件: 17 💬
3306IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino----1件: 337 💬
3307IV Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
3308IV amikacin1件: Amikacin1件: Amikacin 💬--1件: 299 💬
3309IV Apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3310IV treatment with IGSC, 10%----1件: 65 💬
3311Ivacaftor (proposed INN)1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3312Ivacaftor or elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3313Ivacaftor/Ataluren2件: Ataluren,
Ivacaftor		2件: Ataluren ,
Ivacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3314IW-3300 rectal foam----1件: 226 💬
3315Ixazomib (NINLARO®) capsules1件: Ixazomib1件: Ixazomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 13 💬
3316J05A F01----1件: 135 💬
3317J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0----1件: 96 💬
3318JAK inhibitor----2件: 46, 50 💬
3319JAK1 / JAK2 Inhibitor----1件: 46 💬
3320JAK1 / JAK2 Inhibtor----1件: 46 💬
3321Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 85 💬
3322Jaktinib Dihydrochloride Monohydrate 75mg BID and Mimic tablets of jakitinib hydrochloride 50mg BID and Acetylcysteine Effervescent Tablets1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 85 💬
3323Janus Kinase Inhibitor----2件: 46, 97 💬
3324Jianpixiaozhong particles and Wuse Dietotherapy----1件: 222 💬
3325JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3326JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3327JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3328JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3329JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3330Jinarc - Tolvaptan tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3331Jinarc 15 mg tablets, Jinarc 45 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3332Jinarc 30 mg tablets, 90 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3333Jinarc 30 mg tablets, Jinarc 60 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3334Jinarc® 15mg Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3335Jinarc® 30 Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
3336Jintropin AQ----1件: 78 💬
3337JKB-122 in capsule or tablet form----1件: 95 💬
3338JNJ-16240159-AAC----1件: 46 💬
3339JNJ-38518168 / MTX----1件: 46 💬
3340JNJ-38518168-AEK - Over Encapsulated Tablet - 50 mg----1件: 46 💬
3341JNJ-38518168-ZBQ - film-coated tablet - 10 mg----1件: 46 💬
3342JNJ-38518168-ZBQ - film-coated tablet - 10mg----1件: 46 💬
3343JNJ-38518168-ZBQ - film-coated tablet - 3 mg----1件: 46 💬
3344JNJ-38518168-ZBQ - film-coated tablet - 30 mg----1件: 46 💬
3345JNJ-38518168-ZBQ - film-coated tablet - 30mg----1件: 46 💬
3346JNJ-38518168-ZBQ - film-coated tablet - 3mg----1件: 46 💬
3347JNJ-39758979 / MTX----1件: 46 💬
3348JNJ-39758979-AAC - enteric coated tablet - 10 mg----1件: 46 💬
3349JNJ-39758979-AAC - enteric coated tablet - 100 mg----1件: 46 💬
3350JNJ-39758979-AAC - enteric coated tablet - 30 mg----1件: 46 💬
3351JNJ-40346527-AAC1件: JNJ-40346527---1件: 96 💬
3352JNJ-40346527-AAC - capsule - 50 mg1件: JNJ-40346527---1件: 46 💬
3353JNJ-54781532-AAD-10 mg----1件: 97 💬
3354JNJ-54781532-AAD-30 mg----1件: 97 💬
3355JNJ-54781532-AAD-5 mg----1件: 97 💬
3356JNJ-64304500-AAA----1件: 96 💬
3357JNJ-67896049 (ACT-293987)----1件: 86 💬
3358JNJ-67896062 / ACT-064992----2件: 86, 88 💬
3359JNJ-67896062/ ACT-064992----2件: 86, 88 💬
3360JNJ-67896062/ACT-064922----1件: 86 💬
3361JNJ-67896153/ACT-128800----1件: 13 💬
3362JP-1730/F01----2件: 6, 17 💬
3363JP-1730/F02----2件: 6, 17 💬
3364JP-1730/F03----2件: 6, 17 💬
3365JR-141 or Idursulfase1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3366JR-171 (lepunafusp alfa)----1件: 19 💬
3367Jyseleca 100 mg film-coated tablets1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
3368Jyseleca 200 mg film-coated tablets1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
3369Kalydeco 150 mg film-c1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3370Kalydeco 150 mg film-coated tablets1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3371Kamada -AAT for Inhalation or inhaled AAT (AAT)----1件: 231 💬
3372Kamada-AAT for inhalation----1件: 231 💬
3373Kamada-AAT for Inhalation, 160mg----1件: 231 💬
3374Kamada-AAT for Inhalation, 80mg----1件: 231 💬
3375Kamada-API----1件: 231 💬
3376KB001-A1件: KB001---1件: 299 💬
3377KB407 (Nebulization)----1件: 299 💬
3378Kedrion IVIG 10%----1件: 65 💬
3379Kenalog Injectable Product----1件: 70 💬
3380Kesimpta 20 mg Injektionslösung im Fertigpen1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
3381Kesimpta 20 mg solution for injection in pre-filled pen1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
3382Ketamine Infusion1件: Ketamine1件: Ketamine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
3383Ketocal 4:1 liquid Nutricia (intervention)----1件: 256 💬
3384Ketone Ester Elite endurance Nutrition Drink----1件: 6 💬
3385Keyhole limpet hemocyanin (KLH) neo-antigen1件: Keyhole limpet hemocyanin---1件: 13 💬
3386Kineret® (Anakinra)1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46 💬
3387Kineret® or anakinra1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 107 💬
3388KIOVIG 100 mg/ml solution for infusion1件: Human immunoglobulin G---2件: 14, 65 💬
3389Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14 💬
3390KN019, 10 mg/kg----1件: 46 💬
3391KN019, 5mg/kg----1件: 46 💬
3392KPS-0373, High dose----1件: 18 💬
3393KPS-0373, Low dose----1件: 18 💬
3394Kremezin®, Spherical Adsorptive Carbon1件: Activated charcoal---2件: 96, 97 💬
3395KREON de Liberación Inmediata----1件: 299 💬
3396KREON N 25000----1件: 299 💬
3397Kreon® 25,000----1件: 299 💬
3398Kuvan® (sapropterin dihydrochloride)1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
3399KVD824 300 mg Compresse a rilascio modificato----1件: 65 💬
3400KVD900 100 mg Film Coated Tablet----1件: 65 💬
3401KVD900 300 mg Film Coated Tablet----1件: 65 💬
3402KW-0761 0.3 mg/kg IV----1件: 26 💬
3403KW-6002 (istradefylline)1件: Istradefylline1件: Istradefylline 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
3404L - Antineoplastic and immunomodulating agents----1件: 85 💬
3405L-000124467 (freebase)----1件: 46 💬
3406L-123 Ioflupane----1件: 6 💬
3407L-3-(3,4-Dihydroxyphenyl)alanine1件: Alanine1件: Alanine 💬--1件: 6 💬
3408L-alanine1件: Alanine1件: Alanine 💬--1件: 299 💬
3409L-Arg1件: Arginine1件: Arginine 💬--1件: 78 💬
3410L-ARG+GHRH2件: Arginine,
Somatorelin		2件: Arginine ,
Somatorelin 💬		1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 78 💬
3411L-Arginin1件: Arginine1件: Arginine 💬--1件: 65 💬
3412L-Arginin-hydrochlorid-einmolar Fresenius1件: Arginine1件: Arginine 💬--1件: 65 💬
3413L-arginine2件: Arginine,
L-arginine		1件: Arginine 💬--8件: 46, 67, 78, 96, 97, 98, 113, 299 💬
3414L-asparaginase1件: Asparaginase Escherichia coli---1件: 65 💬
3415L-Citrulline and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
3416L-Dopa/ MODOPAR1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3417L-fucose1件: Fucose---1件: 65 💬
3418L-Lysine N acetylcysteinate1件: Lysine1件: Lysine 💬--1件: 299 💬
3419L-Lysine N-acetylcysteinate1件: Lysine1件: Lysine 💬--1件: 299 💬
3420L-Lysine- N-acetylcysteinate1件: Lysine1件: Lysine 💬--1件: 299 💬
3421L-Lysine-N-acetyl-L-cysteinate1件: Lysine1件: Lysine 💬--1件: 299 💬
3422L-Lysine-N-acetylcysteinate1件: Lysine1件: Lysine 💬--1件: 299 💬
3423L-Lysyl-D-Prolyl-L-Threonine Acetate2件: Acetate,
Threonine		1件: Threonine 💬--1件: 97 💬
3424L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate1件: Acetate---1件: 97 💬
3425L01 - Antineoplastic agents----1件: 85 💬
3426L01X - Other antineoplastic agents----1件: 85 💬
3427L01XE - Protein kinase inhibitors----1件: 85 💬
3428L01XE31 - Nintedanib1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
3429L03 AB----1件: 13 💬
3430L03 AB 08----1件: 13 💬
3431L03 AB07----1件: 13 💬
3432L04 AB04----1件: 46 💬
3433L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE1件: Antithymocyte immunoglobulin (rabbit)---1件: 13 💬
3434L606 (Liposomal Treprostinil) Inhalation Solution 51ug1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3435Lacteol forte capsules1件: Lactobacillus acidophilus1件: Lactomin 💬--1件: 49 💬
3436Lactic acid1件: Lactic acid1件: Lactic acid 💬--1件: 299 💬
3437Lactic acid producing organisms1件: Lactic acid1件: Lactic acid 💬--1件: 299 💬
3438Lactizole nebulization----1件: 299 💬
3439Lactobacillus acidophilus1件: Lactobacillus acidophilus1件: Lactomin 💬--1件: 6 💬
3440Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers1件: Lactobacillus acidophilus1件: Lactomin 💬--1件: 6 💬
3441Lactobacillus rhamnosus GG ATCC 531031件: Lactobacillus delbrueckii bulgaricus---1件: 97 💬
3442Lactobacilus acidophilus & bifidobacterium animalis/lactis1件: Lactobacillus acidophilus1件: Lactomin 💬--1件: 97 💬
3443Lactose in water2件: Lactose,
Water		3件: Water ,
Anhydrous lactose ,
Lactose 💬		--1件: 97 💬
3444Lamotrigin actavis----1件: 114 💬
3445Lamotrigin ”Nordic Prime 100 mg----1件: 114 💬
3446Lamotrigin ”Nordic Prime 25 mg----1件: 114 💬
3447Lamotrigin ”Nordic Prime 50 mg----1件: 114 💬
3448Lamotrigine - generic product1件: Lamotrigine1件: Lamotrigine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 38 💬
3449Lamotrigine 25Mg Oral Tablet, Extended Release1件: Lamotrigine1件: Lamotrigine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114 💬
3450LANREOTIDE ACETATE2件: Acetate,
Lanreotide		---4件: 67, 73, 85, 298 💬
3451Lansoprazole, amoxicillin, clarithromycin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		4件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 222 💬
3452Lansoprazole, clarithromycin, amoxycillin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		4件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 63 💬
3453Lantus 100 units/ml solution for injection in a cartridge----1件: 299 💬
3454Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----1件: 299 💬
3455Lapaquistat acetate and current lipid-lowering treatment2件: Acetate,
Lapaquistat		---1件: 79 💬
3456Lapine T-Lymphocyte Immune Globulin1件: Antithymocyte immunoglobulin (rabbit)---4件: 62, 65, 283, 286 💬
3457Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP5件: Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone		5件: Triamcinolone ,
Prednisolone ,
Dapsone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
3458Large Neutral Amino Acid Therapy----1件: 240 💬
3459Laronidase therapy and a stem cell transplant1件: Laronidase1件: Laronidase 💬1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3460LCI699, 1 mg----1件: 75 💬
3461LCI699, 10 mg----1件: 75 💬
3462LCI699, 20 mg----1件: 75 💬
3463LCI699, 5 mg----1件: 75 💬
3464LD / BE----1件: 6 💬
3465LD-aminopterin1件: Aminopterin---1件: 46 💬
3466Leflunomide (permitted, not necessary)1件: Leflunomide1件: Leflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46 💬
3467LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
3468Lenabasum 20 mg Powder in Capsule----1件: 51 💬
3469Lenabasum 5 mg Powder in Capsule----1件: 51 💬
3470Lenabasum 5mg Powder in Capsule----1件: 51 💬
3471Lenadogene nolparvovec1件: Lenadogene nolparvovec---1件: 302 💬
3472Lenalidomide and dexamethasone2件: Dexamethasone,
Lenalidomide		2件: Dexamethasone ,
Lenalidomide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
3473Lenalidomide, Dexamethasone2件: Dexamethasone,
Lenalidomide		2件: Dexamethasone ,
Lenalidomide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
3474Lenalidomide, Dexamethasone and Cyclophosphamide3件: Cyclophosphamide,
Dexamethasone,
Lenalidomide		4件: Cyclophosphamide ,
Dexamethasone ,
Lenalidomide ,
Cyclophosphamide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
3475Lentiviral vector containing ABCA4 gene----1件: 301 💬
3476Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts----1件: 113 💬
3477Lentiviral vector transduced CD34+ cells----1件: 65 💬
3478Lentivirus Alpha-gal A transduced stem cells----1件: 19 💬
3479Lentivirus-mediated delivery of ARSA to the CNS.----1件: 19 💬
3480Leqvio 284 mg solution for injection in pre-filled syringe1件: Inclisiran1件: Inclisiran 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
3481Leuprolide (GnRH agonists)2件: Gonadorelin,
Leuprolide		1件: Gonadorelin 💬1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
3482Leuprolide Acetate (LA)2件: Acetate,
Leuprolide		---1件: 76 💬
3483Leuprolide acetate 11.25 mg2件: Acetate,
Leuprolide		---1件: 76 💬
3484Leuprolide Acetate 3 Month Depot2件: Acetate,
Leuprolide		---1件: 76 💬
3485Leuprolide acetate 30 mg2件: Acetate,
Leuprolide		---1件: 76 💬
3486Leuprolide Acetate 45 mg2件: Acetate,
Leuprolide		---1件: 76 💬
3487Leuprolide acetate depot2件: Acetate,
Leuprolide		---1件: 76 💬
3488Leuprorelin Acetate2件: Acetate,
Leuprolide		---2件: 1, 76 💬
3489Leuprorelin Acetate 3.75mg Injection2件: Acetate,
Leuprolide		---1件: 76 💬
3490Leuprorelin Acetate Depot 3M2件: Acetate,
Leuprolide		---1件: 76 💬
3491Levamisole+cyclosporin A+Glucocorticoids2件: Cyclosporine,
Levamisole		2件: Cyclosporine ,
Levamisole 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 62 💬
3492Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
3493Levemir FlexPen1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
3494LEVODOPA (DC.IT) (FU)1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3495Levodopa (delivered intravenously)1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3496Levodopa (drug), intraduodenal administration1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3497Levodopa (L-DOPA) + Standard care1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3498Levodopa / Benserazid1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3499LEVODOPA / BENSERAZIDE 200 + 50 MG2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3500Levodopa / carbidopa solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3501Levodopa 100 mg / benserazide 25 mg2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3502Levodopa 100 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3503Levodopa 125 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3504Levodopa 150 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3505Levodopa 75 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3506Levodopa acute challenge1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3507Levodopa and carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3508Levodopa and carbidopa SC solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3509Levodopa and carbidopa solution for SC administration2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3510Levodopa and decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3511Levodopa and Domperidone2件: Domperidone,
Levodopa		3件: Levodopa ,
Domperidone ,
Domperidone maleate 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3512Levodopa Benserazide Teva Italia2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3513Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3514Levodopa carbidopa intestinal gel (LCIG)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3515LEVODOPA DC.IT FU1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3516Levodopa infusion1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3517LEVODOPA INN1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3518Levodopa powder for inhalation1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3519Levodopa, carbidopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3520Levodopa, carbidopa, ODM-1042件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3521Levodopa, decarboxylase inhibitor and COMT inhibitor1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3522Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3523Levodopa-carbidopa Immediate Release (LC-IR) Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3524Levodopa-Carbidopa Intestinal Gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3525Levodopa-Carbidopa Intestinal Gel (LCIG)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3526Levodopa/dopa decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3527Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 11件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 34 💬
3528Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 21件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 34 💬
3529Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 31件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 34 💬
3530LFB-IgSC----1件: 65 💬
3531LFB-R603, TGTX1101----1件: 13 💬
3532Lidocaine 1% Injectable Solution1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 34 💬
3533Lidocaine 2% without vessel constrictor1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 51 💬
3534Lidocaine Hydrochloride, Injectable1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
3535Lidocaine Injection 2%1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 168 💬
3536Lidocaine Releasing Intravesical System - LiRIS®1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 226 💬
3537Linerixibat (GSK2330672) 40 mg----1件: 93 💬
3538Linerixibat (GSK2330672) 45 mg----1件: 93 💬
3539Linerixibat (GSK2330672) 45mg----1件: 93 💬
3540Lingzhi and Sen Miao San----1件: 46 💬
3541Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299 💬
3542Linoleic acid supplementation1件: Linoleic acid---1件: 299 💬
3543Linoleic Acid/Oleic Acid2件: Linoleic acid,
Oleic Acid		1件: Oleic acid 💬--1件: 13 💬
3544Linolenic acid1件: alpha-Linolenic acid---1件: 46 💬
3545Liothyronine I 1312件: Liothyronine,
Liothyronine I-131		1件: Liothyronine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬2件: 210, 212 💬
3546Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA)----1件: 19 💬
3547Lipase Lip2 from Yarrowia lipolytica----1件: 299 💬
3548Lipid-lowering agents (Artovastatin)----1件: 50 💬
3549Lipiodol® Ultra Fluid with surgical glues1件: Ethiodized oil2件: Ethiodized oil ,
Ethiodized oil I 131 💬		--1件: 280 💬
3550Lipoic acid1件: Lipoic acid---5件: 2, 5, 13, 14, 20 💬
3551Lipoic acid (LA) with fish oil and LA without fish oil2件: Fish oil,
Lipoic acid		---1件: 13 💬
3552Lipoic acid and omega-3 fatty acids2件: Lipoic acid,
Omega-3 fatty acids		---1件: 13 💬
3553Lipoic acid group1件: Lipoic acid---1件: 2 💬
3554Liposomal aerosol cyclosporine1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
3555Liposomal Amikacin1件: Amikacin1件: Amikacin 💬--1件: 299 💬
3556Liposomal Amikacin (Arikace TM)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
3557Liposomal Amikacin (Arikace™)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
3558Liposomal amikacin for inhalation1件: Amikacin1件: Amikacin 💬--1件: 299 💬
3559Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.1件: Amikacin1件: Amikacin 💬--1件: 299 💬
3560Liposomal amphotericin B (Ambisome®)1件: Amphotericin B1件: Amphotericin B 💬--1件: 299 💬
3561Liposomal Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
3562Liposomal Cyclosporine A 10 mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
3563Liposomal Cyclosporine A 5 mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
3564Liposome encapsulated BoNT-A----1件: 226 💬
3565Liposomed polyphenols resveratrol and curcumin2件: Curcumin,
Resveratrol		---1件: 2 💬
3566Lipoxygenase inhibitor----1件: 160 💬
3567Liprotamase Powder for Oral Solution----1件: 299 💬
3568LIQ861 Inhaled Treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3569Lirentelimab (AK002)1件: Lirentelimab1件: Lirentelimab 💬1件: SIGLEC8 💬-1件: 98 💬
3570LiRIS low dose and LiRIS high dose----1件: 226 💬
3571LiRIS® 400 mg----1件: 226 💬
3572Lisinopril, losartan, and atorvastatin3件: Atorvastatin,
Lisinopril,
Losartan		4件: Lisinopril ,
Atorvastatin ,
Lisinopril ,
Losartan 💬		3件: ACE,
AGTR1,
HMGCR 💬		22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
3573Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----1件: 13 💬
3574Lithium Apogepha2件: Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬		--1件: 2 💬
3575Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)1件: Triacetin1件: Triacetin 💬--1件: 307 💬
3576LIV-GAMMA SN Inj.----1件: 63 💬
3577LIV-GAMMA SN Inj.10%----1件: 63 💬
3578Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules1件: Lactobacillus delbrueckii bulgaricus---1件: 6 💬
3579Live Necator americanus larvae----1件: 13 💬
3580LJN452, 0,01 mg----1件: 93 💬
3581LJN452, 0,03 mg----1件: 93 💬
3582LJN452, 0,1 mg----1件: 93 💬
3583Lloprost(Ventavis,BAYQ6252, 10 µg/mL)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3584Lloprost(Ventavis,BAYQ6252, 20 µg/mL)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3585Local Anesthesia (lidocaine hydrochloride)1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
3586Local Trade Name, 2mg----1件: 6 💬
3587Local Trade Name, 4mg----1件: 6 💬
3588Local Trade Name, 8mg----1件: 6 💬
3589Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)----1件: 13 💬
3590Loestrin (norethindrone acetate and ethinyl estradiol)4件: Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone		3件: Estradiol ,
Norethindrone ,
Ethinyl estradiol 💬		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299 💬
3591Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)4件: Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone		3件: Estradiol ,
Norethindrone ,
Ethinyl estradiol 💬		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 46, 49 💬
3592Lonafarnib, Zoledronic Acid, and Pravastatin3件: Lonafarnib,
Pravastatin,
Zoledronic acid		4件: Zoledronic acid ,
Lonafarnib ,
Pravastatin ,
Zoledronic acid 💬		4件: FDPS,
FNTA,
FNTB,
HMGCR 💬		6件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 333 💬
3593Long term follow up in all patients who received SAR422459 in previous study TDU13583----1件: 301 💬
3594Long-Acting Growth Hormone (LAGH)1件: Somatotropin---1件: 78 💬
3595Long-acting somatostatin1件: Somatostatin1件: Somatostatin 💬5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 67 💬
3596Long-chain n-3 PUFA----1件: 46 💬
3597Lopinavir/ritonavir + nevirapine3件: Lopinavir,
Nevirapine,
Ritonavir		3件: Ritonavir ,
Nevirapine ,
Lopinavir 💬		--1件: 265 💬
3598Lopinavir/ritonavir + zidovudine + lamivudine4件: Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		4件: Lamivudine ,
Zidovudine ,
Ritonavir ,
Lopinavir 💬		--1件: 265 💬
3599Losartan and Atenolol or Propranolol3件: Atenolol,
Losartan,
Propranolol		3件: Atenolol ,
Losartan ,
Propranolol 💬		4件: ADRB1,
ADRB2,
ADRB3,
AGTR1 💬		23件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
3600Losartan and nebivolol2件: Losartan,
Nebivolol		2件: Nebivolol ,
Losartan 💬		2件: ADRB1,
AGTR1 💬		22件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
3601Losartan and other angiotensin receptor blockers2件: Angiotensin II,
Losartan		3件: Angiotensin II ,
Angiotensin II ,
Losartan 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
3602Losartan Tablets & QingReMoShen Granule1件: Losartan1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
3603Lovastatin, then Minocycline/Lovastatin2件: Lovastatin,
Minocycline		2件: Lovastatin ,
Minocycline 💬		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 206 💬
3604Low antigen content diet----1件: 66 💬
3605Low dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
3606Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day1件: Vitamin D---1件: 13 💬
3607Low Dose Aspirin (162 mg/day)1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
3608Low dose naltrexone1件: Naltrexone1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
3609Low FODMAP----1件: 97 💬
3610Low immunogenic interferon-beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3611Low Molecular Weight Heparin Calcium Injection2件: Calcium,
Heparin		1件: Adomiparin 💬1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 224 💬
3612Low Residue Diet Intervention----1件: 21 💬
3613Low-dose Aldesleukin (Proleukin®)1件: Aldesleukin1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 49 💬
3614Low-dose IL-21件: Human interleukin-2---1件: 56 💬
3615Low-dose interleukin-21件: Human interleukin-2---1件: 53 💬
3616Low-dose naltrexone1件: Naltrexone1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
3617Lu AA24493----1件: 18 💬
3618Lu AF28996----1件: 6 💬
3619Lu AF82422----2件: 6, 17 💬
3620Lu AG06466----1件: 13 💬
3621Lu AG13909----1件: 81 💬
3622Lucinactant first1件: Lucinactant1件: Lucinactant 💬--1件: 299 💬
3623LUM/IVA----1件: 299 💬
3624LUM/IVA fixed-dose combination----1件: 299 💬
3625Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3626Lumacaftor plus Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3627Lumacaftor Plus Ivacaftor Combination2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3628Lumacaftor, Ivacaftor Drug Combination2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3629Lumacaftor-ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3630Lumacaftor-Ivacaftor treatment2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3631Lumacaftor/Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3632Lumacaftor/ivacaftor 100mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3633Lumacaftor/ivacaftor 200mg/125mg2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3634Lumacaftor/ivacaftor 200mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3635Lumacaftor/ivacaftor 200mg/83mg tablet2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
3636Lumbar Interbody Fusion with Autograft2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--1件: 70 💬
3637Lumbar Interbody Fusion with NeoFuse2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--1件: 70 💬
3638Luo-Fu-Shan Plaster----1件: 46 💬
3639Luphere depot 3.75mg(Leuprolide acetate 3.75mg)2件: Acetate,
Leuprolide		---1件: 76 💬
3640Lupron (leuprolide acetate)2件: Acetate,
Leuprolide		---1件: 76 💬
3641Lutein (10 or 30 mg/day) capsules1件: Lutein---1件: 90 💬
3642Luteinizing hormone-releasing factor1件: Luteinizing hormone---1件: 254 💬
3643LY03003 ( Rotigotine, extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3644LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3645LY03003( the name of rotigotine)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3646LY03009 F1----1件: 6 💬
3647LY03009 F2----1件: 6 💬
3648LY03009 F3----1件: 6 💬
3649LY03009 F4----1件: 6 💬
3650LY3090106 - IV----1件: 46 💬
3651LY3090106 - SQ----1件: 46 💬
3652LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
3653Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
3654Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
3655LZRSE-Col7A1 Engineered Autologous Epidermal Sheets----1件: 36 💬
3656M281 Injection----1件: 11 💬
3657M2951 (Other Name: Evobrutinib)1件: Evobrutinib1件: Evobrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
3658MABCAMPATH 10 mg/ml concentrado para solución para perfusión1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
3659MABTHERA - 1 FIALA 500 MG 50 ML1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 14, 53 💬
3660MABTHERA - 2 FIALE 100 MG 10 ML1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 19, 65 💬
3661MabThera 100 mg concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
3662MabThera 500 mg (10 mg/ml) concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3663MABTHERA 500 mg concentrado para solución para perfusión1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3664MabThera 500 mg concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 222 💬
3665MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3666Mabthera Infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 83 💬
3667MabThera infusions1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3668MabThera® (rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3669MabThera® 100MG1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 43 💬
3670MabThera® 500MG1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 43 💬
3671MabThera®, 100 mg Concentrado para solución para perfusión1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3672MabThera®, 100 mg concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3673MACIMORELIN ACETATE2件: Acetate,
Macimorelin		1件: Macimorelin 💬1件: GHSR 💬3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78 💬
3674Macitentan (ACT-064992)1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
3675Macitentan 10 mg tablet, once daily.1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
3676Madopar 125 mg T, tablets----1件: 6 💬
3677Madopar 125 mg, orodispersible tablet----1件: 6 💬
3678Madopar Tab. 125 or Perkin Tab. 25-100mg----1件: 6 💬
3679Madopar® 125----1件: 6 💬
3680Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride)2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3681Madopar® 250----1件: 6 💬
3682Madopar® HBS----1件: 6 💬
3683Madopar® HBS 125----1件: 6 💬
3684Magnesium aspartate2件: Magnesium,
Magnesium aspartate		1件: Magnesium L-aspartate 💬--1件: 298 💬
3685MAGNESIUM ASPARTATE HYDROCHLORIDE3件: Magnesium,
Magnesium aspartate,
Magnesium aspartate hydrochloride		1件: Magnesium L-aspartate 💬--1件: 298 💬
3686Mannitol + pulmozyme2件: Dornase alfa,
Mannitol		2件: Mannitol ,
Dornase alfa 💬		--1件: 299 💬
3687Mannitol Inhalant Product1件: Mannitol1件: Mannitol 💬--1件: 299 💬
3688Mannitol inhalation powder1件: Mannitol1件: Mannitol 💬--1件: 299 💬
3689MANNITOLO 18% LDB----1件: 2 💬
3690Manufacturerd by Cambridge Therapeutic Antibody Centre, Burroughs Wellcome, Glaxo Wellcome)----1件: 46 💬
3691Maralixibat (formely SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338 💬
3692Maralixibat (formerly SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
3693Maralixibat (in precedenza SHP625 o LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
3694Marketed plasma-derived VWF/FVIII concentrate----1件: 288 💬
3695Masitinib (AB1010)1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 46 💬
3696MASP-2 antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬3件: 64, 66, 109 💬
3697MASP-2 Antibody, OMS00620646, OMS6206461件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 66 💬
3698Matched isoglycemic clamp----1件: 299 💬
3699MATRICARIA FLOWER1件: Chamomile1件: German chamomile flower 💬--1件: 97 💬
3700MATRICARIA RECUTITA L. FLOS----1件: 97 💬
3701MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
3702MAXOMAT ®, biosynthetic growth hormone1件: Somatotropin---1件: 195 💬
3703Mayzent 0,25 mg Filmtabletten1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3704Mayzent 0.25 mg fi1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3705Mayzent 2 mg film-coated tablets1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3706Mayzent 2 mg Filmtabletten1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3707MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3)----1件: 79 💬
3708MBX-8025, DSIC----1件: 93 💬
3709MBX-8025, Formulation 2----1件: 93 💬
3710MCI-186 in open label phase----1件: 2 💬
3711MDX-1100 (anti-CXCL10 human monoclonal antibody)----1件: 97 💬
3712Measles, Mumps, Rubella vaccination----1件: 107 💬
3713Mecasermin [rDNA Origin] 10mg/ml solution1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 96 💬
3714MEDI-551 100 MG-IV----1件: 13 💬
3715MEDI-551 30 MG-IV----1件: 13 💬
3716MEDI-551 600 MG-IV----1件: 13 💬
3717MEDI9929 anti-TSLP mAb (AMG157)1件: Tezepelumab1件: Tezepelumab 💬1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98 💬
3718Medical air2件: Medical air,
Oxygen		1件: Oxygen 💬--3件: 85, 86, 193 💬
3719Medical air (sham O2)2件: Medical air,
Oxygen		1件: Oxygen 💬--1件: 85 💬
3720Medical Air vs Oxygen2件: Medical air,
Oxygen		1件: Oxygen 💬--1件: 193 💬
3721Medical Standard of Care for ITP----1件: 63 💬
3722Medication to suppress the immune system----1件: 19 💬
3723Medicinal air----1件: 149 💬
3724MEDROL - 4 MG COMPRESSE 30 COMPRESSE----1件: 56 💬
3725Medrol A 16 mg tablets1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
3726Megestrol acetate2件: Acetate,
Megestrol acetate		1件: Megestrol acetate 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76 💬
3727Megestrol Acetate Tablet2件: Acetate,
Megestrol acetate		1件: Megestrol acetate 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76 💬
3728Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d2件: Eflornithine,
Melarsoprol		2件: Melarsoprol ,
Eflornithine 💬		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65 💬
3729Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d2件: Melarsoprol,
Nifurtimox		2件: Melarsoprol ,
Nifurtimox 💬		--1件: 65 💬
3730Melevodopa and decarboxylase inhibitor1件: Melevodopa1件: Melevodopa 💬--1件: 6 💬
3731MELISSAE FOLII DRY AQUEOUS EXTRACT----1件: 97 💬
3732Meloxicam ampoule1件: Meloxicam1件: Meloxicam 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
3733Melphalan fulfenamide hydrochloride1件: Melphalan1件: Melphalan 💬--1件: 28 💬
3734Melphalan, thalidomide and dexamethasone3件: Dexamethasone,
Melphalan,
Thalidomide		3件: Dexamethasone ,
Melphalan ,
Thalidomide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
3735Melphalan-Flufenamide (Melflufen)2件: Melphalan,
Melphalan flufenamide		2件: Melphalan ,
Melphalan flufenamide 💬		--1件: 28 💬
3736MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
3737MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
3738MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
3739MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
3740MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
3741MENTHA × PIPERITA L. FOLIUM----1件: 97 💬
3742MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC9件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine,
Meningococcal polysaccharide vaccine group A,
Meningococcal polysaccharide vaccine group C,
Meningococcal polysaccharide vaccine group W-135,
Meningococcal polysaccharide vaccine group Y,
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen		2件: Meningococcal polysaccharide vaccine group A ,
Meningococcal polysaccharide vaccine group C 💬		--2件: 62, 66 💬
3743MENVEO – Polvere e soluzione per soluzione iniettabile9件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine,
Meningococcal polysaccharide vaccine group A,
Meningococcal polysaccharide vaccine group C,
Meningococcal polysaccharide vaccine group W-135,
Meningococcal polysaccharide vaccine group Y,
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen		2件: Meningococcal polysaccharide vaccine group A ,
Meningococcal polysaccharide vaccine group C 💬		--2件: 61, 62 💬
3744Meperizumab injection----1件: 44 💬
3745Mepolizumab (a-IL-5 antibody)1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 162 💬
3746Mercaptamine, mercamine, 2-aminoethanethiol1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
3747Mercaptopurine (Puri-Nethol)1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 97 💬
3748Meropenem Fresenius Kabi1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
3749Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
3750Meropenem Infusion1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
3751Mesalamine, 5-aminosalicylic acid2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--1件: 96 💬
3752Mesalamine, 5-aminosalicylic acid [5-ASA]2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--1件: 97 💬
3753Mesalamine, 5-ASA1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3754Mesalazine (Asacol®)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3755Mesalazine - TID 1000 mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3756Mesalazine - TID 2x 500 mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3757Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet2件: Mesalazine,
Nitazoxanide		2件: Mesalamine ,
Nitazoxanide 💬		--1件: 97 💬
3758Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3759Mesalazine, Tripterygium glycosides2件: Mesalazine,
Tripterygium wilfordii whole		1件: Mesalamine 💬--1件: 96 💬
3760Mesdopetam (IRL790)1件: Mesdopetam---1件: 6 💬
3761Mesencephalic Neuronal Precursor Cells----1件: 6 💬
3762Mesenchymal cell and fibroblast injection----1件: 96 💬
3763Mesenchymal stem cells derived from bone marrow (BM-MSCs)----1件: 36 💬
3764Mesenchymal Stem Cells extracted from bone marrow----1件: 36 💬
3765Mesenchymal Stem Cells from Wharton ´s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ´s jelly----1件: 51 💬
3766Mesenchymal stem cells isolated from Wharton's jelly----1件: 2 💬
3767Mesenchymal stromal cells (MSC) for infusion1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 96 💬
3768Metalcaptase® 150 mg gastro-resistant tablet----1件: 171 💬
3769Metalcaptase® 300 mg gastro-resistant tablet----1件: 171 💬
3770Metex 10 mg/ml Injektionslösung, Fertigspritze----1件: 46 💬
3771Metex 50 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte----1件: 46 💬
3772Metex® 50 mg/ml Injektionslösung, Fertigspritze----1件: 46 💬
3773Metformin 500 Mg Oral Tablet, up to 4 tablets a day1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
3774Metformin and clemastine in combination2件: Clemastine,
Metformin		2件: Clemastine ,
Metformin 💬		3件: HRH1,
PRKAA1,
PRKAA2 💬		23件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Calcium signaling pathway, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Inflammatory mediator regulation of TRP channels, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
3775Metformin and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
3776METFORMINA - 500 30 COMPRESSE 500 MG1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
3777METFORMINE ARROW 500mg1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46 💬
3778Metformine Sandoz 850 mg filmomhulde tabletten1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 81 💬
3779Methotrexat HEXAL® 2,5 mg Tabletten1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3780Methotrexat Lachema 5 inj. sol1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
3781METHOTREXAT Lederle - Tabletten1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3782Methotrexate 'Lederle' 2,5mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3783Methotrexate 'Lederle' 2.5mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3784Methotrexate 'Lederle' Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3785Methotrexate (Metoject® prefilled pen)1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3786Methotrexate + Infliximab2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3787Methotrexate + Methylprednisolone2件: Methotrexate,
Methylprednisolone		2件: Methotrexate ,
Methylprednisolone 💬		3件: DHFR,
DHFR2,
NR3C1 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 46 💬
3788METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96 💬
3789Methotrexate - Amneal1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3790Methotrexate - DAVA1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3791Methotrexate - Delay1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3792Methotrexate - etanercept - prednisolone arm3件: Etanercept,
Methotrexate,
Prednisolone		3件: Methotrexate ,
Prednisolone ,
Etanercept 💬		5件: DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107 💬
3793Methotrexate - Immediate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3794Methotrexate 50mg/ml solution for injection, pre-filled syringe1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3795Methotrexate ``Lederle`` 2.5mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3796Methotrexate alone1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 107 💬
3797Methotrexate and folic acid2件: Folic acid,
Methotrexate		2件: Folic acid ,
Methotrexate 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 49 💬
3798Methotrexate as methotrexate disodium1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3799Methotrexate injection1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 96, 97 💬
3800Methotrexate Lachema 5inj. sol1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
3801Methotrexate plus ENBREL or ENBREL alone1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3802Methotrexate plus ERB-041 for 12 weeks1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3803Methotrexate pre-filled pen1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3804Methotrexate ® 2.5mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3805Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3806Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3807Methotrexate(necessary)1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3808Methotrexate, Leucovorin and BMS-9861423件: BMS-986142,
Leucovorin,
Methotrexate		3件: Methotrexate ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3809Methotrexate,Adalimumab2件: Adalimumab,
Methotrexate		2件: Methotrexate ,
Adalimumab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3810Methotrexate® 2.5 mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3811Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-beta-Dribofuronamide1件: Adenine1件: Adenine 💬--1件: 46 💬
3812Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-ß-Dribofuronamide1件: Adenine1件: Adenine 💬--1件: 46 💬
3813Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo----1件: 86 💬
3814Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb----2件: 86, 88 💬
3815Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth----2件: 86, 88 💬
3816Methylenetetrahydrofolate reductase (MTHFR) deficiency----1件: 337 💬
3817Methylmalonyl-coenzyme A2件: (R)-methylmalonyl-CoA,
Coenzyme A		---1件: 246 💬
3818Methylphenidate, fluoxetin, risperidone3件: Fluoxetine,
Methylphenidate,
Risperidone		3件: Fluoxetine ,
Risperidone ,
Methylphenidate 💬		5件: DRD2,
HTR2A,
SLC6A2,
SLC6A3,
SLC6A4 💬		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬2件: 179, 206 💬
3819Methylprednisolon-21-hydrogensuccinat, Natriumsalz1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
3820Methylprednisolone (MP) or prednisone (pred)2件: Methylprednisolone,
Prednisone		2件: Methylprednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
3821METHYLPREDNISOLONE ACETATE2件: Acetate,
Methylprednisolone		1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 51 💬
3822Methylprednisolone and azathioprine2件: Azathioprine,
Methylprednisolone		2件: Azathioprine ,
Methylprednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95 💬
3823Methylprednisolone and Mycophenolate mofetil3件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid		3件: Methylprednisolone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬2件: 93, 95 💬
3824Methylprednisolone bolus IV 15 mg/kg/d for 3 days.1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
3825Methylprednisolone IV1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
3826METHYLPREDNISOLONE MYLAN Générique1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
3827Methylprednisolone(intravenously in the 1st-2nd-3rd month )1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
3828Methylprednisolone(intravenously in the 1st-3rd-5th month)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
3829Methylprednisoloni natrii succinas----1件: 50 💬
3830METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO----1件: 300 💬
3831METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL1件: Metoclopramide1件: Metoclopramide 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51 💬
3832MetoHEXAL® Succ ® 23,75 mg Retardtabletten----1件: 113 💬
3833MetoHEXAL® Succ ® 47,5 mg Retardtabletten----1件: 113 💬
3834MetoHEXAL® Succ ® 95 mg Retardtabletten----1件: 113 💬
3835METOJECT 10 mg/ml, solution injectable en seringue pré-remplie1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
3836Metopirone 250 mg capsules/ Cormeto1件: Metyrapone1件: Metyrapone 💬1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
3837METOPROLOL SUCCINATE (PH. EUR.)1件: Metoprolol1件: Metoprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 193 💬
3838Metoprolol succinate + doxazosin2件: Doxazosin,
Metoprolol		2件: Metoprolol ,
Doxazosin 💬		4件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1 💬		13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 57 💬
3839Metoprololsuccinat ”Orion” 25mg----1件: 193 💬
3840METOTREXATO SANDOZ - 2.5 MG COMPRESSE 50 COMPRESSE IN FLACONE PP1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3841Mezavant Gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
3842Mezavant XL 1200 mg gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
3843Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
3844Mezavant XL 1200mg gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
3845Mezavant XL Gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
3846Mezym F----1件: 298 💬
3847MGlu5 antagonist----1件: 206 💬
3848MH004 Ia(0.1%)----1件: 46 💬
3849MH004 Ia(0.3%)----1件: 46 💬
3850MH004 Ia(1%)----1件: 46 💬
3851MH004 Ia(3%)----1件: 46 💬
3852MH004 Ib-1(0.1%)----1件: 46 💬
3853MH004 Ib-1(0.3%)----1件: 46 💬
3854MH004 Ib-1(1%)----1件: 46 💬
3855MH004 Ib-2(0.3%)----1件: 46 💬
3856MH004 Ib-2(1%)----1件: 46 💬
3857MH004 Ib-2(3%)----1件: 46 💬
3858Micellar Paclitaxel for Injection1件: Paclitaxel1件: Paclitaxel 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 46 💬
3859MICOFENOLICO ACIDO1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
3860Microarray analysis----2件: 28, 285 💬
3861Microbiote fécal----1件: 97 💬
3862Microgynon® 30 (Oral contraceptive)----1件: 46 💬
3863Mid dose ANAVEX2-73----1件: 6 💬
3864Midazolam injection1件: Midazolam1件: Midazolam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 21 💬
3865Midodrine or atomoxetine pill2件: Atomoxetine,
Midodrine		2件: Atomoxetine ,
Midodrine 💬		4件: ADRA1A,
ADRA1B,
ADRA1D,
SLC6A2 💬		8件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 17 💬
3866Miglustat (AT2221)1件: Miglustat1件: Miglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 256 💬
3867Minibody against CD8 conjugated to desferrioxamine labeled with zirconium Zr 891件: Deferoxamine1件: Deferoxamine 💬--2件: 51, 53 💬
3868Minocycline 100 mg Film-coated Tablets1件: Minocycline1件: Minocycline 💬--1件: 13 💬
3869Minocycline, then Minocycline/Lovastatin2件: Lovastatin,
Minocycline		2件: Lovastatin ,
Minocycline 💬		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 206 💬
3870Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95 💬
3871Mirapexin / Sifrol1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3872Mirdametinib (MEK Inhibitor)1件: Mirdametinib1件: Mirdametinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
3873Mirdametinib (PD-0325901) oral capsule or dispersible tablet1件: Mirdametinib1件: Mirdametinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
3874Mirikizumab IV1件: Mirikizumab1件: Mirikizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97 💬
3875Mitoxantrone Hydrochloride Liposome Injection1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
3876MK-8457 (free acid)----1件: 46 💬
3877MK0653, ezetimibe1件: Ezetimibe1件: Ezetimibe 💬1件: NPC1L1 💬1件: Fat digestion and absorption 💬1件: 260 💬
3878MK0663, etoricoxib1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
3879MK0812 / Duration of Treatment: 12 Weeks----1件: 46 💬
3880MMF and Dexamethasone1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
3881MMX mesalamine/ mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3882Mobilization of stem cells to prepare for Leukapheresis----1件: 96 💬
3883Moderna mRNA-1273, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
3884Modified Atkins diet----3件: 145, 157, 187 💬
3885Modified lipid formulation----1件: 299 💬
3886Modified mRNA encoding human methylmalonyl-coenzyme A mutase2件: (R)-methylmalonyl-CoA,
Coenzyme A		---1件: 246 💬
3887Modified recombinant human C-type natriuretic peptide----1件: 276 💬
3888Modified-thoracolumbar interfascial plane block----1件: 70 💬
3889MODULEN IBD----1件: 96 💬
3890MODULEN IBD (R) (specific Enteral Nutrition)----1件: 96 💬
3891Molgramostim 300 mcg nebuliser solution1件: Molgramostim1件: Molgramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
3892Molgramostim 300 µg nebulizer solution1件: Molgramostim1件: Molgramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
3893Molgramostim Nebuliser solution 300 mcg1件: Molgramostim1件: Molgramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
3894Molgramostim nebulizer solution1件: Molgramostim1件: Molgramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 299 💬
3895Moli 1901 (2622U90, duramycin)1件: Lancovutide---1件: 299 💬
3896Moli1901 (2622U90, duramycin)1件: Lancovutide---1件: 299 💬
3897MOMETASONE FUROATE2件: Mometasone,
Mometasone furoate		2件: Mometasone furoate ,
Mometasone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162 💬
3898Mono Nuclear Cell (MNC) transplantation----1件: 57 💬
3899Monoamine oxidase B inhibitors----1件: 6 💬
3900Monoclonal antibodies----1件: 96 💬
3901Monoclonal Antibody (MAb)----1件: 271 💬
3902Monoclonal antibody (Mab) sB24M----1件: 269 💬
3903MONOCLONAL ANTIBODY ANTI-IGG1----3件: 37, 96, 97 💬
3904Monoclonal antibody cA2----1件: 96 💬
3905Monoclonal antibody M-T412----1件: 13 💬
3906Monocytes and megacaryocytes culture and RNA extraction----1件: 113 💬
3907Monomethyl fumarate1件: Monomethyl fumarate1件: Monomethyl fumarate 💬--1件: 13 💬
3908Monomethyl fumarate 190 mg1件: Monomethyl fumarate1件: Monomethyl fumarate 💬--1件: 13 💬
3909Monotherapy (Lopinavir/ritonavir) + ABC/3TC2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬		--1件: 265 💬
3910Monovalent [B.1.351] CoV2 preS dTM-AS03----7件: 13, 35, 46, 49, 50, 51, 107 💬
3911Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-9861426件: BMS-986142,
Digoxin,
Flurbiprofen,
Midazolam,
Montelukast,
Pravastatin		5件: Digoxin ,
Flurbiprofen ,
Midazolam ,
Montelukast ,
Pravastatin 💬		24件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
CYSLTR1,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HMGCR,
PTGS1,
PTGS2 💬		49件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
3912Montelukast/ Singulair1件: Montelukast1件: Montelukast 💬1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 98 💬
3913Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections1件: Human interleukin-2---1件: 2 💬
3914Morphine sulphate in intrasite gel1件: Morphine1件: Morphine 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 36 💬
3915Moss-aGal (recombinant human alpha-galactosidase A produced in moss)1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
3916Most recent vaccine to seasonal influenza----1件: 13 💬
3917Moxifloxacin infusion1件: Moxifloxacin1件: Moxifloxacin 💬--1件: 6 💬
3918MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 19 💬
3919MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
3920Mozobil 20mg/mL vial (injectable solution for subcutaneous use)1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
3921Mozobil 20mg/mL vial (injectable solution, subcutaneous use)1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
3922MP and CTX----1件: 222 💬
3923MP-376 (Levofloxacin Solution for Inhalation)1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬		--1件: 299 💬
3924MP-435(dose1) + Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
3925MRA (Actemra)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107 💬
3926MRA, Actemra1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
3927MRNA che codifica l’enzima umano deramificante del glicogeno formulato in una nanopaticella lipidica----1件: 257 💬
3928MRNA encoding the human glycogen debranching enzyme formulated in a lipid nanoparticle delivery----1件: 257 💬
3929MRX Drug Substance (formerly Maralixibat , SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
3930MRX Drug Substance (formerly Maralixibat, SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
3931MSC injection 01----1件: 96 💬
3932MSC injection 02----1件: 96 💬
3933MSC+ATG----1件: 60 💬
3934MSC-AFP----1件: 96 💬
3935MSC-NTF cells transplantation (IM)----1件: 2 💬
3936MSC-NTF cells transplantation (IT)----1件: 2 💬
3937MSC2430913A or ONO-4641 (to be used as synonyms)----1件: 13 💬
3938MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF----1件: 2 💬
3939MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3940MT-1303-FormA----1件: 13 💬
3941MT-1303-FormB----1件: 13 💬
3942MTX plus anti-TNF----1件: 46 💬
3943Mucoid exopolysaccharide P. aeruginosa immune globulin IV----1件: 299 💬
3944Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH)1件: Tripterygium wilfordii whole---1件: 66 💬
3945Multi-modal pain management [Acetaminophen + Gabapentin]2件: Acetaminophen,
Gabapentin		2件: Acetaminophen ,
Gabapentin 💬		7件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
PTGS1,
PTGS2,
SLC6A1 💬		31件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway 💬1件: 70 💬
3946Multi-modal pain management [Fentanyl]1件: Fentanyl1件: Fentanyl 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
3947Multi-modal pain management [Intravenous Ketamine]1件: Ketamine1件: Ketamine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 70 💬
3948Multi-modal pain management [Valium + Gabapentin]1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
3949Multienzymes (lipase, protease etc.)----2件: 298, 299 💬
3950Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)1件: Myelin basic protein---1件: 13 💬
3951Multiple dose- Group B----1件: 97 💬
3952Mupirocin Intranasal Creme1件: Mupirocin1件: Mupirocin 💬--1件: 299 💬
3953Mutation Analysis----1件: 263 💬
3954Mutation in the gene----1件: 8 💬
3955Mycophenolat-Natrium----1件: 66 💬
3956Mycophenolate Mofetil (MMF) 3 g/Day2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 35 💬
3957Mycophenolate mofetil orally 1000 mg twice a day (BID)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
3958Mycophenolate mofetil, low dose steroid2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
3959Mycophenolic acid1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬8件: 11, 43, 49, 51, 60, 66, 96, 222 💬
3960Mycophenolic acid mofetil1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 60 💬
3961Mycophénolate mofétil----1件: 44 💬
3962Myeloablative Conditioning-Closed with amendment L----1件: 65 💬
3963MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML----2件: 19, 65 💬
3964MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion----1件: 65 💬
3965MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion----1件: 65 💬
3966Myfortic 180 mg Filmtabletten1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
3967Myoblast autologous graft----1件: 113 💬
3968Myoblastes autologues----1件: 113 💬
3969Myozyme 50 mg powder for concentrate for solution for infusion1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
3970Myozyme® (alglucosidase alfa)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
3971Myrrhinil-Intest®----1件: 97 💬
3972N acetyl cysteine1件: Cysteine---1件: 19 💬
3973N Acetyl L Leucine1件: Leucine1件: Leucine 💬--1件: 19 💬
3974N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate1件: Guanidine---1件: 113 💬
3975N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬--1件: 127 💬
3976N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬--1件: 127 💬
3977N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬--1件: 127 💬
3978N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
3979N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide----1件: 49 💬
3980N-3 Polyunsaturated Fatty Acids----1件: 96 💬
3981N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide2件: Acetamide,
Pyrazole		---1件: 154 💬
3982N-acetyl cysteine1件: Cysteine---6件: 13, 34, 85, 88, 296, 310 💬
3983N-Acetyl Cysteine (NAC)1件: Cysteine---1件: 90 💬
3984N-acetyl-cysteine1件: Cysteine---1件: 84 💬
3985N-Acetyl-L Leucine1件: Leucine1件: Leucine 💬--1件: 19 💬
3986N-Acetyl-L-Leucine2件: L-Acetylleucine,
Leucine		1件: Leucine 💬--2件: 19, 65 💬
3987N-acetylcystein----1件: 299 💬
3988N-Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬--13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 💬
3989N-acetylcysteine (NAC)1件: Acetylcysteine1件: Acetylcysteine 💬--2件: 51, 299 💬
3990N-acetylcysteine capsule1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 6 💬
3991N-acetylcysteine syrup1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 53 💬
3992N-Acetylcysteine, (NAC)1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 85 💬
3993N-acetylgalactosamine 4-sulfatase----1件: 19 💬
3994N-acetylneuraminic acid----1件: 30 💬
3995N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----1件: 28 💬
3996N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----1件: 13 💬
3997N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate2件: Acetate,
Somatotropin		---1件: 265 💬
3998N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----1件: 96 💬
3999N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----1件: 11 💬
4000N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE5件: Aluminium,
Aluminum hydroxide,
Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein,
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 11 💬
4001N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14 💬
4002N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM1971件: Corynebacterium diphtheriae CRM197 protein---1件: 13 💬
4003N.a.----10件: 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 💬
4004N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----2件: 5, 17 💬
4005Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 86 💬
4006Nabiximols - Sativex3件: Cannabidiol,
Dronabinol,
Nabiximols		3件: Dronabinol ,
Nabiximols ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
4007Nalbuphine Extended-Realease (ER) Tablets1件: Nalbuphine1件: Nalbuphine 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
4008Nalbuphine Extended-Release (ER) Tablets1件: Nalbuphine1件: Nalbuphine 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
4009NAND (Neoandrographolide)----1件: 97 💬
4010Nanobody directed towards the human A1 domain of von Willebrand factor1件: Von Willebrand factor human---1件: 64 💬
4011Nanogam® 50 mg/ml----1件: 65 💬
4012Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4013Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4014Nasal Aztreonam1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
4015Natalizumab (NTZ)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4016Natalizumab 300 MG in 15 ML Injection1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4017Natalizumab for IV Infusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4018Natalizumab for Subcutaneous Injection1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4019Natalizumab Injection [Tysabri]1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4020Natalizumab IV1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4021National Drug Code: 59762-0074----1件: 81 💬
4022NATPARA/NATPAR1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
4023NBT-NM108----1件: 193 💬
4024NBT-NM108 (60 g/day)----1件: 13 💬
4025NC-503 (Anti-amyloidotic (AA) Agent)----1件: 46 💬
4026ND-L02-s0201 for injection----1件: 85 💬
4027Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection3件: Testosterone,
Testosterone undecanoate,
Undecanoic acid		2件: Testosterone ,
Testosterone undecanoate 💬		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13 💬
4028Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
4029Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
4030Nebulized combination ipratropium bromide with salbutamol2件: Ipratropium,
Salbutamol		1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4031Nebulized ipratropium bromide1件: Ipratropium---1件: 86 💬
4032Necator americanus----1件: 13 💬
4033NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50 💬
4034Neo-ASA----1件: 251 💬
4035NeoGAA or avalglucosidase alfa1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4036Neridronic Acid1件: Neridronic Acid---1件: 6 💬
4037NERIXIA*IM EV 1F 25MG----1件: 6 💬
4038NERIXIA*INFUS IV CONC 2F 100MG----1件: 274 💬
4039Nerve Growt Factor - 2.5S----1件: 90 💬
4040Nerve Growth Factor1件: Nerve Growth Factor---3件: 3, 53, 90 💬
4041Neumega (Oprelvekin, Interleukin 11, IL-11)1件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
4042Neupro® 8 mg/24 h1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4043NeuroVax 300ug/mL Dose for IM Injection1件: NeuroVax---1件: 13 💬
4044New formulation adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4045New Formulation Etanercept1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4046New Formulation of rebif - human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4047New thermo stable formulation of epoprostenol sodium1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4048Nexavar (BAY 43-9006) (Sorafenib)1件: Sorafenib1件: Sorafenib 💬8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
4049NG-Monomethyl-L-arginine3件: Arginine,
L-arginine,
Tilarginine		1件: Arginine 💬--1件: 67 💬
4050Ng-monomethyl-L-arginine (drug)3件: Arginine,
L-arginine,
Tilarginine		1件: Arginine 💬--1件: 67 💬
4051NI-0401 (anti-CD3 mAB)1件: Muromonab---1件: 96 💬
4052Niacin First1件: Niacin1件: Niacin 💬--1件: 78 💬
4053Nicorette 10mg/ 16 h1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
4054Nicorette 15 mg/ 16 h1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
4055Nicorette 5 mg/ 16 h1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
4056Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
4057Nicotinic acid1件: Niacin1件: Niacin 💬--1件: 79 💬
4058Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d2件: Eflornithine,
Nifurtimox		2件: Nifurtimox ,
Eflornithine 💬		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65 💬
4059Nifurtimox-Eflronithine Combination Treatment (NECT)1件: Nifurtimox1件: Nifurtimox 💬--1件: 65 💬
4060Nintedanib 150 mg and 100 mg soft capsules1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 227 💬
4061Nitric Oxide for inhalation1件: Nitric Oxide1件: Nitric oxide 💬--2件: 86, 299 💬
4062Nitric Oxide generated by the GeNO nitrosyl delivery system1件: Nitric Oxide1件: Nitric oxide 💬--1件: 86 💬
4063Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----1件: 254 💬
4064Nle4-D-Phe7-alpha-MSH----1件: 254 💬
4065Nomegestrol acetate3件: Acetate,
Nomegestrol,
Nomegestrol acetate		2件: Nomegestrol ,
Nomegestrol acetate 💬		1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
4066Non applicabile----4件: 13, 49, 51, 256 💬
4067Non applicable----2件: 10, 19 💬
4068Non as of yet----1件: 97 💬
4069Non ATG Conditioning regimen----1件: 60 💬
4070Non intervention-Genetic testing----1件: 6 💬
4071Non invasive prenatal diagnosis----3件: 8, 113, 206 💬
4072NON PROPIETRY, THEREFORE N/A----1件: 51 💬
4073Non-anti-TNF biologics----2件: 46, 271 💬
4074Non-biologic anti-rheumatic drugs----1件: 46 💬
4075Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----1件: 46 💬
4076Non-nucleoside reverse transcriptase inhibitors----1件: 265 💬
4077Non-pegylated interferon----1件: 13 💬
4078Non-steroidal anti-inflammatory drug----1件: 46 💬
4079Non-steroidal anti-inflammatory drug (NSAID)----1件: 46 💬
4080Non-steroidal anti-inflammatory drugs----1件: 46 💬
4081Non-steroidal anti-inflammatory drugs (NSAIDs)----1件: 107 💬
4082Nonbiologic DMARDs of investigator's choice----1件: 46 💬
4083None as of yet1件: Interleukin-1 alpha, human recombinant---1件: 46 💬
4084None assigned1件: Interleukin-1 alpha, human recombinant---2件: 231, 299 💬
4085None at this time1件: Interleukin-1 alpha, human recombinant---2件: 96, 140 💬
4086Norditropin 24 IU1件: Somatotropin---1件: 195 💬
4087Norditropin FlexPro 10 mg1件: Somatotropin---1件: 78 💬
4088Norditropin FlexPro 10 mg/1.5 ml1件: Somatotropin---1件: 78 💬
4089Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen1件: Somatotropin---1件: 195 💬
4090Norditropin FlexPro 5 mg/1.5 mL1件: Somatotropin---1件: 78 💬
4091Norditropin FlexPro 5mg/1.5 ml1件: Somatotropin---1件: 78 💬
4092Norditropin NordiFlex®----1件: 78 💬
4093Norditropin NordiFlex® 10 mg/1.5 ml1件: Somatotropin---1件: 78 💬
4094Norditropin NordiFlex® 10mg/1.5 ml1件: Somatotropin---1件: 78 💬
4095Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)1件: Somatotropin---1件: 78 💬
4096Norditropin® FlexPro®----1件: 78 💬
4097Norditropin® FlexPro® pen----1件: 78 💬
4098Norditropin® SimpleXx® 5 mg/1.5ml1件: Somatotropin---1件: 78 💬
4099Normal human immunoglobulin G1件: Human immunoglobulin G---1件: 65 💬
4100Normal Saline 0.9% Infusion Solution----1件: 22 💬
4101Normal Saline for Injection----1件: 13 💬
4102Normal saline instillation----1件: 226 💬
4103Normal saline IV, salt tablets----1件: 299 💬
4104NORMIX*AD 12CPR RIV 200MG----1件: 96 💬
4105Norovirus -specific T-cell (NST) therapy----1件: 65 💬
4106Norucholic acid1件: norUrsodeoxycholic acid---2件: 93, 94 💬
4107Norucholic acid (NCA) 500 mg1件: norUrsodeoxycholic acid---1件: 93 💬
4108NorUDCA (Norursodeoxycholic acid)1件: norUrsodeoxycholic acid---1件: 94 💬
4109NorUrsodeoxycholic Acid1件: norUrsodeoxycholic acid---1件: 94 💬
4110Norursodeoxycholic acid, NCA1件: norUrsodeoxycholic acid---1件: 94 💬
4111Norvir 100 mg film-coated tablets----1件: 299 💬
4112NOVANTRONE*INF 2MG/ML 5ML1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
4113Novo Rapid Insulin (Novonordisk)----1件: 299 💬
4114Novolin-R insulin----1件: 127 💬
4115Novorapid / humalog short acting insulin----1件: 299 💬
4116NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----1件: 299 💬
4117NovoRapid Aspartate----1件: 299 💬
4118NOXAFIL - 40 mg/ml oral suspension1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
4119NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
4120NOXAFIL - oral suspension 40 mg/ml1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
4121NPLATE 500 microgramos polvo para solución inyectable1件: Romiplostim1件: Romiplostim 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
4122NR082 Injection----1件: 302 💬
4123NR2B NMDA Antagonist CP-101,606 (traxoprodil)1件: Ketamine1件: Ketamine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
4124NS-065/NCNP-01----1件: 113 💬
4125NS-089/NCNP-02----1件: 113 💬
4126NSAIDs (permitted,not necessary)----1件: 46 💬
4127NSAIDs and sulfasalazine1件: Sulfasalazine1件: Sulfasalazine 💬--1件: 271 💬
4128NT-I71件: Efineptakin alfa1件: Efineptakin alfa 💬--1件: 25 💬
4129NTCELL Implantation----1件: 6 💬
4130Nucala 100 mg powder for solution for injection1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
4131Nucleoside analogue sparing HAART regimen----1件: 265 💬
4132Nucleoside reverse transcriptase inhibitors----1件: 265 💬
4133NurOwn (MSC-NTF cells)----2件: 2, 13 💬
4134NurOwn® (MSC-NTF cells)----1件: 2 💬
4135Nusinersen Injectable Product1件: Nusinersen1件: Nusinersen 💬1件: SMN2 💬-1件: 3 💬
4136Nutridrink-Impact----1件: 299 💬
4137Nutritional dietary intervention----2件: 96, 97 💬
4138Nutritional Formulation Containing Exogenous Ketones----1件: 201 💬
4139Nutritional supplementation standardized formula----1件: 78 💬
4140Nutropin AQ----4件: 78, 134, 193, 299 💬
4141Nutropin AQ [somatropin (DNA origin) injection]1件: Somatotropin---1件: 299 💬
4142NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable1件: Somatotropin---1件: 78 💬
4143NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung1件: Somatotropin---1件: 65 💬
4144NutropinAq 10mg/2ml solution for injection1件: Somatotropin---1件: 96 💬
4145NW-1015E, EMD 1195686, MSC2191632B----1件: 6 💬
4146NX-13 250mg IR----1件: 97 💬
4147NX-13 500mg IR----1件: 97 💬
4148Obeticholic Acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬3件: 93, 265, 296 💬
4149Obeticholic Acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4150Obeticholic Acid 10 MG1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4151Obeticholic Acid 5 MG1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4152Obeticholic Acid Tablets1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4153Obinutuzumab administration1件: Obinutuzumab1件: Obinutuzumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49 💬
4154OBINUTUZUMAB/ GA1011件: Obinutuzumab1件: Obinutuzumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
4155Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi4件: Epoprostenol,
Iloprost,
Macitentan,
Selexipag		4件: Epoprostenol ,
Iloprost ,
Selexipag ,
Macitentan 💬		3件: EDNRA,
EDNRB,
PTGIR 💬		10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4156Obyoctocog alfa----1件: 288 💬
4157OC oral solution treatment A----1件: 6 💬
4158OCA (INT-747)----1件: 93 💬
4159OCA, INT-747----1件: 93 💬
4160OCH-NCNP1----1件: 13 💬
4161Ocrelizumab (CinnaGen, Iran)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4162Ocrelizumab (Roche, Switzerland)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4163Ocrelizumab / rhuMAb 2H71件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4164Ocrelizumab at home1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4165Ocrelizumab Dose 2 and Dose 31件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4166Ocrelizumab IV1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4167Ocrevus 300 mg, solution à diluer pour perfusion1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4168OCTA-C1-INH1件: Human C1-esterase inhibitor---1件: 65 💬
4169OCTAGAM 50 mg/ml oldatos infúzió----1件: 65 💬
4170Octagam® 10%1件: Human immunoglobulin G---1件: 63 💬
4171OCTANATE 100 UI/ml, poudre et solvant pour solution injectable1件: Beroctocog alfa---1件: 288 💬
4172OCTANATE 50 UI/ml, poudre et solvant pour solution injectable1件: Beroctocog alfa---1件: 288 💬
4173Octaplas infusion1件: Plasma protein fraction (human)---1件: 64 💬
4174OCTOCOG ALFA1件: Antihemophilic factor, human recombinant---1件: 288 💬
4175Octreotide a azione pronta 0,1 mg1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227 💬
4176OCTREOTIDE ACETATE2件: Acetate,
Octreotide		1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227 💬
4177OCTREOTIDE ACETATO1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227 💬
4178Octreotide LAR / Sandostatin LAR (LAR=long acting release)1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
4179ODSH at 0.125 mg/kg/h----1件: 210 💬
4180ODSH at 0.250 mg/kg/h----1件: 210 💬
4181ODSH at 0.375 mg/kg/h----1件: 210 💬
4182Ofatumumab subcutaneous injection1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4183OL adalimumab 40 mg1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
4184OLE BSA Adalimumab +/- MTX1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
4185OLE FD Adalimumab +/- MTX1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
4186Oleic Acid1件: Oleic Acid1件: Oleic acid 💬--2件: 13, 299 💬
4187Oleic acid supplementation1件: Oleic Acid1件: Oleic acid 💬--1件: 299 💬
4188Oleovit D3 14.400 IU/ml oral drops, solution----1件: 13 💬
4189Oligofructose enriched inulin1件: Inulin1件: Inulin 💬--1件: 96 💬
4190OligoG CF-5/20 - 17.5 mg----1件: 299 💬
4191OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299 💬
4192OligoG CF/20 - 27.5 mg----1件: 299 💬
4193OligoG CF/20 - 37.5 mg----1件: 299 💬
4194OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299 💬
4195OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299 💬
4196OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment1件: Alginic acid1件: Alginic acid 💬--1件: 299 💬
4197Oligomer of Sodium Alginate1件: Alginic acid1件: Alginic acid 💬--1件: 299 💬
4198Oligomero morfolino fosforodiamidato per skipping dell’esone 45----1件: 113 💬
4199Oligomero morfolino fosforodiamidato per skipping dell’esone 53----1件: 113 💬
4200OLIPUDASE ALFA1件: Olipudase alfa1件: Olipudase alfa 💬1件: SMPD1 💬5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19 💬
4201Olipudase alfa (GZ402665)1件: Olipudase alfa1件: Olipudase alfa 💬1件: SMPD1 💬5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19 💬
4202Olipudase alfa (rhASM)1件: Olipudase alfa1件: Olipudase alfa 💬1件: SMPD1 💬5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19 💬
4203Olumiant - EU/1/16/1170/001-0081件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
4204Olumiant - EU/1/16/1170/009-0161件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
4205Omadacycline Injection [Nuzyra]1件: Omadacycline1件: Omadacycline 💬--1件: 299 💬
4206Omadacycline Oral Tablet [Nuzyra]1件: Omadacycline1件: Omadacycline 💬--1件: 299 💬
4207Omaveloxolone Capsules, 10 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4208Omaveloxolone Capsules, 150 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4209Omaveloxolone Capsules, 160 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4210Omaveloxolone Capsules, 2.5 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4211Omaveloxolone Capsules, 20 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4212Omaveloxolone Capsules, 300 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4213Omaveloxolone Capsules, 40 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4214Omaveloxolone Capsules, 5 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4215Omaveloxolone Capsules, 80 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
4216Omega 3 fatty acid----1件: 53 💬
4217Omega-3 and Vitamin E supplementation2件: Omega-3 fatty acids,
Vitamin E		1件: Vitamin E 💬--1件: 46 💬
4218Omega-3 fatty acid1件: Omega-3 fatty acids---2件: 46, 66 💬
4219Omega-3 fatty acid ethylester901件: Omega-3 fatty acids---1件: 66 💬
4220Omega-3 Fatty Acid Fish Oil Supplement2件: Fish oil,
Omega-3 fatty acids		---1件: 66 💬
4221Omega-3 fatty acids1件: Omega-3 fatty acids---2件: 13, 79 💬
4222OMEGA-3-ACID TRIGLYCERIDES1件: Omega-3 fatty acids---1件: 299 💬
4223Omegaven (10% fish-oil emulsion----1件: 46 💬
4224Omidubicel (former CordIn)1件: Omidubicel---1件: 60 💬
4225OMNIPAQUE - 300 MG I/ML SOLUZIONE INIETTABILE FLACONE IN POLIPROPILENE DA 50 ML1件: Iohexol1件: Iohexol 💬--1件: 222 💬
4226OMS00620646, OMS620646, MASP-2 Antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 109 💬
4227OMS721 (narsoplimab)1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 66, 222 💬
4228OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 64, 109 💬
4229OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 64, 109 💬
4230ON 01910.NA----1件: 36 💬
4231Onabotulinum Toxin A----1件: 226 💬
4232Onabotulinumtoxin A----2件: 51, 226 💬
4233Onabotulinumtoxin A Injection----1件: 6 💬
4234Onabotulinumtoxina for Injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 149 💬
4235ONASEMNOGENE ABEPARVOVEC1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬1件: SMN1 💬-1件: 3 💬
4236Onasemnogene Abeparvovec-xioi1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬1件: SMN1 💬-1件: 3 💬
4237Once a day Trientine1件: Triethylenetetramine---1件: 171 💬
4238Once daily subcutaneous injection of Genotropin1件: Somatotropin---1件: 78 💬
4239Once weekly subcutaneous injection of TransCon hGH----1件: 78 💬
4240Once-daily insulin detemir1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
4241Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter2件: Iodide,
Sodium iodide		3件: Sodium iodide ,
Sodium iodide I 123 ,
Sodium iodide I 125 💬		--1件: 34 💬
4242Oncoxin + Viusid----1件: 46 💬
4243Ondansetron 8 mg film-coated tablets1件: Ondansetron1件: Ondansetron 💬5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬		2件: Serotonergic synapse, Taste transduction 💬1件: 6 💬
4244One 20cm2/10cm2 autologous skin sheet graft----1件: 160 💬
4245One additional blood sample during a planned blood test----1件: 266 💬
4246One Alpha----2件: 50, 107 💬
4247One Alpha Drops----2件: 50, 107 💬
4248One-alpha1件: Alfacalcidol1件: Alfacalcidol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 50, 107 💬
4249One-Alpha drops1件: Alfacalcidol1件: Alfacalcidol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 50, 107 💬
4250Only 1 arm: treatment with MSC-AFP----1件: 96 💬
4251Only medicinal products registered in Austria will be used in this clinical trial.----1件: 78 💬
4252Only medicinal products registered in Germany will be used in this clinical trial----1件: 78 💬
4253ONO-4641/ MSC2430913A----1件: 13 💬
4254Open Label (Avatrombopag tablets)1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
4255Open label - AL0011件: Latozinemab1件: Latozinemab 💬1件: SORT1 💬3件: Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬1件: 127 💬
4256Open label Namilumab1件: Namilumab---1件: 84 💬
4257Open label RAD001 (only used for post-extension phase)----1件: 158 💬
4258Open-label Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4259Open-label Adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4260OpenBiome FMT product FMP250----1件: 65 💬
4261Oprelvekin, Interleukin 11, IL-111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
4262OPRX-106 (plant cells expressing TNFR-Fc) 2mg----1件: 97 💬
4263OPRX-106 (plant cells expressing TNFR-Fc) 8mg----1件: 97 💬
4264Optimized antiparkinsonian treatment----1件: 6 💬
4265Optinate 5 mg filmcoated tablets----1件: 274 💬
4266Optional pharmacogenetic assessment----1件: 6 💬
4267Optivate® (Human Coagulation Factor VIII)2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
4268Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone2件: Mesalazine,
Methylprednisolone		2件: Mesalamine ,
Methylprednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
4269Oral all-trans retinoic acid (ATRA)1件: Tretinoin1件: Tretinoin 💬3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 94 💬
4270Oral anticoagulant treatment----1件: 86 💬
4271Oral Aztreonam1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
4272Oral bovine type I collagen1件: Bovine type I collagen---1件: 51 💬
4273Oral bovine type II collagen----1件: 46 💬
4274Oral ciprofloxacin plus inhaled colistin2件: Ciprofloxacin,
Colistin		2件: Ciprofloxacin ,
Colistin 💬		--1件: 299 💬
4275Oral Iron1件: Iron---2件: 97, 254 💬
4276Oral levodopa and carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4277Oral lipoic acid (LA)1件: Lipoic acid---1件: 13 💬
4278Oral nutritional supplementation----1件: 2 💬
4279Oral PDE5 inhibitors----1件: 86 💬
4280Oral treprostinil (UT-15C) Sustained Release Tablets1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4281Orelabrutinib( higher dose)1件: Orelabrutinib1件: Orelabrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
4282Orelabrutinib( lower dose)1件: Orelabrutinib1件: Orelabrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
4283Orencia (abatacept)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4284Orencia (trade name)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 50 💬
4285ORENCIA 125 mg solution for injection1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4286ORENCIA 125 mg solution for injection in pre-filled syringe1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬3件: 46, 49, 53 💬
4287ORENCIA 125 mg, solution injectable en seringue préremplie1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4288ORENCIA 250 mg polvo para concentrado para sol. para perfusión1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4289ORENCIA 250mg powder for concentrate for solution for infusion1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4290Orencia abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4291ORENCIA Subcutaneous Injection1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4292ORENCIA*IV 2FL 250MG+2SIR1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
4293Orencia® (Abatacept)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 95 💬
4294ORENCIA® 125 mg solution for injection in pre-filled syringe1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 65 💬
4295Originator (legacy) drug----4件: 46, 96, 97, 271 💬
4296Originator adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
4297Originator rituximab - Rituxan ® or MabThera ®1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4298Orkambi 100 mg/125 mg film-coated tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4299Orkambi 200 mg/125 mg film-coated tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4300Orkambi: contains lumacaftor and ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4301Ornithine alpha ketoglutarate1件: Ornithine1件: Ornithine 💬--1件: 245 💬
4302Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg3件: Estradiol,
Ethinylestradiol,
Norgestimate		3件: Estradiol ,
Ethinyl estradiol ,
Norgestimate 💬		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299 💬
4303Ortho-novum1件: Mestranol1件: Mestranol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 46, 49 💬
4304Ortho-Novum 7771件: Mestranol1件: Mestranol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
4305Ortho-Novum® 1/351件: Mestranol1件: Mestranol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 46 💬
4306OsrhAAT 1 mg/kg IV----1件: 231 💬
4307OsrhAAT 10 mg/kg IV----1件: 231 💬
4308OsrhAAT 20 mg/kg IV----1件: 231 💬
4309OsrhAAT 3 mg/kg IV----1件: 231 💬
4310OsrhAAT 40 mg/kg IV----1件: 231 💬
4311OsrhAAT 60 mg/kg IV----1件: 231 💬
4312OSSIDO DI AZOTO----1件: 294 💬
4313Ossido Nitrico----1件: 86 💬
4314OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107 💬
4315OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 107 💬
4316Other analgesics and antipyretics----1件: 13 💬
4317Other antiepileptics----1件: 140 💬
4318Other biological agent----2件: 46, 96 💬
4319Other COX-2 inhibitor----1件: 271 💬
4320Other Cox-2 inhibitors----1件: 271 💬
4321Other H1 antagonist----1件: 13 💬
4322Other hematological Agents----1件: 65 💬
4323OTHER NERVOUS SYSTEM DRUGS----2件: 6, 13 💬
4324Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac1件: Etodolac1件: Etodolac 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4325Other Non-selective NSAIDs----1件: 271 💬
4326Other non-sponsor pancreatic enzyme replacement therapy----1件: 299 💬
4327OTL-103 Dispersion for Infusion----1件: 65 💬
4328OTL-200 Dispersion for Infusion----1件: 19 💬
4329Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4----1件: 11 💬
4330Ovastat 1000 (Treosulfan injection)1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
4331Ovastat 1000 mg, powder for solution for infusion1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
4332Ovastat 5000 (Treosulfan injection)1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
4333Ovastat 5000 mg, powder for solution for infusion1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
4334Over-encapsulated 150 mg Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
4335Over-encapsulated 75 mg Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
4336Over-encapsulated Irbesartan1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
4337Over-encapsulated Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
4338Overencapsulated Azathioprine (Imuran) 50 mg Tablet1件: Azathioprine1件: Azathioprine 💬--1件: 97 💬
4339OXICODONE DC.IT----1件: 46 💬
4340OXN 10 mg / 5 mg PR----1件: 6 💬
4341OXN 20 mg / 10 mg PR----1件: 6 💬
4342Oxybutynin and darifenacin2件: Darifenacin,
Oxybutynin		2件: Oxybutynin ,
Darifenacin 💬		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
4343Oxybutynin, tolterodine, solifenacin3件: Oxybutynin,
Solifenacin,
Tolterodine		3件: Oxybutynin ,
Tolterodine ,
Solifenacin 💬		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 53 💬
4344Oxycodone Depot ”Sandoz”, depot tablets1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298 💬
4345Oxycodone naloxone prolonged release tablets2件: Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
4346Oxycodone/naloxone prolonged release t3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
4347Oxycodone/Naloxone Prolonged Release tablets2件: Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4348Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4349Oxycodone/naloxone prolonged release tablets 10/5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
4350Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4351Oxycodone/naloxone prolonged release tablets 20/10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
4352Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4353Oxycodone/naloxone prolonged release tablets 5/2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
4354Oxycodonhydrochlorid ”Lannacher”, depot tablets----1件: 298 💬
4355Oxygen, liquid1件: Oxygen1件: Oxygen 💬--2件: 86, 88 💬
4356Oxytocin (OXT) continuous1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
4357Oxytocin nasal spray1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬2件: 72, 193 💬
4358P-188 NF----1件: 113 💬
4359P144 Cytokine Inhibitor----1件: 51 💬
4360P144 Cytokines Inhibitors----1件: 51 💬
4361P144. Cytokines Inhibitors----1件: 51 💬
4362P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬		4件: DRD2,
DRD3,
DRD4,
MAOB 💬		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4363P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬		4件: DRD2,
DRD3,
DRD4,
MAOB 💬		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4364P38 (4) Map Kinase Inhibitor----1件: 46 💬
4365P38 Inhibitor (4)----1件: 46 💬
4366P38 Inhibitor (4) 150mg----1件: 46 💬
4367P38 Inhibitor (4) 25mg----1件: 46 💬
4368P38 Inhibitor (4) 300mg----1件: 46 💬
4369P38 Inhibitor (4) 50mg----1件: 46 💬
4370P38 Inhibitor (4) 75mg----1件: 46 💬
4371P38 Map Kinase Inhibitor----1件: 46 💬
4372P38(4) Map Kinase Inhibitor----1件: 46 💬
4373Pabinafusp alfa1件: Pabinafusp alfa1件: Pabinafusp alfa 💬2件: IDS,
TFRC 💬		8件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬1件: 19 💬
4374Palmitoleic Acid1件: Palmitoleic Acid---1件: 97 💬
4375PALOVAROTENE - 1.5mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4376PALOVAROTENE - 10 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4377PALOVAROTENE - 1mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4378PALOVAROTENE - 2 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4379PALOVAROTENE - 2.5 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4380PALOVAROTENE - 3 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4381PALOVAROTENE - 4 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4382PALOVAROTENE - 5 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
4383Pamidronate (Aredia)1件: Pamidronic acid1件: Pamidronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
4384Pamrevlumab (FG-3019)1件: Pamrevlumab1件: Pamrevlumab 💬1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬1件: 113 💬
4385Pancrease MT 10.5, or MT 21----1件: 299 💬
4386Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)2件: Acarbose,
Pancrelipase		2件: Acarbose ,
Pancrelipase 💬		5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298 💬
4387PANCREATINA (Páncreas Polvo----1件: 299 💬
4388PANCREATINA (Páncreas Polvo)----1件: 299 💬
4389PANCRECARB® (pancrelipase)1件: Pancrelipase1件: Pancrelipase 💬--1件: 299 💬
4390PANCRELIPASE AMYLASE2件: Pancrelipase,
Pancrelipase amylase		1件: Pancrelipase 💬--1件: 299 💬
4391Panzytrat 25.000 FIP-E units of Lipase----1件: 298 💬
4392Panzytrat® 25,000----1件: 299 💬
4393Panzytrat® ok----1件: 299 💬
4394Paquinimod (ABR-215757)1件: Paquinimod---1件: 49 💬
4395Paracetamol (acetaminophen)1件: Acetaminophen1件: Acetaminophen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4396PARACETAMOLO DC.IT FU----1件: 46 💬
4397PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE----1件: 19 💬
4398PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE----1件: 300 💬
4399Paracetamolo Zentiva Italia----1件: 28 💬
4400Parathyroid Hormone (1-84) Human Recombinant1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
4401Parenteral Remodulin (treprostinil) injection1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4402Paroxetine & Prednisolone2件: Paroxetine,
Prednisolone		2件: Prednisolone ,
Paroxetine 💬		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
4403Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone		2件: Prednisolone ,
Paroxetine 💬		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
4404Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone		2件: Prednisolone ,
Paroxetine 💬		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
4405Part 1 Levulan injection----1件: 34 💬
4406Part 1 Levulan surface application----1件: 34 💬
4407Part 1 Levulan surface application twice----1件: 34 💬
4408Part 1 Levulan surface application twice with microneedling----1件: 34 💬
4409Part 1, JM-010 component Group A----1件: 6 💬
4410Part 1, JM-010 component Group B----1件: 6 💬
4411Part 1, JM-010 component Group C----1件: 6 💬
4412Part 1: LJN452----1件: 93 💬
4413Part 2 Adult Alogabat High Dose (aged 15-17)----1件: 201 💬
4414Part 2, JM-010 combination Group A----1件: 6 💬
4415Part 2, JM-010 combination Group B----1件: 6 💬
4416Part 2, JM-010 component Group C----1件: 6 💬
4417Part 2: LJN452 Dose level 1----1件: 93 💬
4418Part 2: LJN452 Dose level 2----1件: 93 💬
4419Part A----1件: 46 💬
4420Part A: 100 mg/mL GSK2618960----1件: 13 💬
4421Part B: Dose of GSK2618960 decided from Part A----1件: 13 💬
4422Part C: Dose of GSK2618960 decided from Part A and B----1件: 13 💬
4423Part I - etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
4424Part I - etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
4425Part I- naproxen 1000 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
4426Part II- etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
4427Part II- etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
4428Part II- naproxen 1000 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
4429Partial Enteral Nutrition----1件: 96 💬
4430PAT-001, 0.1%----1件: 160 💬
4431PAT-001, 0.2%----1件: 160 💬
4432Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----1件: 46 💬
4433PB1046 Injection----1件: 113 💬
4434PB1046 Subcutaneous Injection----1件: 86 💬
4435PB1046, VIP-ELP1-120, Vasomera----1件: 86 💬
4436PBF-999 / 160 mg----1件: 8 💬
4437PBF-999 / 320 mg----1件: 8 💬
4438PBMC autotransplantation----1件: 2 💬
4439PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----1件: 65 💬
4440PD 0299685 at 15mg BID----1件: 226 💬
4441PD 0299685 at 30mg BID----1件: 226 💬
4442PD00377 Na-salt----1件: 85 💬
4443PDE5 inhibitor----1件: 86 💬
4444Peg-Ada----1件: 65 💬
4445Peg-Interferon alpha-2b1件: Interferon alfa-2b1件: Interferon alfa-2b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 34 💬
4446PEG-interleukin-21件: Human interleukin-2---1件: 65 💬
4447Pegcetacoplan (APL-2)1件: Pegcetacoplan1件: Pegcetacoplan 💬1件: C3 💬17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬3件: 2, 61, 62 💬
4448PEGUNIGALSIDASE ALFA1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬--1件: 19 💬
4449Pegunigalsidase alpha----1件: 19 💬
4450PEGylated Intereron Beta-1a----1件: 13 💬
4451Pegylated interferon alfa1件: Interferon alfa1件: Interferon alfa 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 96 💬
4452Pegylated Interferon Alpha2b----1件: 227 💬
4453PEGylated Interferon Beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4454PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE----1件: 171 💬
4455Pemziviptadil (PB1046) Injection----1件: 86 💬
4456PENTAMIDINA ISETIONATO1件: Pentamidine1件: Pentamidine 💬--1件: 61 💬
4457Pentasa Compact 2g, granulate with prolonged release2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4458Pentasa Compact 4g, granulate with prolonged release2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4459Pentosan Polysulfat SP 54® injection solution----1件: 19 💬
4460Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----1件: 113 💬
4461Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265 💬
4462Peri-neural Dexamethasone 1 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
4463PERINDOPRIL ARGININA2件: Arginine,
Perindopril		2件: Arginine ,
Perindopril 💬		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58 💬
4464Perindopril arginine2件: Arginine,
Perindopril		2件: Arginine ,
Perindopril 💬		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58 💬
4465Persantin 100 mg and----1件: 46 💬
4466Personalized extended interval dosing of natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4467Pertactin adsorbed1件: Bordetella pertussis pertactin antigen---1件: 46 💬
4468PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated),
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 46 💬
4469PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis pertactin antigen,
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 46 💬
4470PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated),
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 46 💬
4471PET with 11C-Flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
4472PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----1件: 85 💬
4473PF-00547659 SC injection----2件: 96, 97 💬
4474PF-04236921 SC injection----1件: 96 💬
4475PF-06291826-83/Fx-1006A1件: Fx-1006A---1件: 28 💬
4476PF-06649751 - 15mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
4477PF-06649751 - 1mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
4478PF-06649751 - 5mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
4479PF-06755347 intravenous healthy participant----1件: 63 💬
4480PF-06755347 subcutaneous ITP----1件: 63 💬
4481Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6 💬
4482Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid----1件: 6 💬
4483Pharmacologic approaches to glycemic treatment----1件: 298 💬
4484Phase 1, SQY51----1件: 113 💬
4485Phase 1: Conventiaonal DMARD----1件: 46 💬
4486Phase 1: Etanercept1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4487Phase 1: Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4488Phase 2: Optional ETN, SSZ, HCQ, MTX----1件: 46 💬
4489Phase 2a, SQY51 (cohort 1)----1件: 113 💬
4490Phase 2a, SQY51 (cohort 2)----1件: 113 💬
4491Phase 2a, SQY51 (cohort 3)----1件: 113 💬
4492Phase1 : CDED/Modulen™IBD® + Maintenance therapy----1件: 96 💬
4493Phase2 and 3 :----1件: 96 💬
4494Phenylalanine-free protein substitute in tablet form (XPhe minis)1件: Phenylalanine1件: Phenylalanine 💬--1件: 240 💬
4495Phenylalanine-free protein substitute tablets1件: Phenylalanine1件: Phenylalanine 💬--1件: 240 💬
4496PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR1件: Lysine1件: Lysine 💬--1件: 13 💬
4497PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6 💬
4498PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid----1件: 6 💬
4499Phosphate and betamethasone acetate, 2 mL.3件: Acetate,
Betamethasone,
Phosphate ion		1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235 💬
4500Phosphodiesterase Inhibitors----1件: 51 💬
4501Phosphorodiamidate morpholino oligomer for exon 45 skipping----1件: 113 💬
4502Phosphorodiamidate morpholino oligomer for exon 53 skipping----1件: 113 💬
4503Physiologic serum nebulized nasally----1件: 299 💬
4504PHYSIOLOGISCHE Kochsalzloesung Fresenius - Infusionsloesung----1件: 227 💬
4505Physiologische Kochsalzlösung Fresenius - Infusionslösung----1件: 288 💬
4506Pilocarpine Nitrate 5%2件: Nitrate,
Pilocarpine		2件: Pilocarpine ,
Nitric acid 💬		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299 💬
4507Pimavanserin (ACP-103)1件: Pimavanserin---1件: 6 💬
4508Pimavanserin tartrate (ACP-103)1件: Pimavanserin---1件: 6 💬
4509Pimecrolimus 1% Cream1件: Pimecrolimus1件: Pimecrolimus 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 160 💬
4510Pimozide 2mg/day (current) or 4 mg/day (study initiation)1件: Pimozide1件: Pimozide 💬2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
4511Pioglitazone and Tretinoin2件: Pioglitazone,
Tretinoin		2件: Tretinoin ,
Pioglitazone 💬		4件: PML,
PPARG,
RARA,
RARB 💬		21件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 2 💬
4512Piperacillin sodium , tazobactam sodium2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
4513Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
4514Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie1件: Tazobactam1件: Tazobactam 💬--1件: 299 💬
4515Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie1件: Tazobactam1件: Tazobactam 💬--1件: 299 💬
4516PIR, S-7701----1件: 85 💬
4517Pirepemat x fumarate----1件: 6 💬
4518Pirepemat, 100 mg----1件: 6 💬
4519Pirepemat, 50 mg----1件: 6 💬
4520Pirfenidone and nintedanib2件: Nintedanib,
Pirfenidone		2件: Pirfenidone ,
Nintedanib 💬		14件: CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		106件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
4521Pirfenidone or nintedanib2件: Nintedanib,
Pirfenidone		2件: Pirfenidone ,
Nintedanib 💬		14件: CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		106件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
4522Pirfenidone Solution for Inhalation1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
4523Pirfenidone, deuterated1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
4524PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
4525PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)1件: Water1件: Water 💬--1件: 57 💬
4526PLA + MTX switched to ABA+ MTX, DB----1件: 46 💬
4527Placebo IV----1件: 50 💬
4528Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix1件: Placental Mesenchymal Stem Cells---1件: 118 💬
4529PLACENTEX ® Polydeoxyribonucleotide----1件: 51 💬
4530PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml----1件: 51 💬
4531PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿----1件: 51 💬
4532Plantain NSP----1件: 96 💬
4533Plaquenil - Hydroxychloroquine 200mg Film coated tablets1件: Hydroxychloroquine1件: Hydroxychloroquine 💬--3件: 43, 44, 45 💬
4534Plaquenil 200 mg filmdrasjerte tabletter----1件: 46 💬
4535Plasma analysis for bacterial translocation----1件: 46 💬
4536Plasma from healthy young people treatment + Riluzole1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
4537Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----1件: 96 💬
4538Plasma-derived FVIII/VWF concentrate----1件: 288 💬
4539PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML----1件: 274 💬
4540Plegridy (peginterferon beta-1a), Biogen Idec Ltd1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4541PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4542Plerixafor for Conditioning before HSCT.1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
4543Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 299 💬
4544PLF with NeoFuse----1件: 70 💬
4545Plovamer acetate1件: Acetate---1件: 13 💬
4546Plovamer acetate 0.5 milligram (mg)1件: Acetate---1件: 13 💬
4547Plovamer acetate 10 mg1件: Acetate---1件: 13 💬
4548Plovamer acetate 20 mg1件: Acetate---1件: 13 💬
4549Plovamer acetate 3 mg1件: Acetate---1件: 13 💬
4550PN 200 tablets (500 mg naproxen and 20 mg omeprazole)2件: Naproxen,
Omeprazole		2件: Naproxen ,
Omeprazole 💬		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
4551Pneumo23 / Pneumovax----1件: 46 💬
4552PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14 💬
4553PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE4件: Aluminium,
Aluminium phosphate,
Corynebacterium diphtheriae CRM197 protein,
Phosphate ion		---1件: 46 💬
4554Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F----1件: 46 💬
4555Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F----1件: 46 💬
4556Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F----1件: 222 💬
4557Pneumococcal polysaccharide vaccine solution for injection in a vial----1件: 222 💬
4558Pneumovax II----1件: 13 💬
4559PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml----2件: 62, 66 💬
4560Pneumovax® (pneumococcal polysaccharide vaccine)----1件: 65 💬
4561PNEUMOVAX® 23----1件: 46 💬
4562PO azithromycin1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
4563Poly ICLC----1件: 34 💬
4564POLY(OXY-1,2-ETHANEDIYL), A----1件: 235 💬
4565POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-1件: Diethyl ether1件: Ether 💬--1件: 235 💬
4566POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI1件: Diethyl ether1件: Ether 💬--1件: 235 💬
4567POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1)2件: Diethyl ether,
Teriparatide		2件: Ether ,
Teriparatide 💬		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
4568Polyclonal IgG----1件: 65 💬
4569Polymorphism Analysis----2件: 49, 60 💬
4570Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----1件: 13 💬
4571Pomalidomide and Dexamethasone2件: Dexamethasone,
Pomalidomide		2件: Dexamethasone ,
Pomalidomide 💬		3件: IL6,
NR3C1,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
4572Pooled Plasma (Human), Solvent/Detergent Treated----1件: 64 💬
4573Porcine (pig) PERT----1件: 299 💬
4574Posaconazole 100 MG [Noxafil]1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
4575Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)1件: Activated charcoal---1件: 6 💬
4576Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----1件: 6 💬
4577Post-CPB Drug: Dobutamine Hydrochloride1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
4578Postoperative 3-month exclusive enteral nutrition----1件: 96 💬
4579Powder for Oral Suspension)----1件: 113 💬
4580Pozelimab + Cemdisiran2件: Cemdisiran,
Pozelimab		1件: Pozelimab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
4581PRA023 IV----3件: 51, 96, 97 💬
4582PRALIA 60 mg Subcutaneous Injection Syringe(denosumab)1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
4583PRALIA 60mg Subcutaneous Injection Syringe(denosumab)1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
4584Pramipexol Immediate Release1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4585Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4586Pramipexole Immediate Release1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4587Pramipexole immediate release tablet1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4588Pramipexole IR1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4589Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4590Pre and post-CPB Drug: Dobutamine Hydrochloride1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
4591Pre-filled syringe----1件: 46 💬
4592Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)----1件: 13 💬
4593Precedentemente denominato MEDI2070 e AMG 139----1件: 96 💬
4594Precision dosing with a dashboard----1件: 96 💬
4595Pred + Meth----1件: 46 💬
4596PredniHEXAL® 10mg Tabletten----1件: 46 💬
4597PredniHEXAL® 20mg Tabletten----1件: 46 💬
4598PredniHEXAL® 5mg Tabletten----1件: 46 💬
4599PredniHEXAL® 5mg Tabletten, PredniHEXAL® 10mg Tabletten----1件: 46 💬
4600PredniHEXAL® 5mg Tabletten, PredniHEXAL® 20mg Tabletten----1件: 46 💬
4601Prednisolone & dipyridamole2件: Dipyridamole,
Prednisolone		2件: Dipyridamole ,
Prednisolone 💬		3件: NR3C1,
PDE4A,
PDE5A 💬		7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
4602Prednisolone + mabthera2件: Prednisolone,
Rituximab		2件: Prednisolone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61 💬
4603PREDNISOLONE ACETATE3件: Acetate,
Prednisolone,
Prednisolone acetate		2件: Prednisolone ,
Prednisolone acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
4604Prednisolone and chlorambucil2件: Chlorambucil,
Prednisolone		2件: Chlorambucil ,
Prednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
4605Prednisolone and mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone		3件: Prednisolone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
4606Prednisolone and taper1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
4607Prednisolone Tablets B.P. 5mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
4608PREDNISON 5, 20 Léciva por. tablet nob----1件: 50 💬
4609Prednison 5, 20 Léciva por. tablet nob.----1件: 50 💬
4610Prednison acis® 20 mg----2件: 43, 44 💬
4611Prednison acis® 5 mg----2件: 43, 44 💬
4612Prednison acis¿ 20 mg----2件: 43, 44 💬
4613Prednison acis¿ 5 mg----2件: 43, 44 💬
4614Prednisone (and methylprednisolone)2件: Methylprednisolone,
Prednisone		2件: Methylprednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
4615Prednisone + Inhibace/Cozaar1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4616Prednisone - Azathioprine2件: Azathioprine,
Prednisone		2件: Azathioprine ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 11 💬
4617Prednisone 0,5 mg/kg orally on alternate days1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
4618Prednisone acetate3件: Acetate,
Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 46, 49, 224 💬
4619Prednisone Acetate Tablets3件: Acetate,
Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 224 💬
4620Prednisone alone1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 11, 66 💬
4621Prednisone and Belimumab2件: Belimumab,
Prednisone		2件: Prednisone ,
Belimumab 💬		2件: NR3C1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬1件: 300 💬
4622Prednisone and cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4623Prednisone and Mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		3件: Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 300 💬
4624Prednisone and ustekinumab treatment2件: Prednisone,
Ustekinumab		2件: Prednisone ,
Ustekinumab 💬		4件: IL12A,
IL12B,
IL23A,
NR3C1 💬		29件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 41 💬
4625PREDNISONE ARROW 20mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4626PREDNISONE ARROW 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4627PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 19 💬
4628PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 300 💬
4629Prednisone in full dose1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4630PredniSONE Tablets USP, 1 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46 💬
4631PredniSONE Tablets USP, 10 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4632PredniSONE Tablets USP, 1mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4633PredniSONE Tablets USP, 2.5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4634PredniSONE Tablets USP, 2.5mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4635PredniSONE Tablets USP, 20mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4636PredniSONE Tablets USP, 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46 💬
4637PredniSONE Tablets USP, 5mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4638PredniSONE Tablets, USP1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 41, 43, 44 💬
4639PredniSONE Tablets, USP 10 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4640PredniSONE Tablets, USP 2.5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4641PredniSONE Tablets, USP 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4642PredniSONE Tablets, USP, 1 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4643Prednisone therapy and pharmacokinetic1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
4644Prednisone, ciclosporin and mycophenolate mofetil4件: Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: Cyclosporine ,
Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		8件: IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
4645Prednisone, cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 40 💬
4646Prednisone, FK506, MMF1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
4647Prednisone, low dose rituximab2件: Prednisone,
Rituximab		2件: Prednisone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61 💬
4648Prednisone, methylprednisolone,cyclophosphamides2件: Methylprednisolone,
Prednisone		2件: Methylprednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
4649Preimplantation factor1件: Preimplantation factor---1件: 95 💬
4650Premarin and Provera----1件: 49 💬
4651Preparative regimen 4-6 weeks after Leukapheresis----1件: 96 💬
4652Prescribe N-acetylcysteine tablets1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 90 💬
4653Preservative free artificial tear gel.----1件: 157 💬
4654PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 222 💬
4655Prevenar 13 sospensione per iniezione12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 14 💬
4656Prevenar 13 suspension for injection12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 222 💬
4657Prevenar® (7-valent pneumococcal conjugate vaccine)----1件: 65 💬
4658Prevenar® and Pneumo23®----1件: 49 💬
4659Previously known as R935788----1件: 46 💬
4660Previously referred to as MEDI2070 and AMG 139----2件: 96, 97 💬
4661Previously referred to as MEDI2070 and AMG 139, AGN-151-598----1件: 96 💬
4662Previously termed sc.AAV9.CB.SMN and AVXS-101----1件: 3 💬
4663Pridia (Donepezil Hydrochloride) 5mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
4664PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML----1件: 51 💬
4665Privigen 100 mg/ml, solution pour perfusion----1件: 53 💬
4666PRM-151 (Zinpentraxin Alfa)1件: PRM-151---1件: 85 💬
4667PRN1008 Freebase----1件: 35 💬
4668PRO044 IV----1件: 113 💬
4669PRO044 IV 6 mg/kg----1件: 113 💬
4670PRO044 IV 9 mg/kg----1件: 113 💬
4671PRO045, 0.15 mg/kg/week1件: BMN-045---1件: 113 💬
4672PRO045, 1.0 mg/kg/week1件: BMN-045---1件: 113 💬
4673PRO045, 3.0 mg/kg/week1件: BMN-045---1件: 113 💬
4674PRO045, 6.0 mg/kg/week1件: BMN-045---1件: 113 💬
4675PRO045, 9.0 mg/kg/week1件: BMN-045---1件: 113 💬
4676PRO045, selected dose1件: BMN-045---1件: 113 💬
4677Probiotic - VSL#3----1件: 96 💬
4678Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-141件: Lactobacillus delbrueckii bulgaricus---1件: 46 💬
4679Probiotic Formula Capsule----1件: 97 💬
4680Probiotic Product - Cap----1件: 53 💬
4681PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP----1件: 58 💬
4682PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP----1件: 58 💬
4683PROCHYMAL adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬--1件: 96 💬
4684Prochymal™ adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬--1件: 96 💬
4685Products containing aminosalicylate----1件: 97 💬
4686Products containing azathioprine or 6-mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 97 💬
4687Progressive spacing of TNF-blocker injections----1件: 46 💬
4688Prolastin-C, 120 mg/kg1件: Alpha-1-proteinase inhibitor---1件: 231 💬
4689Prolastin-C, 60 mg/kg1件: Alpha-1-proteinase inhibitor---1件: 231 💬
4690PROLEUKIN® S1件: Aldesleukin1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 65 💬
4691Prolonged-release Fampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
4692Prolotherapy solution of 20% dextrose1件: Dextrose, unspecified form---1件: 70 💬
4693Prometic's Immune Globulin Intravenous 10%----1件: 65 💬
4694Promixin 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299 💬
4695PROMIXIN*NEBUL 30MONOD 1MUI----1件: 299 💬
4696Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299 💬
4697Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----1件: 299 💬
4698Propanoic acid1件: Propanoic acid---2件: 6, 271 💬
4699Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----1件: 13 💬
4700Propofol Injection1件: Propofol1件: Propofol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 70 💬
4701Proposed INN - FILGOTINIB1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
4702Propsoed INN - FILGOTINIB1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
4703Prostacyclin Receptor Agonist1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4704Protease inhibitor----1件: 265 💬
4705Protease inhibitors----1件: 265 💬
4706Protein intake----1件: 240 💬
4707Proteína recombinante estimulante de la megacariopoyesis----1件: 63 💬
4708Proton pump inhibitor (PPI)----1件: 298 💬
4709PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE1件: Modafinil1件: Modafinil 💬--1件: 113 💬
4710PRP injection----1件: 53 💬
4711PRTX-100 (Staphylococcal protein A)1件: Bevifimod---1件: 63 💬
4712PRTX-100 at 1.5 mcg/kg----1件: 46 💬
4713PRTX-100 at 12.0 mcg/kg----1件: 46 💬
4714PRTX-100 at 240 mcg----1件: 46 💬
4715PRTX-100 at 3.0 mcg/kg----1件: 46 💬
4716PRTX-100 at 420 mcg----1件: 46 💬
4717PRTX-100 at 6.0 mcg/kg----1件: 46 💬
4718PRX-102 (pegunigalsidase alfa)1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬--1件: 19 💬
4719PRX002, ELT2, anti-alpha-synuclein monoclonal antibody----1件: 6 💬
4720PsAer IgY----1件: 299 💬
4721Pseudoephedrine + 480 ml water2件: Pseudoephedrine,
Water		2件: Water ,
Pseudoephedrine 💬		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
4722Pseudoephedrine + 50 ml water2件: Pseudoephedrine,
Water		2件: Water ,
Pseudoephedrine 💬		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
4723PSRS11.EFS.IL2RG.pre* retroviral vector----1件: 65 💬
4724PSRS11.EFS.IL2RG.pre* retroviral vector transduce----1件: 65 💬
4725PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells----1件: 65 💬
4726PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----1件: 113 💬
4727PTH1-84 in parent study----1件: 235 💬
4728PU-AD----1件: 2 💬
4729Puerarin injection 400 mg1件: Puerarin---1件: 46 💬
4730Pulmozyme (dornase alfa)1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
4731Pulmozyme (Dornase alpha)1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
4732Pulmozyme single use ampule1件: Dornase alfa1件: Dornase alfa 💬--1件: 299 💬
4733Puri Nethol----1件: 96 💬
4734Puri-Nethol----3件: 86, 96, 97 💬
4735Puri-Nethol 50 mg----1件: 96 💬
4736Purified form of the lysosomal enzyme iduronate-2-sulfatase----1件: 19 💬
4737PURINETHOL - 50 MG COMPRESSE25 COMPRESSE1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
4738PXT002331 - 20mg----1件: 6 💬
4739PXT002331 - dose 1----1件: 6 💬
4740PXT002331 - dose 2----1件: 6 💬
4741PXT3003 Intermediate Dose----1件: 10 💬
4742Pyridostigmine, Prednisone, Tacrolimus3件: Prednisone,
Pyridostigmine,
Tacrolimus		3件: Tacrolimus ,
Prednisone ,
Tacrolimus 💬		6件: NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
4743Pyridostigmine, Tacrolimus2件: Pyridostigmine,
Tacrolimus		2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
4744Pyruvate, creatine, niacinamide2件: Creatine,
Nicotinamide		1件: Niacinamide 💬--1件: 5 💬
4745PZN 8881655(RochePharma AG)----1件: 85 💬
4746Q4W GMA301 IV injections (1000 mg)----1件: 86 💬
4747Q4W GMA301 IV injections (300 mg)----1件: 86 💬
4748Q4W GMA301 IV injections (600 mg)----1件: 86 💬
4749Qi-Ji Shen-Kang formula----1件: 224 💬
4750Qingkailing injection 40 ml----1件: 46 💬
4751QLS-101 ophthalmic solution, 2.0 %----1件: 157 💬
4752QOL assessment, Neuropsychological----1件: 34 💬
4753QR-313 Gel for Topical (Cutaneous) Administration----1件: 36 💬
4754QRL-201 - Dose 1----1件: 2 💬
4755QRL-201 - Dose 2----1件: 2 💬
4756QRL-201 - Dose 3----1件: 2 💬
4757QRL-201 - Dose 4----1件: 2 💬
4758QRL-201 - Dose 5----1件: 2 💬
4759QRL-201 - Dose 6----1件: 2 💬
4760QRL-201 - Dose 7----1件: 2 💬
4761QRL-201- Dose 8----1件: 2 💬
4762QTXEW2-04-AF, EW2, GC-1, QRX-431----1件: 20 💬
4763Quadrivalent influenza vaccine----1件: 13 💬
4764Qutenza (8% capsaicin)1件: Capsaicin1件: Capsaicin 💬1件: TRPV1 💬2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 86 💬
4765R lipoic acid1件: Lipoic acid---1件: 13 💬
4766R(+) pramipexole dihydrochloride monohydrate1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
4767R-ATG----1件: 60 💬
4768R-hGH freeze-dried----1件: 78 💬
4769R788 sodium hexahydrate, RIG2-01, RIG-G----1件: 46 💬
4770R788 Sodium, R788 Na, R788----1件: 46 💬
4771R788, fostamatinib disodium hexahydrate (in USPI/FPI)1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61 💬
4772RA15804589, C19061501-F, DNL788, DN2489, DN0002489----2件: 2, 13 💬
4773RAAV-Olig001-ASPA1件: MYR-101---1件: 307 💬
4774RAAV1-CMV-GAA (study agent) Administration----1件: 256 💬
4775RAAV1.tMCK.human-alpha-sarcoglycan- First cohort----1件: 113 💬
4776RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort----1件: 113 💬
4777RAAV2-ND4----1件: 302 💬
4778RAAV2/2-ND4 VECTOR----1件: 302 💬
4779RAAV9-CB6-AspA----1件: 307 💬
4780Rabbit anti-human thymocyte immunoglobulin2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96 💬
4781Rabbit anti-thymocyte globulin1件: Rabbit---1件: 65 💬
4782Rabbit anti-thymocyte globulin (ATG)1件: Rabbit---1件: 60 💬
4783Rabbit anti-thymocyte globulin (r-ATG)1件: Rabbit---1件: 60 💬
4784Rabbit Anti-Thymoglobulin (rATG)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 285 💬
4785Rabbit antithymocyte globulin2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---3件: 49, 60, 96 💬
4786Rabbit antithymoglobulin (ATG)1件: Rabbit---1件: 60 💬
4787Rabbit ATG2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 60, 285 💬
4788Rabbit ATG, (Genzyme)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 60 💬
4789Rabbit ATG, Cyclosporine, Levamisole4件: Antithymocyte immunoglobulin (rabbit),
Cyclosporine,
Levamisole,
Rabbit		2件: Cyclosporine ,
Levamisole 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
4790Rabbit ATG, Thymoglobuline (Genzyme)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 60 💬
4791RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN1件: Rabbit---2件: 13, 60 💬
4792RAD001, everolimus1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
4793RAD001: Everolimus1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
4794Radiolabelled OligoG CF-5/20 6% Solution----1件: 299 💬
4795Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation----1件: 299 💬
4796Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI)----1件: 299 💬
4797RAG1 LV CD34+ cells----1件: 65 💬
4798Raltegravir and Zidovudine2件: Raltegravir,
Zidovudine		2件: Zidovudine ,
Raltegravir 💬		--1件: 26 💬
4799RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
4800Ranibizumab injection (0.5 mg)1件: Ranibizumab1件: Ranibizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬2件: 166, 301 💬
4801Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
4802RAPA-501 Autologous T cells----1件: 2 💬
4803Rapamicina tópica al 1% y excipiente----1件: 157 💬
4804RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 2 💬
4805Rapamune 1 mg/ml solución oral1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
4806Rapamycin cream, topical, 0.5%, 1.0% w/w1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
4807Rapamycin, sirolimus1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158 💬
4808Raptiva 100 mg/ml powder and solvent for solution for injection1件: Efalizumab1件: Efalizumab 💬1件: ITGAL 💬12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬7件: 11, 13, 46, 53, 61, 95, 96 💬
4809RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE1件: Idebenone1件: Idebenone 💬--1件: 113 💬
4810Rebif (IFN beta-1a subcutaneous three times per week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4811Rebif (IFN ß-1a subcutaneous three times per week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4812Rebif (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4813Rebif (Interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4814Rebif (interferon beta-1a), Merck Serono Europe Ltd2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4815REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4816Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4817REBIF 44 microgramos solución inyectable1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4818REBIF 44 microgramos solución inyectable en jeringa precargada1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4819Rebif 44 micrograms solution for injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4820Rebif 44 micrograms solution for injection in pre-filled syringe1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4821Rebif 8,8 µg, Rebif 22µg1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4822Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4823Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4824Rebif New Formulation + ibuprofen PRN1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
4825Rebif New Formulation + prophylactic Ibuprofen1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
4826Rebif New Formulation 44mcg multidose cartridge1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4827Rebif New Formulation Non Titrated1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4828Rebif New Formulation Titrated1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4829Rebif® (clone 484-39)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4830Rebif® New Formulation1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4831Rebif® New Formulation (IFN-beta-1a, RNF)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4832Rebif® new formulation (RNF)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4833Rebif® New Formulation (RNF) using RebiSmartTM1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4834Rec-h-FGF19----1件: 94 💬
4835Recifercept (proposed INN)----1件: 276 💬
4836Recombiant human Desoxyribonuclease ( rhDNase)1件: Desoxyribonuclease---1件: 299 💬
4837Recombinanat DNA-derived human growth hormone produced in E.coli1件: Somatotropin---1件: 78 💬
4838Recombinant A Disintegrin and Metalloproteinase Thrombospondin Type-1 Motifs 13----1件: 64 💬
4839Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1----1件: 64 💬
4840Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs----1件: 64 💬
4841Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs 13----1件: 64 💬
4842Recombinant A Disintegrin And Metalloproteinase with Thrombospondin Type-1 Motifs 13 (rADAMTS13)----1件: 64 💬
4843Recombinant AAV vector serotype 2 containing the human wild type mitochondrial ND4 gene----1件: 302 💬
4844Recombinant AAV vector serotype 2 containing the human wild typemitochondrial ND4 gene----1件: 302 💬
4845Recombinant ADAMTS13----1件: 64 💬
4846RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE1件: Alpha-1-proteinase inhibitor---1件: 231 💬
4847Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene----1件: 90 💬
4848Recombinant Adeno-Associated Viral vector, serotype 2 (rAAV2/2) containing the human wild-type mitochondrial NADH Dehydrogenase 4 gene (ND4)1件: NADH---1件: 302 💬
4849Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A----1件: 19 💬
4850Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4851Recombinant adenovirus containing the ornithine transcarbamylase gene1件: Ornithine1件: Ornithine 💬--1件: 251 💬
4852Recombinant alpha-galactosidase A1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
4853Recombinant antihumanized anti-human monoclonal antibody directed against the IL-6R----1件: 107 💬
4854Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein1件: Von Willebrand factor human---1件: 288 💬
4855Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein1件: Von Willebrand factor human---1件: 288 💬
4856Recombinant DNA-derived human growth hormone produced in E.coli1件: Somatotropin---1件: 78 💬
4857RECOMBINANT FACTOR FC FUSION PROTEIN2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--2件: 46, 49 💬
4858Recombinant factor VIIII (rFVIII)----1件: 288 💬
4859Recombinant Factor XIII1件: Factor XIII (human)---1件: 288 💬
4860Recombinant Factor XIII (rFXIII)1件: Factor XIII (human)---2件: 97, 288 💬
4861Recombinant form of human nerve growth factor produced in Escherichia Coli.2件: Escherichia coli,
Nerve Growth Factor		---1件: 53 💬
4862Recombinant granulocyte - colony stimulating factor----1件: 39 💬
4863Recombinant Growth Hormone, Genotropin (Pfizer)1件: Somatotropin---1件: 78 💬
4864Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (NEOGAA)3件: Avalglucosidase alfa,
Mannose,
Phosphate ion		1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4865Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan Avalglucosidase Alfa (NeoGAA)3件: Avalglucosidase alfa,
Mannose,
Phosphate ion		1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4866Recombinant human acid alfa-glucosidase----1件: 256 💬
4867Recombinant human acid alfa-glucosidase (ATB200)----1件: 256 💬
4868Recombinant human acid alfa-glucosidase (rhGAA)----1件: 256 💬
4869Recombinant human acid alpha-glucosidase (rhGAA)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4870Recombinant human acid sphingomyelinase----1件: 19 💬
4871RECOMBINANT HUMAN ACID SPHINGOMYELINASE (rhASM)----1件: 19 💬
4872RECOMBINANT HUMAN ALFA-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN1件: Phosphate ion---1件: 256 💬
4873Recombinant human alpha B-crystallin----1件: 13 💬
4874Recombinant human alpha-galactosidase----1件: 19 💬
4875Recombinant human alpha-galactosidase abbreviated as r-h-alpha-GAL----1件: 19 💬
4876Recombinant human alpha-mannosidase----1件: 19 💬
4877Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU)----1件: 19 💬
4878Recombinant Human Angiotensin-Converting Enzyme 22件: Alunacedase alfa,
Angiotensin II		2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
4879Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN012件: Alunacedase alfa,
Angiotensin II		2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
4880Recombinant human anti IL-22 monoclonal antibody IgG1----1件: 46 💬
4881Recombinant human anti-GDF-8 antibody----1件: 113 💬
4882Recombinant Human Apolipoprotein----1件: 79 💬
4883Recombinant Human Apolipoprotein A-I----1件: 79 💬
4884Recombinant Human Apolipoprotein A-I/Phospholipids Complex1件: Omega-3 fatty acids---1件: 79 💬
4885Recombinant human apolipoprotein a1----1件: 79 💬
4886RECOMBINANT HUMAN ARYLSULFATASE A----1件: 19 💬
4887Recombinant Human Arylsulfatase A (rhASA)----1件: 19 💬
4888Recombinant Human Arylsulfatase A (rhASA,----1件: 19 💬
4889Recombinant human Arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
4890Recombinant human brain natriuretic peptide (rhBNP)----1件: 215 💬
4891Recombinant human Cerebral Dopamine Neurotrophic Factor1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4892RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
4893RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
4894RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
4895RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
4896Recombinant human derived macrophage-targeted ß-Glucocerebrosidase----1件: 19 💬
4897RECOMBINANT HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 FUSED TO THE FC FRAGMENT OF IGG1----1件: 166 💬
4898Recombinant human Growth Hormone (Genotropin® )1件: Somatotropin---1件: 78 💬
4899Recombinant Human Growth Hormone (rhGH) Injection1件: Somatotropin---1件: 193 💬
4900Recombinant human growth hormone + rosiglitazone2件: Rosiglitazone,
Somatotropin		1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
4901Recombinant human heparan N-sulfatase----1件: 19 💬
4902Recombinant human heparan N-sulfatase (rhHNS)----1件: 19 💬
4903Recombinant human heparan N-sulfatase [rhHNS]----1件: 19 💬
4904Recombinant human heparan Nsulfatase (rhHNS)----1件: 19 💬
4905Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--1件: 65 💬
4906Recombinant human hyaluronidase + immune globulin intravenous2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--1件: 65 💬
4907Recombinant human IFN beta----1件: 13 💬
4908Recombinant human IGF-1----2件: 78, 299 💬
4909Recombinant Human Insulin Growth Factor 1 (rhIGF-1)1件: Insulin human1件: Insulin human 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 156 💬
4910Recombinant human Insulin-like Growth Factor1件: Insulin human1件: Insulin human 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 96 💬
4911Recombinant human interferon beta1件: Human interferon beta---1件: 13 💬
4912Recombinant human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 26 💬
4913Recombinant Human Interleukin-11 (rhIL-11)1件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 96 💬
4914Recombinant human interleukin-22件: Aldesleukin,
Human interleukin-2		1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 35 💬
4915Recombinant human interleukin-2 (rhIL-2)2件: Aldesleukin,
Human interleukin-2		1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 35 💬
4916Recombinant human interleukin-71件: Interleukin-7---1件: 25 💬
4917Recombinant human lysosomal acid lipase----1件: 19 💬
4918Recombinant human lysosomal acid lipase (rhLAL)----1件: 19 💬
4919Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
4920Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA), lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
4921Recombinant human lysosomal alpha-mannosidase----1件: 19 💬
4922Recombinant human Mab of IgG4 subtype----1件: 46 💬
4923Recombinant human monoclonal antibody----1件: 46 💬
4924Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class----3件: 106, 107, 108 💬
4925Recombinant human monoclonal antibody to Il-17 of the IgG1-k-class----1件: 271 💬
4926Recombinant human monoclonal antibody to inerleukin-1beta of the IgG1-K-class----1件: 46 💬
4927Recombinant human monoclonal antibody to interleukin-1beta of the IgG1-Kappa-class----1件: 46 💬
4928Recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
4929Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110----1件: 19 💬
4930Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 drug substance----1件: 19 💬
4931Recombinant human N-acetylgalactosamine-6-sulfatase1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
4932Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS)1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
4933Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 1101件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
4934Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
4935Recombinant human Nacetylgalactosamine-----1件: 19 💬
4936Recombinant Human Nerve Growth Factor (rhNGF)2件: Cenegermin,
Nerve Growth Factor		1件: Cenegermin 💬1件: NGFR 💬9件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬2件: 53, 90 💬
4937RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH)2件: Albumin human,
Somatotropin		1件: Albumin human 💬--1件: 78 💬
4938Recombinant human von Willebrand Factor1件: Von Willebrand factor human---1件: 288 💬
4939Recombinant humanised anti-human monoclonal antibody directed against the IL-6R----1件: 46 💬
4940Recombinant humanized anti-alpha 4 integrin antibody----1件: 13 💬
4941Recombinant humanized anti-CD20 monoclonal antibody----1件: 13 💬
4942Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal----1件: 46 💬
4943Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal antibody----1件: 46 💬
4944Recombinant humanized anti-human Interleukin-6----1件: 46 💬
4945Recombinant humanized anti-human Interleukin-6 Receptor (IL-6R) monoclonal antibody----1件: 46 💬
4946Recombinant humanized anti-human monoclonal antibody directed against the IL-6R----3件: 46, 51, 107 💬
4947Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg----1件: 331 💬
4948Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6mg/kg----1件: 331 💬
4949Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 8mg/kg----1件: 331 💬
4950Recombinant humanized IgG4 monoclonal antibody----1件: 61 💬
4951Recombinant humanized monoclonal antibody omalizumab to IgE1件: Omalizumab1件: Omalizumab 💬1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
4952Recombinant humanized monoclonal antibody specific for human IL-5----1件: 44 💬
4953Recombinant humanized monoclonal antibody: IgG4 (heavy chain)----1件: 61 💬
4954Recombinant interferon alfa1件: Interferon alfa1件: Interferon alfa 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 26, 28 💬
4955RECOMBINANT INTERFERON BE----1件: 13 💬
4956RECOMBINANT INTERFERON BETA-1B2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4957Recombinant interleukin-111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
4958Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)----1件: 60 💬
4959RECOMBINANT NEISSERIA----1件: 11 💬
4960RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE5件: Aluminium,
Aluminum hydroxide,
Hydroxide ion,
Iron polymaltose,
Lactobacillus casei		2件: Aluminum hydroxide ,
Lactobacillus casei 💬		--1件: 11 💬
4961RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN----1件: 11 💬
4962RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--2件: 11, 13 💬
4963Recombinant porcine coagulation factor VIII (B domain deleted)1件: Beroctocog alfa---1件: 288 💬
4964Recombinant porcine coagulation factor VIII (B-domain deleted)1件: Beroctocog alfa---1件: 288 💬
4965Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene----1件: 19 💬
4966Recombinant TNF-a receptor: IgG Fc fusion protein2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--2件: 46, 271 💬
4967Recombinant truncated SPINT2 protease inhibitor----1件: 299 💬
4968Recombinant von Willebrand Factor1件: Von Willebrand factor human---1件: 288 💬
4969Recombinant von Willebrand Factor (rVWF)1件: Von Willebrand factor human---1件: 288 💬
4970Recombinant von Willebrand Factor 1300IU1件: Von Willebrand factor human---1件: 288 💬
4971Recombinant von Willebrand Factor 650IU1件: Von Willebrand factor human---1件: 288 💬
4972Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII)1件: Von Willebrand factor human---1件: 288 💬
4973Recombinant-methionyl human glial cell line-derived neurotrophic factor----1件: 6 💬
4974Recomibnant human Von Willebrand Factor1件: Von Willebrand factor human---1件: 288 💬
4975RECTABUL2mg rectal form----1件: 97 💬
4976Reduced Intensity Conditioning----2件: 19, 65 💬
4977Reduced Intensity Preparative Regimen----3件: 62, 65, 284 💬
4978Reduced Toxicity Ablative Regimen----3件: 62, 65, 284 💬
4979REF CRUZADA PEI Nº 12-088----1件: 274 💬
4980REGEND001 Autologous Therapy Product----1件: 85 💬
4981REGN1500 250 mg SC/15 mg/kg IV/450 mg SC----1件: 79 💬
4982Regular insulin----1件: 78 💬
4983Regular Novolin R----1件: 6 💬
4984Reh-acteoside1件: Acteoside---1件: 66 💬
4985Remicade (anti tumor necrosis factor inhibitor)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 40 💬
4986REMICADE (INFLIXIMAB)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
4987REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4988Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
4989REMICADE 100 mg polvo para concentrado para solución para perfusión1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
4990Remicade 100 mg powder for concentrate for solution for infusion.1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
4991Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
4992Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning.1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4993REMICADE*EV F 100MG+F 2ML1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4994REMICADE® (Infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4995Remicaide (infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 39 💬
4996Remission induction therapy----2件: 43, 44 💬
4997Remodulin® (treprostinil) 1 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4998Remodulin® (treprostinil) 10 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4999Remodulin® (treprostinil) 2.5 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5000Remodulin® (treprostinil) 5 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5001Remsima (infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
5002REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
5003Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
5004Remsima and Inflectra1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
5005Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i)2件: Angiotensin II,
Dextrose, unspecified form		2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
5006Repaglinide and Insulin1件: Repaglinide1件: Repaglinide 💬2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 299 💬
5007Repatha 140 mg Solution for Injection in Pre-filled Pen1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
5008Repatha 140 mg soluzione per iniezione in penna preriempita.1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
5009Repatha 420 mg solution for injection in cartridge1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
5010Repatha 420 mg soluzione per iniezione in cartuccia1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
5011Replagal (Agalsidase Alfa)1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
5012Replagal agalsidase alfa1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
5013Repository corticotropin injection1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 2, 13, 46, 84, 222 💬
5014Requip Modutab, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5015Requip Modutab, 4mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5016Requip Modutab, 8mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5017REQUIP-MODUTAB , 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5018REQUIP-MODUTAB , 4mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5019REQUIP-MODUTAB , 8mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5020REQUIP-MODUTAB, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5021REQUIP-MODUTAB, 4mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5022REQUIP-MODUTAB, 8mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5023Response to anakinra associated with methotrexate2件: Anakinra,
Methotrexate		2件: Methotrexate ,
Anakinra 💬		4件: DHFR,
DHFR2,
IL1R1,
IL1R2 💬		20件: Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46 💬
5024Response to infliximab associated with methotrexate2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5025Resunab, ajulemic acid, anabasum1件: Ajulemic acid1件: Lenabasum 💬1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299 💬
5026Retinoic acid1件: Tretinoin1件: Tretinoin 💬3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬2件: 94, 231 💬
5027Retinoic Acid Receptor gamma Agonist1件: Tretinoin1件: Tretinoin 💬3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 231 💬
5028Retroviral SF71-gp91phox transduced CD34+ cells----1件: 65 💬
5029REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
5030Revatio 0.8mg/ml solution for injection1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
5031Revatio 10 mg/ml powder for oral suspension1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5032Revatio 20 mg film coated tablets1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5033Revatio 20 mg film-coated tablets----1件: 86 💬
5034Revatio 20 mg Filmtabletten1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5035REVATIO 20 mg, comprimidos recubiertos con película1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5036Revatio inyectable1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5037Revatio ® 20 mg film-coated tablets1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5038Reveglucosidase alfa----1件: 256 💬
5039Reveglucosidase alpha----1件: 256 💬
5040Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir3件: Abacavir,
Lamivudine,
Zidovudine		3件: Lamivudine ,
Zidovudine ,
Abacavir 💬		--1件: 325 💬
5041REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE1件: Eltrombopag---1件: 60 💬
5042REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU1件: Eltrombopag---1件: 60 💬
5043Revolade 25 mg film-coated tablets1件: Eltrombopag---1件: 63 💬
5044Revolade 50 mg film-coated tablets1件: Eltrombopag---1件: 63 💬
5045REVOLADE, PROMACTA1件: Eltrombopag---1件: 63 💬
5046RFB002, rhuFab V21件: Ranibizumab1件: Ranibizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 166 💬
5047RFVIIa, rFVIIa + TXA1件: Coagulation factor VIIa Recombinant Human---1件: 288 💬
5048RG2077 (CTLA4-IgG4m)----1件: 13 💬
5049RG2133 (2',3',5'-tri-O-acetyluridine)1件: Uridine triacetate1件: Uridine triacetate 💬--1件: 21 💬
5050RG6042, formerly ISIS 443139, IONIS-HTTRx----1件: 8 💬
5051RhASA - Dose Level 1----1件: 19 💬
5052RhASA - Dose Level 2----1件: 19 💬
5053RhASA - Dose Level 3----1件: 19 💬
5054Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)----1件: 46 💬
5055RhGAA, acid alpha glucosidase----1件: 256 💬
5056RhGH Norditropin® pen (34 µg/kg)1件: Somatotropin---1件: 78 💬
5057RhIDU (recombinant human-Alpha-L-Iduronidase)----1件: 19 💬
5058RhIGF (Increlex)1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 96 💬
5059RhIGF-I/rhIGFBP-31件: rhIGFBP-3---1件: 113 💬
5060RHNAGLU-IGF2----1件: 19 💬
5061RhTPO in combination with Rituximab2件: Recombinant Human Thrombopoietin,
Rituximab		1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63 💬
5062RhuDex 100 mg (127 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬--1件: 93 💬
5063RhuDex 25 mg (31.75 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬--1件: 93 💬
5064RhuDex 50 mg (63.5 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬--1件: 93 💬
5065RhuMAb Beta7, Anti Beta 7, PRO145223----1件: 97 💬
5066RhuMAb Beta7, Anti Beta7, PRO145223----1件: 97 💬
5067RhuMAb IFNalpha----1件: 49 💬
5068RhumAb to Il-17A (IgG1-k-class)----4件: 13, 46, 56, 96 💬
5069RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class)----1件: 96 💬
5070RhumAb to IL-17A igG1-k-class----1件: 13 💬
5071RhuTNFR:Fc----2件: 46, 271 💬
5072Riboflavin Sodium Phosphate Injection2件: Phosphate ion,
Riboflavin		1件: Riboflavin 💬--1件: 96 💬
5073RIC alloBMT w PTCy in refractory SSc----1件: 51 💬
5074Rice/turkey free diet (R/TFD) group2件: Rice,
Turkey		---1件: 53 💬
5075Rifabutin, Clarithromycin, and Clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin ,
Clofazimine ,
Rifabutin 💬		--1件: 96 💬
5076Rifampin 300mg BID + istradefylline 40mg Day 8 only2件: Istradefylline,
Rifampicin		2件: Rifampin ,
Istradefylline 💬		1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5077Rifampin and azithromycin.2件: Azithromycin,
Rifampicin		3件: Rifampin ,
Azithromycin ,
Azithromycin 💬		--1件: 84 💬
5078Rifaximin delayed release 400 mg film coated tablet1件: Rifaximin1件: Rifaximin 💬--1件: 96 💬
5079Rigosertib Oral Capsules / Rigosertib Intravenous1件: Rigosertib1件: Rigosertib 💬1件: PLK1 💬4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36 💬
5080Rilonacept (IL-1 Trap)1件: Rilonacept1件: Rilonacept 💬2件: IL1A,
IL1B 💬		45件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 107 💬
5081Rilpivirine (RPV) tablet1件: Rilpivirine1件: Rilpivirine 💬--1件: 256 💬
5082Rilpivirine - Injectable Suspension (RPV LA)1件: Rilpivirine1件: Rilpivirine 💬--1件: 256 💬
5083Rilutek 50 mg film-coated tablets1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
5084RILUTEK 50 mg, film-coated tablets1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
5085Riluzole Oral Soluble Film1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
5086Riluzole Oral Soluble film (ROSF) 50 mg1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
5087RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC----1件: 114 💬
5088Riociguat (Adempas, BAY63-2521)1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 51, 86, 88, 299 💬
5089Riociguat granules 0.3% for oral application1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
5090RIPK1 inhibitor----1件: 13 💬
5091Risankizumab 600 mg IV1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
5092Risankizumab IV1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
5093Risankizumab On-Body Injector (OBI)1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
5094Risedronate sodium (Actonel)1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
5095Risedronic acid1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 93, 95, 274 💬
5096Ritonavir (Norvir)1件: Ritonavir1件: Ritonavir 💬--1件: 265 💬
5097Rituxan (INN: Rituximab), brand name in the United States1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5098Rituxan (INN: Rituximab), brand name in the US1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5099Rituxan (US, Canada, Japan), MabThera (rest of the world)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5100Rituxan (US, Canada, Japan), MabThera (rest of world)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53 💬
5101Rituxan® (rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5102Rituximab (anti-CD20)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53 💬
5103Rituximab (Arm A)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 43, 44 💬
5104Rituximab (Arm B)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 43, 44 💬
5105Rituximab (MABTHERA® or RITUXAN®).1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 35, 61 💬
5106Rituximab (RTX) and Azathioprine (AZA)2件: Azathioprine,
Rituximab		2件: Azathioprine ,
Rituximab 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 65 💬
5107Rituximab - MabThera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5108Rituximab 1g IV1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 162 💬
5109Rituximab and Cyclophosphamide IV2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 35 💬
5110Rituximab and Hyaluronidase Human2件: Hyaluronidase,
Rituximab		4件: Rituximab ,
Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 331 💬
5111Rituximab combined with tacrolimus induction + rituximab maintenance2件: Rituximab,
Tacrolimus		3件: Tacrolimus ,
Rituximab ,
Tacrolimus 💬		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
5112Rituximab combined with tacrolimus induction + tacrolimus maintenance2件: Rituximab,
Tacrolimus		3件: Tacrolimus ,
Rituximab ,
Tacrolimus 💬		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
5113Rituximab Infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 222 💬
5114Rituximab IT1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5115Rituximab IV1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5116Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5117Rituximab, Cyclophosphamide, and Corticosteroids2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
5118Rituximab, Mabthera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53 💬
5119Rituximab, MTX, folic acid2件: Folic acid,
Rituximab		2件: Folic acid ,
Rituximab 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5120Rituximab, observational study amon patients with active RA1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5121Rituximab-EU+ Rituximab-Pfizer x 2 Courses1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5122Rituximab-Pfizer (PF-05280586) x 3 courses1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5123Rituximab-US + Rituximab-Pfizer x 2 Courses1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5124Rituximab/ Mabthera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 271 💬
5125Rivastigmin Luye Transdermal Patches - 4.6mg/24h----1件: 6 💬
5126Rivastigmine Luye Transdermal Patch- 9.5mg/24h1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
5127RN624, RI624----1件: 226 💬
5128RNA antisense oligonucleotide for intravitreal injection----2件: 90, 303 💬
5129Ro 001-9265/F02----1件: 41 💬
5130RO 001-9265/F02-01----1件: 46 💬
5131Ro 001-9265/F03----1件: 41 💬
5132Ro 001-9265/F04----1件: 41 💬
5133Ro 002-9893/F02----1件: 46 💬
5134Ro 47-0203 / ACT-050088----1件: 86 💬
5135Ro 487-533/F01----1件: 271 💬
5136Ro 487-5733/F01----1件: 271 💬
5137Ro 487-7533/F01----3件: 46, 107, 271 💬
5138Ro 487-7533/F10----2件: 46, 107 💬
5139Ro 487-7533/F10-02----1件: 46 💬
5140Ro 487-7533/F10-04----4件: 41, 46, 51, 107 💬
5141Ro 491-7523/F18----1件: 206 💬
5142Ro 491-7523/F19----1件: 206 💬
5143Ro 496-4913/F03----2件: 13, 46 💬
5144Ro 496-4913/F07----1件: 13 💬
5145Ro 533-3787/F01- 06----1件: 13 💬
5146Ro 533-3787/F01-06----1件: 11 💬
5147Ro 549-0261/F04----1件: 97 💬
5148Ro 549-0261/F04-02----1件: 96 💬
5149Ro 549-0261/F08-02----1件: 96 💬
5150Ro 723-4292/F02----1件: 8 💬
5151Ro Actemra1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5152Ro-Actemra1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
5153RO001-9265/F04----1件: 46 💬
5154RO04877533/F05/F04----1件: 46 💬
5155RO1061443/F02----1件: 35 💬
5156Ro47-0203 / ACT-050088----2件: 51, 86 💬
5157RO487-7533/F01-F05----1件: 46 💬
5158RO487-7533/F10-04----2件: 46, 51 💬
5159RO4877533/F01----1件: 46 💬
5160RO4877533/F04-F05----1件: 46 💬
5161RO4964913 F07----1件: 13 💬
5162RO4964913/F03----1件: 13 💬
5163RO4964913/F07----1件: 13 💬
5164RO4964913/F07-01----1件: 13 💬
5165RO545-9072/F03----1件: 53 💬
5166Ro549-0261/F04-02----1件: 96 💬
5167RO5490255/F01-02----1件: 85 💬
5168RO5490261 / F02----1件: 97 💬
5169RO5490261/F02----1件: 97 💬
5170RO5490261/F04-02----1件: 97 💬
5171RO6885247/F02----1件: 3 💬
5172RO6885247/F03----1件: 3 💬
5173RO7010939/F13----1件: 49 💬
5174RO7034067 / F12----1件: 3 💬
5175RO7034067 / F13----1件: 3 💬
5176RO7034067/F06 + solvente (RO----1件: 3 💬
5177RO7034067/F06 with solvent (RO7034067/F08)----1件: 3 💬
5178RO7034067/F07 + solvente (RO----1件: 3 💬
5179RO7034067/F07 with solvent (RO7034067/F09)----1件: 3 💬
5180RO7034067/F12----1件: 3 💬
5181RO7034067/F13----1件: 3 💬
5182RO7049665/IgG-IL2/ IgG-IL2ND2----1件: 95 💬
5183RO7112689/F01----1件: 62 💬
5184RO7112689/F03-01----2件: 62, 109 💬
5185RO7112689/F03-10----2件: 62, 109 💬
5186RO7123520/F03-01----1件: 46 💬
5187RO7204239/F01-01----1件: 3 💬
5188RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
5189RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
5190RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
5191RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
5192RO7248824/F02-01----1件: 201 💬
5193RO7248824/F03-01 (Diluent for RO7248824/F02-01----1件: 201 💬
5194RO7490677/ F01-02----1件: 85 💬
5195RO7490677/F01-01----1件: 85 💬
5196RO7490677/F01-02----1件: 85 💬
5197RO7490677/F01-03----1件: 85 💬
5198ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
5199ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5200RoActemra 162 mg solution for injection in pre-filled syringe1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
5201RoActemra 162 mg solution injectable en seringue préremplie1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5202RoActemra 162 mg soluzione iniettabile in siringa preriempita1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 50 💬
5203RoActemra 20 mg/ml concentrado para solución para perfusión1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5204RoActemra 20 mg/ml Concentrate for solution for infusion1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5205RoActemra 20 mg/ml concentrate for solution for infusion.1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5206ROACTEMRA 20 mg/ml, concentrado para solución para perfusión1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬3件: 46, 107, 271 💬
5207RoActemra/Actemra (tocilizumab)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107 💬
5208RoActemra® 20mg/ml Konzentrat1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 266 💬
5209RoActemra®EV Product Code: PRD823211件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5210Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali----1件: 46 💬
5211Roferon-A1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
5212Roferon-A 3miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
5213Roferon-A, 3miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
5214Roferon-A, 4.5miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
5215Roferon-A, 6miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
5216Rokan (r) Novo 120 mg----1件: 18 💬
5217Ropinirole (as hydrochloride)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5218Ropinirole controlled-release (REQUIP CR) for RLS1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5219Ropinirole immediate release1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5220Ropinirole Implant1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5221Ropinirole IR1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5222Ropinirole IR Tablets1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5223Ropinirole PR, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5224Ropinirole XL (formerly CR)1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5225Ropivacaine Hydrochloride Injection1件: Ropivacaine1件: Ropivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
5226Ropivacaine plus normal saline1件: Ropivacaine1件: Ropivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
5227Rosiglitazone (Avandia)1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 222 💬
5228Rotigotine Nasal Spray1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5229Rotigotine, extended-release microspheres1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5230Routine steroid administration group----1件: 85 💬
5231Rozibafusp Alfa----1件: 49 💬
5232RP-A501----1件: 32 💬
5233RPC1063 equiv. to ozanimod HCI1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
5234RPI78M for injection----1件: 20 💬
5235RT234 - vardenafil inhalation powder1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5236RTNV148B IgG----3件: 46, 97, 271 💬
5237Rurioctocog alfa pegol1件: Rurioctocog alfa pegol1件: Rurioctocog alfa pegol 💬--1件: 288 💬
5238RVT-1601 (formerly, PA101B)----1件: 85 💬
5239RVT-1601 (in precedenza PA101B)----1件: 85 💬
5240S 90049 - F36----1件: 6 💬
5241S 90049 - F38----1件: 6 💬
5242S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide----1件: 46 💬
5243S-adenosyl-L-methionine1件: Methionine1件: Methionine 💬--1件: 93 💬
5244S-adenosyl-methionine (SAMe) capsules2件: Ademetionine,
Methionine		2件: Methionine ,
Ademetionine 💬		--1件: 93 💬
5245S-ketamine & midazolam3件: Esketamine,
Ketamine,
Midazolam		3件: Midazolam ,
Esketamine ,
Ketamine 💬		21件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		25件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 70 💬
5246S.c. apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5247S.c. injections of bovine intestinal Alkaline Phosphatase1件: Alkaline Phosphatase---1件: 46 💬
5248S95011 concentrate for solution for infusion----1件: 53 💬
5249SABRIL 500 mg, granules for oral solution1件: Vigabatrin1件: Vigabatrin 💬1件: ABAT 💬7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 158 💬
5250Sabril granules for oral use1件: Vigabatrin1件: Vigabatrin 💬1件: ABAT 💬7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
5251Saffron and Chamomile1件: Chamomile1件: German chamomile flower 💬--1件: 6 💬
5252Saffron supplement for IBD----1件: 97 💬
5253Safinamide (as add-on therapy)1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5254Safinamide + Levodopa2件: Levodopa,
Safinamide		2件: Levodopa ,
Safinamide 💬		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
MAOB 💬		20件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5255Safinamide, MAO-B inhibitor1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5256SAIZEN - 1 FLACONCINO POLV. 8 MG + 1 CARTUCCIA. SOLV. INSERITI IN UN DISPOSITIVO PER LA RICOSTITUZIONE1件: Somatotropin---1件: 78 💬
5257Saizen 8mg click.easy powder for solution for injection1件: Somatotropin---1件: 78 💬
5258Saizen 8mg click.easy power for solution for injection1件: Somatotropin---1件: 78 💬
5259Saizen® solution for injection (referred as Saizen®)----1件: 78 💬
5260Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet2件: Salbutamol,
Sulfate ion		1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 111 💬
5261Salbutamol Only Product in Oral Dose Form1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 111 💬
5262SALBUTAMOL SULFATE PH. EUR.2件: Salbutamol,
Sulfate ion		1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
5263Salbutamol-ratiopharm® N metered-dose aerosol inhaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
5264Salbutamol-ratiopharm® N metereddose aerosol inhaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
5265Salicylic acid1件: Salicylic acid1件: Salicylic acid 💬--1件: 97 💬
5266Saline 0.9% inhalation solution----1件: 299 💬
5267Saline 0.9% NaCl----1件: 235 💬
5268Saline Intranasal Delivery----1件: 6 💬
5269Saline Nasal Mist----1件: 127 💬
5270Salofalk® 1000mg Granu-Stix®1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5271Salofalk® 500 mg gastro-resistant tablet1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5272Salofalk® 500 mg tablets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5273Salofalk® 500mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5274Salofalk® 500mg Granu-Stix®1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5275Sandimmun 50 mg/ml, infuusiokonsentraatti----1件: 97 💬
5276Sandimmun Neoral1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 97, 226 💬
5277SANDIMMUN NEORAL - 10 MG CAPSULE MOLLI 50 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
5278SANDIMMUN NEORAL - 100 MG CAPSULE MOLLI 30 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
5279SANDIMMUN NEORAL - 25 MG CAPSULE MOLLI 50 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
5280SANDIMMUN NEORAL - 50 MG CAPSULE MOLLI 50 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
5281SANDIMMUN NEORAL*30CPS 100MG1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
5282SANDIMMUN NEORAL*50CPS 25MG1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
5283SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----1件: 67 💬
5284Sandostatina Lar IM Fl 20mg +2F----1件: 67 💬
5285Sapelizumab (p-INN)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
5286Sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
5287Sapropterin, sapropterin dihydrochloride1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
5288Sapropterin, sapropterin hydrochloride1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
5289Saquinavir and ritonavir2件: Ritonavir,
Saquinavir		2件: Ritonavir ,
Saquinavir 💬		--1件: 86 💬
5290SAR402671, GZ402671 o GZ/SAR402671----2件: 19, 67 💬
5291SAR402671, GZ402671 or GZ / SAR402671----1件: 19 💬
5292SAR402671, GZ402671 or GZ/SAR402671----3件: 6, 19, 67 💬
5293SAR441344 IV----2件: 13, 49 💬
5294SAR445088 (formerly BIVV020)----1件: 14 💬
5295SAR445088 (IV)----1件: 14 💬
5296Sativex Oromucosal Spray (non-marketed)2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
5297Satralizumab (120 mg/PFS with NSD)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
5298Satralizumab (r-INN)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
5299Satrazlizumab (RO5333787/ Enspryng /SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
5300SB-656933-AAA----1件: 299 💬
5301SB-A6P-HRL Donor Vector----1件: 19 💬
5302SB-FIX----1件: 19 💬
5303SB-IDUA----1件: 19 💬
5304SB2 (infliximab biosimilar)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5305SB2 (proposed biosimilar to infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5306SB5 (proposed biosimilar to adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5307SBC-102, recombinant human lysosomal acid lipase1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5308SC interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5309SC interferon beta-1b2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5310Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)4件: Amitriptyline,
Fluoxetine,
Somatotropin,
Tramadol		3件: Fluoxetine ,
Amitriptyline ,
Tramadol 💬		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78 💬
5311SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety)----1件: 65 💬
5312SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)----1件: 65 💬
5313ScAAV9.U7.ACCA----1件: 113 💬
5314Scopolamine, atropine, edaravone and dexmedetomidine4件: Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		4件: Atropine ,
Scopolamine ,
Dexmedetomidine ,
Edaravone 💬		8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
5315Search for exocrine pancreatic insufficiency at week 0 and 12----1件: 96 💬
5316Search for polymorphisms of RASA1 gene----1件: 281 💬
5317Seasonal influenza vaccine----2件: 13, 46 💬
5318Seasonal influenza vaccine available for the 2012-2013 vaccine campaign----1件: 84 💬
5319Seasonal Quadrivalent influenza vaccine----1件: 13 💬
5320Sebelipasa Alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5321Sebelipase Alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5322Sebelipase alfa (SBC-102)1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5323Sebelipase alfa 0.35 mg/kg1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5324Sebelipase alfa 1 mg/kg1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5325Sebelipase alfa 3 mg/kg1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
5326Second-generation fumaric acid1件: Fumaric acid1件: Fumaric acid 💬--1件: 13 💬
5327Secukinumab (AIN457)1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 46 💬
5328Secukinumab (AIN457) 150 mg s.c.1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
5329Secukinumab 150 mg (2 injections per dose1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 269 💬
5330Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection.1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
5331Secukinumab 150 mg/1 mL Solution for injection1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬2件: 37, 271 💬
5332Secukinumab 300 mg, s.c.1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
5333Secukinumab 75 mg/0.5 ml Solution for injection1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
5334Secukinumab Injection1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 160 💬
5335See D.3.9.3 'Other descriptive name' below----1件: 46 💬
5336See Intervention Description)----1件: 13 💬
5337Selective Immunosuppressive agents----1件: 96 💬
5338Selective Nerve Root Block----1件: 70 💬
5339Selective Serotonin Uptake Inhibitors (SSRI)1件: Serotonin---1件: 2 💬
5340Selexipag, ACT-293987 (NS-304)1件: Selexipag1件: Selexipag 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5341Selumetinib (AZD6244 hyd sulfate) 25mg/m22件: Selumetinib,
Sulfate ion		1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5342Selumetinib (AZD6244 hyd sulfate) 50mg/dose2件: Selumetinib,
Sulfate ion		1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5343Selumetinib capsule formulation1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5344Selumetinib granule formulation1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5345Selumetinib granules in sprinkle capsules for opening 5 mg1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5346Selumetinib granules in sprinkle capsules for opening 7.5 mg1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5347Semi continuous intra-oral administration of LD/CD----1件: 6 💬
5348Serostim®[somatropin (rDNA origin) for injection]1件: Somatotropin---1件: 265 💬
5349Serum albumin1件: Albumin human1件: Albumin human 💬--1件: 78 💬
5350SERUM ALBUMINE 5%----1件: 96 💬
5351Serum containing Avonex1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5352Serum Free Avonex1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5353SESAME OIL, REFINED1件: Sesame oil1件: Sesame oil 💬--1件: 3 💬
5354Sevoflurane anesthetics1件: Sevoflurane1件: Sevoflurane 💬--1件: 296 💬
5355Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane----1件: 96 💬
5356SGLT2 inhibitor----1件: 218 💬
5357Sham O2 (medical air)2件: Medical air,
Oxygen		1件: Oxygen 💬--1件: 86 💬
5358Short Chain Fatty Acids (SCFA) Dietary Supplement----1件: 46 💬
5359Short-acting Insulin (Actrapid)----1件: 299 💬
5360SHR-2010 injection----1件: 66 💬
5361Sialic acid----1件: 30 💬
5362Sialic acid (INN: aceneuramic acid)1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
5363Sialic acid, N-acetylneuraminic acid----1件: 30 💬
5364Sifrol, 0,35 mg Tablette1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5365Sifrol, 0,70 mg Tablette1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5366Sifrol, Mirapexin1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5367Sildenafil (Acute-1 hour)1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
5368Sildenafil (as citrate)1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5369Sildenafil (Revatio) 20 mg TID1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5370Sildenafil 20mg and Bosentan 62.5mg2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
5371Sildenafil and Losartan2件: Losartan,
Sildenafil		2件: Losartan ,
Sildenafil 💬		2件: AGTR1,
PDE5A 💬		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 85 💬
5372Sildenafil by injection1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 210 💬
5373Sildenafil Filmtabletten1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5374Sildenafil singly or in association with Bosentan2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
5375SIMPONI - 50 MG-SOLUZIONE PER INIEZIONE IN PENNA PRERIEMPITA-USO SOTTOCUTANEO-PENNA PRERIEMPITA(VETRO) -0.5 ML 3 (3X1) PENNE PRERIEMPITE1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5376Simponi 50 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte.1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5377SIMPONI 50 mg solución inyectable en pluma precargada1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5378Simponi® (Golimumab)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
5379SimvaHEXAL® 40 mg Filmtabletten----1件: 13 💬
5380Simvastatin 40 mg film-coated tablets1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
5381Simvastatin Alternova1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
5382Simvastatin in relapsing remitting multiple sclerosis1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
5383Simvastatin treatment for 28 days1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 299 💬
5384Simvastatine Sandoz 40 mg filmomhulde tabletten1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
5385Simvastatine Sandoz 40mg deelbare filmomhulde tabletten1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
5386SIN ASIGNAR----1件: 299 💬
5387SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1----1件: 36 💬
5388SIN RV-mediated COL7A1 corrected autologous skin equivalent----1件: 36 💬
5389SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5390SINEMET 100 mg + 25 mg compresse2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5391SINEMET 100 mg + 25 mg tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5392Sinemet IR----1件: 6 💬
5393Sinemet® 100/25----1件: 6 💬
5394Sinemet® 100/25 mg----1件: 6 💬
5395Sinemet® controlled release (Carbidopa/levodopa)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5396Sinemet® CR2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5397Sinemet® CR 100/25----1件: 6 💬
5398SINEMET® Plus 25 mg/100 mg Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5399Single dose-group A----1件: 97 💬
5400Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)----1件: 28 💬
5401Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre----1件: 65 💬
5402Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy----1件: 79 💬
5403SIPONIMOD FUMARIC ACID2件: Fumaric acid,
Siponimod		2件: Fumaric acid ,
Siponimod 💬		2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5404Sirolimus (formerly known as Rapamycin)1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 35 💬
5405Sirolimus (study drug)+ACE inhibitor + statin1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 66 💬
5406Sirolimus 0,1% crème1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 278, 280 💬
5407Sirolimus and Hydroxychloroquine 200 mg2件: Hydroxychloroquine,
Sirolimus		2件: Sirolimus ,
Hydroxychloroquine 💬		1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 89 💬
5408Sirolimus and Hydroxychloroquine 400 mg2件: Hydroxychloroquine,
Sirolimus		2件: Sirolimus ,
Hydroxychloroquine 💬		1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 89 💬
5409Sirolimus, 2%1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 36, 192 💬
5410Sitagliptin and Metformin2件: Metformin,
Sitagliptin		2件: Metformin ,
Sitagliptin 💬		3件: DPP4,
PRKAA1,
PRKAA2 💬		21件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 233 💬
5411Sitaxsentan alone1件: Sitaxentan1件: Sitaxentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
5412Sitaxsentan and Sildenafil2件: Sildenafil,
Sitaxentan		2件: Sitaxentan ,
Sildenafil 💬		2件: EDNRA,
PDE5A 💬		9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
5413Sivatin 40 mg film-coated tablets----1件: 13 💬
5414SK&F101468----1件: 6 💬
5415SLIT Amikacin1件: Amikacin1件: Amikacin 💬--1件: 299 💬
5416SLIT(TM) Amikacin1件: Amikacin1件: Amikacin 💬--1件: 299 💬
5417SLV308 (mono) hydro----1件: 6 💬
5418SLV308 (mono) hydrochlo----1件: 6 💬
5419SLV308 (mono) hydrochlori----1件: 6 💬
5420SLV308 (mono) hydrochloride----1件: 6 💬
5421SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML2件: Medium-chain triglycerides,
Sodium glycerophosphate		1件: Sodium glycerophosphate 💬--1件: 66 💬
5422SMT C1100 (F5----1件: 113 💬
5423SMT C1100 (F5)----1件: 113 💬
5424SMT C1100 (F6----1件: 113 💬
5425SMT C1100 (F6)----1件: 113 💬
5426SNN0029 infusion solution----1件: 2 💬
5427Sobetirome (NV1205)1件: Sobetirome1件: Sobetirome 💬1件: THRB 💬2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 20 💬
5428SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
5429SODIO ASCORBATO DC.IT----1件: 10 💬
5430Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate1件: Pyrrolidine---1件: 97 💬
5431Sodium acetate2件: Acetate,
Sodium acetate		1件: Sodium acetate 💬--2件: 81, 251 💬
5432Sodium acetate (1-13C)2件: Acetate,
Sodium acetate		1件: Sodium acetate 💬--1件: 251 💬
5433SODIUM ACID PYROPHOSPHATE----1件: 166 💬
5434SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE----1件: 166 💬
5435SODIUM ALGINATE1件: Alginic acid1件: Alginic acid 💬--1件: 299 💬
5436Sodium aurothiomalate1件: Sodium aurothiomalate1件: Gold sodium thiomalate 💬--1件: 46 💬
5437Sodium aurothiomalate (intramuscular gold)1件: Sodium aurothiomalate1件: Gold sodium thiomalate 💬--1件: 46 💬
5438Sodium butyrate and zinc oxide2件: Butyric Acid,
Zinc oxide		1件: Zinc oxide 💬--1件: 156 💬
5439Sodium chloride (NaCl)2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 67 💬
5440SODIUM CHLORIDE PH. EUR.2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
5441Sodium Ethanoate (1- 13 C)1件: Acetic acid1件: Acetic acid, glacial 💬--1件: 251 💬
5442Sodium fluoride1件: Sodium fluoride1件: Sodium fluoride 💬--1件: 51 💬
5443Sodium fluoride 18F1件: Sodium fluoride1件: Sodium fluoride 💬--1件: 51 💬
5444Sodium Fusidate1件: Fusidic acid1件: Fusidic acid 💬--1件: 299 💬
5445Sodium iodide2件: Iodide,
Sodium iodide		3件: Sodium iodide ,
Sodium iodide I 123 ,
Sodium iodide I 125 💬		--1件: 34 💬
5446Sodium Nitrate2件: Nitrate,
Sodium nitrate		1件: Nitric acid 💬--2件: 58, 113 💬
5447Sodium Nitrate - double dose2件: Nitrate,
Sodium nitrate		1件: Nitric acid 💬--1件: 113 💬
5448SODIUM NITRITE1件: Nitrite---1件: 86 💬
5449Sodium Nitrite Inhalation Solution1件: Nitrite---1件: 86 💬
5450SODIUM NITROPRUSSIDE1件: Nitroprusside---1件: 51 💬
5451Sodium phenylbutyrate (NaPB)1件: Phenylbutyric acid---1件: 3 💬
5452Sodium phosphate enema, oral rifaximin and polyethylene glycol3件: Phosphate ion,
Polyethylene glycol,
Rifaximin		2件: Rifaximin ,
Polyethylene glycol 3350 💬		--1件: 6 💬
5453Sodium Picosulfate, Magnesium Oxide and Citric Acid4件: Citric acid,
Magnesium,
Magnesium oxide,
Picosulfuric acid		2件: Magnesium oxide ,
Citric acid monohydrate 💬		--1件: 291 💬
5454Sodium Pyruvate in 0.9% Sodium Chloride Solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
5455Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth2件: Dextrose, unspecified form,
Sildenafil		1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5456Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate1件: Acetate---1件: 46 💬
5457Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate1件: Acetate---1件: 46 💬
5458Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen1件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
5459Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen1件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
5460Solid food-based intervention----1件: 96 💬
5461SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 13, 62, 109 💬
5462SOLIRIS 300 mg concentrado para solución para perfusión1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 109 💬
5463Soliris 300 mg concentrate for solution for infusion1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
5464Soliris ™ (eculizumab)1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
5465SOLIRIS® (eculizumab) injection, for intravenous use1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
5466SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53 💬
5467SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML----1件: 56 💬
5468SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML----1件: 56 💬
5469Solu-Cortef 100 MG Injection3件: Hydrocortisone,
Hydrocortisone cypionate,
Hydrocortisone succinate		3件: Hydrocortisone ,
Hydrocortisone cypionate ,
Hydrocortisone succinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
5470Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial'3件: Hydrocortisone,
Hydrocortisone cypionate,
Hydrocortisone succinate		3件: Hydrocortisone ,
Hydrocortisone cypionate ,
Hydrocortisone succinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
5471Solu-medrol inj. PSO LQF 40mg1件: Methylprednisolone hemisuccinate1件: Methylprednisolone hemisuccinate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 50 💬
5472Soluble Fc receptor----1件: 49 💬
5473Soluble Fc-gamma receptor IIb----1件: 49 💬
5474Soluble fiber supplementation----1件: 299 💬
5475Solumedrol IM 125mg/2ml----1件: 13 💬
5476Solution de chlorhydrate de dopamine anaérobie1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5477SOM230 LAR, 20 mg----1件: 75 💬
5478SOM230, 300micrograms----1件: 75 💬
5479SOM230, 600 micrograms----1件: 75 💬
5480SOM230, 900 micrograms----1件: 75 💬
5481SomatoKine/IPLEX----1件: 113 💬
5482Somatropin (INN) recombinant DNA orgin, Escherichia coli2件: Escherichia coli,
Somatotropin		---1件: 78 💬
5483Somatropin (recombinant DNA origin produced in E. coli)1件: Somatotropin---1件: 78 💬
5484Somatropin - adult cohort1件: Somatotropin---1件: 193 💬
5485Somatropin - GH naïve pediatric cohort1件: Somatotropin---1件: 193 💬
5486Somatropin - GH treated cohort1件: Somatotropin---1件: 193 💬
5487Somatropin [rDNA origin] for injection1件: Somatotropin---2件: 46, 96 💬
5488Somatropin AQ1件: Somatotropin---1件: 78 💬
5489SOMATROPIN FOR INJECTION1件: Somatotropin---1件: 78 💬
5490Somatropin Injection1件: Somatotropin---1件: 78 💬
5491Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate5件: Arginine,
Clonidine,
Estradiol,
Estradiol valerate,
Somatotropin		4件: Estradiol ,
Clonidine ,
Estradiol valerate ,
Arginine 💬		5件: ADRA2A,
ADRA2B,
ADRA2C,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
5492Somatuline Autogel1件: Lanreotide---1件: 67 💬
5493Somatuline Autogel 90 mg1件: Lanreotide---1件: 298 💬
5494Somatuline Autosolution----1件: 67 💬
5495Sorafenib (as tosylate)1件: Sorafenib1件: Sorafenib 💬8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5496Sotatercept - 45 mg/vial1件: Sotatercept1件: Sotatercept 💬1件: ACVR2A 💬4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
5497Sotatercept - 60 mg/vial1件: Sotatercept1件: Sotatercept 💬1件: ACVR2A 💬4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
5498Sotrastaurin (INN) acetate2件: Acetate,
Sotrastaurin		1件: Sotrastaurin 💬4件: PRKCD,
PRKCE,
PRKCH,
PRKCQ 💬		29件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 97 💬
5499Soy protein isolate----1件: 227 💬
5500Sparsentan tablets/ Over-encapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
5501SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5502SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM1件: Ioflupane I-123---1件: 2 💬
5503Spesolimab IV infusion1件: Spesolimab1件: Spesolimab 💬1件: IL1RL2 💬1件: Cytokine-cytokine receptor interaction 💬1件: 97 💬
5504Spesolimab SC solution for injection1件: Spesolimab1件: Spesolimab 💬1件: IL1RL2 💬1件: Cytokine-cytokine receptor interaction 💬1件: 97 💬
5505SPH3127 Tablets with Dose A----1件: 97 💬
5506Spiriva Respimat 2.5 microgram, solution for inhalation1件: Tiotropium---1件: 299 💬
5507Spironolactone and conivaptan2件: Conivaptan,
Spironolactone		2件: Spironolactone ,
Conivaptan 💬		3件: AVPR1A,
AVPR2,
NR3C2 💬		6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 86 💬
5508SQ Fludarabine1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 49 💬
5509SR-fampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
5510Ss-Adrenergic cocktail----1件: 299 💬
5511Ss-interferon----1件: 13 💬
5512Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
5513STA-6838, STA-5326 m, S38----1件: 96 💬
5514Stable isotope infusions----1件: 96 💬
5515Stalevo (levodopa/ carbidopa/ entacapone)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5516Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5517Stalevo 100 mg/25 mg / 200 mg----1件: 6 💬
5518Standard 2 hours-infusion----2件: 96, 97 💬
5519Standard analgesia use [Fentanyl]1件: Fentanyl1件: Fentanyl 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
5520Standard analgesia use [Hydromorphone]1件: Hydromorphone1件: Hydromorphone 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
5521Standard analgesia use [Oxygen]1件: Oxygen1件: Oxygen 💬--1件: 70 💬
5522Standard analgesia use [Volatile Anesthesia]----1件: 70 💬
5523Standard care Hyaluronic acid eye drops1件: Hyaluronic acid1件: Hyaluronic acid 💬--1件: 53 💬
5524Standard continuous antiretroviral therapy----1件: 265 💬
5525Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)----1件: 46 💬
5526Standard Formula----1件: 299 💬
5527Standard formula (Enfamil)----1件: 299 💬
5528Standard interval dosing----1件: 13 💬
5529Standard Nutritional Supplement + PERT----1件: 299 💬
5530Standard of Care for Haemophilia A----1件: 288 💬
5531Standard of Care FVIII Replacement therapy----1件: 288 💬
5532Standard of care IV antibiotic(s)----1件: 299 💬
5533Standard of Care: UDCA1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5534Standard therapy (Excluding Immunosuppressants)----1件: 49 💬
5535Standard therapy (Including Immunosuppressants)----1件: 49 💬
5536Standard therapy (without eltrombopag): HD-DXM1件: Eltrombopag---1件: 63 💬
5537Standard treatment with a conventional drug----1件: 13 💬
5538Standardized anthocyanin-rich extract----1件: 97 💬
5539Standardized FODMAP----1件: 97 💬
5540STAPHYLOCOCCAL PROTEIN A1件: Bevifimod---1件: 63 💬
5541Start adalimumab in monotherapy1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
5542STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5543STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5544STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
5545STELARA 130 mg concentrate for solution for infusion1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5546Stelara 130mg / 26mL concentrate for solution for1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5547Stelara 130mg / 26mL concentrate for solution for infusion1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5548STELARA 90 mg solution for injection in pre-filled syringe1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5549Stelara 90mg/1ml solution for injecti1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5550Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
5551Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra3件: Infliximab,
Ustekinumab,
Vedolizumab		3件: Infliximab ,
Vedolizumab ,
Ustekinumab 💬		6件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
5552Stem cell (HPC) implantation----1件: 2 💬
5553Stem cell implantation----1件: 90 💬
5554Sterile Normal Saline (0.9% NaCl)----2件: 62, 254 💬
5555STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V)----1件: 299 💬
5556Sterile saline for injection----1件: 97 💬
5557Sterile Water for Injection1件: Water1件: Water 💬--1件: 78 💬
5558Steroid & Cyclosporin1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
5559Steroid and Proton Pump Inhibitor Therapy----1件: 98 💬
5560Steroid injections----1件: 70 💬
5561Steroids plus azathioprine1件: Azathioprine1件: Azathioprine 💬--1件: 66 💬
5562STK-001 - Multiple Ascending Doses1件: Zorevunersen---1件: 140 💬
5563STK-001 - Single Ascending Doses1件: Zorevunersen---1件: 140 💬
5564Stool analysis----1件: 46 💬
5565STOP arm----1件: 84 💬
5566Stromal Vascular fraction----1件: 51 💬
5567Stromal vascular fraction (SVF)----1件: 96 💬
5568Study medication, azithromycin1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
5569STW5-II----1件: 97 💬
5570STW5-II (Iberogast N, BAY98-7410)----1件: 97 💬
5571Sub-Study: Nintedanib1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
5572Sub-Study: Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
5573Subcutaneous (SC) Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5574Subcutaneous Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5575Subcutaneous and intravenous prostacyclin1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5576Subcutaneous apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5577Subcutaneous Beloranib in Suspension1件: Beloranib---1件: 193 💬
5578Subcutaneous immune globulin G----1件: 14 💬
5579Subcutaneous immunoglobulin----1件: 14 💬
5580Subcutaneous immunoglobulin (SCIG)----1件: 11 💬
5581Subcutaneous immunoglobulins----1件: 11 💬
5582Subcutaneous(SC) Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5583Subcutanious administration----1件: 46 💬
5584Subjects will undergo the 123-I IBVM imaging visit----1件: 6 💬
5585Sublingual nitroglycerine1件: Nitroglycerin1件: Nitroglycerin 💬--1件: 46 💬
5586Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus----1件: 90 💬
5587Subretinal injection of rAAV.hPDE6A----1件: 90 💬
5588Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)----1件: 90 💬
5589Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes----1件: 90 💬
5590Subtenon injection of Wharton jelly derived mesenchymal stem cells----1件: 90 💬
5591Sucrosomial Iron1件: Iron---1件: 97 💬
5592Sulfasalazine + Hydroxychloroquine2件: Hydroxychloroquine,
Sulfasalazine		2件: Sulfasalazine ,
Hydroxychloroquine 💬		--1件: 46 💬
5593Sulfasalazine, SSZ1件: Sulfasalazine1件: Sulfasalazine 💬--1件: 271 💬
5594Sulfate, Magnesium2件: Magnesium,
Sulfate ion		---1件: 64 💬
5595Sulfato de amikacina1件: Amikacin1件: Amikacin 💬--1件: 299 💬
5596Sulfotanshinone Sodium Injection----1件: 224 💬
5597Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]1件: Sulfur hexafluoride1件: Sulfur hexafluoride 💬--1件: 215 💬
5598Sulindac (HLX-0201), dose strength 11件: Sulindac1件: Sulindac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 206 💬
5599Sulindac (HLX-0201), dose strength 21件: Sulindac1件: Sulindac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 206 💬
5600Sulphsalazine, Pentasa, Asacol, Colazide, Depentum----1件: 97 💬
5601SUNPG1622 I dose----1件: 271 💬
5602Supplement nutritional supporting----1件: 291 💬
5603Supportive and immunosuppressive therapy----1件: 66 💬
5604Supportive therapy with: ACE-inhibitor / ARB / Statin----1件: 66 💬
5605Supressi. T-Diet plus Range----1件: 6 💬
5606Surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
5607Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide----1件: 3 💬
5608Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml----1件: 96 💬
5609Suspension containing 250 embryonated, viable TSO/15ml----1件: 96 💬
5610Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml----1件: 96 💬
5611Suspension containing 2500 embryonated, viable TSO/15ml----1件: 96 💬
5612Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml----1件: 96 💬
5613Suspension de microbiote fécal----1件: 97 💬
5614Suspension IR----1件: 46 💬
5615Suspension of 7500 embryonated, viable TSO/15ml----1件: 96 💬
5616Suspension of adipose derived autologous adult stem cells----1件: 96 💬
5617Suspension of autologous CD34+cells transduced with the G1XCGD viral vector----1件: 65 💬
5618Suspension of human autologous MSC 3P in 1,5 ml----1件: 2 💬
5619Suspension of human autologous MSC 3P in 1.5 ml----1件: 2 💬
5620Swallowed fluticasone1件: Fluticasone1件: Fluticasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
5621Symbiotic Formula with DHA and antioxidants----1件: 299 💬
5622Symkevi 100mg/150mg Film-coated tablets2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5623Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)3件: Aldosterone,
Angiotensin II,
Calcium		3件: Angiotensin II ,
Angiotensin II ,
Aldosterone 💬		3件: AGTR1,
AGTR2,
NR3C2 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
5624Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)1件: Human immunoglobulin G---1件: 11 💬
5625SYN115 Tablets, 60 mg----1件: 6 💬
5626Synacthen Ampoules 250 mcg----1件: 113 💬
5627Synacthen Ampoules 250 microgrammi----1件: 113 💬
5628Synbiotic (Synergy I / B.longum)----1件: 96 💬
5629Synthetic 15-amino-acid macrocyclic peptide----1件: 62 💬
5630Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24----1件: 62 💬
5631Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker----1件: 62 💬
5632Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker----1件: 62 💬
5633Synthetic PreImplantation Factor1件: Preimplantation factor---1件: 95 💬
5634Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts----2件: 2, 127 💬
5635Syntocinon 40 IU/ml nasal spray1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5636Syntocinon nasal spray1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
5637Syntocinon®/- Spray1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
5638Systematic chemotherapy and antibodies----1件: 62 💬
5639Systemic anticoagulation----1件: 88 💬
5640Systemic chemotherapy and antibodies----2件: 62, 326 💬
5641Systemic non-biological treatments----2件: 46, 271 💬
5642Süßholzwurzel 1ml/10ml----1件: 97 💬
5643T cell infusion----1件: 285 💬
5644T Cell-Depleted Donor Lymphocyte Infusion----1件: 60 💬
5645T-Cell Depleted & CD34+Select/w/StemCell Enriched Product----1件: 65 💬
5646TA-650 (Infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 97, 271 💬
5647Tabalumab Auto-Injector1件: Tabalumab1件: Tabalumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
5648Tablets Fexinidazole1件: Fexinidazole1件: Fexinidazole 💬--1件: 65 💬
5649TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----1件: 14 💬
5650TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE----2件: 13, 53 💬
5651TACI - FC5----1件: 46 💬
5652TACI-Fc51件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 46, 49 💬
5653Tacrolimus (Advagraf)1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
5654Tacrolimus and MMF1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
5655Tadalafil 20 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5656Tadalafil and ambrisentan upfront combination therapy2件: Ambrisentan,
Tadalafil		2件: Tadalafil ,
Ambrisentan 💬		2件: EDNRA,
PDE5A 💬		9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
5657Tadalafil and Sildenafil2件: Sildenafil,
Tadalafil		2件: Tadalafil ,
Sildenafil 💬		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113 💬
5658Tadalafil- Tablet or Oral suspension1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
5659TADEKINIG ALFA1件: Tadekinig alfa---1件: 65 💬
5660Tafamidis Meglumine 20mg Soft Gelatin Capsule (Clinical trial image)3件: Gelatin,
Meglumine,
Tafamidis		4件: Gelatin ,
Meglumine ,
Donkey glue ,
Tafamidis 💬		1件: TTR 💬1件: Thyroid hormone synthesis 💬1件: 28 💬
5661Tafamidis Meglumine 20mg Soft Gelatin Capsule (Commerical image)3件: Gelatin,
Meglumine,
Tafamidis		4件: Gelatin ,
Meglumine ,
Donkey glue ,
Tafamidis 💬		1件: TTR 💬1件: Thyroid hormone synthesis 💬1件: 28 💬
5662TAK-079, TSF-021, TSF79----1件: 11 💬
5663TAK-715 and methotrexate2件: Methotrexate,
TAK-715		1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
5664TAK-783 and methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
5665Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication)3件: Amoxicillin,
Clarithromycin,
Metronidazole		4件: Amoxicillin ,
Clarithromycin ,
Metronidazole ,
Amoxicillin 💬		--1件: 63 💬
5666Taldefgrobep alfa1件: Talditercept alfa1件: Taldefgrobep alfa 💬1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 3 💬
5667TALIGLUCERASE ALFA1件: Taliglucerase alfa1件: Taliglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
5668Taliglucerase alfa - Recombinant human glucocerebrosidase1件: Taliglucerase alfa1件: Taliglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
5669Taltz (80 mg solution for injection in pre-filled syringe)1件: Ixekizumab1件: Ixekizumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬2件: 107, 271 💬
5670Tamoxifen 20mg Hexal® Filmtabletten1件: Tamoxifen1件: Tamoxifen 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
5671Tamoxifen 40 mg daily for one year1件: Tamoxifen1件: Tamoxifen 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 2 💬
5672Tarceva and Rapamycin1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
5673Target Sequencing by NGS ( Next-generation sequencing)----1件: 65 💬
5674Tasigna® 150 mg1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
5675Tasocitinib (proposed INN)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5676Tasty&Healthy intervention group----1件: 96 💬
5677TAT4 Gel concentration A----1件: 265 💬
5678Tau (18-F-AV-1451)----1件: 127 💬
5679TAUROURSODEOXYCHOLIC ACID1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬--3件: 2, 93, 299 💬
5680Tauroursodeoxycholic acid (TUDCA)1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬--1件: 2 💬
5681Tauroursodeoxycholic Acid Capsules1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬--1件: 93 💬
5682Tauroursoursodeoxycholic acid, brand name Tudcabil----1件: 97 💬
5683TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)1件: Hydrogen---1件: 6 💬
5684TD-1473 Dose A----1件: 97 💬
5685Tears Naturale Forte----1件: 53 💬
5686TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE----1件: 13 💬
5687Tecfidera® 120 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
5688Tecfidera® 120mg magensaftresistente Hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
5689Tecfidera® 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
5690Tecfidera® 240mg magensaftresistente Hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
5691TECHNETIUM (99MTC) EXAMETAZIME2件: Exametazime,
Technetium Tc-99m exametazime		1件: Exametazime 💬--1件: 6 💬
5692Tecifdera (dimethyl fumarate)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
5693Tedizolid IV1件: Tedizolid1件: Tedizolid 💬--1件: 299 💬
5694Teduglutide (ALX-0600)1件: Teduglutide1件: Teduglutide 💬1件: GLP2R 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
5695Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.1件: Teicoplanin1件: Teicoplanin 💬--1件: 299 💬
5696Telavancin Injection1件: Telavancin---1件: 299 💬
5697Tenofovir (TDF) and Emtricitabine (FTC)2件: Emtricitabine,
Tenofovir		2件: Emtricitabine ,
Tenofovir 💬		--1件: 325 💬
5698Tenofovir alafenamide2件: Tenofovir,
Tenofovir alafenamide		2件: Tenofovir ,
Tenofovir alafenamide 💬		--2件: 2, 13 💬
5699Tenofovir alafenamide (TAF)2件: Tenofovir,
Tenofovir alafenamide		2件: Tenofovir ,
Tenofovir alafenamide 💬		--1件: 2 💬
5700TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]2件: Tenofovir,
Tenofovir alafenamide		2件: Tenofovir ,
Tenofovir alafenamide 💬		--1件: 13 💬
5701Tenofovir Disoproxil Fumarate2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬--1件: 265 💬
5702Teriflunomide 14 MG Oral Tablet [Aubagio]1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
5703Teriparatide (FORTEO)1件: Teriparatide1件: Teriparatide 💬1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 274 💬
5704Teriparatide [rDNA origin] contains recombinant human parathyroid hormone (1-34)2件: Parathyroid hormone,
Teriparatide		2件: Parathyroid hormone ,
Teriparatide 💬		2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70 💬
5705Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava2件: Polyethylene glycol,
Teriparatide		2件: Polyethylene glycol 3350 ,
Teriparatide 💬		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
5706Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker2件: Polyethylene glycol,
Teriparatide		2件: Polyethylene glycol 3350 ,
Teriparatide 💬		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
5707Teriparatide Pen Injector1件: Teriparatide1件: Teriparatide 💬1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 274 💬
5708Terlipressin acetate2件: Acetate,
Terlipressin		1件: Terlipressin 💬3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 299 💬
5709Testosterone isocaproate2件: Testosterone,
Testosterone isocaproate		1件: Testosterone 💬1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113 💬
5710Tetanus + pnemococcal vaccines alone----1件: 46 💬
5711Tetanus toxoid (TT) containing vaccine (Td, Tdap)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 13 💬
5712Tetanus toxoid adsorbed1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 46 💬
5713Tetanus toxoid adsorbed booster vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 46 💬
5714Tetanus Toxoid Adsorbed Vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 46 💬
5715Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)3件: Clostridium tetani toxoid antigen (formaldehyde inactivated),
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),
Pertussis vaccine		1件: Pertussis vaccine 💬--1件: 46 💬
5716Tetanus, diphtheria, and acellular pertussis vaccine1件: Pertussis vaccine1件: Pertussis vaccine 💬--1件: 13 💬
5717Tetracosactide acetate2件: Acetate,
Tetracosactide		1件: Cosyntropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 83, 145 💬
5718TETRACT-HIB - 1 SIRINGA PRECARICATA 0.5 ML----1件: 222 💬
5719Tetracycline - Statin - Antimycotic1件: Tetracycline1件: Tetracycline 💬--1件: 13 💬
5720Tetrahydro-6,6,9-tri methyl-3-penthyl-6 H-dibenzo[ b,d ]pyran-1-ol----1件: 298 💬
5721TEV-48574 Dose Regimen A----2件: 96, 97 💬
5722TEZ/IVA----1件: 299 💬
5723Tezacaftor/Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5724Tezacaftor/Ivacaftor + Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5725Tezacaftor/Ivacaftor 100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5726Tezacaftor/Ivacaftor/100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5727Tezepelumab via APFS1件: Tezepelumab1件: Tezepelumab 💬1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98 💬
5728THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE1件: Thalidomide1件: Thalidomide 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
5729Thalidomide, cyclophosphamide and prednisone3件: Cyclophosphamide,
Prednisone,
Thalidomide		4件: Cyclophosphamide ,
Prednisone ,
Thalidomide ,
Cyclophosphamide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331 💬
5730THC 5mg/ml and CBS 50mg/ml----1件: 96 💬
5731The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide----1件: 222 💬
5732The effectiveness of Xeljanz in rheumatoid arthritis patients1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5733The generic name is warfarin and many producers will be involved1件: Warfarin1件: Warfarin 💬2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 49 💬
5734The gut mycobiota and microbiota profile----1件: 299 💬
5735The immunosuppressive agents----1件: 222 💬
5736The investigational medicinal product (IMP) may be labelled as either PF-04236921 106 mg/vial, Clonal SC lyophilized form” or PF-04236921 Powder for Injection, 106 mg/vial”. Supplies labelled with either nomenclature are equivalent.----1件: 96 💬
5737The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA----1件: 96 💬
5738The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA.----1件: 96 💬
5739The lung mycobiota and microbiota profile----1件: 299 💬
5740The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:----1件: 86 💬
5741The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:----1件: 86 💬
5742The Standard Steroid Treatment, Plasma Exchange and rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 85 💬
5743Therapeutic Allogeneic Lymphocytes----3件: 60, 65, 285 💬
5744Therapeutic immune globulin----1件: 205 💬
5745Therapy with disease-modifying anti rheumatic drugs (DMARD)----1件: 46 💬
5746There is no recommended INN----1件: 65 💬
5747THN102 Dosage A----1件: 6 💬
5748Thrombomodulin Alfa1件: Thrombomodulin Alfa1件: Thrombomodulin alfa 💬1件: F2 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬1件: 85 💬
5749Thymosin alpha 1----1件: 299 💬
5750Thymus Tissue for Transplantation----1件: 65 💬
5751Thyroxin, Triiodothyronine1件: Liothyronine1件: Liothyronine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 78 💬
5752TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED)----1件: 46 💬
5753Time and attention----1件: 96 💬
5754Time and attention + active fructooligosaccharide supplementation----1件: 96 💬
5755Timolol Alcon 0.5% collyre1件: Timolol2件: Timolol ,
Timolol 💬		2件: ADRB1,
ADRB2 💬		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
5756Timolol nasal spray1件: Timolol2件: Timolol ,
Timolol 💬		2件: ADRB1,
ADRB2 💬		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
5757Tioctic acid----1件: 2 💬
5758Tiomolibdic acid----1件: 171 💬
5759Tiotropium Respimat 1.25 microgram solution for inhalation1件: Tiotropium---1件: 299 💬
5760Tiotropium Respimat 1.25 microgram, solution for inhalation1件: Tiotropium---1件: 299 💬
5761Tiotropium Respimat 1.25 micrograms solution for inhalation1件: Tiotropium---1件: 299 💬
5762Tiotropium Respimat® inhaler1件: Tiotropium---1件: 299 💬
5763TIP (Tobramycin inhalation powder)1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5764TIS (Tobramycin Inhalation Solution)1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5765TJ202 injection----1件: 49 💬
5766TL011, anti CD20, for the treatment of rheumatoid arthritis----1件: 46 💬
5767TLR7/8 Antagonist (10mg)----1件: 49 💬
5768TLR7/8 Antagonist (2.5mg)----1件: 49 💬
5769TNF alpha----1件: 271 💬
5770TNF alpha blockers----1件: 46 💬
5771TNF alpha inhibitors----1件: 46 💬
5772TNF antagonist----1件: 46 💬
5773TNF Antagonist (enbrel, humire, remicade, cimzia, symponi)3件: Certolizumab pegol,
Etanercept,
Infliximab		3件: Etanercept ,
Infliximab ,
Certolizumab pegol 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5774TNF blockers (infliximab, adalimumab, etanercept)3件: Adalimumab,
Etanercept,
Infliximab		3件: Etanercept ,
Adalimumab ,
Infliximab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
5775TNF Inhibitor----2件: 46, 97 💬
5776TNF Inhibitor (M0-M3)----1件: 46 💬
5777TNF Inhibitor (M3-M12)----1件: 46 💬
5778TNF inhibitor/TCZ----1件: 46 💬
5779TNF inhibitors----1件: 46 💬
5780TNF-a antagonists, non-TNFs, DMARD non-biologics----2件: 46, 271 💬
5781TNF-a inhibitor OR JAK inhibitor----1件: 46 💬
5782TNF-alpha antagonist and other biotherapy----1件: 46 💬
5783TNF-alpha antagonists----3件: 46, 96, 271 💬
5784TNF-alpha Inhibitor----1件: 46 💬
5785TNF-blockers suspension in patients with rheumatoid arthritis----1件: 46 💬
5786TNF-inhibition----1件: 271 💬
5787TNFR:Fc----3件: 46, 107, 271 💬
5788TNR-001, TNFR:FC----1件: 271 💬
5789TNX-650, rhuMAb anti-IL13, aIL-13, MILR1444A----1件: 85 💬
5790TOBI 300 mg / 5 mL nebuliser solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5791TOBI 300 mg/5 ml Lösung für einen1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5792TOBI 300 mg/5 ml Lösung für einen Vernebler1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5793TOBI 300 mg/5 ml Nebuliser Solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5794TOBI 300 mg/5 ml solución para inhalación por nebulizador1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5795TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5796TOBI 300mg/ 5ml solución para inhalación con nebulizador1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5797TOBI 300mg/5mL Nebuliser Solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5798Tobi 300mg/5ml Nebuliser solution.1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5799Tobi 300mg/5ml Solución para inhalación por nebulizador.1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5800Tobi Inhalant Product1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5801Tobi Nebcinal----1件: 299 💬
5802TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5803TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5804TOBI Podhaler 28 mg inhalációs por, kemény kapszula1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5805TOBI*NEBUL 56F 1D 300MG/5ML1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5806TOBI™ Podhaler™ 112 mg inhaled twice daily----1件: 299 💬
5807Tobramicina polvere inalatoria1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5808Tobramycin / Bramitob1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5809Tobramycin / TOBI1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5810Tobramycin for Inhalation1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5811Tobramycin Inhalation Powder1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5812Tobramycin Inhalation Powder (TIP)1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5813Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5814Tobramycin inhalation solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5815Tobramycin Inhalation Solution (TIS)1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5816Tobramycin inhalation solution using a PARI LC® Plus nebulizer.1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5817Tobramycin injection 40mg/1ml1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5818Tobramycin nebulized nasally1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5819Tobramycin Solution for Inhalation1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5820Tobramycin solution for inhalation (TOBI)1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5821Tobramycin solution for inhalation 300 mg1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5822Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
5823Tocilizumab (Actemra or RoActemra)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5824Tocilizumab (Actemra)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5825Tocilizumab (Actemra®)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5826Tocilizumab + Glucocorticoids (GCs)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
5827Tocilizumab + methotrexate(MTX)2件: Methotrexate,
Tocilizumab		2件: Methotrexate ,
Tocilizumab 💬		3件: DHFR,
DHFR2,
IL6R 💬		17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5828Tocilizumab 162Mg/0.9Ml Autoinjector1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
5829Tocilizumab [RoActemra/Actemra]1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬4件: 46, 51, 107, 331 💬
5830Tocilizumab and IV steroids combination1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
5831Tocilizumab Infusion RoAcemtra (EU)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 266 💬
5832Tocilizumab Injectable Product1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 11 💬
5833Tocilizumab Injection1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
5834Tocilizumab Injection 8mg/kg1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5835Tocilizumab IV1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5836Tocilizumab SC 162 mg/0.9 ml disposable auto-injector (AI)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5837Tocilizumab SC 162 mg/0.9 ml pre-filled syringe with safety device (PFS)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
5838Tocilizumab, Abatacept2件: Abatacept,
Tocilizumab		2件: Tocilizumab ,
Abatacept 💬		3件: CD80,
CD86,
IL6R 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
5839Tocopherol acetate3件: Acetate,
Tocopherol,
alpha-Tocopherol acetate		1件: Tocopherol 💬--1件: 49 💬
5840TOCOPHERYL ACETATE2件: Acetate,
alpha-Tocopherol acetate		---1件: 206 💬
5841Tofacitinib (Xeljanz®) 11mg Prolonged Release Tablet1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5842Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84 💬
5843Tofacitinib citate (Phase III formulation)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5844Tofacitinib citrate (clinical trial image)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
5845Tofacitinib citrate (commercial image)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5846Tofacitinib citrate (Phase III formulation)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
5847Tofacitinib citrate (Proposed commercial formulation - debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
5848Tofacitinib citrate (Proposed commercial formulation debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5849Tofacitinib citrate (Proposed commercial formulation – debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
5850Tofacitinib citrate (Proposed commercial formulation- debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5851Tofacitinib citrate (Proposed commercialFormulation - debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
5852Tofacitinib citrate( Phase III formulation)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5853Tolerogenic Fibroblasts----1件: 13 💬
5854Tolfenamic Acid1件: Tolfenamic acid1件: Tolfenamic acid 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 5 💬
5855Tolvaptan in euvolemic hyponatremia1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
5856Tolvaptan IR1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
5857Top down treatment if patient at high risk----2件: 96, 97 💬
5858Topical 0.1% Sirolimus1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 278 💬
5859Topical AmphiMatrix----1件: 51 💬
5860Topical AmphiMatrix with nitroglycerin (MQX-503)1件: Nitroglycerin1件: Nitroglycerin 💬--1件: 51 💬
5861Topical BPM31510 3.0% Cream----1件: 36 💬
5862Topical calcipotriene 0.005% ointment1件: Calcipotriol1件: Calcipotriene 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 51 💬
5863Topical infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 38, 39, 162 💬
5864Topical organogel with nitroglycerin1件: Nitroglycerin1件: Nitroglycerin 💬--1件: 51 💬
5865Topical Preparation H arm----1件: 13 💬
5866Total Body Irradiation----1件: 65 💬
5867Total Body Irradiation (TBI) (Plan 1)----2件: 60, 285 💬
5868TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML----1件: 299 💬
5869Tovaxin Autologous T Cell Vaccine----1件: 13 💬
5870Toxicity, Pharmacokinetics----1件: 34 💬
5871Tozadenant (SYN115) 120 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5872Tozadenant (SYN115) 180 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5873Tozadenant (SYN115) 240 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5874Tozadenant (SYN115) 60 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5875TP05 Coating A----1件: 97 💬
5876TPN-101, 400 mg/day----2件: 2, 127 💬
5877TPO-RAs combining anti-CD 20 monoclonal antibody----1件: 63 💬
5878TR004 (Treg immunotherapy)----1件: 96 💬
5879Trade name depends on the source of the product----1件: 76 💬
5880Trade name depends on the source of the product’----1件: 76 💬
5881Trade Name Xarelto1件: Rivaroxaban1件: Rivaroxaban 💬1件: F10 💬1件: Complement and coagulation cascades 💬1件: 49 💬
5882Traditional antirheumatic drugs----1件: 46 💬
5883Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)----1件: 6 💬
5884Traditional treatment of CGD and TB----1件: 65 💬
5885Tralesinidase alfa----1件: 19 💬
5886Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor1件: Tralokinumab1件: Tralokinumab 💬1件: IL13 💬8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
5887Tramadol /acetaminophen2件: Acetaminophen,
Tramadol		2件: Acetaminophen ,
Tramadol 💬		3件: OPRM1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5888Tramadol hydrochloride + acetaminophen2件: Acetaminophen,
Tramadol		2件: Acetaminophen ,
Tramadol 💬		3件: OPRM1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
5889Tranexamic acid1件: Tranexamic acid1件: Tranexamic acid 💬1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬7件: 46, 70, 215, 227, 274, 288, 299 💬
5890TransCon hGH (ACP-011)----1件: 78 💬
5891TransCon hGH (ACP-011) - 12,1mg----1件: 78 💬
5892TransCon hGH (ACP-011) - 12.1mg----1件: 78 💬
5893TransCon hGH (ACP-011) - 24.2mg----1件: 78 💬
5894TransCon hGH CT-301 (ACP-011) - 12,1mg----1件: 78 💬
5895TRANSCON PEG40 HGH, Transiently PEGylated hGH prodrug----1件: 78 💬
5896Transcriptomic analysis----1件: 50 💬
5897Transdermal fentanyl matrix, gabapentin2件: Fentanyl,
Gabapentin		2件: Fentanyl ,
Gabapentin 💬		6件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
OPRM1,
SLC6A1 💬		12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
5898Transdermal flumazenil (Added 4/2020)1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
5899Transdermal nicotine1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
5900Transduced CD34+ Cells----1件: 285 💬
5901Transduced CD34+ hematopoietic stem cell----2件: 19, 20 💬
5902Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL17A1-encoding retroviral vector----1件: 36 💬
5903Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector----1件: 36 💬
5904Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes.----1件: 36 💬
5905Transduced patient CD34+ cells----1件: 65 💬
5906Transforaminal Epidural Injection----1件: 70 💬
5907Translarna 1000 mg granules for oral suspension1件: Ataluren1件: Ataluren 💬--1件: 113 💬
5908Translarna 125 mg granules for oral suspension1件: Ataluren1件: Ataluren 💬--1件: 113 💬
5909Translarna 250 mg granules for oral suspension1件: Ataluren1件: Ataluren 💬--1件: 113 💬
5910Transplant Conditioning with Mobilization and Alemtuzumab1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 65 💬
5911Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan4件: Alemtuzumab,
Fludarabine,
Melphalan,
Thiotepa		4件: Melphalan ,
Thiotepa ,
Alemtuzumab ,
Fludarabine 💬		2件: CD52,
RRM1 💬		6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
5912Transvamix (100mg/mL THC, 50mg/mL CBD)----1件: 36 💬
5913Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms1件: Lansoprazole1件: Lansoprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 98 💬
5914Treatment A----2件: 34, 46 💬
5915Treatment Algorithm A----1件: 97 💬
5916Treatment Algorithm B----1件: 97 💬
5917Treatment Algorithm C----1件: 97 💬
5918Treatment as Usual (TAU)----1件: 85 💬
5919Treatment defined only by active substance----1件: 50 💬
5920Treatment I----1件: 46 💬
5921Treatment II----1件: 46 💬
5922Treatment III----1件: 46 💬
5923Treatment of MTX and HCQ----1件: 46 💬
5924Treatment of MTX and TwHF----1件: 46 💬
5925Treatment with Adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
5926Treatment with azathioprin----1件: 95 💬
5927Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor4件: Elexacaftor,
Ivacaftor,
Lumacaftor,
Tezacaftor		4件: Ivacaftor ,
Lumacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5928Treprostinil Inhalation Powder1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5929Treprostinil inhalations1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5930Treprostinil Injectable Product1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5931Treprostinil sodium for inhalation1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 85 💬
5932Treprostinil Sodium Solution for Inhalation1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5933TREPROSTINIL SODIUM, UT-151件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5934Treprostinil, UT-15, LRX-15, 15AU81, BW A15AU, U-62, 8401件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5935Tretinoin and Pioglitazone HCL2件: Pioglitazone,
Tretinoin		2件: Tretinoin ,
Pioglitazone 💬		4件: PML,
PPARG,
RARA,
RARB 💬		21件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 2 💬
5936Trexan inj 25 mg/ml----1件: 97 💬
5937Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab2件: Infliximab,
Prednisolone		2件: Prednisolone ,
Infliximab 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5938Tri-O-acetyluridine1件: Uridine triacetate1件: Uridine triacetate 💬--1件: 21 💬
5939Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip)1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5940Triamcinolone Acetonide1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 35, 46, 56 💬
5941Triamcinolone Acetonide and normal saline solution1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 70 💬
5942Triapin& triapin Mite----1件: 19 💬
5943Trichuris suis ova (eggs), embryonated, viable----1件: 13 💬
5944Tricyclic Antidepressants (TCA)----1件: 2 💬
5945Tridecanoic Acid----1件: 156 💬
5946Triheptanoin / Triheptanoina1件: Triheptanoin1件: Triheptanoin 💬--1件: 248 💬
5947Trimethoprim and Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		2件: Trimethoprim ,
Sulfamethoxazole 💬		--1件: 299 💬
5948TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----1件: 14 💬
5949TRIMETOPRIM + SULFAMETOSSAZOLO *----1件: 61 💬
5950Triomar™ (omega-3 fatty acids)1件: Omega-3 fatty acids---1件: 13 💬
5951Tripterygium wilfordii Hook F1件: Tripterygium wilfordii whole---1件: 46 💬
5952Tripterygium wilfordii Hook F (TwHF)1件: Tripterygium wilfordii whole---1件: 46 💬
5953Triptolide-Containing Formulation1件: Triptolide---1件: 67 💬
5954Triptorelin (GnRH agonists)2件: Gonadorelin,
Triptorelin		2件: Triptorelin ,
Gonadorelin 💬		1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
5955Triptorelin embonate, Triptorelin pamoate1件: Triptorelin1件: Triptorelin 💬1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
5956Triterpene dry extract from birch cork----1件: 36 💬
5957Trivalent chromium versus synthetic and/ or biological DMARDs1件: Chromium---1件: 46 💬
5958Trivalent inactivated influenza vaccine----1件: 46 💬
5959Trivalent seasonal influenza vaccine----1件: 13 💬
5960Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
5961Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
5962Truvada and Kaletra1件: Lopinavir1件: Lopinavir 💬--1件: 93 💬
5963Tryptophan (TRP) depletion1件: Tryptophan1件: Tryptophan 💬--1件: 6 💬
5964Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab)4件: Adalimumab,
Etanercept,
Golimumab,
Infliximab		4件: Etanercept ,
Adalimumab ,
Infliximab ,
Golimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5965Tumor Necrosis Factor Inhibitors----1件: 46 💬
5966TVP-1012 (1 mg/day) with levodopa1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5967Twice-daily dosage with 0.5% cyclosporine-A eyedrops1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 90 💬
5968TYF-ADA gene-modified autologous stem cells----1件: 65 💬
5969TYF-IL-2Rg gene-modified autologous stem cells----1件: 65 💬
5970TYK2 Inhibitor----1件: 97 💬
5971TYSABRI 300 mg concentrado para solución para perfusión1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5972TYSABRI 300 mg concentrate for solution for infusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5973TYSABRI 300 mg solution à diluer pour perfusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5974TYSABRI and AVONEX2件: Interferon beta-1a,
Natalizumab		2件: Interferon beta-1a ,
Natalizumab 💬		3件: IFNAR1,
IFNAR2,
ITGA4 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Focal adhesion, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Regulation of actin cytoskeleton, Toll-like receptor signaling pathway, Yersinia infection 💬1件: 13 💬
5975Tysabri Injectable Product1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5976Tysabri ® (Natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5977TYSABRI*IV 1FL 300MG 15ML1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5978Tysabri® (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5979Tyvaso Inhalation Solution1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5980TYVASO® (treprostinil) inhalation solution, for oral inhalation use1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 85 💬
5981Téatrois----1件: 139 💬
5982Téatrois (Tiratricol)1件: Tiratricol1件: Tiratricol 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 139 💬
5983UB-312 Injection----2件: 6, 17 💬
5984UDCA (Ursodeoxycholic acid)1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5985UF-021 (isopropyl unoprostone)1件: Unoprostone1件: Unoprostone 💬1件: PTGFR 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 90 💬
5986UF-021(isopropyl unoprostone)1件: Unoprostone1件: Unoprostone 💬1件: PTGFR 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 90 💬
5987UK: Sativex Oromucosal Spray2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
5988ULIPRISTAL ACETATE2件: Acetate,
Ulipristal		1件: Ulipristal 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 10 💬
5989ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
5990ULTOMIRIS ™ (ravulizumab-cwvz)1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
5991Ultra small particles of iron oxide (USPIO)1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
5992Ultra-high-caloric fatty diet----1件: 2 💬
5993Ultrase® MT12----1件: 299 💬
5994Ultrase® MT20----1件: 299 💬
5995Ultrasmall particles of iron oxide1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
5996Ultrasound-guided Suprascapular Nerve Block----1件: 149 💬
5997Umbilical Cord Based Allogenic Mesenchymal Stem Cell----1件: 113 💬
5998Umbilical Cord Blood After Myeloablative Conditioning----1件: 60 💬
5999Umbilical Cord Blood After Reduced-Intensity Conditioning----1件: 60 💬
6000Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----2件: 93, 296 💬
6001UN-ALPHA-R----1件: 235 💬
6002UN-ALPHA-R 0.25µg----1件: 235 💬
6003Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)1件: Genistein1件: Genistein 💬--1件: 299 💬
6004UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS----1件: 13 💬
6005Untreated to atorvastatin treatment1件: Atorvastatin1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
6006Upadacitinib (ABT-494)1件: Upadacitinib1件: Upadacitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
6007Upadacitinib - Direct compression-yellow1件: Upadacitinib1件: Upadacitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
6008Updacitinib (ABT-494)----1件: 97 💬
6009URBASON FORTE----1件: 13 💬
6010Urbason solubile forte 1000mg----1件: 13 💬
6011URBASON*IM EV 1F 250MG+1F 5ML----1件: 222 💬
6012Urbason® solubile forte 1000 mg----1件: 13 💬
6013Urinary levels of PIIINP as a marker of changes in renal function----1件: 299 💬
6014Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
6015Ursodeoxycholic acid1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬10件: 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
6016Ursodeoxycholic acid (UDCA)1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 94 💬
6017Ursodeoxycholic acid (UDCA) 500 mg1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 46 💬
6018Ursodeoxycholic Acid (URSO)1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6019Ursodeoxycholic Acid 300mg capsule1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6020Ursodeoxycholic Acid 300mg tablet1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6021Ursodeoxycholic Acid Capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6022Ursodeoxycholic acid combination of immunosuppressive agents1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬2件: 93, 95 💬
6023Ursodeoxycholic acid combined with total glucosides of paeony1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6024Ursodeoxycholic acid only1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6025Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)2件: Methylprednisolone,
Ursodeoxycholic acid		2件: Methylprednisolone ,
Ursodiol 💬		2件: NR1H4,
NR3C1 💬		2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93 💬
6026Ursodiol (ursodeoxycholic acid, UDCA)1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 97 💬
6027UrsoFalk® 250 mg tabletten.1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 96 💬
6028Ursofalk® 500 mg film-coated tablets1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6029Ursofalk® 500 mg Filmtabletten1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6030Ursofalk® capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6031Ursolic acid1件: Ursolic acid---1件: 94 💬
6032USAN: sebelipasa alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6033USAN: sebelipase alpha----1件: 19 💬
6034Ustekinumab (approximately 6 mg/kg)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 49 💬
6035Ustekinumab + MTX (Group 2)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46 💬
6036Ustekinumab + MTX (Group 3)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46 💬
6037Ustekinumab 130 mg IV1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6038Ustekinumab 1mg/kg (IP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6039Ustekinumab 3 mg/kg (IP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6040Ustekinumab 6 mg/kg (IP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6041Ustekinumab 90 mg (SC) Group 11件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6042Ustekinumab 90 mg (SC) Group 21件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6043Ustekinumab approximately 6 mg/kg (IV)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6044Ustekinumab Dose Based on BSA and Body Weight1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 97 💬
6045Ustekinumab induction1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 97 💬
6046Ustekinumab Injection1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 160 💬
6047Ustekinumab Injection [Stelara]1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6048Ustekinumab IV1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 49, 97 💬
6049Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6050Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6051Ustekinumab liquid in prefilled syringe1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 84 💬
6052UTTR1147A, IL22-Fc, IL-22Fc1件: Efmarodocokin alfa1件: Efmarodocokin alfa 💬1件: IL22 💬4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬2件: 96, 97 💬
6053UTTR1147A/RO7021610 (Active)----2件: 96, 97 💬
6054UVADEX and UVAR XTS Photopheresis System1件: Methoxsalen1件: Methoxsalen 💬--1件: 96 💬
6055UVEDOSE 100 000 UI, solution buvable en ampoule----1件: 13 💬
6056UX143, BPS804----1件: 274 💬
6057UX701 (1.0 × 10^13 genome copies/kg)----1件: 171 💬
6058UX701 (2.0 × 10^13 genome copies/kg)----1件: 171 💬
6059UX701 (5.0 × 10^12 genome copies/kg)----1件: 171 💬
6060V-Fend----1件: 299 💬
6061V1512 and Entacapone1件: Entacapone1件: Entacapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
6062Vaccination against TBE----1件: 46 💬
6063Vaccination with vaccine against hepatitis A and B----1件: 299 💬
6064Vaccine Vivotif + Vaccine Dukoral6件: Recombinant Cholera Toxin B Subunit,
Typhoid Vaccine Live,
Vibrio cholerae Inaba 48 classical biotype, heat inactivated,
Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, heat inactivated		---1件: 97 💬
6065Vaccine Vivotif + Vaccine Dukoral + oats7件: Oat,
Recombinant Cholera Toxin B Subunit,
Typhoid Vaccine Live,
Vibrio cholerae Inaba 48 classical biotype, heat inactivated,
Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, heat inactivated		---1件: 97 💬
6066VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B----3件: 61, 62, 66 💬
6067VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----2件: 61, 62 💬
6068VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135)----3件: 61, 62, 66 💬
6069Valproate, Levocarnitine2件: Levocarnitine,
Valproic acid		2件: Valproic acid ,
Levocarnitine 💬		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
6070Valproic Acid1件: Valproic acid1件: Valproic acid 💬7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬7件: 3, 5, 26, 65, 90, 222, 256 💬
6071Valproic Acid (VPA)1件: Valproic acid1件: Valproic acid 💬7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
6072Valproic Acid and Levocarnitine2件: Levocarnitine,
Valproic acid		2件: Valproic acid ,
Levocarnitine 💬		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
6073Valproid acid plus corticosteroids----1件: 26 💬
6074Vaminolac, komb.----1件: 97 💬
6075Vamorolone 4% suspension for oral dosing1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
6076Vancomycin hydrochloride inhalation powder1件: Vancomycin1件: Vancomycin 💬--1件: 299 💬
6077Vancomycin inhalation powder1件: Vancomycin1件: Vancomycin 💬--1件: 299 💬
6078Varenicline Nasal Spray1件: Varenicline1件: Varenicline 💬2件: CHRNA4,
CHRNB2 💬		4件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬1件: 53 💬
6079Vasoactive intestinal peptide----1件: 85 💬
6080Vasomera (PB1046) Injection----1件: 86 💬
6081Vasopressin, Arginine2件: Arginine,
Vasopressin		2件: Vasopressin ,
Arginine 💬		3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 210 💬
6082Vastarel 20mg film coated tablets----1件: 58 💬
6083Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S1件: AstraZeneca COVID-19 Vaccine---1件: 299 💬
6084VAY736 antibody----1件: 53 💬
6085Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana----1件: 19 💬
6086Vedolizumab 300 MG Injection [Entyvio]1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
6087Vedolizumab 300 mg IV1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
6088Vedolizumab Injection1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
6089Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
6090Vedolizumab intravenous injection1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
6091Vedolizumab IV1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬3件: 94, 96, 97 💬
6092Vedolizumab IV (Entyvio¿)1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
6093Vedolizumab IV (Entyvio™)1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
6094Vedolizumab IV 300 mg1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
6095Vedolizumab IV, Placebo IV, Placebo SC1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
6096Vedolizumab IV, Placebo SC1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
6097Vedolizumab subcutaneous injection1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
6098Vedolizumab, Entyvio1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
6099Vedolizumab, Ustekinumab, or Tofacitinib3件: Tofacitinib,
Ustekinumab,
Vedolizumab		3件: Vedolizumab ,
Ustekinumab ,
Tofacitinib 💬		9件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
JAK1,
JAK2,
JAK3,
TYK2 💬		65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬1件: 97 💬
6100Vehicle of ADX-102 Topical Dermal Cream----1件: 160 💬
6101VELAGLUCERASE ALFA1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
6102Velaglucerasi alfa----1件: 19 💬
6103VELMANASE ALFA1件: Velmanase alfa1件: Velmanase alfa 💬1件: MAN2B1 💬2件: Lysosome, Other glycan degradation 💬1件: 19 💬
6104Velmanase Alfa (e.g. Lamazym)1件: Velmanase alfa1件: Velmanase alfa 💬1件: MAN2B1 💬2件: Lysosome, Other glycan degradation 💬1件: 19 💬
6105Venetoclax Oral Tablet, 200 mg1件: Venetoclax1件: Venetoclax 💬1件: BCL2 💬43件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
6106Venetoclax Oral Tablet, 400 mg1件: Venetoclax1件: Venetoclax 💬1件: BCL2 💬43件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
6107Ventavis (Iloprost, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6108Ventavis(Iloprost)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6109Ventolin® Evohaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
6110Ventolin¿ Evohaler¿1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
6111Verde de Indocianina (Indocyanine Green)1件: Indocyanine green1件: Indocyanine green 💬--1件: 235 💬
6112Verorab® (PVRV----1件: 65 💬
6113Verum arm receiving Gilenya®----1件: 13 💬
6114Verum arm receiving Vitamin D oil1件: Vitamin D---1件: 13 💬
6115Vestronidase alfa1件: Vestronidase alfa1件: Vestronidase alfa 💬1件: GUSB 💬8件: Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
6116Vett Lentiviral con gene ABCA4----1件: 301 💬
6117VEYONDI 650IU powder and solvent for solution for injection----1件: 288 💬
6118VEYVONDI 1300 IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
6119VEYVONDI 1300I IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
6120VEYVONDI 1300IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
6121VEYVONDI 650IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
6122VFEND 40 mg/ml powder for oral suspension1件: Voriconazole1件: Voriconazole 💬--1件: 299 💬
6123VIB7734, MEDI7734----1件: 49 💬
6124Vigabatrin: Vigabatrin new ST formulation then Sabril®1件: Vigabatrin1件: Vigabatrin 💬1件: ABAT 💬7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
6125VigantOL oil plus interferon beta-1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6126Vigantol® Oil----1件: 13 💬
6127Vigantol® Öl 20.000 I.E./ml----1件: 13 💬
6128Vimizim® (elosulfase alfa)1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
6129Vinblastine, vincristine, prednisone, daunorubicin4件: Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		4件: Prednisone ,
Daunorubicin ,
Vinblastine ,
Vincristine 💬		12件: NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬1件: 65 💬
6130Viokase 16 (pancrelipase) + Nexium2件: Esomeprazole,
Pancrelipase		2件: Pancrelipase ,
Esomeprazole 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298 💬
6131Viokase® 16----1件: 298 💬
6132Viral load driven treatment interruption----1件: 265 💬
6133VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE----1件: 46 💬
6134Visilizumab (Nuvion)1件: Visilizumab1件: Visilizumab 💬3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 97 💬
6135Visilizumab (Nuvion®1件: Visilizumab1件: Visilizumab 💬3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 97 💬
6136Vitamin A1件: Vitamin A1件: Vitamin A 💬2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬3件: 13, 53, 90 💬
6137Vitamin AD sig: 1 tablet/tid----1件: 90 💬
6138Vitamin B sig: 10mg/tid----1件: 90 💬
6139Vitamin B12, B9, B6, C supplementation1件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 229 💬
6140Vitamin D in arm B1件: Vitamin D---1件: 46 💬
6141Vitamin D2 ( calciferol )2件: Ergocalciferol,
Vitamin D		1件: Ergocalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
6142Vitamin D3 - high dose1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 6 💬
6143Vitamin D3 400 IU1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
6144Vitamin D3 6000 IU1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
6145Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
6146VITAMIN E - TGPS1件: Vitamin E1件: Vitamin E 💬--1件: 299 💬
6147Vitamin K supplementation, dose #11件: Phylloquinone---1件: 299 💬
6148Vitamin K supplementation, dose #21件: Phylloquinone---1件: 299 💬
6149Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:11件: Choline1件: Choline 💬--1件: 299 💬
6150VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA----1件: 13 💬
6151Vitamins: B6, B12, and folate1件: Folic acid1件: Folic acid 💬--1件: 49 💬
6152VIUSID/ALZER----1件: 6 💬
6153Vizamyl (flutemetamol(F-18))2件: Flutemetamol,
Flutemetamol (18F)		---3件: 5, 7, 127 💬
6154VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide1件: Volanesorsen1件: Volanesorsen 💬1件: APOC3 💬2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
6155VOLIBRIS® (ambrisentan)1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
6156VOLIBRIS™ tablets1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
6157Volixibat (formely SHP626, LUM002 or SAR548304B)1件: Volixibat1件: Volixibat 💬--1件: 94 💬
6158Voltarol SR (generics also available in the EU)----1件: 46 💬
6159Von willebrand factor1件: Von Willebrand factor human---2件: 64, 288 💬
6160Von Willebrand factor (Recombinant)1件: Von Willebrand factor human---1件: 288 💬
6161Von Willebrand factor and coagulation factor VIII in combination2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
6162Von Willebrand Factor Antigen1件: Von Willebrand factor human---1件: 288 💬
6163Von Willebrand Factor Ristocetin Cofactor1件: Von Willebrand factor human---1件: 288 💬
6164Von Willebrand Faktor----1件: 288 💬
6165Voncento, Biostate®2件: Antihemophilic factor human,
Von Willebrand factor human		---1件: 288 💬
6166VONICOG ALFA1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
6167VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
6168VPRIV 400 Units powder for solution of infusion1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
6169VR040/Aspirair® inhaler----1件: 6 💬
6170VTX002 is not biologic----1件: 97 💬
6171VWD factor VIII concentrate1件: Beroctocog alfa---1件: 288 💬
6172VWF gene analysis----1件: 288 💬
6173VWF/FVIII products----1件: 288 💬
6174VX-121/TEZ/D-IVA----1件: 299 💬
6175VX-371 in hypertonic saline----1件: 299 💬
6176VX-371 in saline----1件: 299 💬
6177VX-445 / TEZ / IVA----1件: 299 💬
6178VX-445 / TEZ / IVA FDC----1件: 299 💬
6179VX-445 /TEZ/IVA----1件: 299 💬
6180VX-445/TEZ/IVA----1件: 299 💬
6181VX-659/ TEZ/IVA1件: VX-659---1件: 299 💬
6182VX-659/TEZ/IVA1件: VX-659---1件: 299 💬
6183VX-659/Tezacaftor/Ivacaftor3件: Ivacaftor,
Tezacaftor,
VX-659		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6184VX-661 / VX-770----1件: 299 💬
6185VX-661 Plus Ivacaftor Combination1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6186VX-661, VRT-893661----1件: 299 💬
6187VX-661/Ivacaftor1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6188VX-661/ivacaftor (VX-770) 100mg/150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6189VX-661/ivacaftor 100 mg/ 150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6190VX-661/ivacaftor 100mg/150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6191VX-661/ivacaftor 100mg/150mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6192VX-661/ivacaftor 50 mg/ 75 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6193VX-661/VX-770 (TEZ/IVA)----1件: 299 💬
6194VX-770, VRT-8130077----1件: 299 💬
6195VX-770, VRT-813077----1件: 299 💬
6196VX-809 & VX-770----1件: 299 💬
6197VX-809 / VX-770----1件: 299 💬
6198VX-809, VRT-826809----1件: 299 💬
6199VY-AADC01----1件: 6 💬
6200VY-AADC02----1件: 6 💬
6201Warfarin+ Vitamin K2件: Phylloquinone,
Warfarin		1件: Warfarin 💬2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 46 💬
6202WATER FOR INJECTION1件: Water1件: Water 💬--1件: 35 💬
6203Water for injections1件: Water1件: Water 💬--1件: 299 💬
6204WATER FOR INJECTIONS, EP1件: Water1件: Water 💬--1件: 299 💬
6205WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6206Wheat/milk free diet (W/MFD) group1件: Wheat1件: Wheat 💬--1件: 53 💬
6207White chocolate (0% cocoa)1件: Cocoa---1件: 6 💬
6208WILATE 1000 I.U.1件: Von Willebrand factor human---1件: 288 💬
6209WILATE 500 I.U.1件: Von Willebrand factor human---1件: 288 💬
6210WILATE® 4501件: Von Willebrand factor human---1件: 288 💬
6211Withhold IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
6212Withhold IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
6213Withhold IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
6214Wound topically irrigated with 500mg TXA----1件: 70 💬
6215XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6216XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6217XC130-A10H----1件: 6 💬
6218XCEL-MC-ALPHA----1件: 13 💬
6219XELJANZ 5 mg film-coated tablets1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
6220Xeljanz 5mg film-coated tablets1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
6221Xeljanz® 11mg Prolonged Release Tablet2件: Manganese citrate,
Tofacitinib		1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
6222Xenon contrast agent1件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 22 💬
6223XGEVA - 120 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 1.7 ML 4 FLACONCINI1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
6224Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung1件: Omalizumab1件: Omalizumab 💬1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
6225XP21279 and carbidopa (experimental)1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6226XYZAL - 20 COMPRESSE RI1件: Levocarnitine1件: Levocarnitine 💬--1件: 53 💬
6227Yellow fever vaccine1件: Yellow fever vaccine1件: Yellow fever vaccine 💬--8件: 40, 44, 46, 50, 51, 52, 53, 107 💬
6228Yellow Fever vaccine (17D)1件: Yellow fever vaccine1件: Yellow fever vaccine 💬--8件: 40, 44, 46, 50, 51, 52, 53, 107 💬
6229YISAIPU® ( An etanercept biosimilar)2件: Etanercept,
Yisaipu		1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6230YM672 (IPD®)----1件: 226 💬
6231YONDELIS 0,25 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
6232Yondelis 0.25 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
6233YONDELIS 1 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
6234Yondelis 1 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
6235Yttrium-90 radiolabelled anti-CD66 antibody1件: Yttrium Y-90---1件: 28 💬
6236Yttrium­90 radiolabelled anti­CD66----1件: 28 💬
6237Yu-Shen formula----1件: 224 💬
6238Z102 (Prednisolone and Dipyridamole).2件: Dipyridamole,
Prednisolone		2件: Dipyridamole ,
Prednisolone 💬		3件: NR3C1,
PDE4A,
PDE5A 💬		7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
6239Zatolmilast/ BPN147701件: Zatolmilast1件: Zatolmilast 💬1件: PDE4D 💬5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 206 💬
6240Zavesca® Prescription1件: Miglustat1件: Miglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 256 💬
6241ZEPOSIA® (ozanimod)1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97 💬
6242ZGN-440 for Injectable Suspension----1件: 193 💬
6243Zhu-Bai formula----1件: 224 💬
6244Zinc acetate3件: Acetate,
Zinc,
Zinc acetate		1件: Zinc acetate 💬--2件: 171, 299 💬
6245Zinc acetate (20mg/d)3件: Acetate,
Zinc,
Zinc acetate		1件: Zinc acetate 💬--1件: 299 💬
6246ZINC ACETATE DIHYDRATE2件: Acetate,
Zinc acetate		1件: Zinc acetate 💬--1件: 171 💬
6247Zinc and Copper2件: Copper,
Zinc		---1件: 2 💬
6248Zink Natur-Drogeriet----1件: 171 💬
6249Zinpetraxin Alfa----1件: 85 💬
6250Zofran - no intubation----1件: 98 💬
6251Zoledronic acid1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬12件: 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 💬
6252Zoledronic Acid 5Mg/Bag 100Ml Inj1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 5, 6, 17 💬
6253Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
6254Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product.1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
6255Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion,generic medicinal product1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
6256ZOLEDRONIC ACID MONOHYDRATE1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
6257Zoledronic acid, pravastatin2件: Pravastatin,
Zoledronic acid		3件: Zoledronic acid ,
Pravastatin ,
Zoledronic acid 💬		2件: FDPS,
HMGCR 💬		6件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 333 💬
6258Zolgensma 2 x 1013 vector genomes/mL solution for infusion1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬1件: SMN1 💬-1件: 3 💬
6259Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬1件: SMN1 💬-1件: 3 💬
6260Zolpidem first dose1件: Zolpidem1件: Zolpidem 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
6261Zostavax (varicella zoster virus) vaccine1件: Varicella zoster vaccine (live/attenuated)---1件: 46 💬
6262ZUGLIMET - 500 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/AL----1件: 67 💬
6263Zuretinol Acetate2件: Acetate,
Zuretinol acetate		---1件: 90 💬
6264ZX008 (Fenfluramine Hydrochloride)1件: Fenfluramine1件: Fenfluramine 💬5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
6265ZX008 - 0.2 mg/kg/day----1件: 140 💬
6266ZX008 - 0.8 mg/kg/day----1件: 140 💬
6267ZYN002 - CBD Transdermal Gel----1件: 206 💬
6268ZYN002 - transdermal gel----1件: 206 💬
6269ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE1件: Abiraterone---1件: 75 💬
6270ÁCIDO GADOBÉNICO----1件: 96 💬
6271Ácido risedrónico----1件: 274 💬